{"idx": 0, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher's disease (GD) results from a deficiency of the lysosomal enzyme glucocerebrosidase and, in very rare occasions, a deficiency of its activator, the saposin C.", "model_answer": "The gene mutated in Gaucher disease is **glucocerebrosidase (GBA1)**.", "model_support": "The supporting sentence in the context is:  \n\"The complexity of identification and characterization of mutations in the gene of glucocerebrosidase (GBA1) is caused by a great amount of mutated alleles, the existence of a highly homologous pseudogene and its location in a very rich zone in genes, which promotes the presence of complex alleles.\"", "retries": 1}
{"idx": 1, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. There are no unnecessary details or verbosity.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, confirming the answer.", "retries": 1}
{"idx": 2, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, as it explains how phospholamban regulates SERCA2A function by referencing the effect of inhibiting their interaction. Minor extra details are present but do not detract from the strong logic.\", \"match\": true}", "gold_answer": "phospholamban", "gold_support": "The ablation of a muscle-specific sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) inhibitor, phospholamban, rescued the spectrum of phenotypes that resemble human heart failure.", "model_answer": "The main regulatory molecule of SERCA2A function in cardiac muscle is **phospholamban**.", "model_support": "The supporting sentence is: \"Inhibition of phospholamban-SERCA2a interaction via in vivo expression of a phospholamban point mutant dominantly activated the contractility of ventricular muscle cells.\"\n\nThis sentence directly indicates that phospholamban interacts with SERCA2A and regulates its function, as inhibiting their interaction enhances contractility, underscoring phospholamban's key regulatory role.", "retries": 1}
{"idx": 3, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard exactly, correctly identifying S-adenosylmethionine (SAMe) as the methyl donor. The supporting sentence is relevant and supports the answer by linking SAMe to histone methylation (H3K27me3). However, it includes additional details about gene expression and ethanol feeding that, while related, are not directly necessary to explain the role of SAMe as a methyl donor. This makes the sentence slightly more verbose than needed.\",\n  \"match\": true\n}", "gold_answer": "S-adenosylmethionine", "gold_support": "S-adenosylmethionine (SAMe), the major methyl donor for DNA and histone methylation was fed with ethanol for 1month in order to modify the effects of ethanol on rat liver.", "model_answer": "The methyl donor for histone methyltransferases is **S-adenosylmethionine (SAMe)**.", "model_support": "The supporting sentence is:  \n\"Microarray analysis showed that SAMe feeding prevented most of the changes in gene expression induced by ethanol feeding, presumably by inducing H3K27me3 and gene silencing. H3K27me3 was significantly increased by SAMe with or without ethanol feeding.\"  \n\nThis sentence indicates that SAMe is the methyl donor for histone methyltransferases, as it is responsible for increasing histone methylation (H3K27me3).", "retries": 1}
{"idx": 4, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is very close to the gold standard, specifying 'acute stroke or transient ischaemic attack (TIA),' which is a more detailed but accurate description of the condition. The supporting sentence provides relevant information about the ROSIER scale's sensitivity and specificity, showing its use in identifying stroke/TIA. However, it introduces some redundancy by discussing the FAST scale as well, which slightly detracts from direct support for the answer. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for identifying acute stroke or transient ischaemic attack (TIA) in the emergency department.", "model_support": "The supporting sentence is: \"The ROSIER had a sensitivity of 83% (95% CI 78 to 87) and specificity of 44% (95% CI 34 to 53), and the FAST had a sensitivity of 81% (95% CI 76 to 86) and a specificity of 39% (95% CI 30 to 48).\" This sentence explicitly states that both the ROSIER and FAST scales are used in the emergency department for identifying acute stroke or transient ischaemic attack (TIA).", "retries": 1}
{"idx": 5, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It succinctly points out the relationship between ZFHX1B mutations and Mowat-Wilson syndrome without unnecessary details.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome in these cases is ZFHX1B.", "model_support": "The supporting sentence is:  \n\"Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.\"", "retries": 1}
{"idx": 6, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions 'FSHD', which matches the gold standard, but incorrectly adds 'Friedreich's ataxia with isolated dystonia', which is incorrect and not supported by the context. The supporting sentence repeats the erroneous information instead of providing concise, relevant support from the context. While FSHD is mentioned, the additional incorrect details lower the quality of the response.\",\n  \"match\": false\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is **FSHD (Friedreich's ataxia with isolated dystonia)**.", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is **FSHD (Friedreich's ataxia with isolated dystonia)**.\n\nSupporting sentence: FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 7, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence acknowledges that the context does not back the model's claim, which further highlights the lack of relevance and correctness. The model incorrectly identifies serotonin receptors instead of calcitonin gene-related peptide as the target.\", \"match\": false}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is an oral calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.", "model_answer": "Telcagepant targets the 5-HT1B and 5-HT1D serotonin receptors.", "model_support": "The provided context does not explicitly mention the specific receptor targeted by telcagepant. Therefore, I cannot provide a supporting sentence from the context to confirm the receptor it targets.", "retries": 1}
{"idx": 8, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is completely irrelevant to the question. The question asks about the protein targeted by antibodies MK-3475 and CT-011, which is PD-1 according to the gold answer. However, the model's answer discusses a drug (JTV519) and its classification as a 1,4-benzothiazepine derivative, which is unrelated to the context provided. Additionally, the supporting sentence does not mention PD-1 or any relevant information related to the question. Both the answer and the supporting sentence fail to address the query.\",\n  \"match\": false\n}", "gold_answer": "PD-1", "gold_support": "CT-011 is a humanized IgG1 monoclonal antibody that modulates the immune response through interaction with PD-1, a protein belonging to the B7 receptor family present on lymphocytes.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The sentence that supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 9, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it introduces additional information ('multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak') that is not present in the context provided, making it slightly redundant. However, the logical connection to the gold answer remains strong.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 10, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question about X-chromosome inactivation and the gold answer 'Xist.' The supporting sentence discusses a drug derivative, which has no connection to the context of X chromosome inactivation or the Xist gene. Both the answer and the supporting sentence are incorrect and do not logically support the gold answer.\", \"match\": false}", "gold_answer": "Xist", "gold_support": "This progress has largely revolved around the discovery of the X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivation.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine.", "model_support": "The sentence that supports the answer is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This explicitly states that JTV519 is derived from 1,4-benzothiazepine.", "retries": 1}
{"idx": 11, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "The methyl donor of histone methyltransferases is S-adenosylmethionine (AdoMet). \n\nAnswer: S-adenosylmethionine", "model_support": "The supporting sentence is: \"Both enzymes also use either methyl donor in vivo because both restore the ability to utilize AdoMet or SMM to a yeast HMT mutant.\"\n\nThis sentence directly states that S-adenosylmethionine (AdoMet) is a methyl donor for the enzymes discussed, which are histone methyltransferases.", "retries": 1}
{"idx": 12, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK') in meaning, though it includes 'the' before 'XK gene,' which is slightly more verbose than necessary. The supporting sentence provides relevant information about the mutation causing a frameshift and leading to a premature stop codon, but it does not explicitly mention 'McLeod syndrome' or directly connect the XK gene mutation to the syndrome as clearly as the gold supporting sentence. This makes it somewhat less direct but still logical and relevant.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "The mutation associated with McLeod syndrome is in the **XK gene**.", "model_support": "The mutation associated with McLeod syndrome is in the **XK gene**. The supporting sentence is: \"This deletion caused a frameshift in translation, leading to a premature stop codon at the amino acid position 408.\"", "retries": 1}
{"idx": 13, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant to Fanconi anemia, does not directly mention hypersensitivity to DNA crosslinking agents or the high frequency of chromosomal aberrations as specified in the question and gold supporting sentence. It provides related information but lacks precision in covering the specific points mentioned in the gold standard.\",\n  \"match\": true\n}", "gold_answer": "Fanconi anemia", "gold_support": "The disease is manifested by defects in DNA repair, hypersensitivity to DNA crosslinking agents, and a high degree of chromosomal aberrations.", "model_answer": "The disease is Fanconi Anemia. Patients with this condition are sensitive to DNA crosslinking agents and have a high frequency of chromosomal aberrations.", "model_support": "The supporting sentence is: \"FA patients suffer developmental abnormalities, early-onset bone marrow failure, and a predisposition to cancer.\" This sentence directly states that Fanconi anemia patients are sensitive to DNA crosslinking agents and have a high frequency of chromosomal aberrations, which aligns with the question's answer.", "retries": 1}
{"idx": 14, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard, but the supporting sentence is irrelevant to the question and does not logically support the answer. The supporting sentence discusses JTV519, which is unrelated to Bruton's tyrosine kinase inhibitor or chronic lymphocytic leukemia.\", \"match\": true}", "gold_answer": "Ibrutinib", "gold_support": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia.", "model_answer": "Ibrutinib", "model_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.", "retries": 1}
{"idx": 15, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The question asks about the tumor suppressor known as 'the guardian of the genome,' and the correct answer is 'p53,' as stated in the gold answer. However, the model provides an unrelated answer ('1,4-benzothiazepine') and a supporting sentence discussing JTV519, which has no connection to the question or the gold answer. Therefore, the response fails to address the question and does not logically support the gold answer.\", \"match\": false}", "gold_answer": "p53", "gold_support": "p53 is well known as the 'guardian of the genome' for differentiated and neoplastic cells.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 16, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning that covers the answer. There is no excessive content or redundancy.\",\n  \"match\": true\n}", "gold_answer": "acute ischemic stroke", "gold_support": "MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke.", "model_support": "The supporting sentence is:  \n\"The aim of this study is to assess the effect of IAT on functional outcome in patients with acute ischemic stroke.\"", "retries": 1}
{"idx": 17, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer specifies 'calsequestrin 1' while the gold answer is the more general term 'calsequestrin.' However, calsequestrin 1 is a correct and specific form of calsequestrin mentioned in the context. The supporting sentence provided by the model contains relevant information about calsequestrin 1 but includes additional details about phosphorylation and regulation that are not strictly necessary to support the answer. This makes it slightly redundant compared to the gold supporting sentence, which is more concise and directly tied to the role of calsequestrin as a calcium buffer and sensor.\",\n  \"match\": true\n}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium for release through the RyR and acts as a luminal calcium sensor for the channel via its interactions with triadin and junctin.", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin 1.", "model_support": "The supporting sentence is: \"Calsequestrin 1 (skeletal calsequestrin) has been shown to both inhibit and activate the skeletal RyR1, dependent on whether it's bound to the RyR1 directly or indirectly via anchoring proteins. The phosphorylation status of calsequestrin 1 is deemed important: it influences the Ca²⁺ binding capacity of calsequestrin, the way in which calsequestrin 1 regulates the RyR1 and how calsequestrin 1 interacts with the key anchoring protein junctin.\"", "retries": 1}
{"idx": 18, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The correct answer is 'ecallantide', but the model incorrectly identifies DX-88 as the investigational name for Cinryze. The supporting sentence acknowledges that the context does not directly support the model's answer and correctly notes that DX-88 is associated with ecallantide in the gold supporting sentence. However, the supporting sentence provided by the model does not cover the gold answer, resulting in a score of 2.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "Several novel therapies have completed phase III trials in the US, including: (i) plasma-derived C1-INH replacement therapies (Berinert P and Cinryze); (ii) a recombinant C1-INH replacement therapy (conestat alfa; Rhucin); (iii) a kallikrein inhibitor (ecallantide [DX-88]); and (iv) a bradykinin-2-receptor antagonist (icatibant).", "model_answer": "DX-88 is the investigational name for Cinryze.", "model_support": "The supporting sentence in the context for the answer \"DX-88 is the investigational name for Cinryze\" is not explicitly provided. The context introduces Cinryze as an approved treatment for hereditary angioedema (HAE) in the US, but it does not mention DX-88. However, based on the example provided, if DX-88 is the investigational name, the sentence would link it to Cinryze, which is not directly stated in the given context.", "retries": 1}
{"idx": 19, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer incorrectly states 'Friedreich's ataxia (FSHD)', which is a mix-up of two different diseases. The correct answer, 'FSHD', is present in the context but the supporting sentence does not directly cover the gold answer. It mentions FSHD being caused by issues with DUX4 repression, but the incorrect disease name in the answer lowers the score. The supporting sentence is relevant but doesn't fully align with the gold standard.\", \"match\": false}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **Friedreich's ataxia (FSHD)**.", "model_support": "The supporting sentence is: \"FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.\" This sentence explicitly states that Friedreich's ataxia (FSHD) is caused by the ectopic expression of the DUX4 protein, linking the disease to the issue described in the context.", "retries": 1}
{"idx": 20, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes additional descriptive terms ('papulovesicular') that, while accurate, make the answer more verbose than necessary. The supporting sentence discusses the resolution of the rash with a gluten-free diet or dapsone, which is relevant but does not directly define or describe dermatitis herpetiformis as the gold supporting sentence does. It introduces information about treatment rather than focusing on the association with gluten sensitivity.\",\n  \"match\": false\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is papulovesicular dermatitis herpetiformis.", "model_support": "The supporting sentence is:  \n\"The rash resolves when the patient is placed on a gluten-free diet and/or dapsone.\"", "retries": 1}
{"idx": 21, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence provided by the model is irrelevant to the question and does not support the gold answer. The model focuses on hyperinsulinism while missing the explicit mention of growth hormone deficiency in the context.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described.", "model_answer": "The context explicitly mentions that patients with Costello syndrome experienced persistent hyperinsulinemic hypoglycemia, requiring diazoxide therapy to manage the condition. This indicates an excessive production of insulin rather than a deficiency. However, the question specifically asks about a hormone deficiency. Based on the provided information, there is no mention of a hormone deficiency; the issue appears to be related to an overproduction of insulin, not a deficiency. Therefore, the answer is:\n\nNo hormone deficiency is explicitly mentioned in the context provided. The condition is associated with hyperinsulinism, which is an excessive production of insulin.\n\nAnswer: No hormone deficiency is explicitly mentioned; the context discusses hyperinsulinism, an excessive insulin production.", "model_support": "The sentence \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak\" explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, directly supporting the answer.", "retries": 1}
{"idx": 22, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes additional details about mutations in FBN1 and specific exons, which are not necessary to directly support the mode of inheritance. This makes the sentence slightly more verbose than needed, though the logic connecting the answer to the context remains strong.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).", "model_answer": "The mode of inheritance for Acromicric dysplasia is autosomal dominant.", "model_support": "The supporting sentence is: \"mutations in FBN1 in the dominant form of GD and in AD (exon 41-42, encoding TGFβ binding protein-like domain 5 (TB5) of FBN1).\" This sentence indicates that Acromicric dysplasia (AD) has a dominant form of inheritance.", "retries": 1}
{"idx": 23, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'JTV519 is a derivative of 1,4-benzothiazepine,' is completely irrelevant to the question, which asks for the main regulatory molecule of SERCA2A function in cardiac muscle. The gold answer, 'phospholamban,' is clearly stated in the context and supported by the gold supporting sentence. The model's supporting sentence discusses JTV519's role in stabilizing RyR2s, which does not address SERCA2A regulation or phospholamban. Both the answer and supporting sentence are incorrect and off-topic.\", \"match\": false}", "gold_answer": "phospholamban", "gold_support": "SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholamban, protein phosphatase 1, inhibitor-1, and PKCα.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 24, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but adds extra details ('absence of thyroid antibodies') not explicitly required by the question. The supporting sentence, while relevant, is somewhat verbose and includes information beyond what is necessary to justify the answer. Logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "Subclinical hypothyroidism and absence of thyroid antibodies are common in Williams syndrome.", "model_support": "Subclinical hypothyroidism and absence of thyroid antibodies are common in Williams syndrome.\n\n**Supporting sentence:** None of our patients had overt hypothyroidism; 29 patients (31.5%) had subclinical hypothyroidism. Thyroid antibodies were absent in all patients.", "retries": 1}
{"idx": 25, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying 'IL-1β' as the molecule targeted by Gevokizumab. The supporting sentence is concise, directly relevant, and logically explains that Gevokizumab modulates IL-1β signaling, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Gevokizumab targets interleukin-1β (IL-1β).", "model_support": "The supporting sentence that confirms that Gevokizumab targets interleukin-1β (IL-1β) is:\n\n\"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"\n\nThis sentence explicitly states that gevokizumab acts on IL-1β signaling, confirming that IL-1β is the molecule targeted by the drug.", "retries": 1}
{"idx": 26, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. It states there are three TAp73 isoforms in humans, whereas the gold answer specifies seven. The supporting sentence is relevant but does not cover the gold answer, as it simply restates the incorrect number of isoforms without providing additional context or evidence that aligns with the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is three. These isoforms include TAp73α, TAp73β, and TAp73γ, which are distinct variants produced through alternative splicing of the p73 gene. Each isoform serves unique functions in regulating cellular processes such as apoptosis and cell cycle control.", "model_support": "The supporting sentence for the answer is:\n\n\"The number of TAp73 isoforms identified in humans is three.\"", "retries": 1}
{"idx": 27, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer 'thioredoxin fold' is incorrect and does not match the gold standard 'SECIS'. The supporting sentence discusses thioredoxin-like folds, which, while mentioned in the context, is irrelevant to the specific question about the stem-loop structure at the 3' end of selenoprotein genes. It neither identifies the correct structure (SECIS) nor provides logical support for it.\",\n  \"match\": false\n}", "gold_answer": "SECIS", "gold_support": "Selenocysteine (Sec, U) insertion into proteins is directed by translational recoding of specific UGA codons located upstream of a stem-loop structure known as Sec insertion sequence (SECIS) element.", "model_answer": "The stem loop present at the 3' end of selenoprotein genes is known as the **thioredoxin fold**.\n\nAnswer: thioredoxin fold", "model_support": "The supporting sentence is: \"SelL proteins possess a thioredoxin-like fold wherein the UxxU motif corresponds to the catalytic CxxC motif in thioredoxins, suggesting a redox function of SelL proteins.\"", "retries": 1}
{"idx": 28, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('naloxone'), as it focuses on the routes of administration rather than identifying the medication itself. The supporting sentence is relevant but does not directly cover the gold answer, which should simply highlight 'naloxone' as the key medication for opioid overdose.\",\n  \"match\": false\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "The study concludes that both intravenous (i.v.) and subcutaneous (s.q.) administration of naloxone are equally effective in managing suspected acute opioid overdose. Therefore, either route can be used based on clinical circumstances and preferences.\n\nAnswer: Both intravenous and subcutaneous naloxone administration are effective.", "model_support": "The supporting sentence is: \"There was no clinical difference in the time interval to respiratory rate > or =10 breaths/min between naloxone 0.8 mg s.q. and naloxone 0.4 mg i.v. for the out-of-hospital management of patients with suspected opioid overdose.\"", "retries": 1}
{"idx": 29, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "The mutation associated with McLeod syndrome in the provided context is in the **XK gene**. \n\nAnswer: XK", "model_support": "The supporting sentence is: \"This deletion caused a frameshift in translation, leading to a premature stop codon at the amino acid position 408. We conclude this single-base deletion causes defective Kx protein, which is responsible for the McLeod phenotype in this patient.\" This sentence explicitly states that the mutation is in the **XK gene**, leading to the production of defective Kx proteins responsible for the McLeod phenotype.", "retries": 1}
{"idx": 30, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and accurate, contains slight redundancy by focusing on the URL rather than providing a more comprehensive explanation like the gold supporting sentence. The logic is sound but could be more informative.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is the database available for the identification of chorion proteins in Lepidopteran proteomes.", "model_support": "The supporting sentence is:  \n\"LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\"", "retries": 1}
{"idx": 31, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it provides the full name instead of the abbreviation. The supporting sentence is relevant and covers the key point that DUX4 expression is linked to FSHD. However, it introduces additional details about the non-spliced isoform, which, while accurate, are not necessary to directly support the answer. This slight redundancy lowers the score from a perfect 5.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is Facio-scapulo-humeral dystrophy (FSHD).", "model_support": "The supporting sentence is: \"The DUX4-fl pathogenic transcript was detected in FSHD biopsies but also in controls. Importantly, in FSHD fetuses, we mainly detected the non-spliced DUX4-fl isoform.\" This sentence indicates that the DUX4 protein is ectopically expressed in FSHD, specifically in the non-spliced isoform, which is linked to the disease.", "retries": 1}
{"idx": 32, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'formononetin,' does not match the gold standard, 'medicarpin.' However, formononetin is mentioned in the context as a related compound. The supporting sentence discusses the possible role of an enzyme in synthesizing formononetin but does not directly state it as the major phytoalexin, and it fails to cover the gold answer, medicarpin. The supporting sentence is relevant but does not fully support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.", "model_support": "The sentence that supports the answer is: \"The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.\"\n\nThis sentence directly links the isoflavone 7-O-methyltransferase (IOMT) to the synthesis of formononetin, which is identified as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 33, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer matches the gold standard but is capitalized differently (which is acceptable). However, the supporting sentence provided by the model is entirely irrelevant to the question and answer. It discusses JTV519 and RyR2s, which are unrelated to Bruton's tyrosine kinase inhibitor or its role in CLL treatment. The supporting sentence does not cover the gold answer.\",\n  \"match\": true\n}", "gold_answer": "ibrutinib", "gold_support": "Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1.", "model_answer": "Ibrutinib", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 34, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is slightly more detailed than the gold standard ('stroke') by including 'transient ischaemic attack (TIA),' which, while correct, is not required based on the gold answer. The supporting sentence provides relevant information and connects the ROSIER scale to stroke diagnosis effectively, but it introduces additional details about TIA that are not needed. Overall, the logic is strong, but there is minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "ROSIER scale is used for diagnosing acute stroke and transient ischaemic attack (TIA).", "model_support": "The ROSIER scale is used for diagnosing acute stroke and transient ischaemic attack (TIA). This is supported by the context where the study aims to compare the effectiveness of diagnostic scales for these conditions, and the ROSIER scale is specifically mentioned in the results.", "retries": 1}
{"idx": 35, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'Hypothyroidism,' is very close to the gold answer, 'thyroid,' as hypothyroidism is a specific thyroid functional disorder characteristic of Pendred syndrome. However, it does not fully match the broader term 'thyroid' used in the gold answer. The supporting sentence provided by the model discusses measuring thyroid hormone levels but is somewhat lengthy and indirect compared to the gold supporting sentence, which directly mentions thyroid functional disorders and hypothyroidism as part of the classical triad of symptoms. The logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "Hypothyroidism.", "model_support": "The supporting sentence that indicates the hormone abnormalities in Pendred syndrome is:\n\n\"In the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scintography were conducted.\"\n\nThis sentence shows that thyroid hormone levels were evaluated, pointing to potential hypothyroidism, a characteristic feature of Pendred syndrome.", "retries": 1}
{"idx": 36, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes additional information ('and other crucial biological processes') that, while not incorrect, makes it less precise. The supporting sentence repeats the model's answer verbatim, which adds redundancy and lacks the concise relevance of the gold supporting sentence. However, the logic connecting CNEs to development is present, making the response reasonable but in need of more focus.\",\n  \"match\": false\n}", "gold_answer": "development", "gold_support": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.", "model_answer": "The process that conserved noncoding elements mostly regulate is the regulation of development and other crucial biological processes.", "model_support": "The process that conserved noncoding elements mostly regulate is the regulation of development and other crucial biological processes. \n\nSupporting sentence: \"some of which have been implicated in the regulation of crucially important processes, including development.\"", "retries": 1}
{"idx": 37, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is incorrect and irrelevant to the question. However, the provided supporting sentence correctly identifies that SEA0400 inhibits the NCX, aligning with the gold answer. The supporting sentence contains slight redundancy by mentioning SNP's effects but still logically supports the correct answer (NCX). Therefore, the score reflects a mix of an incorrect answer with a mostly correct but slightly verbose supporting sentence.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The sentence supporting the answer is: \"These effects of SNP were prevented by SEA0400.\" This indicates that SEA0400 inhibits the NCX, as it blocks SNP's effects mediated by this ion antiporter/exchanger. \n\nAnswer: The small molecule SEA0400 is an inhibitor of the Na+/Ca²⁺ exchanger (NCX). Supporting sentence: These effects of SNP were prevented by SEA0400.", "retries": 1}
{"idx": 38, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and aligns with the gold standard, as rheumatoid arthritis is indeed more common in women. However, the supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, whereas the gold supporting sentence clearly exists and provides relevant data (the ratio of women to men studied). The model's supporting sentence is thus inaccurate, though the logic behind the answer itself is reasonable.\", \"match\": true}", "gold_answer": "women", "gold_support": "RESULTS: We studied 312 women and 126 men with early RA.", "model_answer": "Rheumatoid Arthritis is more common in women than in men.", "model_support": "The context provided does not include a sentence that directly supports the statement that Rheumatoid Arthritis is more common in women than in men. The study focuses on gender differences in symptoms, follow-up duration, and treatment patterns but does not provide data on the incidence or prevalence of RA in each gender. Therefore, there is no supporting sentence within the given context for that answer.", "retries": 1}
{"idx": 39, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly redundant as it references the title of the review rather than directly quoting the relevant sentence from the context that explicitly states p53 as 'guardian of the genome.' While the logic is sound, a more concise and direct supporting sentence would improve the response.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence in the context that refers to p53 as \"the guardian of the genome\" is the title of the review: **\"The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.\"**", "retries": 1}
{"idx": 40, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'), but the supporting sentence is missing. The context provided by the gold supporting sentence clearly identifies betrixaban as an orally active direct factor Xa inhibitor, which would have supported the answer if included. Without this, the logic behind the answer is not fully substantiated, though the answer itself is correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "The clotting factor inhibited by betrixaban is **factor Xa**.", "model_support": "The context provided does not mention betrixaban, so there is no supporting sentence within it that directly addresses the inhibition of factor Xa by betrixaban.", "retries": 1}
{"idx": 41, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes additional details (mentioning TIA and the emergency department), making it slightly more verbose than necessary. The supporting sentence is relevant but does not directly state that ROSIER is used for stroke assessment, instead focusing on comparing diagnostic scales. This makes the logic less direct and mixes in broader context about sensitivity and specificity.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for assessing acute stroke or transient ischaemic attack (TIA) in the emergency department.", "model_support": "Supporting sentence: **\"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"**", "retries": 1}
{"idx": 42, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Na(+)/Ca(2+) exchanger' and 'sodium-calcium exchanger' are equivalent in this context). However, the supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, whereas the gold supporting sentence directly mentions SEA0400 as an inhibitor of NCX. The correct supporting sentence from the context could have been used to provide concise and logical support.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "Concerning the role of NCX in NO cytotoxicity, we have found, using the specific inhibitor of NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), that NCX is involved in NO-induced cytotoxicity in cultured microglia, astrocytes, and neuronal cells.", "model_answer": "SEA0400 is an inhibitor of the sodium-calcium exchanger (NCX). \n\nAnswer: sodium-calcium exchanger", "model_support": "The context provided does not mention SEA0400 or its role as an inhibitor of the sodium-calcium exchanger (NCX). Therefore, there is no supporting sentence in the given context to answer the question about SEA0400.", "retries": 1}
{"idx": 43, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Facio-scapulohumeral Dystrophy (FSHD1),' matches the gold standard 'FSHD' closely, with the added specificity of FSHD1, which is accurate but slightly more detailed than required. The supporting sentence provides relevant information directly linking FSHD1 to ectopic DUX4 expression; however, it contains slight redundancy by specifying 'contraction of the array to fewer than 10 repeats,' which, while correct, is not essential to support the answer. Overall, the logic is strong, but minor verbosity reduces the score.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facio-scapulohumeral Dystrophy (FSHD1).", "model_support": "The supporting sentence is: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\" This directly links FSHD1 to ectopic DUX4 expression.", "retries": 1}
{"idx": 44, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is completely irrelevant to the question, as it discusses a drug derivative (JTV519) instead of the most widely used model for studying multiple sclerosis. The supporting sentence also does not address the question and is unrelated to the gold answer or its supporting sentence. Both are incorrect and fail to logically support the correct response.\",\n  \"match\": false\n}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE), a widely recognized animal model of multiple sclerosis (MS), is highly useful for studying inflammation, demyelination, and neurodegeneration in the central nervous system (CNS).", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 45, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Factor Xa', is correct but does not match the gold standard format ('xa'), which is a minor discrepancy. However, the supporting sentence provided by the model is irrelevant and overly verbose, discussing clinical trials rather than directly supporting the fact that betrixaban inhibits Factor Xa. It lacks concise and logical reasoning.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"Betrixaban was tested in Phase II studies in orthopedic thromboprophylaxis (EXPERT) and atrial fibrillation (EXPLORE-Xa), and is being evaluated in a Phase III trial of extended thromboprophylaxis in medical patients (APEX). This article details the pharmacology, preclinical and clinical development of betrixaban.\"", "retries": 1}
{"idx": 46, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, as '1,4-benzothiazepine' aligns with the gold answer 'benzothiazepine.' The supporting sentence from the model is relevant and directly references JTV519 as a 1,4-benzothiazepine derivative, which supports the answer. However, it introduces additional details (e.g., 'multi-channel blocker') that are not necessary for answering the question, making it slightly more verbose than needed. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a **1,4-benzothiazepine derivative** and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 47, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('BRG1'), but the supporting sentence is completely irrelevant to the question. The provided sentence discusses JTV519, a 1,4-benzothiazepine derivative, which has no connection to the interaction between FANCA and BRG1. Therefore, while the answer is correct, the supporting sentence does not cover the gold answer or provide any relevant reasoning.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 48, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model answer correctly identifies the 5-HT2A receptors, which matches the gold standard. However, the supporting sentence provided is entirely irrelevant to the question and does not support the answer in any way. The correct supporting sentence should have referenced the suitability of [18F]altanserin for quantifying 5-HT2A receptors, as outlined in the context.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors evaluated with [18F]altanserin are the **5-HT2A receptors**.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"\n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, directly answering the question about the chemical compound group from which JTV519 is derived.", "retries": 1}
{"idx": 49, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model acknowledges that there is no direct supporting sentence in the context, which aligns with the fact that the gold supporting sentence was not present in the model's context. This demonstrates accurate recognition of the lack of support within the given context.\", \"match\": true}", "gold_answer": "Semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "LY450139 is the investigational name of Semagacestat.", "model_support": "The context provided does not mention LY450139 or Semagacestat together. The only sentence relevant to Semagacestat is: \"Semagacestat is currently being studied in two phase III clinical trials.\" However, since LY450139 is not mentioned in the context, there is no sentence that directly supports the answer. \n\nAnswer: There is no supporting sentence for LY450139 in the given context.", "retries": 1}
{"idx": 50, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to factor Xa). The supporting sentence is relevant and correctly identifies betrixaban as a factor Xa inhibitor, but it contains slight redundancy by discussing the broader context of anticoagulants rather than directly focusing on betrixaban. This makes it slightly less concise than ideal, though the logic remains strong.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is:\n\n\"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"\n\nThis sentence identifies betrixaban as a member of the factor Xa inhibitor class, confirming the answer.", "retries": 1}
{"idx": 51, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('xa' is the abbreviation for factor Xa). The supporting sentence is concise, directly relevant, and logically covers the answer by identifying betrixaban as a factor Xa inhibitor. Minor extra details are acceptable since the logic is strong.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The sentence that supports the answer is: \"Examples of direct factor Xa inhibitors include betrixaban...\" This directly identifies betrixaban as a factor Xa inhibitor. \n\nAnswer: Betrixaban inhibits factor Xa.  \nSupporting sentence: Examples of direct factor Xa inhibitors include betrixaban...", "retries": 1}
{"idx": 52, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it includes additional information about phosphorylated alpha-synuclein and dystrophic axonal terminals, which slightly increases verbosity without being directly necessary to confirm the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "The antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The supporting sentence is: \"The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals.\" This sentence confirms that the antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.", "retries": 1}
{"idx": 53, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'ARMO', is incorrect and does not match the gold standard, which is 'aryl hydrocarbon receptor interacting protein'. Furthermore, the supporting sentence provided by the model is completely irrelevant to the question, discussing JTV519 and RyR2s, which have no connection to pituitary adenomas or the gold supporting sentence. Both the answer and supporting sentence fail to address the correct gene or provide relevant reasoning.\", \"match\": false}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "The gene implicated in the familial isolated pituitary adenoma (FIPA) is ARMO (ARMAdillo-Virchow domain-containing protein). \n\nAnswer: ARMO", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence directly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 54, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying that Mepolizumab targets interleukin-5 (IL-5). Minor extra details like the method of administration are acceptable as they do not detract from the clarity or correctness of the logic.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks.", "model_answer": "Mepolizumab targets interleukin-5 (IL-5).", "model_support": "The supporting sentence is: \"Mepolizumab, a monoclonal antibody targeting interleukin-5 (IL-5), was administered either intravenously or subcutaneously.\"", "retries": 1}
{"idx": 55, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer. The context mentions 'all 5 N-terminal isoforms,' which the model correctly identifies, but it fails to recognize that TAp73 itself has multiple isoforms (7 as per the gold answer). As a result, while the model provides a plausible explanation based on partial understanding, it misses key information needed for full accuracy.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context explicitly lists five N-terminal isoforms of p73: TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. Among these, TAp73 is one isoform. Therefore, only one TAp73 isoform has been identified in humans.\n\nAnswer: 1", "model_support": "The context explicitly lists five N-terminal isoforms of p73: TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. Among these, TAp73 is one isoform. Therefore, only one TAp73 isoform has been identified in humans.\n\nSupporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR.", "retries": 1}
{"idx": 56, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('template strand') does not match the gold standard ('the transcribed strand'), but it is present in the context as a related concept. The supporting sentence is relevant to transcription-coupled repair (TCR) but does not cover the gold answer. It mentions XP-C fibroblasts and TCR of active genes but does not explicitly refer to the transcribed strand, which is central to the gold answer.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "The transcription-coupled repair (TCR) targets the template strand of DNA, as it is the strand that is actively being transcribed by RNA polymerase. This repair is crucial for maintaining transcriptional continuity and ensuring that UV-induced damage does not disrupt the process.\n\nAnswer: template strand", "model_support": "The supporting sentence is: \"In contrast, XP complementation group C (XP-C) fibroblasts retain proficient TCR of active genes.\" This directly links transcription-coupled repair (TCR) to the template strand, as it is the strand actively being transcribed by RNA polymerase during transcription.", "retries": 1}
{"idx": 57, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK'), but it is slightly more verbose by specifying 'the XK gene' instead of just 'XK.' The supporting sentence is relevant and covers the answer well, though it contains additional information about other disorders that could be seen as slightly redundant. Despite this, the logic connecting the absence of XK to McLeod syndrome is clear.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.", "model_support": "The sentence that supports the answer is: \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\" This sentence directly states that the absence of the XK gene is a cause of McLeod syndrome.", "retries": 1}
{"idx": 58, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks about the disorder PBT2 has been tested for, but the model provides information about JTV519, which is unrelated. The supporting sentence also discusses JTV519 and does not logically support the gold answer related to Alzheimer's disease.\", \"match\": false}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"  \nThis sentence explicitly identifies JTV519 as a derivative of the 1,4-benzothiazepine group of chemical compounds.", "retries": 1}
{"idx": 59, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('5-HT2A'). The supporting sentence is relevant and provides detailed evidence about the evaluation of 5-HT2A receptors using [18F]altanserin, specifically discussing reproducibility in regions with high receptor density. However, it includes additional details (e.g., specific percentages) that are not strictly necessary to support the answer, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.", "model_answer": "The [18F]altanserin evaluates the 5-HT2A receptors in the brain, particularly in regions with high receptor density.\n\nAnswer: 5-HT2A receptors", "model_support": "The supporting sentence is:  \n\"In cortical brain regions with a high density of 5-HT2A receptors, the outcome parameter (binding potential, BP1) showed high reproducibility, with a median difference between the two group measurements of 6% (range 5-12%), whereas in regions with a low receptor density, BP1 reproducibility was lower, with a median difference of 17% (range 11-39%).\"", "retries": 1}
{"idx": 60, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'PCSK9,' matches the gold standard 'proprotein convertase subtilisin/kexin type 9' as it is the accepted abbreviation. However, the supporting sentence provided by the model is not ideal—it references trial tolerability data rather than directly explaining how Evolocumab targets PCSK9. The gold supporting sentence provides a more accurate and detailed explanation of the mechanism. Despite this, the model's supporting sentence still implies relevance to PCSK9 inhibitors, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab and alirocumab are fully human monoclonal antibodies inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds to hepatic LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Evolocumab targets the enzyme PCSK9.", "model_support": "The enzyme targeted by Evolocumab is **PCSK9**. \n\n**Supporting sentence:** \"Phase II (for evolocumab and alirocumab) and III (for evolocumab) trials show that PCSK9 inhibitors are equally well tolerated, with adverse events mainly limited to mild-to-moderate nasopharyngitis, injection-site pain, arthralgia and back pain.\"", "retries": 1}
{"idx": 61, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and unrelated to the question. The supporting sentence provided by the model discusses a drug derivative (JTV519) and has no relevance to restless leg syndrome or its association with iron deficiency as described in the context. Both the answer and supporting sentence are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "iron", "gold_support": "The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, confirming the answer.", "retries": 1}
{"idx": 62, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer is accurate and aligns well with the gold standard 'stroke,' though it is slightly more verbose by specifying 'recognize acute stroke in the emergency room.' The supporting sentence is relevant and supports the answer effectively, but it is slightly redundant compared to the concise gold supporting sentence. Overall, the logic is strong, and the information provided is correct.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used to recognize acute stroke in the emergency room.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\"", "retries": 1}
{"idx": 63, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks for a tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia, but the model provides '1,4-benzothiazepine,' which is unrelated. The supporting sentence discusses JTV519, which is not pertinent to the gold answer or the context of Bcr-Abl. Both the answer and supporting sentence fail to address the correct information.\", \"match\": false}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) arises as a consequence of a chromosomal translocation giving rise to the Philadelphia chromosome and Bcr-Abl oncogene.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence that identifies JTV519 as a derivative of the 1,4-benzothiazepine group is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 64, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The question asks about the tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia, which is BCR-ABL. However, the model's answer discusses JTV519, a compound unrelated to the context of the question. The supporting sentence also does not address the gold answer or provide relevant information.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) originates from a hematopoietic stem cell carrying the Philadelphia (Ph) chromosome and oncogenic BCR-ABL1 fusion gene.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 65, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by specifying 'factor Xa'. The supporting sentence is relevant and covers the answer, but contains some redundancy by discussing broader classes of anticoagulants instead of directly focusing on betrixaban as an Xa inhibitor. Overall, the logic is sound, but it could be more concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is **factor Xa**.", "model_support": "The supporting sentence is: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\" This sentence indicates that betrixaban is part of the factor Xa inhibitors, which is the clotting factor inhibited by betrixaban.", "retries": 1}
{"idx": 66, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('repressor'). The supporting sentence is relevant and provides evidence for Bach1 functioning as a repressor by mentioning how diamide reverses the suppression of transcriptional activity caused by Bach1. However, it contains slightly more detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence. The logic is sound but could be streamlined.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1, one of the most inducible phase 2 proteins.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The supporting sentence is: \"Diamide showed restricted Nrf2 nuclear translocation and ARE-driven reporter activity but reversed the ARE transcriptional activity suppressed by ectopically expressed Bach1.\"\n\nThis sentence indicates that Bach1 suppresses the transcriptional activity of ARE-governed genes, as diamide reverses this suppression, demonstrating that Bach1 functions as a transcriptional repressor.", "retries": 1}
{"idx": 67, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by introducing additional context about alpha-synucleinopathy that is not directly necessary to support the specific answer about Lewy bodies. However, the logic is still strong and aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of the Lewy bodies is alpha-synuclein, as stated in the supporting sentence: \"The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells...\"", "retries": 1}
{"idx": 68, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('a tick') is correct but not specific enough to match the gold standard ('Ixodes ricinus'). The supporting sentence provided is completely irrelevant to the question, as it discusses a drug derivative and calcium channels rather than ticks or Louping ill virus.\", \"match\": false}", "gold_answer": "Ixodes ricinus", "gold_support": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.", "model_answer": "The vector of Louping ill virus is a tick.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 69, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard; it incorrectly states that APOBEC3B is predominantly cytoplasmic, whereas the gold answer specifies 'nuclear.' The supporting sentence mentions that APOBEC3B is excluded from chromatin during mitosis, which is relevant but does not address its localization after mitosis, where it becomes nuclear. This makes the supporting sentence insufficient to cover the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "APOBEC3B is predominantly cytoplasmic.", "model_support": "Supporting sentence: APOBEC3B, APOBEC3D, APOBEC3F, and APOBEC3G are excluded from chromatin throughout mitosis.", "retries": 1}
{"idx": 70, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'eosinophils,' does not match the gold standard, 'interleukin-5.' While eosinophils are mentioned in the context as a related component, the molecule directly targeted by mepolizumab is interleukin-5. The supporting sentence mentions that mepolizumab targets eosinophils, which is factually incorrect since it targets interleukin-5 to reduce eosinophil levels. The sentence is relevant but does not cover the gold answer.\", \"match\": false}", "gold_answer": "interleukin-5", "gold_support": "We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.", "model_answer": "Mepolizumab targets eosinophils.", "model_support": "The supporting sentence is: \"Mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.\" \n\nThis sentence explicitly states that mepolizumab is designed to target eosinophils.", "retries": 1}
{"idx": 71, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, albeit with minor differences in formatting (e.g., 'MECp2' vs. 'methyl-CpG-binding protein 2 (Mecp2)'). The supporting sentence is relevant and provides logical support for the answer but contains slight redundancy by discussing additional details about electrophysiological and neurochemical deficits, which are not directly necessary for justifying the hallmark status of Mecp2 mutation in Rett syndrome.\",\n  \"match\": true\n}", "gold_answer": "methyl-CpG-binding protein 2 (Mecp2)", "gold_support": "The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction.", "model_answer": "The methyl-CpG-binding protein that becomes the hallmark for Rett syndrome when mutant is MECp2.", "model_support": "The supporting sentence is: \"Recent studies have begun to characterize the breathing phenotype of Mecp2 mutant mice and to define underlying electrophysiological and neurochemical deficits.\" This sentence highlights the role of Mecp2 mutant mice in understanding Rett syndrome, indicating that Mecp2's mutation is a hallmark of the condition.", "retries": 1}
{"idx": 72, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the description of the rash is accurate, the gold answer specifies 'dermatitis herpetiformis' as the typical rash associated with gluten sensitivity, which the model does not directly provide. The supporting sentence is relevant but fails to cover the gold answer since it focuses on a lack of explicit detail in the context rather than aligning with the provided gold supporting sentence, which clearly connects dermatitis herpetiformis to gluten sensitivity.\",\n  \"match\": false\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "The typical rash associated with gluten sensitivity, particularly in the context of dermatitis herpetiformis, is characterized by papular, hive-like lesions. These appear in areas where the skin folds, such as the elbows, knees, and behind the ears, presenting as red, raised bumps that may be itchy or painful, with some scaling or exudate. This rash is distinct from conditions like eczema or psoriasis, differing in both appearance and underlying mechanisms.", "model_support": "The supporting sentence for the typical rash associated with gluten is not explicitly present in the provided context. The context discusses dermatitis herpetiformis, characterized by granular IgA precipitates in the papillary dermis, and its association with gluten-sensitive enteropathy. However, it does not provide a detailed description of the rash's appearance. Therefore, the description of the rash as papular, hive-like lesions in areas like the elbows, knees, and behind the ears is not directly supported by the given context.", "retries": 1}
{"idx": 73, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer is correct and matches the gold standard. However, the supporting sentence provided is completely irrelevant to the question and does not support the use of flumazenil in benzodiazepine overdose. The supporting sentence discusses JTV519, which is unrelated to the context of flumazenil or benzodiazepine toxicity.\", \"match\": true}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Flumazenil is used as the antidote in benzodiazepine overdose.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 74, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes additional details (mentioning TIA and the emergency department) which are accurate but not necessary for the specific question asked. The supporting sentence references a part of the context that describes the study design rather than directly focusing on the ROSIER scale's use for stroke assessment, making it somewhat relevant but not as concise or directly supportive as it could be.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "ROSIER scale is used for the assessment of patients with suspected acute stroke or transient ischaemic attack (TIA) in the emergency department.", "model_support": "The supporting sentence is:  \n\"Design: A cross-sectional observational study of patients with suspected acute stroke in an emergency department in a UK hospital.\"", "retries": 1}
{"idx": 75, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying 'PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)' as the enzyme targeted by Evolocumab. However, the supporting sentence is unnecessarily verbose and introduces irrelevant details (e.g., liver X receptor pathway), which are not mentioned in the context or gold supporting sentence. While it logically supports the answer, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "BACKGROUND: Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies.", "model_answer": "Evolocumab targets the enzyme **PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)**.", "model_support": "The context provided does not explicitly state that Evolocumab targets the enzyme PCSK9. However, based on general knowledge, Evolocumab is known to target the enzyme **PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)**, which is involved in the liver X receptor pathway and helps reduce LDL cholesterol levels. Since the context focuses on the trial results and does not mention the specific enzyme targeted, the supporting sentence for this answer is not directly provided in the context.", "retries": 1}
{"idx": 76, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer identifies the correct condition (dermatitis herpetiformis) as the typical rash associated with gluten, matching the gold standard. However, the supporting sentence provided by the model is somewhat redundant because it elaborates on the characteristics of the rash, which are not directly asked for in the question. The gold supporting sentence is more concise and directly relevant to the relationship between gluten and dermatitis herpetiformis. Despite this, the model's supporting sentence still logically supports the answer with reasonable clarity.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "This contrasts to the situation in dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent.", "model_answer": "The typical rash associated with gluten is the one seen in dermatitis herpetiformis. It presents as a red, inflamed, itchy rash in flexural areas such as the elbows, knees, buttocks, and back, often characterized by small, grouped blisters filled with fluid.", "model_support": "The supporting sentence for the question \"What is the typical rash associated with gluten?\" is not explicitly found in the provided context. The context discusses the treatment of linear IgA disease (LAD) with a gluten-free diet (GFD) and mentions that the skin eruption of LAD is being studied for gluten dependence. However, it does not explicitly describe the rash associated with gluten. If you are referring to the rash associated with gluten, such as in dermatitis herpetiformis, the description would be:\n\n\"Typical rash associated with gluten is the one seen in dermatitis herpetiformis. It presents as a red, inflamed, itchy rash in flexural areas such as the elbows, knees, buttocks, and back, often characterized by small, grouped blisters filled with fluid.\"", "retries": 1}
{"idx": 77, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"  \n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 78, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information directly tied to DNMT1, but it focuses on the crystal structure rather than its role in methylation maintenance, making it slightly less aligned with the gold supporting sentence. It contains minor redundancy by emphasizing structural details not critical for the answer.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNMT1**.", "model_support": "The supporting sentence is: \"We report on the crystal structure of a productive covalent mouse DNMT1(731-1602)-DNA complex containing a central hemimethylated CpG site.\"\n\nThis sentence explicitly identifies DNMT1 as the enzyme involved in the maintenance of DNA (cytosine-5)-methylation.", "retries": 1}
{"idx": 79, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying 'Dnmt1' as the enzyme responsible for maintaining DNA methylation. The supporting sentence is relevant but contains slight redundancy by mentioning the manipulation of enzymes in general rather than focusing solely on Dnmt1's role in maintaining methylation. However, it still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining the methylation marks through cell division.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1).", "model_support": "The supporting sentence is: \"Manipulation of these enzymes, especially Dnmt1, provides a means to alter DNA methylation levels.\" This sentence directly identifies DNMT1 as the enzyme involved in maintaining DNA methylation.", "retries": 1}
{"idx": 80, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing medicarpin's role in biosynthesis; however, it focuses on a specific detail about methylation rather than providing the broader context given in the gold supporting sentence. This makes it slightly less comprehensive but still logically connected.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence is: \"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\" This sentence explicitly identifies medicarpin as the compound involved in the biosynthesis process, confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 81, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('bcr-abl') in meaning, using the equivalent term 'BCR-ABL'. The supporting sentence provided by the model acknowledges that the context doesn't explicitly state the target but correctly references external knowledge about Imatinib targeting BCR-ABL. However, it is slightly verbose and explains the lack of direct evidence in the context rather than directly quoting the concise gold supporting sentence. With some redundancy, it still provides logical support.\", \"match\": true}", "gold_answer": "bcr-abl", "gold_support": "Imatinib mesylate (Glivec) is a selective inhibitor of bcr-abl tyrosine kinase, the product of the Philadelphia chromosome, which is the hallmark of chronic myeloid leukaemia (CML).", "model_answer": "The target tyrosine kinase for Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is **BCR-ABL**.", "model_support": "The context provided does not explicitly mention that Imatinib targets BCR-ABL. The information about Imatinib's use in CML patients and achieving CCR is present, but the specific mention of BCR-ABL as the target tyrosine kinase is not included. Therefore, the supporting sentence for this answer is not found within the given context. The answer is based on external knowledge where Imatinib is known to target the BCR-ABL fusion protein in Philadelphia-chromosome positive chronic myeloid leukemia.", "retries": 1}
{"idx": 82, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'Factor Xa' is very close to the gold standard 'xa,' with only minor differences in formatting. However, the supporting sentence is somewhat lengthy and includes information not directly relevant to the specific question about betrixaban inhibiting factor Xa. While it mentions factor Xa inhibitors and discusses their characteristics, it does not directly link betrixaban to factor Xa as concisely as the gold supporting sentence. The logic is reasonable but could be more focused.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"Several of these agents have been tested in clinical trials for various indications, including AF, with favorable results. In particular, apixaban and rivaroxaban have shown superiority and noninferiority, respectively, to warfarin in phase III clinical trials for stroke prevention in AF. These agents have also been shown to be safe in terms of bleeding risk. Despite these advantages, factor Xa inhibitors have several characteristics, such as potential interactions with other drugs (inhibitors of cytochrome P450 and P-glycoprotein) and the inability to reverse their anticoagulant effects, as well as concerns about poor patient compliance, which must be considered when initiating patients on a novel factor Xa inhibitor.\"\n\nThis sentence supports the answer because it explicitly states that the drugs in question, including betrixaban, are direct factor Xa inhibitors.", "retries": 1}
{"idx": 83, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX') conceptually, as NCX1 is a specific isoform of the Na+/Ca2+ exchanger (NCX). However, the gold answer uses the broader term 'NCX,' which is also correct. The supporting sentence provided by the model is relevant but slightly verbose and includes details about SEA0400 reducing cell damage, which is not directly necessary to support the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "SEA0400 is an inhibitor of the Na+/Ca²+ exchanger NCX1.", "model_support": "The small molecule SEA0400 is an inhibitor of the Na+/Ca²+ exchanger NCX1.\n\n**Supporting sentence:** In RGC-5, SEA0400 at 0.3 and 1 microM significantly inhibited OGD-induced cell damage. OGD-induced cell damage was aggravated by ouabain (a Na(+),K(+)-ATPase inhibitor) at 100 microM, and this increased damage was significantly reduced by SEA0400 at 1 microM.", "retries": 1}
{"idx": 84, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying '5-HT2A' as the receptor evaluated with [18F]altanserin. The supporting sentence is relevant and provides logical support by mentioning the investigation of 5-HT2A receptor binding using [(18) F]altanserin. However, it includes additional details about other tracers and regions, which slightly increases verbosity without being strictly necessary to support the answer.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.", "model_support": "The sentence that supports the evaluation of 5-HT2A receptors with [18F]altanserin is:\n\n\"5-HT2A receptor binding in pig cortex and cerebellum was investigated by autoradiography with [(3) H]MDL 100907, [(18) F]MH.MZ, and [(18) F]altanserin.\"\n\nThis sentence explicitly states that both [(18) F]MH.MZ and [(18) F]altanserin were used to study 5-HT2A receptor binding, confirming that [18F]altanserin can evaluate these receptors.", "retries": 1}
{"idx": 85, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'factor Xa' is equivalent to 'Xa'. The supporting sentence is relevant and covers the answer, but it includes additional context about the coagulation cascade, making it slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\" This sentence clearly identifies that betrixaban, as a direct factor Xa inhibitor, targets factor Xa for inhibition.", "retries": 1}
{"idx": 86, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('IL-1β'), but the supporting sentence is slightly indirect and includes additional context about metabolic activation and β-cell failure, which is not strictly necessary to justify the answer. While the logic connecting IL-1β to Gevokizumab is sound, the supporting sentence could be more concise by directly referencing Gevokizumab as an anti-IL-1β antibody.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Gevokizumab targets interleukin (IL)-1β.", "model_support": "The supporting sentence that indicates Gevokizumab targets interleukin (IL)-1β is:\n\n\"Metabolic activation of the innate immune system governed by interleukin (IL)-1β contributes to β-cell failure in type 2 diabetes.\"\n\nThis sentence establishes the rationale behind the study, highlighting IL-1β as the target of Gevokizumab, an IL-1β-neutralizing antibody.", "retries": 1}
{"idx": 87, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about NF1 being associated with a specific condition, but it does not directly address the genetic mutation or its role as a tumor suppressor gene like the gold supporting sentence. Thus, while logical, it contains slight redundancy by introducing information about pilocytic astrocytoma rather than staying focused on NF1 mutations.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis 1 gene (NF1 ) fulfills the criteria of a tumor suppressor gene and is deleted or mutated heterozygously in patients with NF1.", "model_answer": "The gene mutated in type 1 neurofibromatosis is NF1.", "model_support": "The supporting sentence is: \"Neurofibromatosis type 1 (NF1) is strongly associated with the development of pilocytic astrocytoma (PA), frequently appearing as optic glioma.\"", "retries": 1}
{"idx": 88, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard ('Stroke'), as diagnosing acute stroke or TIA effectively points to the same concept. However, it is slightly more detailed than necessary. The supporting sentence is relevant and supports the answer by mentioning the ROSIER scale's role in assessing suspected acute stroke, but it introduces the comparison with the FAST scale, which adds unnecessary information not directly related to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for diagnosing acute stroke or transient ischaemic attack (TIA).", "model_support": "Supporting sentence: The simpler FAST scale could replace the more complex ROSIER for the initial assessment of patients with suspected acute stroke in the emergency department.", "retries": 1}
{"idx": 89, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'Naloxone' is equivalent to 'naloxone'. The supporting sentence provides relevant information but includes unnecessary details and lacks clarity compared to the concise gold supporting sentence. The logic is sound, but the redundancy reduces its effectiveness.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Naloxone should be administered when managing patients with suspected acute opioid overdose.", "model_support": "The supporting sentence is: \"To out-of-hospital patients with suspected opioid overdose would have a more rapid therapeutic onset than naloxone given subcutaneously (s.q).\" This explicitly states that Naloxone is the medication used in managing such patients.", "retries": 1}
{"idx": 90, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('XIST'). However, the supporting sentence provided by the model is incorrect because it states there is no explicit mention of XIST in the context, while the gold supporting sentence clearly identifies a relevant sentence that explicitly mentions XIST and its role in X-chromosome inactivation. The model's supporting sentence should have pointed to the same sentence as the gold supporting sentence for full accuracy.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "The transcript responsible for X-chromosome inactivation is the XIST transcript.", "model_support": "In the provided context, there is no explicit mention of the XIST transcript or gene responsible for X-chromosome inactivation. The discussion focuses on the X-inactivation center (XIC) and the process of inactivation without naming the specific gene involved. Therefore, no sentence in the context directly supports the answer that the XIST transcript is responsible for X-chromosome inactivation.\n\nAnswer: There is no supporting sentence in the provided context that directly mentions the XIST transcript.", "retries": 1}
{"idx": 91, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The SECIS element is the correct name for the stem loop required for selenocysteine incorporation, while 'SECIS element-distal stem-loop' refers to a different structure downstream of the SECIS element that inhibits Sec insertion. The supporting sentence is relevant but does not cover the gold answer, as it discusses the inhibition caused by the distal stem-loop rather than the role of the SECIS element itself.\", \"match\": false}", "gold_answer": "SECIS", "gold_support": "Cotranslational incorporation of Sec into SelS depends on the recoding of the UGA codon, which requires a Selenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript.", "model_answer": "The stem loop in question is the SECIS element-distal stem-loop, located downstream of the SECIS element in the 3' end of the mRNA encoding selenoproteins.\n\nAnswer: SECIS element-distal stem-loop", "model_support": "The supporting sentence is: \"the 140 nucleotides downstream of the SECIS element inhibit Sec insertion.\"\n\nThis sentence directly refers to the stem loop located downstream of the SECIS element, which is known as the SECIS element-distal stem-loop.", "retries": 1}
{"idx": 92, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains slight redundancy by mentioning the suppression of estradiol concentrations, which is not necessary to directly support the answer about CYP17A1 inhibition. The gold supporting sentence is more concise while still being clear and specific.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "CYP17A1", "model_support": "The sentence that supports the answer is: \"Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.\" This explicitly identifies that Orteronel inhibits CYP17A1.\n\nSupporting sentence: Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.", "retries": 1}
{"idx": 93, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and correct, is less direct compared to the gold supporting sentence. The chosen sentence discusses immunoreactivity in neuronal soma, which is not as concise or directly related to Lewy bodies as the gold supporting sentence. It introduces slight redundancy by not focusing solely on Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "The antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The supporting sentence is: \"Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein.\" This indicates that the antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.", "retries": 1}
{"idx": 94, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is unnecessarily verbose and includes irrelevant information about JTV519, which is not related to the context of the question. While the model correctly references general knowledge about imatinib targeting BCR-ABL, the inclusion of unrelated content reduces clarity and conciseness. The gold supporting sentence is more direct and relevant.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib mesylate is a tyrosine kinase inhibitor with high affinity for the BCR-ABL fusion protein expressed by the hematopoietic cells in chronic myelogenous leukemia (CML).", "model_answer": "The target tyrosine kinase is **BCR-ABL**.", "model_support": "The context provided discusses JTV519, a drug that stabilizes RyR2 calcium leak channels, and is unrelated to the tyrosine kinase BCR-ABL. Therefore, the supporting sentence for the answer regarding imatinib's target kinase, BCR-ABL, is not present in the provided context. However, based on general knowledge, imatinib (Gleevec) is known to target the BCR-ABL tyrosine kinase involved in Philadelphia-chromosome positive chronic myelogenous leukemia. \n\nAnswer: The target tyrosine kinase is **BCR-ABL**.", "retries": 1}
{"idx": 95, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'non-Hodgkin's lymphoma,' does not match the gold standard, which is 'celiac disease.' However, non-Hodgkin's lymphoma is mentioned in the context as a related histologic subtype. The supporting sentence provided by the model is relevant but does not cover the gold answer ('celiac disease') and repeats the model's answer without additional reasoning or connection to the correct gold answer.\",\n  \"match\": false\n}", "gold_answer": "celiac disease", "gold_support": "Retrospective chart review was performed to detect associated disease processes, such as celiac disease.", "model_answer": "Small bowel lymphoma is commonly associated with non-Hodgkin's lymphoma.", "model_support": "Small bowel lymphoma is commonly associated with non-Hodgkin's lymphoma.\n\n**Supporting sentence:** This patient group comprised 10 patients with non-Hodgkin's lymphoma (NHL) of various subtypes. No cases of Hodgkin's lymphoma were encountered.", "retries": 1}
{"idx": 96, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer (STX3) is incorrect and does not match the gold standard (XK). Additionally, the supporting sentence admits that there is no relevant information in the context to support the model's answer, making it irrelevant and logically unsupported. The correct gene, XK, is clearly mentioned in the gold supporting sentence.\", \"match\": false}", "gold_answer": "XK", "gold_support": "Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features.", "model_answer": "The gene associated with McLeod syndrome is **STX3**.", "model_support": "The context provided does not mention the gene STX3 associated with McLeod syndrome. Therefore, there is no supporting sentence within the given context that directly links the gene STX3 to McLeod syndrome. It appears that the information about STX3 is external to the provided text.", "retries": 1}
{"idx": 97, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The context mentions five N-terminal isoforms of p73, but this does not imply that there are only five TAp73 isoforms, as TAp73 itself can have multiple variants. The supporting sentence is relevant to the context but fails to cover the gold answer, which specifies seven TAp73 isoforms.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context mentions that five N-terminal isoforms of p73 have been identified in humans: TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. Therefore, the number of TAp73 isoforms identified in humans is five.\n\nAnswer: 5", "model_support": "The context explicitly states that all five N-terminal isoforms of p73, including TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73, were measured. This clearly indicates that there are five TAp73 isoforms identified in humans.\n\nSupporting sentence: \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR...\"\n\nAnswer: 5", "retries": 1}
{"idx": 98, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable as they do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B.\n\nAnswer: ZFHX1B", "model_support": "The supporting sentence that identifies the gene responsible for the development of Mowat-Wilson syndrome is:\n\n\"Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.\"\n\nThis sentence directly mentions that the ZFHX1B gene is associated with MWS, confirming its role in the development of the syndrome.", "retries": 1}
{"idx": 99, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard, as 'Na+/Ca2+ exchanger (NCX1)' refers specifically to the NCX isoform mentioned in the gold answer ('NCX'). The supporting sentence chosen by the model is relevant and provides evidence regarding SEA0400's role in inhibiting the Na+/Ca2+ exchanger. However, it includes additional information about ouabain and its interaction with SEA0400, which slightly obscures the direct link between SEA0400 and NCX inhibition. This makes the supporting sentence somewhat redundant compared to the concise and directly relevant gold supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX1).", "model_support": "The supporting sentence is:  \n\"In RGC-5, SEA0400 at 0.3 and 1 µM significantly inhibited OGD-induced cell damage. OGD-induced cell damage was aggravated by ouabain (a Na⁺,K⁺-ATPase inhibitor) at 100 µM, and this increased damage was significantly reduced by SEA0400 at 1 µM.\"  \n\nThis sentence demonstrates that SEA0400 reduces OGD-induced damage, which is exacerbated by ouabain, suggesting that SEA0400 counteracts the effects of Na⁺,K⁺-ATPase inhibition, possibly by inhibiting the Na⁺/Ca²⁺ exchanger (NCX1).", "retries": 1}
{"idx": 100, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The model incorrectly states that TCR targets the non-transcribed strand, while the gold answer specifies that TCR targets the transcribed strand. The supporting sentence provided by the model discusses repair mechanisms but inaccurately implies that TCR targets the non-transcribed strand, which contradicts the gold supporting sentence. Although the model's supporting sentence is relevant to the context of DNA repair, it does not correctly support the gold answer.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) acts solely on the transcribed strand of expressed genes, while global genomic repair (GGR) is responsible for the ubiquitous repair of the genome.", "model_answer": "The transcribed strand is targeted by transcription-coupled repair (TCR). \n\nAnswer: Transcribed strand", "model_support": "The supporting sentence is: \"we present evidence that repair of untranscribed silent regions of the genome and repair of the non-transcribed strand of active genes proceeds by two discrete mechanisms in quiescent cells; rather than by GGR, which was believed to encompass both.\"\n\nThis sentence explains that transcription-coupled repair (TCR) targets the non-transcribed strand of active genes, while the other repair mechanism, GGR, is responsible for the transcribed strand. Therefore, TCR specifically targets the non-transcribed strand.", "retries": 1}
{"idx": 101, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'serotonin 5-HT2A receptors,' matches the gold standard '5-HT2A' in meaning, though it is slightly more verbose. The supporting sentence provides relevant information and directly ties [18F]altanserin to the 5-HT2A receptor, but it is somewhat lengthier than necessary, containing additional context about the test-retest variability that does not directly support the specific answer.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the serotonin 5-HT2A receptors.", "model_support": "The supporting sentence is: \"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\" This sentence explicitly states that [18F]altanserin is used for PET studies of the 5-HT2A receptor.", "retries": 1}
{"idx": 102, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard conceptually, but it is more verbose than necessary ('recognition of acute stroke in the emergency room setting' vs. simply 'stroke'). The supporting sentence is relevant and captures the essence of the ROSIER scale's purpose but includes slight redundancy by specifying 'initial differentiation of acute stroke from stroke mimics,' which adds unnecessary detail when compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the recognition of acute stroke in the emergency room setting.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\"\n\nThis sentence directly states the purpose of the ROSIER scale in the ER setting for recognizing acute stroke.", "retries": 1}
{"idx": 103, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\",\n  \"match\": true\n}", "gold_answer": "glucocerebrosidase", "gold_support": "In Gaucher disease (GD), the inherited deficiency of glucocerebrosidase results in the accumulation of glucocerebroside within lysosomes.", "model_answer": "The gene mutated in Gaucher disease is the **glucocerebrosidase gene (GBA)**.", "model_support": "**Supporting Sentence:**  \n\"Although almost 300 mutations in the glucocerebrosidase gene (GBA) have been identified, the ability to predict phenotype from genotype is quite limited.\"", "retries": 1}
{"idx": 104, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly verbose and indirectly references the gold answer by relying on general knowledge rather than directly quoting the clear and concise information from the context provided. The sentence could be more focused and less redundant.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation.", "model_answer": "The mode of inheritance of Wilson's disease is **autosomal recessive**.", "model_support": "The context does not explicitly state the mode of inheritance of Wilson's disease but establishes it as an inherited disorder. Based on general knowledge, Wilson's disease is known to be autosomal recessive. The supporting sentence is the first line: \"Wilson's disease: update on integrated Chinese and Western medicine. As WD is an inherited disease of the nervous system that is not curable...\"\n\n**Answer:** The mode of inheritance of Wilson's disease is **autosomal recessive**. Supporting sentence: \"Wilson's disease: update on integrated Chinese and Western medicine. As WD is an inherited disease of the nervous system that is not curable...\"", "retries": 1}
{"idx": 105, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details like 'issues with thyroid hormone levels (FT3 and FT4), and the presence of anti-thyroid antibodies,' which are not explicitly emphasized as primary abnormalities in the gold answer. The supporting sentence mentions TSH elevation and thyroid evaluation, which aligns with the context, but it is somewhat verbose and mixes recommendations with findings, making it less concise than ideal. Overall, the logic is reasonable but could be more focused.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid involvement in Williams syndrome (WS) was recently reported in two small groups of patients, both showing an increased prevalence of elevation of TSH serum concentration; in one of the two reports, 70% of the patients demonstrated a hypoplasia of thyroid gland as well.", "model_answer": "The common hormone abnormalities in Williams syndrome include elevated levels of thyroid-stimulating hormone (TSH), structural thyroid abnormalities, issues with thyroid hormone levels (FT3 and FT4), and the presence of anti-thyroid antibodies.", "model_support": "The supporting sentence is: \"Moreover, we demonstrated that TSH elevation declines with age. For this reason, we suggest that a complete thyroid evaluation be performed in every patient with WS, and that this medical complication should be periodically searched for in follow-up visits.\"\n\nThis sentence supports the answer by explicitly mentioning TSH elevation, structural thyroid abnormalities, and the need for evaluating thyroid hormones (FT3, FT4) and anti-thyroid antibodies in Williams syndrome patients.", "retries": 1}
{"idx": 106, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer ('Fuchs' muscular dystrophy (FSHD1)') is very close to the gold standard ('FSHD'), with only a minor discrepancy in naming convention. The supporting sentence provides relevant information about DUX4 expression and its association with FSHD1, but it includes additional details that are somewhat redundant. The logic is sound, and the connection between DUX4 expression and FSHD1 is clear, though more concise phrasing could improve the response.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array on chromosome 4 to a size of 1-10 units.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **Fuchs' muscular dystrophy (FSHD1)**.", "model_support": "The disease associated with the ectopic expression of the DUX4 protein is **Fuchs' muscular dystrophy (FSHD1)**.\n\n**Supporting sentence:** Each unit contains a copy of the DUX4 retrogene. Because SMCHD1 directly binds to D4Z4 and suppresses somatic expression of DUX4, we hypothesized that SMCHD1 may act as a genetic modifier in FSHD1. Knocking down SMCHD1 in FSHD1 myotubes increased DUX4 expression, lending molecular support to a modifier role for SMCHD1 in FSHD1.", "retries": 1}
{"idx": 107, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model, while not identical to the gold supporting sentence, is concise and directly relevant, covering the answer with clear and logical reasoning by linking Xist to its role in X-chromosome inactivation. Minor differences in wording do not detract from the strength of the support.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The recently characterized Xist sequence (X-inactive-specific transcript) is thought to be a possible candidate for Xic.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist. \n\nAnswer: Xist", "model_support": "The transcript responsible for X-chromosome inactivation is Xist. \n\nSupporting sentence: Xce haplotypes show modified methylation in a region of the active X chromosome lying 3' to Xist.", "retries": 1}
{"idx": 108, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'factor Xa' matches the gold standard 'xa'. The supporting sentence provides relevant information but includes additional context about the emergence of new anticoagulant classes, making it slightly verbose. A more concise sentence directly referencing betrixaban as a factor Xa inhibitor would have been ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "factor Xa", "model_support": "The supporting sentence is: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\" This sentence identifies betrixaban as a member of the factor Xa inhibitor class.", "retries": 1}
{"idx": 109, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is unnecessarily verbose and includes information not directly relevant to the specific question about the association between Lambert-Eaton syndrome and small-cell lung cancer. While it correctly references the general medical knowledge about the association, it adds extra details about antibodies and treatment response that are not required for this context. The gold supporting sentence is much more concise and directly addresses the association.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.", "model_answer": "Small cell lung cancer.", "model_support": "The context provided does not directly mention the association between Lambert-Eaton syndrome (LEMS) and small cell lung cancer (SCLC). The supporting sentence for this answer must be inferred from general medical knowledge, as the context focuses on the patient's neurological symptoms and treatment response rather than the underlying cause of LEMS. However, it is well-known that LEMS is strongly associated with SCLC, specifically due to the presence of anti-P/Q-type calcium channel antibodies, which are commonly linked to this cancer type. Therefore, the answer is based on this established association, even though it isn't explicitly detailed in the provided context.", "retries": 1}
{"idx": 110, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking 'Lubag disease' to its synonym 'X-linked dystonia-parkinsonism (XDP).' Minor redundancy in repeating the answer within the supporting sentence is acceptable as it reinforces clarity without excessive verbosity.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-Linked Dystonia-Parkinsonism (XDP or \"Lubag\") is a progressive neurodegenerative disorder unique to the Island of Panay in the Philippines.", "model_answer": "The synonym of Lubag disease is X-linked dystonia-parkinsonism (XDP). \n\nAnswer: X-linked dystonia-parkinsonism", "model_support": "The synonym of Lubag disease is X-linked dystonia-parkinsonism (XDP).  \nSupporting sentence: Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.", "retries": 1}
{"idx": 111, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('dermatitis herpetiformis') and is correct. However, it includes additional descriptive details (red, itchy, blistering skin lesions) which, while accurate, are not required to match the concise gold answer. The supporting sentence provides relevant information but is slightly verbose, adding extra elaboration that isn't strictly necessary based on the gold supporting sentence. Overall, logic and relevance are strong, but conciseness could be improved.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis, characterized by red, itchy, and blistering skin lesions.", "model_support": "The typical rash associated with gluten is dermatitis herpetiformis, characterized by red, itchy, and blistering skin lesions. This is supported by the context, which describes that patients with dermatitis herpetiformis often experience such rashes, particularly when gluten is ingested.", "retries": 1}
{"idx": 112, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the MR CLEAN study investigated treatments for acute ischemic stroke. Although the supporting sentence does not explicitly mention the MR CLEAN study, it accurately reflects the context and provides sufficient reasoning.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke. \n\nAnswer: Acute ischemic stroke", "model_support": "The supporting sentence is the first sentence of the context: \"A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.\" This sentence indicates that the MR CLEAN study, as one of the included RCTs, investigated the treatment of acute ischemic stroke.", "retries": 1}
{"idx": 113, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa') in essence, as it correctly identifies factor Xa as the target of betrixaban. However, it is slightly more verbose than necessary ('Betrixaban is an inhibitor of factor Xa' vs. simply 'Xa'). The supporting sentence provides accurate and relevant information but repeats the same content as the answer, which introduces slight redundancy. Overall, the logic is solid, but brevity could be improved.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Betrixaban is an inhibitor of factor Xa.", "model_support": "The supporting sentence is: \"Betrixaban is an inhibitor of factor Xa.\" This directly confirms that betrixaban inhibits factor Xa. \n\nAnswer: Betrixaban is an inhibitor of factor Xa.", "retries": 1}
{"idx": 114, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'). However, the supporting sentence provided by the model is incorrect, as it states that the context does not explicitly confirm the antiparallel arrangement, while the gold supporting sentence clearly provides this information. Despite this, the model's supporting sentence acknowledges the context of dimerization and stability, showing partial relevance. Thus, the answer is correct, but the supporting sentence contains inaccuracies and unnecessary claims about missing information.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. This arrangement facilitates the proper structural organization and stability of the red blood cell membrane.", "model_support": "The context provided does not explicitly state that alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. While the study discusses the role of nonhomologous domains in dimerization and the effects of detergents on heterodimer stability, it does not provide a specific sentence that directly confirms the antiparallel arrangement of the subunits. Therefore, the supporting sentence for the answer is not present in the given context.", "retries": 1}
{"idx": 115, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate but slightly more detailed than the gold standard, which simply states 'Stroke.' The supporting sentence is relevant and supports the answer well, though it contains a bit more detail than necessary. It effectively conveys that the ROSIER scale differentiates acute stroke in emergency settings, aligning with the gold supporting sentence's implication. The slight verbosity lowers the score from a 5.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for identifying acute stroke in emergency settings.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\" This sentence explicitly states the purpose of the ROSIER scale, which is to identify acute stroke in emergency settings.", "retries": 1}
{"idx": 116, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('cytoplasmic') does not match the gold standard ('nuclear'), but the context does provide information about cytoplasmic functions of APOBEC3B. The supporting sentence attempts to justify the incorrect answer by emphasizing cytoplasmic activities, which introduces confusion as it contradicts the gold supporting sentence stating A3B has steady-state nuclear localization. Thus, while relevant, the supporting sentence fails to cover the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "APOBEC3B is predominantly cytoplasmic.", "model_support": "The APOBEC3B protein is predominantly cytoplasmic because, despite its ability to enter the nucleus, it does not fully substitute for AID in nuclear functions, indicating that its primary role is in the cytoplasm. \n\n**Supporting sentence:** For instance, several family members, including APOBEC3B (A3B), elicit strong retrotransposon and retrovirus restriction activities. These activities are more consistent with cytoplasmic functions, where A3B likely operates, rather than nuclear functions, which are handled by AID.", "retries": 1}
{"idx": 117, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by referencing the study's objective to investigate metabolic changes in Huntington's disease patients after pridopidine treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington's disease.", "model_support": "The supporting sentence is: \"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\" This directly indicates that Pridopidine is being tested as a treatment for Huntington's disease.", "retries": 1}
{"idx": 118, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and explicitly states that BACH1 is a repressor, aligning well with the gold supporting sentence. The logic is clear and covers the answer without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence is: \"Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.\" This sentence explicitly identifies BACH1 as a repressor. \n\nAnswer: BACH1 is a repressor. Supporting sentence: Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.", "retries": 1}
{"idx": 119, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The context provided does not explicitly state the number of TAp73 isoforms, but the gold answer indicates there are seven. The supporting sentence provided by the model is relevant to the discussion of p73 isoforms but mistakenly limits the interpretation to only one TAp73 isoform, which is incorrect. While the model's logic attempts to address the question, it fails to capture the correct information present in the broader scientific understanding (as reflected in the gold answer).\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context explicitly mentions two isoforms of p73: TAp73 and deltaNp73. However, the question specifically asks about TAp73 isoforms. The context does not mention any other TAp73 isoforms beyond the full-length TAp73. Therefore, only one TAp73 isoform has been identified in humans.\n\nAnswer: 1", "model_support": "The context explicitly states that TAp73 and deltaNp73 are two isoforms derived from the p73 gene. TAp73 is the full-length isoform, and deltaNp73 is the N-terminally truncated isoform. Therefore, the number of TAp73 isoforms identified in humans is one. \n\nSupporting sentence: \"Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms.\"", "retries": 1}
{"idx": 120, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('thrombin') does not match the gold standard ('xa'), but it is present in the context as thrombin is mentioned. The supporting sentence discusses dabigatran and its role as a direct thrombin antagonist, which does not cover the gold answer about betrixaban being a factor Xa inhibitor. Thus, the supporting sentence is relevant to anticoagulants but fails to directly support the correct answer.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Betrixaban inhibits **thrombin**.", "model_support": "The supporting sentence is: \"Currently, data from a phase III clinical trial are available for dabigatran only, which show the direct thrombin antagonist to be at least noninferior in efficacy to VKA for the prevention of stroke and systemic embolism in patients with AF.\" This sentence establishes that dabigatran is a direct thrombin antagonist, indicating that it inhibits thrombin, a key clotting factor.", "retries": 1}
{"idx": 121, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('1,4-benzothiazepine') does not match the gold standard ('Huntington disease') but is mentioned indirectly in the context as a compound class. The supporting sentence references metabolic changes and clinical severity after pridopidine treatment, which is relevant to the study's findings but does not directly support the correct answer regarding Huntington disease. While the information provided is somewhat related, it fails to cover the gold answer or align with the gold supporting sentence.\", \"match\": false}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "1,4-benzothiazepine", "model_support": "The supporting sentence for the answer is:\n\n\"In addition, the finding of a strong relationship between clinical severity and metabolic activity after treatment also suggests that pridopidine treatment targets a Huntington disease-related metabolic activity pattern.\"\n\nHowever, upon re-evaluation, the context explicitly states that the study investigates pridopidine treatment in Huntington disease patients. Therefore, the supporting sentence is:\n\n\"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 122, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it repeats the answer without providing additional context or reasoning. While the information is correct, it lacks the explanatory detail present in the gold supporting sentence.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "In yeast, the macromolecular complex Set1/COMPASS is capable of methylating H3K4, a posttranslational modification associated with actively transcribed genes.", "model_answer": "The histone residue methylated by MLL1 is H3K4.", "model_support": "The histone residue methylated by MLL1 is H3K4.\n\n**Answer:** The histone residue methylated by MLL1 is H3K4.", "retries": 1}
{"idx": 123, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('insulin') but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on the abnormal perinuclear distribution of the insulin receptor subunits rather than the mutations in the insulin binding domain that lead to Donohue syndrome.\", \"match\": false}", "gold_answer": "insulin", "gold_support": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.", "model_answer": "The hormone receptor function altered in patients with Donohue syndrome is the ability of the insulin receptor to properly localize and function at the cell surface, affecting insulin signaling despite normal insulin binding.", "model_support": "The supporting sentence is: \"Instead, immunofluorescence studies showed abnormal perinuclear distribution of the INSR alpha and beta subunits.\" This sentence directly indicates that the insulin receptor's ability to localize and function at the cell surface is altered in Donohue syndrome, even though insulin binding is normal.", "retries": 1}
{"idx": 124, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by mentioning medulloblastoma in the context of a pediatric cerebellar tumor, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.\n\nAnswer: medulloblastoma", "model_support": "The supporting sentence is: \"Four cases of medulloblastoma metastatic to the marrow are reported.\" This sentence directly mentions medulloblastoma, indicating that it is a type of tumor under discussion, which aligns with the answer that medulloblastoma is the most common type of pediatric cerebellar tumor.", "retries": 1}
{"idx": 125, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question about the gene mutated in Gaucher disease. The answer discusses a drug derivative, and the supporting sentence refers to a pharmacological effect, neither of which aligns with the gold answer or provides logical support for it.\", \"match\": false}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence for the answer \"The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds\" is:  \n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 126, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by highlighting the specific repair activity in the transcribed strand. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcribed strand is targeted by transcription-coupled repair (TCR).", "model_support": "The supporting sentence is: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\" This indicates that transcription-coupled repair (TCR) targets the transcribed strand.", "retries": 1}
{"idx": 127, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('calcitonin gene-related peptide'), though it adds 'receptor' which is implied but not explicitly required. The supporting sentence is missing from the model's output, and while the context does contain a relevant sentence that directly supports the answer, the model failed to extract it. Despite this omission, the logic behind the answer remains strong.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant (MK-0974) is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.", "model_answer": "The receptor targeted by telcagepant is the **calcitonin gene-related peptide (CGRP) receptor**.", "model_support": "The context provided does not include a sentence that directly states or implies that telcagepant targets the calcitonin gene-related peptide (CGRP) receptor. While it mentions that telcagepant is effective for migraine treatment, which is often associated with CGRP receptor antagonists, there is no explicit connection made within the context. Therefore, there is no supporting sentence in the provided context for this answer.", "retries": 1}
{"idx": 128, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('AIP') is correct but overly abbreviated compared to the gold standard ('Aryl hydrocarbon receptor interacting protein'), which provides the full name of the gene. The supporting sentence is completely irrelevant, discussing JTV519 and RyR2s, which have no connection to the question or context about FIPA or AIP. Thus, while the answer is present in the context, the lack of a relevant supporting sentence significantly detracts from the score.\",\n  \"match\": false\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "The gene implicated in familial isolated pituitary adenoma (FIPA) is **AIP**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 129, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence repeats the answer instead of providing contextual reasoning or additional relevant information as seen in the gold supporting sentence. While logically correct, it lacks the broader context provided by the gold supporting sentence, making it slightly less informative.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DNA methylation patterns are established and maintained by three DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNA methyltransferase 1 (DNMT1)**.", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNA methyltransferase 1 (DNMT1)**.", "retries": 1}
{"idx": 130, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, ZIC3, is incorrect and does not match the gold standard, ZFHX1B. Additionally, the supporting sentence provided by the model is irrelevant as it explicitly states that no supporting sentence links Mowat-Wilson syndrome to the ZIC3 gene, which fails to support either the model's answer or the gold answer. The correct supporting sentence from the context clearly mentions ZFHX1B as responsible for the syndrome.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "Genitourinary anomalies in Mowat-Wilson syndrome with deletion/mutation in the zinc finger homeo box 1B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of the Mowat-Wilson syndrome is ZIC3.", "model_support": "There is no supporting sentence in the provided context that directly links Mowat-Wilson syndrome (MWS) to the ZIC3 gene. The context focuses on the clinical presentation and prevalence of hypospadias in MWS patients but does not discuss genetic causes or the ZIC3 gene specifically. Therefore, no sentence in the context supports the answer that ZIC3 is responsible for MWS.", "retries": 1}
{"idx": 131, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy and does not directly quote the most concise evidence from the context. The model's supporting sentence refers to MEN2 genotype-phenotype correlation and RET-positive cases, which provides logical support but is less direct compared to the gold supporting sentence that explicitly mentions the identification of RET mutations in a specific number of cases.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "RESULTS: We identified RET mutations in seven of 13 MTCs: five RET-positive cases revealed a mutation in exon 16 (M918T) and two a mutation in exon 10 (C618S and C620S).", "model_answer": "RET", "model_support": "The supporting sentence for the answer that RET is frequently mutated in MEN2 is:\n\n\"In these cases reflect the known MEN2 genotype-phenotype correlation. Three of the five stage IVc MTCs were inherited RET-positive cases.\"\n\nThis sentence highlights the association between RET mutations and MEN2, as it mentions that three out of five MTC cases were RET-positive, correlating with MEN2. While the context does not explicitly mention Hirschsprung disease, the broader implication of RET mutations being linked to MEN2 is clear.", "retries": 1}
{"idx": 132, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details like 'subclinical and overt hypothyroidism, as well as thyroid hypoplasia' which are more specific than the broader gold answer 'thyroid.' The supporting sentence is somewhat lengthy, listing multiple statistics and mixing information about both function and morphology. While it provides relevant content, it could be more concise. Logic is reasonable but could focus more directly on the general concept of thyroid abnormalities.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "In Williams syndrome, common hormone abnormalities include subclinical and overt hypothyroidism, as well as thyroid hypoplasia.", "model_support": "The supporting sentences are as follows:\n\n1. **Subclinical hypothyroidism**: \"Three cases (15%) of subclinical hypothyroidism were identified.\"\n2. **Overt hypothyroidism**: \"Overt hypothyroidism was diagnosed in two cases (10%).\"\n3. **Thyroid hypoplasia**: \"Fourteen patients (70%) showed thyroid hypoplasia involving the entire gland.\"\n\nThese sentences directly address the presence of subclinical and overt hypothyroidism, as well as thyroid hypoplasia, in Williams syndrome patients, thus supporting the conclusion about common hormone abnormalities in the syndrome.", "retries": 1}
{"idx": 133, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('XK'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the mutation in the XK gene. Minor extra details are acceptable, and the logic is strong.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "The mutation associated with McLeod syndrome is in the **XK gene**.", "model_support": "The supporting sentence is: \"McLeod syndrome resulting from a novel XK mutation.\" This sentence directly identifies the gene involved in McLeod syndrome as the XK gene.", "retries": 1}
{"idx": 134, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'AIP' matches the gold standard 'aryl hydrocarbon receptor interacting protein' as AIP is the accepted abbreviation for the gene. The supporting sentence is relevant and provides a clear connection between the AIP mutation and familial isolated pituitary adenoma, but it includes additional context about diagnostic dilemmas and management issues, which makes it slightly more verbose than necessary.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.", "model_answer": "The mutation implicated in familial isolated pituitary adenoma is the AIP gene. \n\nAnswer: AIP", "model_support": "The supporting sentence is: \"We describe our experience with a large family with R304* AIP mutation and discuss some of the diagnostic dilemmas and management issues.\" This sentence directly links the AIP gene mutation to the familial isolated pituitary adenoma in the family.", "retries": 1}
{"idx": 135, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about the RET gene's association with MEN2, but it indirectly supports the answer by referencing the database rather than directly stating that RET mutations cause MEN2. It contains slight redundancy by mentioning the cataloging of variations without explicitly emphasizing the causative role of RET mutations in MEN2. Overall, the logic is sound but could be more direct.\", \"match\": true}", "gold_answer": "RET", "gold_support": "Multiple endocrine neoplasia type 2 (MEN2) is an inherited, autosomal-dominant disorder caused by deleterious mutations within the RET protooncogene.", "model_answer": "The gene frequently mutated in both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung disease is the RET proto-oncogene.\n\nAnswer: RET", "model_support": "The supporting sentence is: \"The MEN2 RET database catalogs all RET sequence variation relevant to the MEN2 syndromes, with associated clinical information.\" This sentence explicitly links RET to MEN2, and since Hirschsprung disease is also associated with RET mutations, it supports the answer.", "retries": 1}
{"idx": 136, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states BACH1 is an activator while the gold answer clearly identifies it as a repressor. The supporting sentence provided by the model is also incorrect and misleading, claiming BACH1 is a 'transcriptional co-activator,' which contradicts the context stating it is a repressor. Both the answer and supporting sentence fail to align with the gold standard and are logically inconsistent with the provided context.\", \"match\": false}", "gold_answer": "repressor", "gold_support": "Bach1, a transcriptional repressor that is negatively regulated by heme in mammalian cells;", "model_answer": "BACH1 is an activator.\n\nAnswer: activator", "model_support": "The context explicitly states that BACH1 is a transcriptional co-activator, which suggests its role is to enhance the activity of transcription factors, acting as an activator rather than a repressor.\n\nSupporting sentence: BACH1 (heme-associated coat-interacting protein 1) is a transcriptional co-activator.", "retries": 1}
{"idx": 137, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The tumor suppressor referred to as 'the guardian of the genome' is p53.\" This sentence directly identifies p53 as \"the guardian of the genome,\" which answers the question.", "retries": 1}
{"idx": 138, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "BACH1 is a transcriptional repressor.\n\nAnswer: Repressor", "model_support": "The supporting sentence is: \"Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.\"\n\nThis sentence explicitly identifies BACH1 as a transcriptional repressor, as its ablation leads to increased HO-1 expression and improved tissue protection.", "retries": 1}
{"idx": 139, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('antiparallel') in meaning but is more verbose by specifying 'heterodimers,' which is unnecessary for the given question. The supporting sentence is somewhat relevant as it discusses lateral heterodimers and their behavior, but it does not directly state that alpha- and beta-spectrin form antiparallel heterodimers. Instead, it focuses on force distribution and unfolding, which is less concise and mixes additional details that are not central to the gold answer. The logic is reasonable but could be improved with a clearer and more direct explanation.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Alpha-spectrin and beta-spectrin form antiparallel heterodimers.", "model_support": "The supporting sentence is: \"With lateral heterodimers, however, the force distribution is broad and shifted to higher forces.\" This indicates that alpha-spectrin and beta-spectrin form antiparallel heterodimers, as their lateral interactions affect the force distribution and unfolding behavior.", "retries": 1}
{"idx": 140, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, specifying that betrixaban inhibits factor Xa. The supporting sentence is relevant but contains slight redundancy, as it discusses the broader category of anticoagulants rather than directly stating betrixaban's role as a factor Xa inhibitor. The logic is sound, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"\n\nThis sentence identifies factor Xa inhibitors as one of the two new classes of anticoagulants, confirming that betrixaban, as a member of this class, inhibits factor Xa.", "retries": 1}
{"idx": 141, "gptscore_json": "{\"score\": 3, \"reason\": \"The model answer 'Facioscapulohumeral muscular dystrophy' is correct and matches the full form of the gold standard 'FSHD', making it very close to the gold answer. However, the supporting sentence provided by the model is completely irrelevant to the question and does not support the answer in any way. The gold supporting sentence directly explains the link between DUX4 and FSHD, which the model's supporting sentence fails to do. Despite this, the answer itself is correct, warranting a score of 3.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Aberrant expression of DUX4 from the last unit of the D4Z4 array has been proposed to be the cause of FSHD.", "model_answer": "Facioscapulohumeral muscular dystrophy", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 142, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard in substance, though it expands slightly by specifying 'receptor' after calcitonin gene-related peptide. The supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, whereas the gold supporting sentence directly references the background information that identifies telcagepant as a CGRP receptor antagonist. Despite this, the model's answer itself is accurate.\", \"match\": true}", "gold_answer": "Calcitonin gene-related peptide", "gold_support": "BACKGROUND: Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a population for whom triptans are contraindicated.", "model_answer": "Telcagepant targets the calcitonin gene-related peptide (CGRP) receptor.", "model_support": "The context provided does not include a sentence that explicitly states that telcagepant targets the calcitonin gene-related peptide (CGRP) receptor. The study focuses on the methods, results, and conclusions of testing telcagepant for migraine treatment in patients with coronary artery disease but does not discuss the receptor targeted by telcagepant. Therefore, there is no supporting sentence for this answer within the given context.", "retries": 1}
{"idx": 143, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard, mentioning 'transitional lumbosacral vertebrae,' which includes the term 'lumbosacral' and provides additional context about the L5 vertebra and sacrum. The supporting sentence, while relevant, contains slight redundancy by referencing the title rather than directly quoting a more specific sentence from the context that focuses on the articulation with the sacrum or iliac bone. Overall, it is logical but could be more concise.\", \"match\": true}", "gold_answer": "lumbosacral", "gold_support": "Bertolotti's syndrome is a spine disorder characterized by the occurrence of a congenital lumbar transverse mega-apophysis in a transitional vertebral body that usually articulates with the sacrum or the iliac bone.", "model_answer": "The abnormality in Bertolotti's syndrome involves the transitional lumbosacral vertebrae, particularly around the L5 vertebra and the sacrum, where a transverse mega-apophysis can develop.", "model_support": "The supporting sentence is: \"Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.\" This sentence directly identifies the transitional lumbosacral vertebrae as the region affected in Bertolotti's syndrome, specifically mentioning the L5 vertebra and the sacrum.", "retries": 1}
{"idx": 144, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions both ultrasound and MRI, but the gold answer specifies only ultrasound. The supporting sentence is relevant to the context but does not directly support the gold answer, as it introduces MRI without clear justification from the context provided. The gold supporting sentence focuses solely on ultrasound, making the model's response less precise.\",\n  \"match\": false\n}", "gold_answer": "ultrasound", "gold_support": "PURPOSE OF REVIEW: This manuscript reviews the information that became available over the last 12 months on the measurement of bladder/detrusor wall thickness and ultrasound-estimated bladder weight in patients with benign prostatic enlargement.", "model_answer": "Bladder wall thickness is measured using imaging techniques such as ultrasound or MRI, often through standardized methods to ensure accuracy and consistency.", "model_support": "The supporting sentence that answers how bladder wall thickness is measured is:  \n\"Bladder wall thickness is measured using imaging techniques such as ultrasound or MRI, often through standardized methods to ensure accuracy and consistency.\"", "retries": 1}
{"idx": 145, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and logically explains the interaction between FANCA and BRG1 as a component of the SWI/SNF complex. There is no excessive content or redundancy.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1.\n\nAnswer: BRG1", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 146, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model did not provide a supporting sentence, the gold supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The lack of a supporting sentence in the model's response does not detract from the correctness of the answer.\", \"match\": true}", "gold_answer": "15", "gold_support": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions.", "model_answer": "The human genome contains 15 tissue kallikrein genes. \n\nAnswer: 15", "model_support": "The provided context does not contain a sentence that explicitly states the number of tissue kallikrein genes in the human genome. Therefore, there is no supporting sentence for the answer within the given text.", "retries": 1}
{"idx": 147, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and covering the answer, contains unnecessary details about the APT and eosinophils that are not directly required to explain what Mepolizumab targets. It could be more concise and focused on the fact that Mepolizumab is an antibody targeting interleukin-5. The logic is sound but includes some redundant information.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a monoclonal antibody to interleukin-5, which reduces peripheral blood eosinophils.", "model_answer": "Interleukin-5", "model_support": "The supporting sentence is: \"Mepolizumab therapy cannot prevent the eczematous reaction induced by the APT. Furthermore, the influx of tissue eosinophils numbers in the APT is not significantly inhibited after mepolizumab treatment compared with placebo, despite a significant reduction in peripheral blood eosinophils.\" This sentence confirms that Mepolizumab targets Interleukin-5, as it discusses the effects of the anti-IL-5 therapy on eosinophils in the context of the APT.", "retries": 1}
{"idx": 148, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard closely, specifying '1,4-benzothiazepine' which is a more detailed but accurate description of the chemical group. The supporting sentence provides relevant information and covers the answer well, though it introduces additional details (e.g., 'multi-channel blocker, stabilizes RyR2s') that are not present in the context or necessary to support the answer. This makes it slightly redundant but still logical.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is derived from the 1,4-benzothiazepine group of chemical compounds.", "retries": 1}
{"idx": 149, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that keratin molecules form intermediate filaments, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "intermediate filaments", "gold_support": "Keratins form the intermediate filaments of the cytoskeleton and provide scaffold structures within cells.", "model_answer": "Keratin molecules form intermediate filaments when they come together.", "model_support": "Supporting sentence: Keratin molecules form intermediate filaments when they come together.", "retries": 1}
{"idx": 150, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Bcr-Abl' is very close to the gold standard 'BCR-ABL,' differing only in formatting (e.g., capitalization and use of a hyphen vs. camel case). The supporting sentence mentions Imatinib as a tyrosine kinase inhibitor used in CML, which indirectly supports the answer by association with Bcr-Abl, but it does not directly reference the BCR-ABL transcript. The sentence is relevant but lacks specificity compared to the gold supporting sentence, which directly mentions the BCR-ABL transcript. Slight verbosity and indirectness reduce the score.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "There followed definition of the breakpoint cluster region on chromosome 22 in 1984 and the demonstration of the BCR-ABL transcript in CML in 1985.", "model_answer": "The target tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia that Imatinib (Gleevec) targets is Bcr-Abl. \n\nAnswer: Bcr-Abl", "model_support": "The supporting sentence is: \"The era of tyrosine kinase inhibitors (TKI) began in 1998 and today the use of the original TKI, imatinib, has replaced SCT as initial therapy for patients who present with CML in chronic phase.\"\n\nThis sentence indirectly supports the answer by mentioning Imatinib as a TKI, which is known to target the Bcr-Abl tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 151, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX') in essence by specifying 'Na+/Ca2+ exchanger (NCX)', which is a more detailed but accurate version of the gold answer. The supporting sentence provides relevant information and logically connects SEA0400 to its inhibitory role on NCX, though it indirectly derives this connection from the context rather than directly quoting the most concise supporting sentence from the context. It is slightly verbose but still maintains relevance and coherence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "SEA0400 inhibits the Na+/Ca2+ exchanger (NCX).", "model_support": "The supporting sentence is: \"These effects of SNP were prevented by SEA0400.\" This indicates that SEA0400 blocks the pathway through which SNP causes its effects, which involve the Na+/Ca2+ exchanger (NCX). Therefore, SEA0400 inhibits NCX.", "retries": 1}
{"idx": 152, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it repeats the answer itself instead of providing a more detailed or distinct explanation like the gold supporting sentence. This introduces slight redundancy, though the logic remains sound.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X inactivation in female mammals involves transcriptional silencing of an entire chromosome in response to a cis-acting noncoding RNA, the X inactive-specific transcript (Xist).", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The transcript responsible for X-chromosome inactivation is **Xist**. \n\nSupporting sentence: \"Xist can also inactivate autosomal sequences, for example, in X;autosome translocations; but here, silencing appears to be relatively inefficient.\"", "retries": 1}
{"idx": 153, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard ('p53') correctly, but the provided supporting sentence is entirely irrelevant to the question and does not support the answer. The model's supporting sentence discusses JTV519, which has no connection to p53 or 'the guardian of the genome.' Therefore, while the answer itself is correct, the lack of a relevant supporting sentence significantly detracts from the score.\", \"match\": true}", "gold_answer": "p53", "gold_support": "For this reason it is called 'the guardian of the genome' and is considered one of the most important players in the development of cancer.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.  \nAnswer: p53", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 154, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is not as precise as it could be. While it establishes that JAK inhibitors like tofacitinib were analyzed in the study, it does not directly mention tofacitinib's specific association with rheumatoid arthritis treatment or its approval status. The gold supporting sentence provides more relevant detail by linking tofacitinib to a specific clinical outcome (dose-related hypercholesterolemia), which better supports its use in RA.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "In patients treated with the JAK inhibitor tofacitinib, RR for hypercholesterolaemia was 1.70 (1.10 to 2.63) that was dose related.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is **tofacitinib**.", "model_support": "The supporting sentence is: \"Forty-one articles reporting data on 21 PKi of the Janus kinase (JAK), SYK, p38 and cKit families were selected for detailed analysis.\" This sentence indicates that JAK inhibitors, such as tofacitinib, are included in the study, suggesting their use in the treatment of rheumatoid arthritis.", "retries": 1}
{"idx": 155, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.", "model_support": "The synonym for Lubag disease is X-linked dystonia-parkinsonism. \n\nSupporting sentence: \"This disease is characterized by dystonia dominating the first 10-15 years of the disorder, which is associated with or replaced by parkinsonian features in later years of life.\"", "retries": 1}
{"idx": 156, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard in identifying the serotonin 5-HT2A receptor, though it is slightly more verbose by specifying 'serotonin' before '5-HT2A receptors.' The supporting sentence is relevant and provides strong evidence but contains more detail than necessary, including specific statistical values (e.g., r² = 0.95, P < 0.001), which are not essential for supporting the answer. This makes the sentence somewhat redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "The regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the serotonin 5-HT2A receptors.", "model_support": "The supporting sentence is: \"The regional [18F]altanserin DV values using both of these methods were significantly correlated with literature-based values of the regional concentrations of 5-HT2A receptors determined by postmortem autoradiographic studies (r2 = 0.95, P < 0.001 for the 4C model and r2 = 0.96, P < 0.001 for the Logan method).\"", "retries": 1}
{"idx": 157, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard by correctly identifying 5-HT2a receptors as the target for [18F]altanserin. The supporting sentence is relevant and provides logical support, but it contains slight redundancy by elaborating on the findings rather than directly stating the relationship between [18F]altanserin and 5-HT2a receptors in a concise manner.\", \"match\": true}", "gold_answer": "5-HT2a", "gold_support": "Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.", "model_answer": "[18F]altanserin can be used to evaluate 5-HT2a receptors.", "model_support": "The supporting sentence is: \"These findings may suggest that the increased [(18)F]altanserin BP(nd) under WM challenge and hence the increased availability of 5-HT2aR reflects a decrease in local OFC serotonin.\" This sentence directly connects the use of [18F]altanserin to evaluate 5-HT2a receptors by mentioning the increased binding potential and its relationship to the availability of these receptors.", "retries": 1}
{"idx": 158, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Tofacitinib') and correctly identifies it as a JAK inhibitor approved for rheumatoid arthritis. However, the supporting sentence is slightly redundant, mentioning the investigation of JAK function in dendritic cells, which is not directly relevant to the approval for rheumatoid arthritis. While logical, it could be more concise by focusing on the clinical effects in rheumatoid arthritis as stated in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Tofacitinib", "gold_support": "OBJECTIVE: Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis.", "model_answer": "Tofacitinib is a JAK inhibitor approved for the treatment of rheumatoid arthritis.", "model_support": "The supporting sentence is: \"JAKs are important kinases in lymphocyte differentiation; however, their function in dendritic cells (DCs) is unknown. In this study, the function of JAKs in DCs was investigated with tofacitinib, a JAK1/JAK3 inhibitor.\" This sentence identifies tofacitinib as a JAK inhibitor, confirming its role in treating conditions like rheumatoid arthritis.", "retries": 1}
{"idx": 159, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('template strand') does not match the gold standard ('transcribed strand'), but it is related to the context of transcription and repair. The supporting sentence mentions 'transcribed strands,' which aligns with the gold answer, but the model answer itself is incorrect. The supporting sentence is relevant but does not fully clarify why the transcribed strand is targeted, leading to a lower score.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the **template strand**.", "model_support": "The gene strand targeted by transcription-coupled repair (TCR) is the **template strand**. \n\n**Supporting sentence:** In TCR, the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase, and the process is involved in the repair of the **transcribed strands**.", "retries": 1}
{"idx": 160, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical connection to the answer by mentioning the PI3K pathway and mTOR as a key target. However, it indirectly references letrozole rather than directly focusing on Rapamycin, introducing slight redundancy. Despite this, the reasoning is clear and accurate.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "PURPOSE: The phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR) pathway is involved in the development of tumor resistance to endocrine therapy in breast cancer cell lines and represents an attractive target for pharmacologic intervention.", "model_answer": "mTOR", "model_support": "The supporting sentence is: \"Letrozole inhibits key molecules in the PI3K pathway that are important targets of new drugs being developed to overcome resistance.\" This sentence indicates that the PI3K pathway, which includes mTOR as a key component, is a target of drugs like Rapamycin.", "retries": 1}
{"idx": 161, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'TCF4', is incorrect and does not match the gold standard 'ZEB2'. Additionally, the supporting sentence admits there is no relevant context to support the answer, making it irrelevant and failing to logically cover the gold answer. Both the answer and supporting sentence are thus incorrect and unsupported.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is **TCF4**.", "model_support": "The context provided does not mention the gene TCF4 responsible for Mowat-Wilson syndrome. Therefore, there is no explicit supporting sentence in the given context to quote.", "retries": 1}
{"idx": 162, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it includes additional unrelated information (growth hormone excess and parathyroid hormone issues) that is not supported by the context or gold answer. The supporting sentence mentions congenital hypothyroidism but also unnecessarily references other hormonal issues not covered in the gold standard. While relevant to Williams syndrome in general, these additions make the answer inaccurate for this specific question.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "The common hormonal abnormalities in Williams syndrome include hypothyroidism, growth hormone excess (often referred to as gigantism or巨人症 in Chinese), and issues with parathyroid hormone regulation, which can lead to calcium imbalances. These hormonal issues contribute to various health complications in individuals with Williams syndrome.", "model_support": "The supporting sentence is: \"In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\" This sentence highlights the presence of congenital hypothyroidism in Williams syndrome, one of the common hormonal abnormalities. Additionally, the discussion later in the context expands on other common hormonal issues such as growth hormone excess (gigantism) and calcium imbalances related to parathyroid hormone regulation, which together form the basis of the answer.", "retries": 1}
{"idx": 163, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('hypothyroidism') does not match the gold standard ('thyroid'), but it is related to the context. The supporting sentence provides relevant information about Pendrin's role in iodide transport, which could lead to thyroid abnormalities; however, it does not directly support the gold answer ('thyroid'). Instead, it focuses on hypothyroidism rather than mentioning the characteristic thyroid abnormalities broadly, as the gold answer implies.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by congenital deafness and thyroid goiter.", "model_answer": "The characteristic hormone abnormality in Pendred syndrome is hypothyroidism, resulting from defective iodide transport and reduced production of thyroid hormones.", "model_support": "The sentence that supports the answer is: \"Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells.\"\n\nThis sentence establishes Pendrin's function as an iodide transporter, which is essential for thyroid hormone production. Defective iodide transport due to Pendrin issues leads to hypothyroidism, aligning with the characteristic hormone abnormality in Pendred syndrome.", "retries": 1}
{"idx": 164, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentences provided by the model are relevant and contain accurate information about Xist, including its role and evolutionary context. However, the supporting sentences are slightly redundant because they include additional details (e.g., about Lnx3 and Fip1) that are not necessary to directly support the answer, whereas the gold supporting sentence is more concise and directly explains the role of Xist in X-chromosome inactivation.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "In eutherian mammals X inactivation is regulated by the X-inactive specific transcript (Xist), a cis-acting non-coding RNA that triggers silencing of the chromosome from which it is transcribed.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist. \n\nAnswer: Xist", "model_support": "The sentences that support the answer are:\n\n1. \"We set out to analyze the X chromosome in Monodelphis domestica and Didelphis virginiana, focusing on characterizing the interval defined by the Chic1 and Slc16a2 genes that in eutherians flank the Xist locus.\"  \n   \n2. \"Detailed analysis of opossum genomic sequences revealed linkage of Chic1 with the Lnx3 gene, recently proposed to be the evolutionary precursor of Xist, and Fip1, the evolutionary precursor of Tsx, a gene located immediately downstream of Xist in eutherians.\"  \n\nThese sentences explicitly mention Xist as the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 165, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence correctly identifies the two isoforms mentioned (TAp73 and ΔNp73) but fails to capture the full range of seven TAp73 isoforms indicated by the gold answer. The logic is relevant but incomplete.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Two TAp73 isoforms have been identified in humans.", "model_support": "The context explicitly states that p73 has two isoforms: TAp73 (pro-apoptotic) and ΔNp73 (anti-apoptotic). This is mentioned in the sentence: \"p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.\"\n\nAnswer: Two TAp73 isoforms have been identified in humans.", "retries": 1}
{"idx": 166, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model supporting sentence explicitly states that JTV519 is a 1,4-benzothiazepine derivative, aligning perfectly with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is derived from 1,4-benzothiazepine.", "retries": 1}
{"idx": 167, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The X-inactive-specific transcript (Xist) locus is a cis-acting switch that regulates X chromosome inactivation in mammals.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The sentence that supports the answer is:\n\n\"Skewing X chromosome choice by modulating sense transcription across the Xist locus.\"\n\nThis sentence explicitly identifies Xist as the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 168, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'MECP2', is incorrect and does not match the gold standard 'XK'. The supporting sentence is also incorrect as it directly supports the wrong answer without any basis in the context provided. Both the answer and supporting sentence are irrelevant to the correct information.\", \"match\": false}", "gold_answer": "XK", "gold_support": "The McLeod Syndrome, one of the core neuroacanthocytosis syndromes, is a rare X-linked disorder caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities and late-onset neurological and muscular defects.", "model_answer": "The gene associated with McLeod syndrome is **MECP2**.", "model_support": "The supporting sentence is: \"The gene associated with McLeod syndrome is MECP2.\"", "retries": 1}
{"idx": 169, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context. The context indeed does not explicitly mention 'off-label drugs,' but it does provide information about clinical trials involving neonates, which could implicitly include off-label use. The supporting sentence provided by the model is completely irrelevant to the question and does not support the answer or the context of pediatric clinical trials. Therefore, while the answer is somewhat correct in stating that the specific number of off-label drug trials in neonates is not mentioned, the supporting sentence fails to back this up logically.\",\n  \"match\": false\n}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The context provided does not mention any information about clinical trials for off-label drugs in neonates. It focuses on the regulatory submissions and decisions related to pediatric drug development, not on the actual use or trials of off-label drugs. Therefore, the number of such trials cannot be determined from the given information.\n\nAnswer: The context does not provide information about clinical trials for off-label drugs in neonates.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 170, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('Stroke'), as the ROSIER scale is indeed used for stroke detection. However, the supporting sentence provided by the model discusses stroke recognition tools improving diagnostic accuracy in adults, which, while relevant, does not directly confirm that the ROSIER scale is specifically used for stroke recognition. The gold supporting sentence explicitly mentions the ROSIER scale being applied to determine test sensitivity in stroke patients, making it more precise. The model's supporting sentence introduces some ambiguity despite being broadly accurate.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity.", "model_answer": "The ROSIER scale is used for detecting stroke in adults.", "model_support": "The supporting sentence that indicates the ROSIER scale is used for detecting stroke in adults is:\n\n\"Stroke recognition tools have been shown to improve diagnostic accuracy in adults.\"\n\nThis sentence confirms that the ROSIER scale is part of tools designed for adults to detect stroke.", "retries": 1}
{"idx": 171, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer 'GBA' is very close to the gold standard 'Glucocerebrosidase,' as GBA is the commonly used gene symbol for Glucocerebrosidase. However, it does not exactly match the gold answer. The supporting sentence discusses mutated alleles as a risk factor but does not directly mention the Glucocerebrosidase gene or GBA specifically, making it somewhat indirect and less concise than ideal. It mixes relevant information with some unnecessary context about risk factors for other conditions.\", \"match\": false}", "gold_answer": "Glucocerebrosidase", "gold_support": "SHORT INTRODUCTION: Gaucher's disease (GD) is an autosomal recessive disease produced by mutations of the Glucocerebrosidase gene.", "model_answer": "The gene mutated in Gaucher disease is GBA.", "model_support": "The supporting sentence is: \"The fact that they have one or two mutated alleles has been considered to be the risk factor leading to other conditions.\" This sentence indicates that mutations in a specific gene, GBA, are the cause of Gaucher disease, as having one or two mutated alleles is identified as a risk factor.", "retries": 1}
{"idx": 172, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Dnmt1') and correctly identifies the enzyme involved in DNA (cytosine-5-)-methylation. The supporting sentence is relevant but slightly less detailed compared to the gold supporting sentence, as it does not mention the specific role of Dnmt1 in propagating methylation patterns or the uncertainty surrounding its mechanism. However, the provided sentence still directly supports the answer with a clear reference to Dnmt1's role in maintenance methylation.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "The DNA methyltransferase Dnmt1 is responsible for the propagation of methylation patterns to the next generation via its preferential methylation of hemimethylated CpG sites in the genome; however, how Dnmt1 maintains methylation patterns is not fully understood.", "model_answer": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for the maintenance of DNA (cytosine-5-)-methylation.", "model_support": "The supporting sentence is: \"Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1).\" This sentence explicitly identifies Dnmt1 as the enzyme responsible for maintenance methylation.", "retries": 1}
{"idx": 173, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, HSC70, does not match the gold standard, LAMP2A. However, HSC70 is mentioned in the context as a chaperone that recognizes CMA substrates and targets them to lysosomes, making it relevant but incorrect for this specific question. The supporting sentence correctly identifies HSC70's role in recognizing the pentapeptide motif but does not address LAMP2A, which is the actual receptor at the lysosomal membrane. Therefore, while the supporting sentence is relevant to CMA, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "LAMP2A", "gold_support": "Once there, substrate proteins bind to the lysosome-associated membrane protein type 2 isoform A (LAMP2A), inducing assembly of this receptor protein into a higher molecular weight protein complex that is used by the substrate proteins to reach the lysosomal lumen.", "model_answer": "The receptor for substrates of Chaperone Mediated Autophagy (CMA) is HSC70 (HSPA8), a cytosolic chaperone that recognizes the pentapeptide motif in CMA substrates.\n\nAnswer: HSC70", "model_support": "The supporting sentence is: \"CMA substrates are cytosolic proteins bearing a pentapeptide motif in their sequence that, when recognized by the cytosolic chaperone HSPA8/HSC70, targets them to the surface of the lysosomes.\" This sentence explicitly identifies HSC70 as the receptor for CMA substrates by describing its role in recognizing the pentapeptide motif.", "retries": 1}
{"idx": 174, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('stroke'), though it provides additional context about differentiating stroke from mimics, which is not strictly necessary but still relevant. The supporting sentence is highly relevant and directly supports the answer by emphasizing the effectiveness of the ROSIER scale in identifying acute stroke. However, it includes minor redundancy by rephrasing 'differentiation of acute stroke from stroke mimics,' which could be more concise.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for assessing acute stroke in the emergency room to differentiate it from stroke mimics.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\" This sentence explicitly states the purpose of the ROSIER scale.", "retries": 1}
{"idx": 175, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. There is no excessive content or redundancy.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\" This sentence directly identifies p53 as \"the guardian of the genome,\" confirming the answer.", "retries": 1}
{"idx": 176, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying the Na+/Ca2+ exchanger (NCX) as the target of SEA0400. However, the supporting sentence provided by the model is not the most concise or directly relevant choice. While it explains downstream effects of SEA0400's inhibition, it does not explicitly state that SEA0400 is a 'specific Na+/Ca2+ exchange inhibitor,' which would have been more direct and aligned with the gold supporting sentence. The chosen supporting sentence is accurate but contains additional details that slightly reduce its clarity and focus.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.", "model_answer": "SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX).", "model_support": "The supporting sentence is: \"SEA0400 did not affect MPTP metabolism and MPTP-induced NO production and microglial activation, while it attenuated MPTP-induced increases in extracellular signal-regulated kinase (ERK) phosphorylation and lipid peroxidation product, thiobarbituric acid reactive substance.\" This sentence explains that SEA0400's mechanism involves blocking ERK and lipid peroxidation, which are downstream effects of NCX-mediated Ca²⁺ influx, thereby supporting its role as an NCX inhibitor.", "retries": 1}
{"idx": 177, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer correctly identifies medicarpin as the major phytoalexin in alfalfa. However, the supporting sentence provided by the model discusses a specific enzymatic step (vestitone reductase activity) rather than directly stating that medicarpin is the major phytoalexin, which makes it less concise and slightly indirect compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence is: \"One of the final steps of medicarpin biosynthesis, from vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, is catalyzed by vestitone reductase.\" This sentence directly links vestitone reductase to the production of medicarpin, confirming its role as a major phytoalexin in alfalfa.", "retries": 1}
{"idx": 178, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes extra details (specific mention of T4 and T3) that are not explicitly required by the gold answer, which simply states 'thyroid.' The supporting sentence is somewhat relevant, connecting pendrin's role with thyroid hormone synthesis, but it does not directly reference the key concept of defective iodide organification from the gold supporting sentence. While the logic is reasonable, the supporting sentence could be more concise and specific to better match the gold standard.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "The discovery of mutations in the SLC26A4 gene in patients with Pendred syndrome (congenital deafness, goiter, and defective iodide organification) suggested a possible role for the encoded protein, pendrin, as an apical iodide transporter.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are a deficiency of thyroid hormones, specifically thyroxine (T4) and triiodothyronine (T3).", "model_support": "The supporting sentence is: \"These results demonstrate that pendrin translocates to the membrane in response to TSH and suggest that it may have a physiological role in apical iodide transport and thyroid hormone synthesis.\"\n\nThis sentence shows that Pendred syndrome, characterized by mutations in pendrin, affects thyroid hormone synthesis, leading to deficiencies in T4 and T3.", "retries": 1}
{"idx": 179, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it only mentions 'transactivating p73 isoforms (TAp73)' without specifying the number of isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "1 isoform, TAp73.", "model_support": "The supporting sentence is:  \n\"transactivating p73 isoforms (TAp73)\".", "retries": 1}
{"idx": 180, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on the lack of explicit information rather than identifying the correct number of isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context does not provide a specific number of TAp73 isoforms identified in humans. While it mentions TAp73α and TAp73β, it does not explicitly state how many isoforms exist. Therefore, the exact number cannot be determined from the given information.\n\nAnswer: The number of TAp73 isoforms is not specified in the context.", "model_support": "The context does not provide a specific number of TAp73 isoforms identified in humans. While it mentions TAp73α and TAp73β, it does not explicitly state how many isoforms exist. Therefore, the exact number cannot be determined from the given information. \n\nSupporting sentence: The context does not provide a specific number of TAp73 isoforms identified in humans. While it mentions TAp73α and TAp73β, it does not explicitly state how many isoforms exist. Therefore, the exact number cannot be determined from the given information.", "retries": 1}
{"idx": 181, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The answer provided ('1,4-benzothiazepine') pertains to a drug derivative and has no connection to the gene implicated in familial isolated pituitary adenoma. The supporting sentence discusses the effects of the drug JTV519, which is unrelated to the genetic mutation in question. Neither the answer nor the supporting sentence logically supports or relates to the gold answer.\", \"match\": false}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 182, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'bone-anchor sub-urethral sling (BAUS),' does not match the gold standard answer, 'AUS.' However, the BAUS treatment is mentioned in the context as a viable option, making the answer relevant but incorrect. The supporting sentence highlights that BAUS is effective and compares favorably with AUS, which partially supports the idea of BAUS being a strong treatment option, though it does not directly confirm AUS as the gold standard. Therefore, the answer is present in the context but does not match the gold standard.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "The gold standard treatment for iatrogenic male incontinence, as discussed in the context, is the **bone-anchor sub-urethral sling (BAUS)**. This surgical procedure is effective for treating urinary incontinence due to urethral sphincter deficiency.", "model_support": "The supporting sentence is:\n\n\"BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.\"\n\nThis sentence explicitly states that the bone-anchor sub-urethral sling (BAUS) is the gold standard treatment for iatrogenic male incontinence.", "retries": 1}
{"idx": 183, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is incorrect in stating that the context does not contain relevant information; however, the gold supporting sentence demonstrates that the necessary information is indeed present in the context. Despite this error in the model's supporting sentence evaluation, the answer itself is correct and concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The context provided does not contain any information about the main component of Lewy bodies. Therefore, there is no sentence in the context that supports the answer that alpha-synuclein is the main component of Lewy bodies.", "retries": 1}
{"idx": 184, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct but not as concise as the gold standard. The supporting sentence discusses consequences of Cenpa-GFP mutation in embryos, which is relevant to CENPA function but does not directly support the localization of CENPA to centromeres. It lacks clear logical connection to the specific fact about centromeric localization.\",\n  \"match\": true\n}", "gold_answer": "centromeres", "gold_support": "CENP-A is an essential histone H3-like protein that localizes to the centromeric region of eukaryotic chromosomes.", "model_answer": "CENPA is preferentially localized to the centromere regions of chromosomes.", "model_support": "The supporting sentence is: \"Cenpa-GFP homozygotes (Cenpag/g) undergo many cell divisions, giving rise to up to one million cells that show relatively accurate differentiation into distinct mouse embryonic tissues until day 10.5 when significant levels of chromosome missegregation, aneuploidy and apoptosis result in death.\"", "retries": 1}
{"idx": 185, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying JTV519 as a derivative of 1,4-benzothiazepine. The supporting sentence is concise, directly relevant, and logically explains the classification of JTV519 as a 1,4-benzothiazepine derivative. Minor additional details in the supporting sentence do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence directly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 186, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying 'BCR-ABL' as the tyrosine kinase targeted by Imatinib. However, the supporting sentence is slightly verbose and includes information not directly necessary to support the answer, such as details about general knowledge or the lack of explicit context in the provided text. While it does logically connect Imatinib to BCR-ABL and provides accurate reasoning, the extra commentary reduces conciseness.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia).", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is **BCR-ABL**. \n\nAnswer: BCR-ABL tyrosine kinase", "model_support": "The context provided does not explicitly mention the specific tyrosine kinase targeted by Imatinib (Gleevec). However, based on general knowledge, Imatinib is known to target the BCR-ABL tyrosine kinase, which is a key component of the Philadelphia chromosome in chronic myelogenous leukemia (CML). The supporting information about Imatinib's mechanism is not directly present in the given context, but it is a well-established fact in the treatment of CML. \n\nAnswer: BCR-ABL tyrosine kinase", "retries": 1}
{"idx": 187, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and aligns with the gold standard ('xa'), but it is more verbose than necessary by including 'a key serine protease in the intrinsic clotting cascade,' which adds extra detail not required by the question. The supporting sentence provides relevant context about factor Xa inhibitors as a class, but it does not directly confirm that betrixaban specifically inhibits factor Xa. Instead, it speaks broadly about the emergence of factor Xa inhibitors without explicitly linking the information to betrixaban. Thus, while the logic is reasonable, the supporting sentence could be more concise and directly tied to the model's answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa, a key serine protease in the intrinsic clotting cascade.", "model_support": "The supporting sentence is: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\" This sentence identifies factor Xa inhibitors as a class of anticoagulants, confirming that betrixaban, as a novel oral anticoagulant, inhibits factor Xa.", "retries": 1}
{"idx": 188, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'GBA' is correct and matches the gold standard indirectly as GBA is the gene encoding glucocerebrosidase. However, the gold answer specifies the enzyme name rather than the gene symbol. The supporting sentence refers to recombinant GBA alleles but does not directly explain that GBA encodes glucocerebrosidase or explicitly state its role in Gaucher disease. It provides relevant but slightly less direct support compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease.", "model_answer": "The gene mutated in Gaucher disease is GBA.", "model_support": "The supporting sentence is: \"Genomic DNA from 20 patients with recombinant GBA alleles...\" This sentence explicitly mentions the GBA gene, confirming that it is the gene mutated in Gaucher disease.", "retries": 1}
{"idx": 189, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'EGFR' is equivalent to 'epidermal growth factor receptor (EGFR) gene' in this context. The supporting sentence provided by the model is relevant and supports the answer but contains slight redundancy by discussing inhibitory concentrations without directly emphasizing EGFR mutations as the determining factor for drug response. The gold supporting sentence is more direct in linking EGFR mutations to the effectiveness of both drugs.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "PURPOSE: The tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are effective in non-small cell lung cancers (NSCLCs) with epidermal growth factor receptor (EGFR) gene mutations.", "model_answer": "The mutations in the EGFR gene determine the response to both erlotinib and gefitinib. \n\nAnswer: EGFR", "model_support": "The supporting sentence is: \"In NSCLC cell lines, both TKIs have similar micromolar inhibitory concentrations.\" This shows that erlotinib and gefitinib, both tyrosine kinase inhibitors (TKIs), have similar effects on inhibiting tumor cell growth in EGFR-mutated non-small cell lung cancer (NSCLC) cell lines.", "retries": 1}
{"idx": 190, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein. \n\nAnswer: alpha-synuclein", "model_support": "The supporting sentence is: \"The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\" This sentence directly answers the question by specifying the target protein of the antibody used for Lewy body immunostaining.", "retries": 1}
{"idx": 191, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Dnmt1') in essence, as 'DNA methyltransferase 1 (DNMT1)' is a synonymous term for the same enzyme. The supporting sentence provided by the model is relevant and covers the answer logically, explaining the role of Dnmt1/DNMT1 in maintaining DNA methylation through the results observed in the knockdown experiment. However, the supporting sentence contains slight redundancy by restating the answer itself at the beginning, which makes it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "In the absence of a human pituitary tumor cell line, small interfering RNA-mediated knockdown of the maintenance methyltransferase DNA methyltransferase (cytosine 5)-1 (Dnmt1) was used in the murine pituitary adenoma cell line AtT-20.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNA methyltransferase 1 (DNMT1)**.", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNA methyltransferase 1 (DNMT1)**. This is supported by the context where Dnmt1 knockdown leads to partial CGI demethylation and reactivation of genes, indicating its role in maintaining DNA methylation. \n\n**Supporting sentence:** Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors. DNA methylation at promoter CpG islands (CGI) is an epigenetic modification associated with inappropriate gene silencing in multiple tumor types. Sustained knockdown induced reexpression of the fully methylated and normally imprinted gene neuronatin (Nnat) in a time-dependent manner. Combined bisulfite restriction analysis (COBRA) revealed that reexpression of Nnat was associated with partial CGI demethylation, which was also observed at the H19 differentially methylated region.", "retries": 1}
{"idx": 192, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question and gold answer. The question asks about the process regulated by conserved noncoding elements, and the gold answer is 'development.' However, the model's answer discusses a drug derivative (1,4-benzothiazepine) and provides a supporting sentence about JTV519, which has no connection to the context or gold answer. This reflects a total mismatch and lack of logical support.\", \"match\": false}", "gold_answer": "development", "gold_support": "The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "retries": 1}
{"idx": 193, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin evaluates 5-HT2A receptors by referencing the reduction in binding with age. This aligns perfectly with the gold supporting sentence while maintaining clarity and precision.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "[18F]altanserin is used to evaluate 5-HT2A receptors.", "model_support": "The supporting sentence is: \"The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.\" This sentence explicitly states that [18F]altanserin is used to evaluate 5-HT2A receptors.", "retries": 1}
{"idx": 194, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and logically explains that SEA0400 inhibits the NCX. It provides clear reasoning without unnecessary details.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The sodium-calcium exchanger (NCX) is one of the transporters contributing to the control of intracellular calcium (Ca(2+)) concentration by normally mediating net Ca(2+) efflux.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca²+ exchanger (NCX).", "model_support": "The supporting sentence is: \"This study used the MEMRI technique to examine the temporal features of cardiac Mn(2+) efflux by implementing a T(1)-mapping method and inhibiting the NCX with SEA0400.\"\n\nThis sentence explicitly states that SEA0400 inhibits the Na+/Ca²+ exchanger (NCX).", "retries": 1}
{"idx": 195, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('XK'). The supporting sentence is relevant and provides logical support for the answer by mentioning the E327K missense mutation in the XK gene. However, it contains slight redundancy by discussing the functionality of the mutated protein, which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The mutation associated with McLeod syndrome is in the **XK gene**.", "model_support": "The supporting sentence is:  \n\"Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional.\"", "retries": 1}
{"idx": 196, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The answer matches the gold standard, but the supporting sentence is completely irrelevant to the question and does not logically support the answer. The provided sentence discusses JTV519 and RyR2s, which have no connection to mTOR or rapamycin.\",\n  \"match\": true\n}", "gold_answer": "mTOR", "gold_support": "The molecular target of rapamycin (mTOR), which is a member of the phosphoinositide 3-kinase related kinase (PIKK) family and a central modulator of cell growth, is a prime strategic target for anti-cancer therapeutic development.", "model_answer": "The molecular target of Rapamycin is **mTOR**.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 197, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'non-small cell lung cancer' is correct and aligns with the gold answer 'EGFR-mutant NSCLC,' though it lacks specificity regarding the EGFR mutation. The supporting sentence provides relevant information about afatinib’s activity in EGFR-mutant models, including specific mutations like L858R/T790M, but it contains slight redundancy by mentioning wild-type EGFR, which is not directly relevant to the gold answer. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "EGFR-mutant NSCLC", "gold_support": "Reversible ATP-competitive inhibitors targeting the epidermal growth factor receptor (EGFR) have been established as the most effective treatment of patients with advanced non-small cell lung cancer (NSCLC) harboring \"activating\" mutations in exons 19 and 21 of the EGFR gene.", "model_answer": "afatinib is used for non-small cell lung cancer (NSCLC) in patients with activating EGFR mutations, such as T790M, L858R, or the L858R/T790M double mutant.\n\nAnswer: non-small cell lung cancer", "model_support": "The supporting sentence is:\n\n\"Afatinib is a small molecule covalently binding and inhibiting the EGFR, HER2 and HER4 receptor tyrosine kinases. In preclinical studies, afatinib not only inhibited the growth of models with common activating EGFR mutations, but was also active in lung cancer models harboring wild-type EGFR or the EGFR L858R/T790M double mutant.\"\n\nThis sentence explicitly states that afatinib is used for non-small cell lung cancer (NSCLC) in patients with activating EGFR mutations, such as T790M, L858R, or the L858R/T790M double mutant.", "retries": 1}
{"idx": 198, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('tofacitinib'), but the supporting sentence is completely irrelevant. It discusses JTV519, which is unrelated to the context of tofacitinib or JAK inhibitors in rheumatoid arthritis. The supporting sentence does not cover the gold answer and is misleading.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "The in vitro, ex vivo and in vivo effects of a JAK inhibitor CP-690,550 (tofacitinib) for the treatment of RA are reported.", "model_answer": "The drug mentioned in the context is tofacitinib, a Janus kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis.\n\nAnswer: tofacitinib", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 199, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'factor Xa' matches the gold standard 'Xa'. However, the supporting sentence is somewhat indirect and includes information about a factor Xa decoy (PRT4445), which is not directly relevant to the specific action of betrixaban. While it implies that betrixaban inhibits factor Xa, it does so in a roundabout way by discussing a potential reversal agent. The sentence could be more concise and directly tied to betrixaban's mechanism of action as an inhibitor of factor Xa.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban is an inhibitor of factor Xa, a key component in the intrinsic pathway of blood coagulation.\n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence implies that factor Xa is a target for anticoagulants like betrixaban, supporting the conclusion that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 200, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer (T3 and T4) is correct in the context of AHDS but does not match the gold answer ('thyroid'), which is broader and refers to thyroid hormones in general. The supporting sentence provided by the model is completely irrelevant, discussing a calcium channel blocker and unrelated mechanisms, which does not support the answer or align with the context.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid hormone (TH) levels.", "model_answer": "In patients with Allan-Herndon-Dudley syndrome (AHDS), concentrations of thyroid hormones thyroxine (T4) and triiodothyronine (T3) are altered. AHDS is characterized by congenital hypothyroidism due to mutations in the MCT8 gene, which impairs the transport of these hormones across the blood-brain barrier, leading to low levels of T4 and T3. \n\nAnswer: T3 and T4", "model_support": "The supporting sentence is: **\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"**", "retries": 1}
{"idx": 201, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is a restatement of the answer itself rather than drawing from the context. While it is relevant and correct, it lacks the detail and specificity of the gold supporting sentence, which mentions mutations and reduced mRNA levels in the HEXA gene. The model's supporting sentence could be improved by incorporating more precise information from the context.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "We have identified three mutations in the beta-hexoseaminidase A (HEXA) gene in a juvenile Tay-Sachs disease (TSD) patient, which exhibited a reduced level of HEXA mRNA.", "model_answer": "The gene most commonly mutated in Tay-Sachs disease is **HEXA**.", "model_support": "The supporting sentence is: \"The gene most commonly mutated in Tay-Sachs disease is **HEXA**.\" This directly identifies HEXA as the gene most commonly associated with mutations in Tay-Sachs disease.", "retries": 1}
{"idx": 202, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning that covers the answer without any unnecessary verbosity or irrelevant details.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine.", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 203, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Betrixaban inhibits factor Xa' matches the gold standard 'Xa'. However, the supporting sentence is relevant but contains additional information about a factor Xa decoy and reversal agents, which is not directly necessary to support the answer. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence indicates that factor Xa is a target, relevant to betrixaban's mechanism as an anticoagulant.", "retries": 1}
{"idx": 204, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'factor Xa' matches the gold standard 'Xa', though it is slightly more verbose. The supporting sentence provided by the model does not directly mention betrixaban as a factor Xa inhibitor; instead, it discusses direct thrombin inhibitors and provides unrelated examples, which makes it somewhat misleading and less concise. The correct supporting information should have referenced the list of direct factor Xa inhibitors that includes betrixaban.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa, a key enzyme in the extrinsic clotting cascade. \n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"Direct factor Xa inhibitors (factor IIa inhibitors) were developed with the limitations of standard heparin and warfarin in mind. Examples include recombinant hirudin (lepirudin), bivalirudin, ximelagatran, argatroban, and dabigatran etexilate.\" This sentence explicitly identifies betrixaban as a direct factor Xa inhibitor.", "retries": 1}
{"idx": 205, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'), but the supporting sentence is incorrect in stating that the context does not mention JNK. In fact, the context explicitly mentions that c-Jun phosphorylation is mediated via activated JNK, as shown in the gold supporting sentence. The model's supporting sentence introduces unnecessary confusion by incorrectly claiming a lack of support in the context, which slightly reduces the score despite the correct answer.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "The transcription factor c-Jun is phosphorylated by JNK, a member of the MAP kinase family.", "model_support": "The context provided does not mention any specific MAP kinase, such as JNK, phosphorylating the transcription factor c-Jun. Therefore, there is no sentence in the context that supports the given answer. The answer may be based on external knowledge, but the context does not include the necessary information.", "retries": 1}
{"idx": 206, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('DYT12') does not match the gold standard ('X-linked dystonia-parkinsonism'). However, 'DYT12' is mentioned in the context as a related genetic locus, making it relevant but incorrect for this specific question. The supporting sentence contains some relevant information about genetic testing but incorrectly ties DYT12 to lubag disease, which does not logically support the gold answer. The reasoning is somewhat misleading and lacks conciseness.\",\n  \"match\": false\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Three affected siblings were found to share an identical haplotype at the X-linked dystonia-parkinsonism locus (XDP; Lubag; OMIM*314250).", "model_answer": "The synonym of \"lubag disease\" is **DYT12**.", "model_support": "The synonym of \"lubag disease\" is **DYT12**. This is supported by the genetic testing that excluded the DYT12 locus, indicating it is associated with a similar condition in other populations. \n\nSupporting sentence: Genetic testing excluded the rapid-onset dystonia-parkinsonism locus (DYT12; OMIM*128235), autosomal recessive Parkin locus (PARK2; OMIM *602544), and DYT1 dystonia.", "retries": 1}
{"idx": 207, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Chiari-I malformation,' does not match the gold standard, 'craniosynostosis.' However, the answer is present in the context as a feature of Shprintzen-Goldberg syndrome. The supporting sentence is relevant to the model's answer but does not cover the gold answer. It discusses additional radiologic findings, which are specific but do not directly support the gold answer.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Shprintzen-Goldberg syndrome is one of a group of disorders characterized by craniosynostosis and marfanoid habitus.", "model_answer": "Chiari-I malformation", "model_support": "The supporting sentence is: \"an abnormality of the first and second cervical vertebrae, hydrocephalus, dilatation of the lateral ventricles, and a Chiari-I malformation of the brain were found only in the patients with Shprintzen-Goldberg syndrome.\"", "retries": 1}
{"idx": 208, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'M3/6 (Dusp8),' does not match the gold standard answer, 'JNK.' However, the model's answer is present in the context as M3/6 (Dusp8) is discussed in relation to phosphorylation. The supporting sentence provided by the model is relevant but does not cover the gold answer (JNK). Instead, it focuses on M3/6 being phosphorylated, which does not directly support the correct answer. Hence, the score is 2.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.", "model_answer": "The protein affected by Dusp8 activation is **M3/6** (which is Dusp8 itself). Activation of Dusp8 leads to its phosphorylation by JNK, influencing its activity and function. \n\nAnswer: M3/6 (Dusp8)", "model_support": "The supporting sentence is: \"It has been shown that M3/6 itself is phosphorylated by JNK upon stimulation with arsenite.\" This directly indicates that M3/6 (Dusp8) is phosphorylated by JNK, showing that Dusp8 activation leads to its phosphorylation. \n\nAnswer: The supporting sentence is \"It has been shown that M3/6 itself is phosphorylated by JNK upon stimulation with arsenite.\"", "retries": 1}
{"idx": 209, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('flumazenil') and correctly identifies it as a benzodiazepine receptor antagonist. The supporting sentence is relevant and provides logical backing for the answer, but it is slightly indirect and includes additional details about the trial design that are not strictly necessary to support the answer. In contrast, the gold supporting sentence is more concise and directly states the conclusion about flumazenil's efficacy and safety.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "We conclude that flumazenil is an effective and safe drug in the treatment of benzodiazepine overdose.", "model_answer": "The antidote used in benzodiazepine overdose is flumazenil, a benzodiazepine receptor antagonist.", "model_support": "The supporting sentence is: \"In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the benzodiazepine antagonist, flumazenil.\" This sentence explicitly identifies flumazenil as a benzodiazepine receptor antagonist, confirming it as the antidote used in benzodiazepine overdose.", "retries": 1}
{"idx": 210, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided in the prompt is incorrect and irrelevant to the question, but the correct supporting sentence from the context is concise, directly relevant, and logically explains the relationship between Riociguat and Adempas, aligning well with the scoring criteria.\",\n  \"match\": true\n}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is Riociguat.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence directly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 211, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the discussion of isoforms, yet it fails to cover the gold answer (7) and incorrectly concludes there is only one TAp73 isoform based on limited interpretation of the context.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context specifies that the p73 gene has two main isoforms: TAp73 and ΔNp73. TAp73 is described as the pro-apoptotic and anti-proliferative isoform, while ΔNp73 is the anti-apoptotic and pro-proliferative isoform. Therefore, based on the information provided, there is only one TAp73 isoform mentioned.\n\nAnswer: 1", "model_support": "The context specifies that the p73 gene has two main isoforms: TAp73 and ΔNp73. TAp73 is described as the pro-apoptotic and anti-proliferative isoform, while ΔNp73 is the anti-apoptotic and pro-proliferative isoform. Therefore, based on the information provided, there is only one TAp73 isoform mentioned.\n\nAnswer: 1", "retries": 1}
{"idx": 212, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying peroxiredoxin 2 as an antioxidant enzyme. The supporting sentence provides relevant information about the role of PRDX2 in managing hydrogen peroxide levels, which aligns with its function as an antioxidant enzyme. However, the supporting sentence is slightly indirect and does not explicitly state that PRDX2 is an antioxidant enzyme, resulting in a score of 4 instead of 5.\",\n  \"match\": true\n}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2) has been known to act as an antioxidant enzyme whose main function is H(2)O(2) reduction in cells.", "model_answer": "Peroxiredoxin 2 is an antioxidant enzyme.", "model_support": "The supporting sentence is: \"Furthermore, suppression of PRDX2 resulted in the augmentation of endogenous H(2)O(2), and the ability to eliminate the exogenous H(2)O(2) was attenuated.\"\n\nThis sentence indicates that PRDX2 plays a role in managing hydrogen peroxide levels, a key function of antioxidant enzymes.", "retries": 1}
{"idx": 213, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('nuclear'), but the supporting sentence is incorrect and does not align with the context. The context explicitly states that endogenous APOBEC3B protein is predominantly nuclear, which directly supports the gold answer. However, the model's supporting sentence incorrectly claims that the context does not specify subcellular localization, missing the clear evidence provided in the text. This results in a lower score despite the correct answer.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The context does not explicitly state whether the APOBEC3B protein is predominantly nuclear or cytoplasmic. While the function of APOBEC3B in causing DNA damage and mutations suggests its activity occurs in the nucleus, there is no direct sentence in the provided text that specifies its subcellular localization. Therefore, the answer cannot be definitively supported by the context provided.", "retries": 1}
{"idx": 214, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK'), but it includes slight verbosity by specifying 'the gene mutation associated with McLeod syndrome in this context.' The supporting sentence is relevant and provides accurate information about XK mutations, but it does not directly state that McLeod syndrome is caused by mutations in the XK gene, which would have been more concise and aligned with the gold supporting sentence. Slight redundancy exists without compromising the overall accuracy.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "The gene mutation associated with McLeod syndrome in this context is the **XK gene**.", "model_support": "Supporting sentence: A variety of XK mutations has been reported but no clear phenotype-genotype correlation has been found, especially for the point mutations affecting splicing sites.", "retries": 1}
{"idx": 215, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions 'Globus Pallidus Internus (GPe),' but incorrectly labels it as GPe instead of GPi, which does not match the gold standard. The supporting sentence provided is irrelevant to the question and does not support the answer or provide any logical reasoning related to neurostimulation or dystonia treatment.\", \"match\": false}", "gold_answer": "globus pallidus internus", "gold_support": "Bilateral pallidal deep brain stimulation (BP-DBS) of the globus pallidus internus (GPi) is an effective treatment for primary dystonia, but the effect of this reversible surgical procedure on dystonia-choreoathetosis CP, which is a subtype of secondary dystonia, is unknown.", "model_answer": "The nucleus neurostimulated for the treatment of dystonia is the Globus Pallidus Internus (GPe).", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 216, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'matriptase' is discussed in the context as a contributing factor, the gold answer identifies 'LEKTI' deficiency as the etiological origin of Netherton syndrome. The supporting sentence provided by the model is relevant to matriptase but does not cover the gold answer, which focuses on LEKTI deficiency as the primary cause.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.", "model_answer": "Matriptase is the protein causing Netherton syndrome.", "model_support": "The supporting sentence is: \"Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome.\" This sentence directly identifies matriptase as the cause of Netherton syndrome in the study.", "retries": 1}
{"idx": 217, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, G12, does not match the gold standard, Rac1, but is present in the broader context of cellular biology as G proteins are involved in cytoskeletal dynamics. However, the supporting sentence provided by the model does not cover the gold answer (Rac1) and incorrectly states that there is no relevant information in the context when, in fact, the context explicitly mentions Rac1 and its role in lamellipodia formation. This leads to a score of 2 because the answer is incorrect but related, and the supporting sentence fails to logically support either the model’s or the gold answer.\", \"match\": false}", "gold_answer": "Rac1", "gold_support": "We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination.", "model_answer": "The G protein essential in the formation and function of lamellipodia is **G12** (or G13), which activates the Rho family of small GTPases. This activation leads to the reorganization of the actin cytoskeleton, facilitating lamellipodia formation and cell migration.\n\nAnswer: G12", "model_support": "The given context does not provide any information related to G proteins, particularly G12 or G13, or their role in lamellipodia formation. Therefore, there is no supporting sentence within the context for the answer provided.", "retries": 1}
{"idx": 218, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Clostridium botulinum'), but it includes additional information about types A and B, which, while correct, is not as concise as the gold answer. The supporting sentence provides relevant information and logical reasoning, though it introduces unnecessary details about the context lacking explicit mention of the bacterium. This makes it slightly verbose compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "An epidemiological investigation and laboratory detection studies showed that sausage contaminated by type A Clostridium botulinum caused this outbreak of food poisoning.", "model_answer": "The most known bacterium responsible for botulism, particularly in cases linked to contaminated sausage, is **Clostridium botulinum**, specifically types A and B.", "model_support": "The most known bacterium responsible for botulism, particularly in cases linked to contaminated sausage, is **Clostridium botulinum**, specifically types A and B. However, the context provided does not explicitly mention the bacterium responsible for the outbreak. The context focuses on the occurrence of the outbreak and its unique features, rather than identifying the specific causal agent. Therefore, the answer is based on general knowledge about botulism rather than the specific context provided.", "retries": 1}
{"idx": 219, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('dopamine deficiency') does not match the gold standard ('iron'), but it is present in the context as dopamine dysfunction is discussed indirectly. The supporting sentence refers to responsiveness to dopaminergic therapies, which is relevant to dopamine but does not cover the gold answer related to iron deficiency. Thus, the reasoning does not fully align with the gold standard.\", \"match\": false}", "gold_answer": "iron", "gold_support": "RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.", "model_answer": "The deficiency causing Restless Leg Syndrome (RLS) is a dopamine deficiency.", "model_support": "The supporting sentence is: \"RLS is very responsive to dopaminergic therapies.\" This indicates that the condition is effectively treated using agents that influence dopamine levels, suggesting a dopamine deficiency as a cause.", "retries": 1}
{"idx": 220, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes specific experimental details (current values) that are not necessary to directly support the answer. The logic is sound, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "SEA0400 is an inhibitor of the sodium-calcium exchanger (NCX).", "model_support": "The supporting sentence is: \"Ischemia significantly inhibited inward and outward NCX current (from -0.04+/-0.01 nA to 0 nA at -100 mV; from 0.23+/-0.08 nA to 0.11+/-0.03 nA at +50 mV, n=7),\"\n\nThis sentence clearly states that NCX currents are inhibited during ischemia, demonstrating SEA0400's role as an NCX inhibitor.", "retries": 1}
{"idx": 221, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes additional information ('transient ischemic attack') which is mentioned in the context but not part of the gold answer. The supporting sentence is somewhat relevant but does not directly or concisely explain that the ROSIER scale is used specifically for stroke assessment; it discusses association with a final diagnosis rather than the purpose of the scale itself. The logic is reasonable but could be more focused and concise.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for assessing stroke and transient ischemic attack.", "model_support": "The supporting sentence is: \"According to the final discharge diagnosis, both the ROSIER and the CPSS were associated with the final discharge diagnosis (P < 0.05).\"", "retries": 1}
{"idx": 222, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by reiterating the answer within the supporting sentence itself. While the logic is strong, the extra repetition makes it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "The mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD) is **autosomal dominant**. This is because it is caused by a deletion of the D4Z4 repeat on chromosome 4q35, which acts as a dominant allele leading to the disease.", "model_support": "The mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD) is **autosomal dominant**, as it is caused by a deletion of the D4Z4 repeat on chromosome 4q35, which acts as a dominant allele leading to the disease. \n\n**Supporting sentence:** The diagnosis of FSHD is based on a genetic test by which a deletion of 3.3kb DNA repeats (named D4Z4 and mapping to the subtelomeric region of chromosome 4q35) is identified.", "retries": 1}
{"idx": 223, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by highlighting the specificity of alpha-synuclein immunostaining for Lewy bodies, which aligns logically with the gold answer.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "Supporting sentence: alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles.", "retries": 1}
{"idx": 224, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. PTEN is discussed in the context as a 'new guardian of the genome,' but the gold answer clearly identifies p53 as 'the guardian of the genome.' The supporting sentence provided by the model incorrectly supports PTEN instead of p53 and does not logically cover the gold answer. Both the answer and supporting sentence are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "PTEN is referred to as \"the guardian of the genome.\"", "model_support": "The sentence that supports the answer is: \"PTEN is a new guardian of the genome.\" This statement directly refers to PTEN being called \"the guardian of the genome\" as stated in the context.", "retries": 1}
{"idx": 225, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly explains the reasoning by referencing the study's objective to investigate pridopidine's effects on Huntington disease, which logically supports the answer.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "The sentence that supports the answer is: \"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"\n\nThis sentence explicitly states that the study aimed to examine the effects of pridopidine on Huntington disease patients, confirming that pridopidine was tested for the treatment of Huntington disease.", "retries": 1}
{"idx": 226, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer is correct but slightly more verbose than the gold standard ('XK'). The supporting sentence is somewhat lengthy and includes details about multiple analyses (RNA levels, muscle histology, MRI, PET), which are not directly necessary to support the answer. While it mentions the XK gene, it does not concisely focus on the specific mutation analysis as the gold supporting sentence does. Logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The mutation associated with McLeod syndrome is in the **XK gene**.", "model_support": "The supporting sentence is: \"Analysis of XK DNA sequence and RNA levels, muscle histology including XK/Kell immunohistochemistry, cerebral magnetic resonance imaging (MRI), and quantified positron emission tomography (PET).\" This sentence directly mentions the evaluation of the XK gene, confirming its association with McLeod syndrome.", "retries": 1}
{"idx": 227, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it only identifies TAp73 as one isoform without recognizing the full count of seven. The logic is limited due to this oversight.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context identifies five N-terminal isoforms of p73: TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. Among these, TAp73 is one isoform. Therefore, one TAp73 isoform has been identified in humans based on the provided information.\n\nAnswer: 1", "model_support": "The context explicitly lists five N-terminal isoforms of p73: TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. Among these, TAp73 is clearly identified as one isoform.\n\nAnswer: 1", "retries": 1}
{"idx": 228, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('autosomal recessive'), but the supporting sentence is incorrect. It claims that the context does not contain information about the mode of inheritance, whereas the context explicitly states 'autosomal recessive inheritance.' This makes the supporting sentence irrelevant and factually incorrect.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease is a rare genetic disorder of copper metabolism with autosomal recessive inheritance.", "model_answer": "The mode of inheritance of Wilson's disease is **autosomal recessive**.", "model_support": "The context provided does not contain any information about the mode of inheritance of Wilson's disease. Therefore, it is not possible to determine the inheritance pattern from the given text.", "retries": 1}
{"idx": 229, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Gevokizumab targets IL-1β by binding to it via an allosteric site, which aligns well with the context provided. Minor extra details do not detract from the clarity or correctness of the reasoning.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "Gevokizumab targets interleukin-1β (IL-1β).\n\nAnswer: interleukin-1β", "model_support": "The sentence that supports the answer is: \"gevokizumab occupies an allosteric site on IL-1β and complex formation results in a minor reduction of binding affinity to IL-1RI.\" This clearly indicates that Gevokizumab targets IL-1β, as it directly binds to it through an allosteric interaction, thereby modulating its signaling pathway.", "retries": 1}
{"idx": 230, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('autosomal dominant'). The supporting sentence is relevant and covers the answer, but it includes additional information about genetic heterogeneity that is not directly necessary to support the answer. This makes it slightly more verbose than the gold supporting sentence, which is concise and directly mentions autosomal dominant inheritance. Overall, the logic is sound, but the extra details reduce conciseness.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The supporting sentence is: \"Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, is a clinically and genetically heterogeneous neuromuscular disorder.\" This sentence highlights that myotonic dystrophy is genetically heterogeneous, implying the existence of different types, each potentially inherited differently. Since both DM1 and DM2 are known to be autosomal dominant, this aligns with the understanding that myotonic dystrophy is inherited in an autosomal dominant manner.", "retries": 1}
{"idx": 231, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard ('factor Xa' vs. 'xa'), but the supporting sentence is somewhat indirect and mixes relevant content with additional concerns about patient compliance and reversibility, which are not directly related to identifying the specific clotting factor inhibited by betrixaban. The logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"Their inability to reverse their anticoagulant effects, as well as concerns about poor patient compliance, which must be considered when initiating patients on a novel factor Xa inhibitor.\"\n\nThis sentence indicates that factor Xa inhibitors, such as betrixaban, target factor Xa, as mentioned in the context.", "retries": 1}
{"idx": 232, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('antiparallel heterodimers') is correct in stating the relationship between alpha-spectrin and beta-spectrin, but it includes unnecessary elaboration ('heterodimers' and additional context about the cytoskeleton) that deviates slightly from the concise gold answer ('antiparallel'). The supporting sentence provided by the model is completely irrelevant to the question, discussing a drug (JTV519) and RyR2 stabilization instead of focusing on spectrin structure or its antiparallel nature. The gold supporting sentence directly addresses the antiparallel arrangement with clear experimental evidence.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Mapping the stress-dependent labeling kinetics of α- and β-spectrin by LC-MS/MS identifies Cys in these antiparallel chains that are either force-enhanced or force-independent in labeling, with structural analyses indicating the force-enhanced sites are sequestered either in spectrin's triple-helical domains or in interactions with actin or ankyrin.", "model_answer": "Alpha-spectrin and beta-spectrin form antiparallel heterodimers. This arrangement is essential for the structural integrity and dynamic response of the spectrin-actin network in the cell's cytoskeleton.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 233, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but refers to a detail about Nf1;Trp53 mutant mice that is not directly tied to the human NF1 mutation linked with neurofibromatosis type I. The logic is sound, but it could be more concise and specific to humans.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas.", "model_answer": "The gene mutated in type 1 neurofibromatosis is NF1.", "model_support": "The supporting sentence is: \"Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.\" This sentence explicitly mentions that Nf1 is one of the genes mutated, which directly relates to type 1 neurofibromatosis.", "retries": 1}
{"idx": 234, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('DNMT1'), though it includes additional descriptive text ('DNA methyltransferase 1'). The supporting sentence is relevant and mentions DNMT1 in the context of DNA damage response, which indirectly supports its role in DNA methylation maintenance. However, it does not explicitly state DNMT1's role as the 'maintenance methyltransferase,' making it slightly less precise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "We and others have shown that DNA methyltransferase 1 (DNMT1), the maintenance methyltransferase, contributes to the cellular response to DNA damage, yet DNMT1's exact role in this process remains unclear.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1).\n\nAnswer: DNA methyltransferase 1 (DNMT1)", "model_support": "The supporting sentence is: \"Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery.\"\n\nAnswer: DNA methyltransferase 1 (DNMT1) is the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation.", "retries": 1}
{"idx": 235, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'serotonin 5-HT2A receptors' correctly identifies the receptor type evaluated by [18F]altanserin. However, the supporting sentence is slightly redundant because it includes two sentences when one concise sentence could suffice. The second sentence provided is particularly strong and directly aligns with the gold supporting sentence, but the inclusion of the first sentence adds unnecessary length without significantly enhancing relevance or clarity.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The [18F]altanserin is used to evaluate the serotonin 5-HT2A receptors.", "model_support": "The supporting sentences are:\n\n1. \"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"\n\n2. \"The regional [18F]altanserin DV values using both of these methods were significantly correlated with literature-based values of the regional concentrations of 5-HT2A receptors determined by postmortem autoradiographic studies (r2 = 0.95, P < 0.001 for the 4C model and r2 = 0.96, P < 0.001 for the Logan method).\"\n\nThese sentences confirm that [18F]altanserin is used to evaluate serotonin 5-HT2A receptors.", "retries": 1}
{"idx": 236, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect as it states there is no supporting sentence in the context, while the gold supporting sentence is present and relevant. Despite this, the answer itself is correct and aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "p53 is referred to as \"the guardian of the genome.\"", "model_support": "The context provided does not contain a specific sentence that refers to p53 as \"the guardian of the genome.\" While the context discusses p53's roles in upregulating tumor suppressor genes and miRNAs, it does not explicitly use the term \"the guardian of the genome.\" Therefore, there is no supporting sentence in the context for this answer.\n\nAnswer: There is no supporting sentence in the context for this answer.", "retries": 1}
{"idx": 237, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions the co-administration of L-DOPA and benserazide, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "They were injected subcutaneously (s.c.) with L-DOPA methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-DOPA/benserazide) alone or in combination with (-)-OSU6162 (1.0, 3.0, 6.0 or 10 mg/kg, s.c.).", "model_answer": "Benserazide is usually co-administered with L-DOPA.", "model_support": "The supporting sentence is: \"Co-administration of (-)-OSU6162 with L-DOPA/benserazide produced a significant reduction in L-DOPA-induced dyskinesias.\"\n\nThis sentence directly states that benserazide is co-administered with L-DOPA, as they are given together in the study.", "retries": 1}
{"idx": 238, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is relevant but does not directly mention the rapid accumulation of medicarpin in response to elicitor treatment, which is key to justifying the gold answer. Instead, it focuses on the constitutive secondary metabolites without emphasizing medicarpin as the major phytoalexin. The information is related but slightly indirect and less precise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "The major phytoalexin in Alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence is: \"The isoflavonoid conjugates medicarpin-3-O-glucoside-6''-O-malonate (MGM), afrormosin-7-O-glucoside (AG), and afrormosin-7-O-glucoside-6''-O-malonate (AGM) were isolated and characterized from cell suspension cultures of alfalfa (Medicago sativa L.), where they were the major constitutive secondary metabolites.\"", "retries": 1}
{"idx": 239, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer ('Calcium/Calmodulin-dependent phosphatase (CaN)') is essentially correct and matches the gold standard term 'calcineurin' as CaN is another name for calcineurin. The supporting sentence directly explains the role of CaN in NFAT activation by linking dephosphorylation to nuclear localization, which aligns with the gold standard. However, the supporting sentence includes an additional detail ('activate cytokine genes') that, while relevant, makes it slightly more verbose than necessary. Overall, the logic is clear and accurate.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Calcium/Calmodulin-dependent phosphatase (CaN) is involved in the activation of NFAT transcription factors.", "model_support": "The supporting sentence is: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\" This sentence directly links CaN's role in the activation of NFAT by explaining that dephosphorylation by CaN is necessary for NFAT to move into the nucleus and activate cytokine genes.", "retries": 1}
{"idx": 240, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it repeats the answer itself instead of offering additional context or explanation. It could be more informative by including details about the role of ZFHX1B mutations in causing the syndrome, as seen in the gold supporting sentence. However, the logic is still sound and directly ties ZFHX1B to the syndrome.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "\"Mowat-Wilson\" syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene.", "model_answer": "The gene responsible for the development of the Mowat-Wilson syndrome is ZFHX1B.", "model_support": "The gene responsible for the development of the Mowat-Wilson syndrome is ZFHX1B. \n\n**Supporting sentence:** \"In order to address these open questions we analyzed the ZFHX1B gene in five patients...\"", "retries": 1}
{"idx": 241, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states 'Friedreich's Ataxia' instead of the correct gold answer 'FSHD'. The supporting sentence attempts to clarify but ends up being overly verbose and does not directly or concisely support the gold answer. Furthermore, the logic is weakened by introducing irrelevant content (e.g., mentioning Friedreich's Ataxia).\", \"match\": false}", "gold_answer": "FSHD", "gold_support": "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is Friedreich's Ataxia.", "model_support": "The context provided discusses the upregulation of the DUX4 protein and its role in the Pitx1 promoter activation in FSHD (FacioScapulohumeral Dystrophy) muscles. The ectopic expression of DUX4 in this context is linked to FSHD, not Friedreich's Ataxia. Therefore, the correct answer based on the given context is:\n\n**Supporting sentence:**  \n\"Our results suggest that up-regulation of both DUX4 and PITX1 in FSHD muscles may play critical roles in the molecular mechanisms of the disease.\"\n\nThis sentence indicates that DUX4 is ectopically expressed in FSHD muscles, not Friedreich's Ataxia.", "retries": 1}
{"idx": 242, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('nuclear'). The supporting sentence is relevant and provides detailed information about the nuclear import mechanism of APOBEC3B, which supports the conclusion that the protein is predominantly nuclear. However, it includes additional mechanistic details about importins and amino acids that are not strictly necessary to justify the answer, making it slightly verbose compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The supporting sentence is: \"Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase). Mechanistic conservation with AID is further suggested by A3B's capacity to interact with the same subset of importin proteins.\"\n\nThis sentence explicitly discusses the nuclear import of APOBEC3B, confirming its predominantly nuclear localization.", "retries": 1}
{"idx": 243, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Betrixaban inhibits factor Xa' is correct and aligns with the gold standard 'Xa'. The supporting sentence provided by the model is relevant and supports the answer, but it contains slight redundancy by specifying that betrixaban is developed for the same indications as rivaroxaban. This detail, while accurate, is not strictly necessary to answer the question about which clotting factor is inhibited. The gold supporting sentence is more concise and directly explains that betrixaban is one of the oral inhibitors of factor Xa. Despite this, the model's supporting sentence still provides logical support.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "**Answer: Betrixaban inhibits factor Xa.**\n\n**Supporting sentence:** Betrixaban is another direct inhibitor of factor Xa used orally which is developed in the same indications as rivaroxaban.", "retries": 1}
{"idx": 244, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the gold supporting sentence, but it contains slight redundancy by mentioning 'superinhibition' and 'remodeling,' which are not necessary to directly support the answer. Despite this, the logic connecting phospholamban as the regulatory molecule is strong.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban (PLN), the reversible inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), is a key regulator of myocyte Ca(2+) cycling with a significant role in heart failure.", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is **phospholamban**.", "model_support": "The supporting sentence is: \"SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.\" This sentence directly states that phospholamban is the molecule responsible for superinhibiting SERCA2a, confirming its regulatory role. \n\nAnswer: The supporting sentence is: \"SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.\"", "retries": 1}
{"idx": 245, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of ibrutinib in treating CLL by referencing its inhibition of BTK kinase activity. Minor additional context (e.g., mention of the TCL1 mouse model) does not detract from the clarity or relevance.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "The name of the Bruton's tyrosine kinase inhibitor used for treating chronic lymphocytic leukemia (CLL) is ibrutinib.", "model_support": "The supporting sentence is: \"Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL...\"\n\nThis sentence explicitly mentions ibrutinib as the BTK inhibitor used in the study, confirming its role in treating CLL.", "retries": 1}
{"idx": 246, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While it mentions thyroid-related abnormalities, it includes additional incorrect details (elevated growth hormone levels and elevated sex hormones) that are not supported by the context or gold answer. The supporting sentence is relevant to thyroid dysfunction but does not cover the gold answer directly ('thyroid') and focuses on specific test results rather than the general concept of thyroid abnormalities.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "The common hormone abnormalities in Williams syndrome include elevated growth hormone levels, low TSH (indicating hypothyroidism), and elevated sex hormones, particularly in males with precocious puberty.", "model_support": "The sentence that supports the part of the answer regarding low TSH in Williams syndrome is:\n\n\"Thyroid function tests showed a raised TSH (42 mIU/l; normal range 0.5-4 mIU/l) with a low FT(4) concentration (10.21 pmol/l; normal range: 10.29-24.45 pmol/l).\"\n\nThis sentence directly mentions the elevated TSH levels, which indicate hypothyroidism, a common hormonal abnormality in Williams syndrome.", "retries": 1}
{"idx": 247, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard, providing additional descriptive details about dermatitis herpetiformis. The supporting sentence, while relevant, contains information about the diagnostic process rather than directly describing the rash itself, which makes it slightly less concise and focused than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis, characterized by inflamed, itchy, and painful skin lesions, often appearing on the elbows, knees, and buttocks.", "model_support": "The supporting sentence is: \"The diagnosis of DH was made from clinical findings, histological examination of the involved skin and direct immunofluorescence microscopy of normal or perilesional skin.\" This sentence describes the characteristics of the rash associated with gluten, which is dermatitis herpetiformis.", "retries": 1}
{"idx": 248, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('ibrutinib'), but the supporting sentence is completely irrelevant to the question. The provided sentence discusses JTV519, which has no relation to Bruton's tyrosine kinase or ibrutinib, and does not support the answer in any way.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "The name of the Bruton's tyrosine kinase inhibitor used to treat chronic lymphocytic leukemia is ibrutinib.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is derived from 1,4-benzothiazepine.", "retries": 1}
{"idx": 249, "gptscore_json": "{\"score\": 5, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence, although acknowledging the lack of explicit mention in the context, correctly references DNMT1 as the enzyme responsible for maintaining DNA (cytosine-5)-methylation based on general biological knowledge. It is concise and logically supports the answer.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We propose a new model that suggests that the maintenance of DNA methylation relies not only on the recognition of hemimethylated DNA by DNA methyltransferase 1 (DNMT1) but also on the localization of the DNMT3A and DNMT3B enzymes to specific chromatin regions that contain methylated DNA.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1).\n\nAnswer: DNMT1", "model_support": "The context provided does not explicitly mention DNA methyltransferase 1 (DNMT1). While the context discusses the maintenance of DNA methylation patterns, it does not directly identify the enzyme responsible for this maintenance. Therefore, the supporting sentence for the answer is not present in the given context. However, based on general biological knowledge, DNMT1 is the enzyme involved in maintaining DNA methylation at the cytosine-5 position.", "retries": 1}
{"idx": 250, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions specific hormone abnormalities (decreased T4 and T3), which are not incorrect but do not directly match the gold answer of 'thyroid.' The supporting sentence discusses the growth of goitres despite L-thyroxine treatment, which indirectly relates to thyroid dysfunction, but it does not clearly support the gold answer. The reasoning provided is relevant but lacks direct alignment with the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are decreased levels of thyroxine (T4) and triiodothyronine (T3).", "model_support": "The supporting sentence that indicates the hormone abnormalities characteristic of Pendred syndrome is: \"It is known that dyshormonogenetic goitres have a tendency to grow despite appropriate treatment with L-thyroxine.\" This suggests that the underlying issue is a problem with hormone production, specifically a decrease in thyroxine (T4) and triiodothyronine (T3), as these are the primary hormones affected in Pendred syndrome.", "retries": 1}
{"idx": 251, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'CYP17', is very close to the gold standard 'CYP17A1'. While 'CYP17' is a commonly used abbreviation, it does not fully match the more precise 'CYP17A1' as given in the gold answer. The supporting sentence mentions suppression of androgen synthesis but does not directly state that Orteronel inhibits CYP17A1 or specify its role in androgen synthesis, making it somewhat less precise than the gold supporting sentence. However, the overall logic and relevance are still strong.\", \"match\": false}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "The enzyme inhibited by Orteronel is **CYP17**.", "model_support": "The enzyme inhibited by Orteronel is **CYP17**.\n\n**Supporting sentence:** Early reports of clinical studies demonstrate that orteronel treatment leads to more complete suppression of androgen synthesis than conventional androgen deprivation therapies that act in the testes alone.", "retries": 1}
{"idx": 252, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard. The supporting sentence is relevant and provides accurate context, but it includes a slight redundancy by defining MM (multiple myeloma) when it is already clear from the context. This makes it slightly more verbose than necessary, though the logic and relevance are strong.\",\n  \"match\": true\n}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, indicated for multiple myeloma (MM) treatment, is available in 3.5-mg vials, a quantity higher than the average dose commonly prescribed.", "model_answer": "Velcade (bortezomib) is mainly used for the treatment of multiple myeloma, a type of blood cancer.", "model_support": "The drug Velcade (bortezomib) is mainly used for the treatment of multiple myeloma, a type of blood cancer. Supporting sentence: From November 2007 to October 2009 all patients with MM treated with bortezomib were identified via the Evidências database. MM stands for multiple myeloma.", "retries": 1}
{"idx": 253, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about BCR-ABL being targeted by Imatinib. However, it contains slight redundancy by elaborating on ATP and downstream effects, which is not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a hematopoietic stem cell cancer driven by the BCR-ABL fusion protein that arises from the translocation of chromosomes 9 and 22.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia chromosome positive chronic myelogenous leukemia is **BCR-ABL**. Imatinib inhibits this kinase, which is a key driver of leukemia progression in CML.", "model_support": "The sentence that supports the answer is:\n\n\"In the absence of ATP, BCR-ABL is not able to activate downstream effector tyrosine kinase molecules that drive wBC proliferation.\"\n\nThis sentence directly indicates that Imatinib targets BCR-ABL, a tyrosine kinase involved in Philadelphia chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 254, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'bulbar dystonia' does not match the gold standard 'X-linked dystonia-parkinsonism.' However, the term 'bulbar dystonia' is mentioned indirectly in the context through the discussion of lingual dystonia. The supporting sentence discusses botulinum toxin injection for lingual dystonia but does not logically or directly support the gold answer. Thus, while the answer is incorrect, it has some tangential relevance to the context.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The synonym of \"lubag disease\" is \"bulbar dystonia.\"", "model_support": "The supporting sentence is: \"botulinum toxin injection for severe lingual dystonia was successful.\" This sentence mentions \"lingual dystonia,\" which is a synonym for \"bulbar dystonia,\" confirming the synonym relationship.", "retries": 1}
{"idx": 255, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer correctly identifies dermatitis herpetiformis as the typical rash associated with gluten, which matches the gold standard. However, it includes additional descriptive details (symmetric, erythematous, blistering, common areas) that, while accurate, are not directly supported by the context provided. The supporting sentence acknowledges that the context does not explicitly describe the rash but correctly ties DH to gluten sensitivity. It is relevant and covers the answer, though it could be more concise by removing the unnecessary explanation about the lack of direct description in the context.\",\n  \"match\": true\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "BACKGROUND: Dermatitis herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80% of DH patients have gluten sensitive enteropathy manifested by crypt hyperplasia and villous atrophy.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis (DH), which presents as a symmetric, erythematous, and often blistering rash common in areas like the elbows, knees, and buttocks.", "model_support": "The context provided does not explicitly mention the typical rash associated with gluten. However, based on the information given, dermatitis herpetiformis (DH) is a condition associated with gluten sensitivity, as mentioned in the context. The context focuses on the role of metalloelastase (MMP-12) in the pathobiology of DH blisters and the involvement of other matrix metalloproteinases (MMPs). It does not directly describe the appearance or characteristics of the rash. Therefore, there is no specific sentence in the context that supports the answer provided.", "retries": 1}
{"idx": 256, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('nuclear') but is present in the context. The supporting sentence discusses a mechanism related to APOBEC3B but does not directly address its subcellular localization or support the claim of being predominantly cytoplasmic. Furthermore, it does not align with the gold supporting sentence which clearly states that APOBEC3B appeared predominantly nuclear.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "The supporting sentence is: \"Together, these data combined to suggest a model in which APOBEC3B or APOBEC3F provide a preintegration barrier to L1 retrotransposition.\" This indicates that APOBEC3B functions in a cytoplasmic mechanism, supporting the conclusion that it is predominantly cytoplasmic. \n\nAnswer: APOBEC3B protein is predominantly cytoplasmic.", "retries": 1}
{"idx": 257, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by identifying 'acute ischemic stroke' as the disease investigated in the MR CLEAN study. Minor extra details in the supporting sentence do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke.", "model_support": "The supporting sentence is: \"A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.\" This sentence explicitly identifies the disease under investigation as acute ischemic stroke.", "retries": 1}
{"idx": 258, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and matches the gold standard ('factor Xa' is equivalent to 'xa'). However, the supporting sentence does not directly reference the key information that betrixaban is a direct factor Xa inhibitor. Instead, it discusses its evaluation for prophylaxis and prevention without explicitly stating its mechanism of action. The logic connecting the supporting sentence to the answer is reasonable but could be more concise and directly relevant.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: factor Xa", "model_support": "The supporting sentence for the answer is: \"Betrixaban is currently being evaluated for prophylaxis against venous thromboembolic disease (VTED) and the prevention of stroke and systemic embolism associated with nonvalvular atrial fibrillation.\" This indirectly confirms that betrixaban inhibits factor Xa, as it is mentioned alongside PRT4445, a factor Xa decoy. \n\nAnswer: factor Xa", "retries": 1}
{"idx": 259, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'PD-1' as the correct protein targeted by the antibodies. The supporting sentence is concise and directly relevant, clearly indicating that PD-1 blockade was studied, which logically supports the answer. Although the model supporting sentence does not explicitly mention CT-011 or MK-3475, it still correctly identifies the target protein through reasoning about PD-1 blockade, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "The antibodies MK-3475 and CT-011 target the PD-1 protein.", "model_support": "The supporting sentence is: \"We examined the effect of PD-1 blockade on T-cell response to DC/tumor fusions ex vivo.\" This sentence indicates that the study used PD-1 blockade, which implies that the target of the antibodies MK-3475 and CT-011 is the PD-1 protein.", "retries": 1}
{"idx": 260, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FGFR3' is an acceptable abbreviation for 'fibroblast growth factor receptor 3 (FGFR3)'). The supporting sentence is relevant and aligns with the context, but it is slightly less specific than the gold supporting sentence. While the model correctly identifies the FGFR3 gene mutation as relevant, its supporting sentence lacks the precision and clarity of the gold sentence, which explicitly mentions the confirmation of phenotypic findings related to the FGFR3 mutation.\",\n  \"match\": true\n}", "gold_answer": "fibroblast growth factor receptor 3 (FGFR3)", "gold_support": "These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.", "model_answer": "The mutation associated with Achondroplasia is in the FGFR3 gene. \n\nAnswer: FGFR3", "model_support": "The supporting sentence is: \"Hypochondroplasia due to FGFR3 gene mutation (N540K)...\"", "retries": 1}
{"idx": 261, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'JNK (c-Jun N-terminal kinase)', is correct and matches the gold standard. However, the supporting sentence provided by the model does not directly mention JNK or its role in phosphorylating c-Jun, instead focusing on c-Jun accumulation without specifying the kinase responsible. The gold supporting sentence explicitly states that JNK mediates c-Jun phosphorylation, making the model's supporting sentence inadequate.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "The MAP kinase that phosphorylates c-Jun is JNK (c-Jun N-terminal kinase).", "model_support": "The supporting sentence that indicates which MAP kinase phosphorylates c-Jun is:\n\n\"Tylophorine treatment increased the accumulation of c-Jun protein, a component of activator protein 1 (AP1), in carcinoma cells.\"\n\nThis sentence suggests that c-Jun is a component of AP1, which is typically activated by JNK (c-Jun N-terminal kinase), a MAP kinase.", "retries": 1}
{"idx": 262, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns well with the gold standard, as 'stroke' is the core disorder the ROSIER scale is used for. However, the model answer adds extra information ('transient ischemic attack (TIA)') which, while related, isn't strictly necessary to match the gold answer. The supporting sentence is relevant and covers the use of the ROSIER scale but contains slight redundancy by specifying 'prehospital setting,' which could be more concise. Overall, the logic is strong, but minor verbosity reduces the score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for diagnosing stroke or transient ischemic attack (TIA) in the prehospital setting.", "model_support": "The supporting sentence is: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\" This sentence directly indicates that the ROSIER scale is utilized for diagnosing stroke in the prehospital setting.", "retries": 1}
{"idx": 263, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer by confirming the presence of an NF1 germline mutation, but it includes specific experimental details (e.g., 'c.499 del TGTT', 'PCR', 'exon 4') that are not necessary to directly support the answer. This makes it slightly more verbose than the gold supporting sentence, which is more concise while still providing sufficient context.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "It is well known that patients with von Recklinghausen syndrome (NF-1) (OMIM 162200) carrying NF1 germline mutations are predisposed to endocrine tumors including pheochromocytomas and duodenal somatostatinomas.", "model_answer": "The gene mutated in Type 1 neurofibromatosis is NF1.", "model_support": "The supporting sentence is: \"The germline mutation c.499 del TGTT known in the family was confirmed by polymerase chain reaction (PCR) and direct sequencing of exon 4 in DNA extracted from peripheral blood.\" This sentence confirms that the NF1 gene is mutated in Type 1 neurofibromatosis.", "retries": 1}
{"idx": 264, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'antioxidant enzyme,' aligns with the gold standard 'antioxidant,' as it correctly identifies the type of enzyme. However, the supporting sentence provided by the model is incorrect because it states there is no explicit mention of PRDX2 as an antioxidant enzyme in the context, whereas the gold supporting sentence clearly provides evidence ('an antioxidant enzyme has a key role'). The model's supporting sentence should have referenced this part of the text for accuracy. Despite this, the logic connecting the answer to the context is still strong, though slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "antioxidant", "gold_support": "Here, we offer the first evidence that an antioxidant enzyme has a key role in this transition.", "model_answer": "PeroxiRedoxin-2 (PRDX2) is an antioxidant enzyme that functions in detoxifying reactive oxygen species.", "model_support": "The context provided does not include a sentence that explicitly states that Peroxiredoxin-2 (PRDX2) is an antioxidant enzyme that functions in detoxifying reactive oxygen species. The closest mention is of gliotoxin's Prx-like activity, but this does not directly confirm PRDX2's role as an antioxidant enzyme within the context. Therefore, based on the given information, there is no supporting sentence that directly answers the question.", "retries": 1}
{"idx": 265, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explicitly stating that pridopidine is being tested for Huntington disease. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or relevance.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for treatment of Huntington disease.", "model_support": "The supporting sentence is: \"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.\" This sentence explicitly states that pridopidine is being tested as a treatment for Huntington disease.", "retries": 1}
{"idx": 266, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is relevant but does not directly mention S-adenosylmethionine as the methyl donor, which is key to supporting the answer. Instead, it vaguely establishes Ezh2 as a histone methyltransferase without explicitly linking it to SAMe. The gold supporting sentence is more direct and precise in identifying SAMe as the methyl donor by mentioning its competition with the inhibitor. Thus, while the logic is reasonable, the supporting sentence could be more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "S-Adenosyl methionine", "gold_support": "To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine.", "model_answer": "The methyl donor for histone methyltransferases, such as Ezh2 in the Polycomb repressive complex 2, is S-adenosylmethionine (SAMe).\n\nAnswer: S-adenosylmethionine", "model_support": "The supporting sentence is:\n\n**\"Ezh2 (Enhancer of zeste homolog 2) protein is the enzymatic component of the Polycomb repressive complex 2 (PRC2), which represses gene expression by methylating lysine 27 of histone H3 (H3K27)...\"**\n\nThis sentence establishes that Ezh2 is a histone methyltransferase, which implies that it uses a methyl donor such as S-adenosylmethionine (SAMe) for its enzymatic activity.", "retries": 1}
{"idx": 267, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The model answer discusses a drug derivative, which has no relation to the characteristic feature of Dyke-Davidoff-Masson syndrome. The gold answer identifies 'cerebral hemiatrophy' as the correct feature, supported by the context. The supporting sentence provided by the model does not address the gold answer or provide any logical support for the correct answer.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 268, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the topic of p73 isoforms; however, it incorrectly interprets the number of TAp73 isoforms by conflating the two major classes (TAp73 and DeltaNp73) with the specific count of TAp73 variants, which should be 7 according to the gold answer. The sentence also lacks sufficient clarity in distinguishing between general p73 isoforms and the specific TAp73 subset.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context mentions that the p73 gene produces two isoforms: TAp73 and DeltaNp73. These isoforms have opposing functions. Therefore, there are two TAp73 isoforms identified in humans.\n\nAnswer: 2", "model_support": "The context explicitly states that the p73 gene produces two isoforms: TAp73 and DeltaNp73. Therefore, there are **2 TAp73 isoforms** identified in humans.\n\nSupporting sentence: \"Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.\"\n\nAnswer: 2", "retries": 1}
{"idx": 269, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer incorrectly identifies BACH1 as an activator when it is actually a repressor according to the gold standard. The supporting sentence provided by the model is overly verbose and does not directly or concisely support the incorrect answer. It includes excessive details that do not logically lead to the conclusion that BACH1 is an activator. Instead, the context clearly states that BACH1 represses HO-1, which contradicts the model's answer.\", \"match\": false}", "gold_answer": "repressor", "gold_support": "BTB and CNC homolog 1 (Bach1) is a transcriptional repressor of heme oxygenase-1 (HO-1).", "model_answer": "BACH1 is an activator as it promotes the expression of pro-inflammatory genes and contributes to tissue injury processes.", "model_support": "The transcriptional regulator BACH1 is an activator as it promotes the expression of pro-inflammatory genes and contributes to tissue injury processes. \n\n**Supporting sentence:** Bach1 plays an important role in the feedback regulation of HO-1 expression, which protects cells from various insults including oxidative stress and inflammatory cytokines. However, the role of Bach1 in intestinal inflammation remains unclear. In this study, the role of Bach1 in intestinal mucosal injury was elucidated using 8-week-old female C57BL/6 (wild-type) and homozygous Bach1-deficient C57BL/6 mice. Intestinal mucosal injuries induced by a single subcutaneous administration of indomethacin were evaluated macroscopically, histologically, and biochemically. Mucosal protein content and chemokine mRNA levels were determined by real-time PCR. Our results showed that the indomethacin-induced intestinal injury was remarkably improved in Bach1-deficient mice. Histological examination showed that the area of injured lesion was decreased in Bach1-deficient mice compared to wild-type mice. Administration of indomethacin induced expression of inflammatory chemokines such as KC, MIP1alpha and MCP1, which was suppressed in Bach1-deficient mice. Myeloperoxidase activity in the intestinal mucosa was also significantly decreased in Bach1-deficient mice. Additionally, Bach1 deficiency enhanced immunopositivity of HO-1 in the intestinal mucosa after indomethacin administration. Disruption of the Bach1 gene thus caused inhibition of mucosal injury, indicating that inhibition of Bach1 may be a novel therapeutic strategy for treating indomethacin-induced intestinal injury.", "retries": 1}
{"idx": 270, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and logically covers the answer by citing the context where BACH1 is explicitly referred to as a transcriptional repressor. There are no issues with verbosity or irrelevance.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The sentence \"Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.\" directly identifies Bach1 as a transcriptional repressor, supporting the answer.", "retries": 1}
{"idx": 271, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, acknowledges the context accurately, and explains why no direct supporting sentence exists in the given context, which aligns with the evaluation criteria. Although the model notes the lack of explicit support in the context, the answer itself is correct and logically derived from general knowledge about botulism.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "BACKGROUND: Botulism is a serious neuroparalytic disease caused by toxins of Clostridium botulinum.", "model_answer": "The most known bacterium responsible for botulism (sausage-poisoning) is *Clostridium botulinum*.", "model_support": "The context provided does not explicitly identify the bacterium responsible for botulism, focusing instead on the types of botulinum toxin (A, B, E, AB) detected in clinical samples and foods in Iran. Therefore, there is no specific sentence within the context that directly supports the answer that *Clostridium botulinum* is the most known bacterium responsible for botulism. The context discusses the identification of toxin types rather than the bacterial species.", "retries": 1}
{"idx": 272, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by linking ZEB2 gene deletions to Mowat-Wilson syndrome. Although the model supporting sentence focuses on deletions, it still strongly supports the answer without unnecessary verbosity.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for the development of the Mowat-Wilson syndrome is **ZEB2**.", "model_support": "The supporting sentence is: \"Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\" This explicitly identifies ZEB2 as the gene responsible for Mowat-Wilson syndrome, as it directly links gene deletions in ZEB2 to the condition.", "retries": 1}
{"idx": 273, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and identifies Clostridium botulinum as the bacterium responsible for botulism, but it introduces slight redundancy by mentioning 'group III organisms and their mosaic variants,' which is more specific than required. The gold supporting sentence is more general and directly supports the answer without additional specificity.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease in animals is mainly caused by toxins produced by Clostridium botulinum strains belonging to group III, although outbreaks due to toxins produced by group I and II organisms have been recognized.", "model_answer": "The most known bacterium responsible for botulism is **Clostridium botulinum**.", "model_support": "The supporting sentence is: \"Multiplex real-time PCR for detecting and typing Clostridium botulinum group III organisms and their mosaic variants.\" This sentence directly identifies the bacterium responsible for botulism, specifically Clostridium botulinum group III, which is the most known organism associated with botulism.", "retries": 1}
{"idx": 274, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and directly mentions nestin in the context of neural precursor cells, aligning with the gold answer. However, the model's supporting sentence repeats the answer itself instead of offering a more explanatory or distinct sentence like the gold supporting sentence. This results in slight redundancy, which prevents a perfect score.\",\n  \"match\": true\n}", "gold_answer": "nestin", "gold_support": "Only a minority of stem cells expressed nestin, a marker for neural precursor cells.", "model_answer": "The intermediate filament protein used as a non-specific marker for neuronal precursor cells in the subventricular zone is **nestin**.", "model_support": "The intermediate filament protein used as a non-specific marker for neuronal precursor cells in the subventricular zone is **nestin**.\n\nSupporting sentence: \"In serum-free medium supplemented with specific growth factors, a markedly higher percentage of nestin-positive cells was observed.\"", "retries": 1}
{"idx": 275, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but does not directly quote the most concise and exact part of the context that explicitly states 'main component.' Instead, it implies the answer indirectly by mentioning the interaction between synphilin-1 and alpha-synuclein. The logic is sound, but the supporting sentence could be more direct.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is:  \n\"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"", "retries": 1}
{"idx": 276, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and matches the gold standard ('ecallantide'), but the provided supporting sentence does not directly support the answer. The chosen supporting sentence discusses the clinical benefits of DX-88 and capsule endoscopy rather than specifying that DX-88 is ecallantide. Although the context supports the answer elsewhere, the selected sentence mixes relevant and less relevant content, making it less concise and logical in relation to the specific answer.\", \"match\": true}", "gold_answer": "ecallantide", "gold_support": "DX-88 (ecallantide), a 60-amino acid recombinant protein discovered through phage display technology, is a highly specific, potent inhibitor of human plasma kallikrein that has been used successfully in the treatment of patients experiencing acute HAE attacks.", "model_answer": "DX-88 is the investigational name for ecallantide.", "model_support": "Supporting sentence: This case study demonstrates that DX-88 can produce dramatic clinical benefits in a patient with an acute abdominal HAE attack, resolving both symptoms and pathologic signs. Furthermore, it illustrates the usefulness of videos obtained from capsule endoscopy in identifying the presence of bowel occlusion and demonstrating its subsequent rapid resolution upon administration of DX-88.  \n\nHowever, the exact sentence supporting the answer \"DX-88 is the investigational name for ecallantide\" is not directly provided in the context.", "retries": 1}
{"idx": 277, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('semagacestat') but is present in the context as it correctly identifies LY450139 as a γ-secretase inhibitor. However, the supporting sentence, while relevant, does not cover the gold answer and lacks explicit mention of 'semagacestat,' which is crucial for full accuracy.\", \"match\": false}", "gold_answer": "semagacestat", "gold_support": "The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.", "model_answer": "The drug LY450139 is an investigational name for a γ-secretase inhibitor.", "model_support": "The supporting sentence is: \"We show here that Aβ(1-15) and Aβ(1-16) increase while Aβ(1-34) decreases in response to treatment with the γ-secretase inhibitor LY450139, which is in agreement with previous studies.\" This explicitly states that LY450139 is a γ-secretase inhibitor.", "retries": 1}
{"idx": 278, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly redundant and less direct compared to the gold supporting sentence. While it correctly identifies cysteine as the key residue and explains its importance, it introduces unnecessary details about other genetic variants, which detracts from conciseness. The logic is sound but could be more focused.\",\n  \"match\": true\n}", "gold_answer": "cysteine", "gold_support": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease due to mutations involving loss or gain of a cysteine residue in the NOTCH3 gene.", "model_answer": "The most commonly mutated amino acid residue in CADASIL syndrome is **cysteine**.", "model_support": "The sentence that supports the answer is: \"Moreover genetic variants different from loss or gain of a cysteine residue are identified and presented.\" This implies that while other mutations exist, the most commonly identified mutations involve cysteine residues, which are critical in the EGF-like domains of the NOTCH3 protein.", "retries": 1}
{"idx": 279, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('p53'), but the supporting sentence is somewhat indirect and does not fully capture the reasoning behind why p53 is called 'the guardian of the genome.' While it mentions p53, it focuses on genetic polymorphism and immunostaining rather than its role in controlling apoptosis and cell cycle arrest. The logic is reasonable but less concise and relevant compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "di", "gold_support": "The p53 gene has been referred to as 'the guardian of the genome' because it controls apoptosis and cell cycle arrest.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"These results suggest that genetic polymorphism of p53 codon 72 played a role in the determination of H. pylori-associated gastroduodenal diseases, but p53 immunostaining did not correlate with those of the p53 genetic polymorphism analysis.\"\n\nThis sentence refers to p53, known as \"the guardian of the genome,\" by mentioning its role in genetic polymorphism and immunostaining analysis.", "retries": 1}
{"idx": 280, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Factor Xa' vs. 'xa'), and the supporting sentence is relevant and supports the answer. However, the chosen supporting sentence is slightly indirect and less precise compared to the gold supporting sentence, which explicitly states that betrixaban directly binds to factor Xa. The model's supporting sentence discusses the general importance of factor Xa inhibition but does not directly confirm betrixaban’s action as clearly as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Factor Xa is inhibited by betrixaban. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence that indicates betrixaban inhibits factor Xa is: \"Their inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\" This sentence confirms that direct factor Xa inhibitors, including betrixaban, target this specific clotting factor. \n\n**Answer:** Factor Xa is inhibited by betrixaban. Supporting sentence: \"Their inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\"", "retries": 1}
{"idx": 281, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor extra detail in the model's supporting sentence does not detract from the strong logic.\", \"match\": true}", "gold_answer": "p53", "gold_support": "This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The sentence that supports the answer is: \"often referred to as the 'guardian of the genome.'\" This directly identifies p53 as the tumor suppressor known by that term.", "retries": 1}
{"idx": 282, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('microautophagy') does not match the gold standard ('chaperone-mediated autophagy (CMA)'). However, the supporting sentence is relevant as it discusses a process involving direct lysosomal engulfment, which could be confused with CMA. The explanation provided in the supporting sentence does not directly mention Hsc70 or LAMP-2A, which are key components of the correct pathway. Therefore, while the model captures some aspects of autophagy pathways, it fails to accurately identify the correct one.\", \"match\": false}", "gold_answer": "chaperone-mediated autophagy (CMA)", "gold_support": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes through the LAMP-2A (Lysosome-associated membrane protein type 2A) receptor.", "model_answer": "The KFERQ motif triggers microautophagy, a process where proteins are directly engulfed by lysosomes without the formation of autophagosomes. This pathway is distinct from macroautophagy, which involves autophagosome formation.", "model_support": "The supporting sentence is: \"The KFERQ motif of cytosolic proteins is known to directly trigger microautophagy, a process where proteins are directly engulfed by lysosomes without the formation of autophagosomes. This pathway is distinct from macroautophagy, which involves autophagosome formation.\"\n\nThis sentence explicitly states that the KFERQ motif triggers microautophagy by directly engulfing proteins into lysosomes, distinguishing it from macroautophagy.", "retries": 1}
{"idx": 283, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'the template strand,' does not match the gold standard, 'the transcribed strand.' However, the supporting sentence is relevant and discusses transcription-coupled repair (TCR), though it incorrectly infers that TCR targets the template strand. The gold supporting sentence explicitly states that TCR preferentially repairs the transcribed strand, which directly contradicts the model’s inference. Thus, while the supporting sentence demonstrates some understanding of TCR, it fails to align with the correct answer.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "It has been previously shown that disruption of RAD26 in yeast strain W303-1B results in a strain that is deficient in transcription-coupled repair (TCR), the preferential repair of the transcribed strand of an expressed gene over the non-transcribed strand and the rest of the genome.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the template strand.", "model_support": "The context does not explicitly state that transcription-coupled repair (TCR) targets the template strand. However, the process of transcription-coupled repair is inherently linked to the transcription of the template strand, as it involves the simultaneous repair of DNA damage while the strand is being transcribed. While the context discusses chromatin remodeling by RAD26 and its role in gene expression, it does not provide direct evidence that TCR specifically targets the template strand. Therefore, the answer that TCR targets the template strand is an inference based on the nature of TCR, not a direct statement from the context provided.\n\n**Answer:** The context does not provide a direct sentence supporting this claim.", "retries": 1}
{"idx": 284, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (mentioning SERCA and SERCA2a) that, while correct, are not necessary for answering the question directly. The supporting sentence provided by the model is completely irrelevant to the question, as it discusses JTV519 rather than providing a relevant explanation for SERCA2's role in calcium transport. This reduces the score despite the answer being mostly correct.\",\n  \"match\": false\n}", "gold_answer": "SERCA2", "gold_support": "During diastole, muscle relaxation occurs as Ca2+ is again removed from cytosol, predominantly by accumulation into SR via the action of SERCA2a.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA (Sarco(endo)plasmic reticulum Ca²⁺ ATPase). Specifically, SERCA2 is the primary isoform in most cells, while SERCA2a is the predominant form in the heart.", "model_support": "The supporting sentence that identifies JTV519 as a derivative of 1,4-benzothiazepine is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 285, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy. The model's supporting sentence mentions that NF1 is a tumor-suppressor gene, which is true and related, but does not directly reference its role in coding for neurofibromin or its interaction with GTPase-activating proteins as described in the gold supporting sentence.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "The NF1 gene codes for a protein called \"neurofibromin.\" It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation.", "model_answer": "The gene mutated in Type 1 neurofibromatosis is **NF1**.", "model_support": "The supporting sentence is: \"The NF1 gene is a tumor-suppressor gene.\" This sentence directly identifies NF1 as a tumor-suppressor gene, which is crucial for understanding its role in neurofibromatosis.", "retries": 1}
{"idx": 286, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about H3K4 methylation, mentioning dSet1/COMPASS as responsible for this modification in Drosophila, which corresponds to MLL1. However, it indirectly references MLL1 through dSet1 without explicitly linking it back to human MLL1, making it slightly less direct compared to the gold supporting sentence. This introduces a minor redundancy but still offers logical support.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Methylation of histone H3 lysine 4 (H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax (Trx).", "model_answer": "The histone residue methylated by MLL1 is H3K4. \n\nAnswer: H3K4", "model_support": "The supporting sentence that indicates which histone residue is methylated by MLL1 is: \"dSet1/COMPASS is the major monoubiquitination-dependent H3K4 di- and trimethylase in Drosophila.\"\n\nThis sentence directly states that dSet1, which corresponds to MLL1 in Drosophila, is responsible for methylating H3K4.", "retries": 1}
{"idx": 287, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the context suggests that Bmi-1 is involved in regulating p16INK4a (as per the gold answer), the model incorrectly concludes that Bmi-1 does not regulate any CDK inhibitor. The supporting sentence provides relevant information but fails to cover the correct answer (p16INK4a) and instead supports an incorrect conclusion. The logic is somewhat present but ultimately flawed due to misinterpretation.\", \"match\": false}", "gold_answer": "p16INK4", "gold_support": "Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.", "model_answer": "The study indicates that Bmi-1 does not regulate p16INK4a, p14ARF, or h-TERT, as there is no correlation between Bmi-1 expression and these CDK inhibitors. Therefore, based on the provided context, Bmi-1 does not regulate any specific CDK inhibitor mentioned in the study.\n\nAnswer: Bmi-1 does not regulate any specific CDK inhibitor in this study.", "model_support": "The study indicates that Bmi-1 does not regulate p16INK4a, p14ARF, or h-TERT, as there is no correlation between Bmi-1 expression and these CDK inhibitors. Therefore, based on the provided context, Bmi-1 does not regulate any specific CDK inhibitor mentioned in the study.\n\nAnswer: Bmi-1 does not regulate any specific CDK inhibitor in this study.", "retries": 1}
{"idx": 288, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('Semagacestat') but is related to the context as it correctly identifies LY450139 as a γ-Secretase modulator. However, the supporting sentence incorrectly states that there is no mention of LY450139 in the context, when in fact the gold supporting sentence clearly references it. The supporting sentence fails to cover the gold answer and introduces confusion.\", \"match\": false}", "gold_answer": "Semagacestat", "gold_support": "The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.", "model_answer": "LY450139 is the investigational name of a γ-Secretase modulator drug.", "model_support": "The context provided does not mention LY450139, a γ-Secretase modulator. Therefore, there is no supporting sentence in the given context for LY450139 being an investigational name of a γ-Secretase modulator drug.\n\nAnswer: There is no supporting sentence in the provided context.", "retries": 1}
{"idx": 289, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the connection between 'Lubag disease' and 'X-linked dystonia-parkinsonism'. Although the model's supporting sentence includes a quote from the context, it remains focused and effectively supports the answer without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome.", "model_answer": "The synonym of \"lubag disease\" is **X-linked dystonia-parkinsonism**.", "model_support": "The synonym of \"lubag disease\" is **X-linked dystonia-parkinsonism**. This is supported by the statement: \"In a Filipino woman with suspected Parkinson disease, we confirmed the presence of all changes specific for X-linked dystonia-parkinsonism in genomic DNA.\"", "retries": 1}
{"idx": 290, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer 'antiparallel' matches the gold standard. However, the supporting sentence provided is completely irrelevant to the question and does not logically support the answer. The correct supporting sentence should have been directly related to the formation of antiparallel heterodimers by alpha- and beta-spectrin as described in the context.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Alpha-spectrin and beta-spectrin form antiparallel heterodimers.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 291, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'Xa', though it is slightly more verbose. The supporting sentence provides relevant information and covers the answer logically, but it contains some redundancy by discussing the broader landscape of anticoagulants rather than directly focusing on betrixaban as a Factor Xa inhibitor. Despite this, the logic is clear and the connection to the answer is strong.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Factor Xa.", "model_support": "The supporting sentence is: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\" This sentence identifies Factor Xa as one of the targets of the new anticoagulant classes, confirming that betrixaban inhibits Factor Xa.", "retries": 1}
{"idx": 292, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' in essence, as the '1,4-' prefix is a more specific but correct descriptor. The supporting sentence from the model is relevant and supports the answer well, but it introduces additional details (e.g., 'multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak') that are not directly necessary to justify the classification of JTV519 as a benzothiazepine derivative, leading to slight verbosity.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 293, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Zfhx1b' is correct and matches the gold standard 'ZFHX1B' in meaning, though it uses a different format (lowercase vs uppercase). The supporting sentence provided by the model is relevant but slightly indirect; while it connects the mouse model's malformations to human Mowat-Wilson syndrome, it doesn't explicitly mention the role of heterozygous mutations or the broader clinical features as comprehensively as the gold supporting sentence. There is some redundancy in discussing the mouse model, which makes it less concise compared to the ideal.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is Zfhx1b.", "model_support": "The supporting sentence is: \"These mutant mice display craniofacial and gastrointestinal malformations that show resemblance to those found in human patients with Mowat-Wilson syndrome.\"\n\nThis sentence directly connects the effects of Zfhx1b mutation in mice to the characteristics of Mowat-Wilson syndrome in humans, indicating Zfhx1b's role in the development of the syndrome.", "retries": 1}
{"idx": 294, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it contains slight redundancy by mentioning Parkinson's disease belonging to the group of Lewy body disorders, which is not directly necessary for explaining the composition of Lewy bodies. The logic is clear but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. This is supported by the context which states that Parkinson's disease (PD) belongs to the group of Lewy body disorders, directly linking PD to Lewy bodies and their composition. \n\nAnswer: The main component of Lewy bodies is alpha-synuclein.\n\nSupporting sentence: Parkinson disease (PD) belongs to the group of Lewy body disorders.", "retries": 1}
{"idx": 295, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states there is only 1 TAp73 isoform identified in humans, whereas the gold answer indicates there are 7. The supporting sentence provided by the model is irrelevant and does not logically support the answer; it mentions upregulation of certain isoforms but does not address the number of TAp73 isoforms at all.\", \"match\": false}", "gold_answer": "7", "gold_support": "The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "model_answer": "1 TAp73 isoform has been identified in humans.", "model_support": "The supporting sentence is: \"TAp73, DeltaNp73 and DeltaN'p73 were significantly upregulated in tumors.\" This indicates that there is only one TAp73 isoform identified in humans.\n\nAnswer: 1 TAp73 isoform has been identified in humans.", "retries": 1}
{"idx": 296, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('flumazenil'), but the supporting sentence provided by the model is irrelevant to the context of benzodiazepine overdose and flumazenil. The model's supporting sentence discusses JTV519, which is unrelated to the question and does not logically support the use of flumazenil as an antidote. A correct supporting sentence should have referenced the treatment of benzodiazepine intoxication with flumazenil.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15-1788).", "model_answer": "Flumazenil is the antidote used in benzodiazepine overdose. It acts as a benzodiazepine receptor antagonist, reversing the sedative effects without causing withdrawal symptoms.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 297, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'vestitone', does not match the gold standard 'medicarpin'. However, vestitone is mentioned in the context as an intermediate in the biosynthesis pathway of medicarpin. The supporting sentence discusses the conversion to vestitone but does not directly support vestitone as the major phytoalexin, as it is only an intermediate. Thus, the answer is incorrect but present in the context, and the supporting sentence is relevant but does not cover the gold answer.\", \"match\": false}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is vestitone.", "model_support": "The supporting sentence is: \"We have isolated a 1.18 kb alfalfa cDNA (pIFRalf1) which, when expressed in Escherichia coli, converts 2'-hydroxyformononetin stereospecifically to (3R)-vestitone, as would be predicted for IFR from alfalfa.\"\n\nThis sentence directly states that vestitone is the product of IFR's action on 2'-hydroxyformononetin, making it a major phytoalexin in alfalfa.", "retries": 1}
{"idx": 298, "gptscore_json": "{\"score\": 1, \"reason\": \"The answer provided by the model ('5-HT1B/D receptor') is incorrect and does not match the gold standard ('calcitonin gene-related peptide'). The supporting sentence is also incorrect as it implies telcagepant is a triptan, which it is not. Triptans target serotonin receptors, but telcagepant specifically targets the CGRP receptor as stated in the context. The logic is flawed, and the information provided does not align with the correct answer.\", \"match\": false}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.", "model_answer": "Telcagepant targets the **5-HT1B/D receptor**, which is a type of serotonin receptor.", "model_support": "The supporting sentence is: \"patients were randomized 2:1 to double-blind treatment with telcagepant 280/300 mg or rizatriptan 10 mg for an acute mild, moderate, or severe migraine.\" This implies that telcagepant is a triptan, a class of drugs known to target the 5-HT1B/D receptor.", "retries": 1}
{"idx": 299, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model answer matches the gold standard exactly, specifying 'Dnmt1' as the enzyme responsible for DNA (cytosine-5-)-methylation. The supporting sentence is concise, directly relevant, and provides clear reasoning by highlighting Dnmt1's role in maintaining methylation at hemimethylated CpG sites. Minor extra details do not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "The maintenance methylation of hemimethylated CpG sites by the DNA methyltransferase Dnmt1 is the molecular basis of the inheritance of DNA methylation patterns.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is Dnmt1 (DNA methyltransferase 1).", "model_support": "The supporting sentence is: \"Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.\" This sentence directly identifies Dnmt1 as the enzyme responsible for maintaining DNA methylation.", "retries": 1}
{"idx": 300, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly connects α-synuclein to Lewy bodies, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "The main component of the Lewy bodies is α-synuclein.\n\nAnswer: α-synuclein", "model_support": "The sentence that supports the answer is: \"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.\" This explicitly states that α-Synuclein (AS) is a main component of Lewy bodies.", "retries": 1}
{"idx": 301, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer ('Two TAp73 isoforms') does not match the gold standard ('7'). Additionally, the supporting sentence provided is irrelevant to the question and does not support either the model's answer or the gold answer. The supporting sentence discusses a completely unrelated topic (JTV519 and RyR2s).\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Two TAp73 isoforms have been identified in humans: TAp73 alpha full-length and Delta Np73 alpha.", "model_support": "Supporting sentence: **JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.**", "retries": 1}
{"idx": 302, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'). The supporting sentence is relevant and supports the answer by referencing TCR's role in repairing the transcribed strand. However, it introduces slight redundancy by mentioning the 'template strand,' which is not directly relevant to the gold answer and could confuse the precise focus on the 'transcribed strand.' Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand. TCR specifically addresses DNA lesions that occur in the template strand during transcription, ensuring that transcription can continue despite damage.", "model_support": "The supporting sentence is: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\" This sentence explicitly states that transcription-coupled repair (TCR) addresses DNA lesions in the transcribed strand, aligning with the answer that TCR targets the transcribed strand.", "retries": 1}
{"idx": 303, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer, 'CCN1', is incorrect and does not match the gold standard 'ZFHX1B'. The supporting sentence repeats the incorrect answer without providing any relevant or logical reasoning. It fails to reference ZFHX1B or any correct context from the provided background information, making both the answer and supporting sentence irrelevant.\",\n  \"match\": false\n}", "gold_answer": "ZFHX1B", "gold_support": "Haploinsufficiency of a gene termed ZFHX1B (also known as SIP1) on chromosome 2 is responsible for this condition, and clinical genetic testing for MWS recently became available.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is **CCN1**.", "model_support": "The supporting sentence is: \"The gene responsible for the development of Mowat-Wilson syndrome is **CCN1**.\"", "retries": 1}
{"idx": 304, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('CYP17A1') and provides additional clarification about the specific activity (17,20-lyase) being inhibited, which is correct but slightly more detailed than required. The supporting sentence is relevant and supports the answer with logical reasoning, referencing the specificity of Orteronel for 17,20-lyase activity over 17-hydroxylase activity. However, it introduces some redundancy by elaborating on the comparison between activities, which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "The enzyme inhibited by Orteronel is **CYP17A1**, specifically its 17,20-lyase activity.", "model_support": "The supporting sentence is: \"In human CYP17A1 and human adrenal tumor cells, orteronel inhibited 17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity in cell-free enzyme assays...\"\n\nThis sentence explicitly states that Orteronel inhibits the 17,20-lyase activity of CYP17A1, confirming the answer.", "retries": 1}
{"idx": 305, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\" This sentence directly identifies p53 as the tumor suppressor known as \"the guardian of the genome,\" answering the question.", "retries": 1}
{"idx": 306, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer '1,4-benzothiazepine' is completely incorrect and unrelated to the gold answer 'iron'. The supporting sentence mentions iron deficiency, which is relevant, but it does not align with the incorrect answer provided. The mismatch between the answer and the supporting sentence, along with the incorrect answer, results in a score of 1.\", \"match\": false}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The deficiency causing restless leg syndrome (RLS) in this context is **iron deficiency**. The context explicitly states that RLS is manifested by iron deficiency from chronic hemoptysis in the described cystic fibrosis patient. \n\n**Supporting sentence:** \"Restless leg syndrome manifested by iron deficiency from chronic hemoptysis in cystic fibrosis.\"", "retries": 1}
{"idx": 307, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Semagacestat,' matches the gold standard but is presented in a verbose form ('LY450139 is the investigational name of Semagacestat') rather than the concise format expected. The supporting sentence provided by the model is completely irrelevant to the question, discussing JTV519 instead of LY450139 or semagacestat, which detracts from its logical support for the answer.\",\n  \"match\": true\n}", "gold_answer": "semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "LY450139 is the investigational name of Semagacestat.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 308, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard, as 'SERCA (sarcoplasmic/endoplasmic reticulum calcium ATPase)' is a valid and equivalent way of expressing 'Sarcoplasmic reticulum Ca(2+)-ATPase.' However, the supporting sentence provided by the model repeats the answer without adding further concise reasoning or context. While it is relevant, it could be more informative like the gold supporting sentence, which provides additional details about SERCA's role in calcium homeostasis and disease implications.\",\n  \"match\": true\n}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is **SERCA (sarcoplasmic/endoplasmic reticulum calcium ATPase)**.", "model_support": "The main calcium pump of the sarcoplasmic reticulum is **SERCA (sarcoplasmic/endoplasmic reticulum calcium ATPase)**. \n\n**Supporting sentence:** Modulation of rabbit muscle sarcoplasmic reticulum Ca(2+)-ATPase activity by novel quercetin derivatives.", "retries": 1}
{"idx": 309, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SECIS') but includes additional wording ('stem-loop structure') that, while correct, is unnecessary for this context. The supporting sentence contains relevant information about SECIS elements and their stem-loop structure, confirming its role in function, but it is slightly verbose and less direct compared to the gold supporting sentence. Overall, the logic is sound, but some redundancy exists.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Two functional SECIS elements were identified in the 3' untranslated region of the rat selenoprotein P mRNA, with predicted stem-loops and critical nucleotides similar to those in the SECIS elements in the type I iodothyronine 5' deiodinase (5'DI) and glutathione peroxidase selenoprotein mRNAs.", "model_answer": "The name of the stem loop present in the 3' end of genes encoding for selenoproteins is the SECIS stem-loop structure.", "model_support": "The supporting sentence is:\n\n\"Site-directed mutational analyses of three SECIS elements confirmed that conserved nucleotides in the loop and in unpaired regions of the stem are critical for activity. This indicates that multiple contact sites are required for SECIS function.\"\n\nThis sentence directly refers to the stem-loop structure, confirming its role in SECIS function, thus supporting the answer.", "retries": 1}
{"idx": 310, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK'). The supporting sentence is relevant and mentions the XK gene, but it is slightly vague and lacks specific details about the mutation or analysis compared to the gold supporting sentence. It does not explicitly mention the missense mutation in exon 3, which would have made it more precise.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The gene associated with McLeod syndrome is the **XK gene**.", "model_support": "The supporting sentence is: \"Analysis of XK DNA sequence and RNA levels.\" This sentence directly refers to the evaluation of the XK gene, confirming its role in McLeod syndrome.", "retries": 1}
{"idx": 311, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'myelosuppression' is mentioned as a dose-limiting toxicity in the context, it is not identified as the major adverse effect of Adriamycin; cardiotoxicity is. The supporting sentence also focuses on myelosuppression rather than cardiotoxicity and therefore does not cover the gold answer.\", \"match\": false}", "gold_answer": "Cardiotoxicity", "gold_support": "Cardiotoxicity is a major adverse effect of the anthracycline antibiotics and can be acute or chronic; in the acute setting, electrocardiographic abnormalities may be seen, including ST-T elevations and arrhythmias, but chronic cardiotoxicity represents a serious adverse effect that may be lethal due to the development of irreversible, cumulative dose-dependent, congestive cardiomyopathy.", "model_answer": "The major adverse effect of Adriamycin (doxorubicin) is myelosuppression, particularly neutropenia and leucopenia, which are dose-limiting toxicities.", "model_support": "The major adverse effect of Adriamycin (doxorubicin) is myelosuppression, predominantly neutropenia and leucopenia, which are dose-limiting toxicities. \n\nSupporting sentence: Myelosuppression, predominantly neutropenia and leucopenia, is the dose-limiting toxicity.", "retries": 1}
{"idx": 312, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating the relationship between DX-88 and ecallantide.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.", "model_answer": "DX-88 is the investigational name of ecallantide.", "model_support": "The supporting sentence is: \"DX-88 is the investigational name of ecallantide.\" This sentence directly identifies DX-88 as the investigational name of the drug, confirming the answer.", "retries": 1}
{"idx": 313, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (ERK) does not match the gold standard (JNK), but ERK is mentioned in the context as part of the MAP kinase family. The supporting sentence acknowledges that the context does not explicitly support the model's answer, which is accurate, but it fails to identify the correct supporting evidence for JNK from the gold supporting sentence.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "The expressions of Bcl-2, Bax, caspase-3, extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal protein kinases (JNK), and p38 were evaluated by Western blot.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is ERK (Extracellular signal-regulated kinase).", "model_support": "The context provided does not explicitly mention ERK or any specific MAP kinase. It refers to the MAPK pathway in general but does not specify which member of the MAP kinase family is involved. Therefore, there is no sentence in the context that supports the answer that ERK phosphorylates c-jun.", "retries": 1}
{"idx": 314, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "Using SEA0400, a potent and selective inhibitor of the Na+-Ca2+ exchanger (NCX), we examined whether NCX is involved in nitric oxide (NO)-induced disturbance of endoplasmic reticulum (ER) Ca2+ homeostasis followed by apoptosis in cultured rat microglia.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+-Ca2+ exchanger.\n\nAnswer: Na+-Ca2+ exchanger", "model_support": "The supporting sentence is:  \n\"8. SNP increased Na+-dependent 45Ca2+ uptake and this increase was blocked by SEA0400.\"  \n\nThis sentence directly demonstrates that SEA0400 inhibits the Na+-Ca2+ exchanger, as it blocks the increased Ca2+ uptake mediated by this exchanger.", "retries": 1}
{"idx": 315, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'vimentin,' does not match the gold standard, 'nestin,' but vimentin is a known intermediate filament protein associated with precursor cells in other contexts. The supporting sentence acknowledges that the context does not mention vimentin, making it relevant but failing to support the gold answer. The gold supporting sentence specifically highlights nestin as the correct marker for neuronal precursor cells in the subventricular zone, which the model's response does not address.\", \"match\": false}", "gold_answer": "nestin", "gold_support": "In the subventricular zone, this effect was exerted selectively on a precursor subpopulation expressing nestin but not neuronal or glial cell-specific proteins.", "model_answer": "The intermediate filament protein vimentin is often used as a non-specific marker for various precursor cells, including those in the subventricular zone. \n\nAnswer: vimentin", "model_support": "The context provided does not explicitly mention vimentin or reference it as a marker for neuronal precursor cells in the subventricular zone. Therefore, there is no supporting sentence within the given context that directly addresses the use of vimentin as a marker for these cells.", "retries": 1}
{"idx": 316, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('peroxiredoxin enzyme') does not match the gold standard ('antioxidant'), but it is present in the context. The supporting sentence mentions PRDX2 but focuses on its identification as an 'Srx-dependent modified enzyme' rather than clearly defining it as an antioxidant, which is the key point of the gold answer. Therefore, while the supporting sentence is relevant, it does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats.", "model_answer": "Peroxiredoxin 2 (PRDX2) is a peroxiredoxin enzyme.", "model_support": "The supporting sentence that identifies Peroxiredoxin 2 (PRDX2) as a peroxiredoxin enzyme is:\n\n\"Gene expression of PRDX2, identified as an Srx-dependent modified enzyme, was stimulated by gonadotropins.\"\n\nThis sentence clearly states that PRDX2 is a peroxiredoxin enzyme.", "retries": 1}
{"idx": 317, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The correct answer is 'Fungi,' but the model incorrectly states 'Protista.' The supporting sentence mentions that Microsporidia are eukaryotic parasites, which is true but does not provide evidence for their classification under Protista or Fungi. The gold supporting sentence directly references phylogenetic analysis linking Microsporidia to Fungi, which the model's supporting sentence fails to address.\", \"match\": false}", "gold_answer": "Fungi", "gold_support": "Phylogenetic analysis indicates a relationship between the Microsporidia and the Fungi.", "model_answer": "Microsporidia belong to the Protista kingdom.", "model_support": "The supporting sentence is: \"Microsporidia are a group of obligate intracellular eukaryotic parasites that infect a wide variety of species, including humans.\" This sentence identifies Microsporidia as eukaryotes, which aligns with their classification under the Protista kingdom.", "retries": 1}
{"idx": 318, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('1,4-benzothiazepine') does not match the gold standard ('Huntington disease'), but the supporting sentence correctly identifies that pridopidine is being tested for Huntington disease. The supporting sentence is relevant but overly verbose and includes unnecessary details about the disease rather than focusing on the direct relationship between pridopidine and Huntington disease.\", \"match\": false}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"OBJECTIVES: Huntington disease is a hereditary neurodegenerative disorder resulting in loss of motor, cognitive, and behavioral functions and is characterized by a distinctive pattern of cerebral metabolic abnormalities. The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\" This sentence explicitly states that pridopidine is being tested for the treatment of Huntington disease.", "retries": 1}
{"idx": 319, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and unrelated to the question. The supporting sentence provided by the model discusses a different topic (1,4-benzothiazepine) which is irrelevant to spectrin subunits or their arrangement. Both the answer and supporting sentence fail to address the gold answer or provide logical support.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "The spectrin heterodimer is formed by the antiparallel lateral association of an alpha and a beta subunit, each of which comprises largely a series of homologous triple-helical motifs.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 320, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the context but does not cover the gold answer. The model incorrectly identifies 'lingual dystonia' as a synonym for 'lubag disease,' when the correct synonym is 'X-linked dystonia-Parkinsonism.' Additionally, the supporting sentence focuses on lingual dystonia rather than directly addressing the relationship between 'lubag' and 'X-linked dystonia-Parkinsonism.'\", \"match\": false}", "gold_answer": "X-linked dystonia-Parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The synonym for \"lubag disease\" in the given context is likely \"lingual dystonia.\" This is because the context specifically mentions the treatment of lingual dystonia with botulinum toxin, and \"lubag\" might be a misspelling or abbreviation for \"lingual.\" \n\nAnswer: Lingual dystonia", "model_support": "The synonym for \"lubag disease\" in the given context is \"lingual dystonia.\" This is evident from the context, where botulinum toxin injection was used successfully to treat severe lingual dystonia. It is likely that \"lubag\" is an abbreviation or misspelling of \"lingual.\" \n\nSupporting sentence: Botulinum toxin injection for severe lingual dystonia was successful.", "retries": 1}
{"idx": 321, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX).", "model_support": "The supporting sentence is: \"The change of NCX current and the increase of [Ca2+]i during I/R can be blocked by SEA0400 in a dose-dependent manner with an EC50 value of 31 nM and 28 nM for the inward and outward NCX current, respectively.\" This sentence explicitly identifies SEA0400 as an inhibitor of the Na+/Ca2+ exchanger (NCX).", "retries": 1}
{"idx": 322, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A' is synonymous with 'Serotonin 5-HT2A receptor'). The supporting sentence is concise, directly relevant, and logically supports the answer by specifying that [18F]altanserin is used to evaluate the serotonin 5-HT2A receptor. There is no excessive content or redundancy.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.", "model_answer": "The [18F]altanserin can evaluate the serotonin 5-HT2A receptors. \n\nAnswer: Serotonin 5-HT2A receptor", "model_support": "The supporting sentence is: \"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\" This sentence explicitly states that [18F]altanserin is used to evaluate the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 323, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer is 'thyroid,' which implies that the abnormalities are related to thyroid function, but it does not explicitly state low T3/T4 or elevated TSH as the model answer does. The supporting sentence provides some relevant context (impaired iodine transport), but it does not align well with the gold supporting sentence and introduces speculative details about low thyroid hormone levels that are not directly supported by the context provided. Therefore, while the model answer is present in the broader context of thyroid dysfunction, it does not precisely cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter.", "model_answer": "The hormone abnormalities characteristic of Pendred syndrome include low levels of thyroid hormones (T3 and T4) with normal or elevated thyrotropin (TSH) levels. This is due to impaired iodine transport in the thyroid gland, leading to insufficient production of thyroid hormones.", "model_support": "The hormone abnormalities characteristic of Pendred syndrome include low levels of thyroid hormones (T3 and T4) with normal or elevated thyrotropin (TSH) levels. This is due to impaired iodine transport in the thyroid gland, leading to insufficient production of thyroid hormones. \n\nSupporting sentence: This suggests that the thyroid is not responding appropriately to iodine, leading to low thyroid hormone levels despite normal TSH.", "retries": 1}
{"idx": 324, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly ties EWS/FLI1 to the development of Ewing sarcoma, but it includes additional details about miRNA-708 and chemoresistance, which are not necessary to answer the question. This makes it slightly more verbose than required, though it still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "The fusion protein involved in the development of Ewing sarcoma is EWS/FLI1.", "model_support": "The supporting sentence that directly answers the question about the fusion protein EWS/FLI1 involved in the development of Ewing sarcoma is:\n\n**\"EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.\"**\n\nThis sentence clearly states that EWS/FLI1 is involved in the development of Ewing sarcoma by its regulation of EYA3.", "retries": 1}
{"idx": 325, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Stroke'), and the supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the ROSIER scale is used as a stroke recognition tool.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for stroke.", "model_support": "The supporting sentence is: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\" This sentence explicitly mentions that the ROSIER is used for stroke.", "retries": 1}
{"idx": 326, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While '7,2'-dihydroxy-4'-methoxyisoflavanol' is mentioned in the context, it is an intermediate compound in medicarpin biosynthesis, not the major phytoalexin itself. The supporting sentence focuses on this intermediate step rather than identifying medicarpin as the major phytoalexin, thus failing to cover the gold answer. The model's supporting sentence is relevant but misaligned with the gold answer.\",\n  \"match\": false\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa is **7,2'-dihydroxy-4'-methoxyisoflavanol**.", "model_support": "The sentence that supports the answer is: \"One of the final steps of medicarpin biosynthesis, from vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, is catalyzed by vestitone reductase.\"", "retries": 1}
{"idx": 327, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The ROSIER scale is used for stroke recognition, but the model provides an answer related to a chemical compound (1,4-benzothiazepine), which has no connection to the context of the ROSIER scale or strokes. Similarly, the supporting sentence discusses JTV519, which is unrelated to the ROSIER scale or strokes. Both the answer and supporting sentence fail to address the gold standard or provide relevant information.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 328, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is relevant but contains slight redundancy and does not directly quote the phrase 'guardian of the genome' as the gold supporting sentence does. The model's supporting sentence discusses p53's role in cancer but lacks the concise relevance of the gold sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is:  \n\"In addition, p53 generally confers the cancer cell sensitivity to chemoradiation. Thus, p53 becomes the most appealing target for mechanism-driven anticancer drug discovery.\"  \n\nThis sentence directly refers to p53 as \"the guardian of the genome,\" emphasizing its role in tumor suppression and cancer treatment.", "retries": 1}
{"idx": 329, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('women') matches the gold standard, but the supporting sentence does not cover the gold answer. The model's supporting sentence discusses the lack of incidence data in the context rather than using the provided information about the higher number of women (n=225) compared to men (n=67) at baseline, which supports the gold answer. The reasoning is relevant but fails to directly connect to the evidence in the gold supporting sentence.\", \"match\": true}", "gold_answer": "women", "gold_support": "RESULTS: At baseline, men (n = 67) and women (n = 225) had similar disease activity and radiographic damage; men, however, had significantly worse erosion, while women had worse joint space narrowing.", "model_answer": "Rheumatoid Arthritis is more common in women than in men, with a female-to-male incidence ratio of approximately 3:1.", "model_support": "The context provided does not directly address the incidence of Rheumatoid Arthritis (RA) in men versus women. The study focuses on gender differences in treatment responses and disease characteristics among a cohort of early RA patients. While the conclusion mentions that men and women had similar baseline disease activity and joint damage, it does not provide information about the overall incidence of RA in men or women.\n\nThe context does not contain a supporting sentence for the claim that \"Rheumatoid Arthritis is more common in women than in men, with a female-to-male incidence ratio of approximately 3:1.\" This information is not present in the provided text.", "retries": 1}
{"idx": 330, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context, as it elaborates on hypothyroidism, which relates to thyroid abnormalities. However, the supporting sentence provided by the model is entirely irrelevant to the question and does not support the answer or the gold standard. The correct supporting sentence should have been directly tied to thyroid abnormalities in Williams syndrome.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "The hormone abnormalities commonly associated with Williams syndrome include hypothyroidism, characterized by low levels of thyroxine (T4) and elevated thyrotropin-stimulating hormone (TSH). This is based on the context provided, which describes a patient with Williams-Beuren syndrome presenting with congenital hypothyroidism.", "model_support": "The sentence that supports the answer is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 331, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard. The supporting sentence provides relevant information and captures the essence of the gold supporting sentence but includes additional details that slightly reduce its conciseness. It explains the opposing roles of Hsp90 and Hsp70 but adds information about the lack of direct evidence for Hsp70 upregulation, which is unnecessary given the context provided. Despite this, the logic is sound and aligns well with the gold answer.\", \"match\": true}", "gold_answer": "Hsp70", "gold_support": "Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation.", "model_answer": "Hsp70 is involved in the degradation process facilitated by Hsp90 inhibition but is not explicitly stated to be upregulated in the context provided. The study highlights the opposing roles of Hsp90 and Hsp70 in regulating Nox protein stability, with Hsp70 promoting Nox degradation. However, there is no direct evidence in the context that Hsp70 levels increase during Hsp90 inhibition.\n\nAnswer: Hsp70", "model_support": "The study discusses the opposing roles of Hsp90 and Hsp70 in regulating Nox protein stability. Hsp90 typically stabilizes Nox proteins, but when inhibited, Hsp70 and CHIP promote their ubiquitination and degradation. While Hsp70 is involved in the degradation process facilitated by Hsp90 inhibition, there is no direct evidence in the provided context that Hsp70 levels increase during Hsp90 inhibition. Therefore, the answer is:\n\nAnswer: Hsp70", "retries": 1}
{"idx": 332, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('antioxidant') but is present in the context as 'peroxiredoxin reductase,' which is a more specific term. The supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, while the gold supporting sentence clearly exists and directly supports the gold answer. The model's supporting sentence fails to cover the gold answer.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, was the most upregulated while tribbles homolog 3 (TRB3), a pro-apoptotic protein, was the most downregulated, implying a beneficial effect of lithium on neuronal cells.", "model_answer": "Peroxiredoxin 2 (PRDX2) is a type of enzyme classified as a peroxiredoxin reductase. It functions as an antioxidant by reducing peroxides, aiding in the detoxification of reactive oxygen species and protecting cells against oxidative stress.", "model_support": "The context provided does not mention Peroxiredoxin 2 (PRDX2) or its function as a peroxiredoxin reductase. Therefore, there is no supporting sentence in the given context that addresses this question.", "retries": 1}
{"idx": 333, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard, identifying 'I-1' as the main inhibitor of PP1. The supporting sentence provided by the model is relevant and directly supports the answer by emphasizing that Ser67-phosphorylated I-1 is a potent inhibitor of PP1. However, the supporting sentence adds slight redundancy by specifying Ser(67) phosphorylation, which, while accurate, is not necessary to meet the gold standard's requirement. Overall, the logic is strong, but this additional detail reduces conciseness.\", \"match\": true}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.", "model_answer": "The main inhibitor of protein phosphatase 1 (PP1) in this context is **I-1**, specifically when phosphorylated on Ser(67).", "model_support": "The supporting sentence is: \"Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.\"\n\nThis sentence directly states that I-1, when phosphorylated on Ser(67), is a potent inhibitor of protein phosphatase 1 (PP1), confirming the main inhibitor.", "retries": 1}
{"idx": 334, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard, correctly identifying alpha-synuclein as the main component of Lewy bodies. However, the supporting sentence is somewhat off-topic and mixes relevant and irrelevant content by discussing multiple system atrophy rather than Parkinson's disease or Lewy body dementia as specified in the context. The logic is reasonable but could be more concise and directly focused on the gold answer.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of the Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.\" This sentence directly links alpha-synuclein as the main component of Lewy bodies, specifically noting their presence in neuronal inclusions, which are Lewy bodies.", "retries": 1}
{"idx": 335, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds') is completely irrelevant to the question about the ROSIER scale. However, the supporting sentence provided by the model is relevant and correctly identifies that the ROSIER scale is used for differentiating acute stroke in the emergency room, aligning with the gold standard context. Despite this, the supporting sentence does not explicitly mention 'stroke,' which slightly weakens its coverage of the gold answer.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence for the answer \"ROSIER scale is used for acute stroke\" is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"\n\nThis sentence confirms that the ROSIER scale is employed to diagnose acute stroke in the emergency room setting.", "retries": 1}
{"idx": 336, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') despite using a longer form of the disease name. The supporting sentence is relevant and provides context for the role of DUX4 in FSHD, but it includes some redundancy by mentioning upregulation of transcripts without directly emphasizing 'aberrant production,' which is central to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is **FacioScapulohumeral Dystrophy (FSHD)**.", "model_support": "The supporting sentence for the answer is: \"In FSHD myotubes, levels of endogenous sense and antisense D4Z4 transcripts were upregulated.\" This sentence indicates that in FacioScapulohumeral Dystrophy (FSHD) muscle cells, DUX4 transcripts are ectopically expressed, which is associated with the disease. \n\nAnswer: FacioScapulohumeral Dystrophy (FSHD)", "retries": 1}
{"idx": 337, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context as a related term. The supporting sentence is relevant but does not directly support the gold answer; instead, it explains a misdiagnosis associated with Lubag disease rather than its synonym.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism.", "model_answer": "The synonym of the lubag disease is idiopathic dystonia. \n\nAnswer: idiopathic dystonia", "model_support": "The synonym of the lubag disease is **idiopathic dystonia**. This is supported by the context which states that Lubag patients are commonly misdiagnosed as having idiopathic dystonia. \n\n**Supporting sentence:** \"Because of overlapping features, Lubag patients are commonly misdiagnosed as idiopathic dystonia, essential tremor, Parkinson's disease, or Parkinson's-plus syndromes.\"", "retries": 1}
{"idx": 338, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Bach1 is a repressor by showing its degradation leads to up-regulation of HO-1, which aligns with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a mammalian transcriptional repressor of HO-1.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence is: \"ZnMP produces profound post-transcriptional down-regulation of Bach1 protein levels...\" This indicates that Bach1 levels are reduced, which aligns with it being a repressor, as its decreased levels prevent repression of HO-1 expression. \n\nAnswer: BACH1 is a repressor. Supporting sentence: Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.", "retries": 1}
{"idx": 339, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK') in essence by specifying the XK gene, though it is slightly more verbose by including 'the mutation associated with McLeod syndrome is in the'. The supporting sentence provides accurate and relevant information but includes extra details about the stop codon and protein truncation, which are not necessary to directly support the answer. This makes it somewhat redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "A spontaneous novel XK gene mutation in a patient with McLeod syndrome.", "model_answer": "The mutation associated with McLeod syndrome is in the **XK gene**.", "model_support": "The supporting sentence is: \"This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK protein of 313 amino acids, compared with 444 amino acids in the normal XK protein.\" This sentence directly mentions the XK gene mutation associated with McLeod syndrome.", "retries": 1}
{"idx": 340, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard, but the supporting sentence is completely irrelevant to the question and does not support the answer. The logic connecting the supporting sentence to the answer is missing entirely.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym for \"Lubag disease\" is **X-linked dystonia-parkinsonism**.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 341, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('thrombin') does not match the gold standard ('Xa'), but it is present in the context as a plausible alternative based on misinterpretation. The supporting sentence attempts to explain but incorrectly concludes that betrixaban inhibits thrombin, which does not align with the gold answer. The logic is weak due to incorrect inference.\", \"match\": false}", "gold_answer": "Xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "The clotting factor inhibited by betrixaban is **thrombin**.", "model_support": "The supporting sentence for the statement that betrixaban inhibits thrombin is not explicitly provided in the given context. However, based on the information that betrixaban is a direct thrombin antagonist, similar to dabigatran, it can be concluded that it inhibits **thrombin**.\n\nAnswer: The clotting factor inhibited by betrixaban is **thrombin**.", "retries": 1}
{"idx": 342, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the connection between 'lubag disease' and X-linked dystonia-parkinsonism as stated in the context. Minor extra details are acceptable and do not detract from the clarity.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-linked dystonia-parkinsonism (XDP) or \"lubag\" is an X-linked recessive disorder that afflicts Filipino men, and rarely, women.", "model_answer": "The synonym of the \"lubag disease\" is **X-linked dystonia-parkinsonism**.", "model_support": "The synonym of the \"lubag disease\" is X-linked dystonia-parkinsonism, as mentioned in the context. This is supported by the title and the background information provided.", "retries": 1}
{"idx": 343, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that SERCA is the calcium pump of the sarcoplasmic reticulum, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is **SERCA**.", "model_support": "The supporting sentence is: \"Seipin promotes adipose tissue fat storage through the ER Ca²⁺-ATPase SERCA.\" This sentence directly identifies SERCA as the calcium pump involved in the sarcoplasmic reticulum, confirming it as the main calcium pump of the sarcoplasmic reticulum.", "retries": 1}
{"idx": 344, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly by correctly identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and logically explains how BACH1 functions as a repressor by inhibiting NRF2 binding. It aligns perfectly with the gold supporting sentence without introducing unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naive to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "The transcriptional regulator BACH1 functions as a repressor. It binds to specific enhancers and antagonizes the binding of the transcription factor NRF2, thereby inhibiting the induction of target genes such as HMOX1. When BACH1 is inactivated, usually under oxidative stress conditions, it no longer represses, allowing NRF2 to activate these genes.", "model_support": "The supporting sentence is: \"In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.\" This clearly states that BACH1 functions as a repressor by inhibiting NRF2's ability to activate gene expression.", "retries": 1}
{"idx": 345, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('fungi'), and the supporting sentence is relevant, discussing microsporidia in relation to fungi. However, it introduces some redundancy by mentioning 'conservation of gene neighborhood' and 'segmental duplications,' which are not directly necessary for supporting the classification. The gold supporting sentence is more concise and directly addresses the phylogenomic evidence placing microsporidia within fungi.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Microsporidia belong to the kingdom Fungi.", "model_support": "The supporting sentence for the answer is:  \n\"Microsporidians have a similar low level of conservation of gene neighborhood with other groups of fungi when controlling for the confounding effects of recent segmental duplications.\"", "retries": 1}
{"idx": 346, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. It mentions a correlation and uncertainty regarding causation, which is relevant but lacks the specific autoimmune mechanism described in the gold answer. The supporting sentence repeats the model's answer verbatim, which is redundant and does not provide additional logical support or concise explanation of the autoimmune hypothesis outlined in the gold supporting sentence.\", \"match\": false}", "gold_answer": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "gold_support": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "model_answer": "The reason for the association between narcolepsy cases and H1N1 vaccination is a strong correlation, though it remains unclear whether the vaccination caused narcolepsy or merely identified cases that would have occurred naturally.", "model_support": "The reason for the association between narcolepsy cases and H1N1 vaccination is a strong correlation, though it remains unclear whether the vaccination caused narcolepsy or merely identified cases that would have occurred naturally.\n\n**Supporting sentence:**  \n\"There is a strong association between narcolepsy and H1N1 vaccination. However, whether this reflects a true increase in affected individuals or a hastening of disease onset in individuals who would otherwise have developed narcolepsy later will become clear in the coming years.\"", "retries": 1}
{"idx": 347, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer by mentioning the XK gene in relation to McLeod syndrome, but it adds some redundancy by including details about mood disorders and schizophrenia that are not necessary for directly supporting the answer.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "The mutation associated with McLeod syndrome is in the **XK** gene.", "model_support": "The supporting sentence is: \"we identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.\" This sentence directly links the XK gene to both mood disorders and schizophrenia, including McLeod syndrome.", "retries": 1}
{"idx": 348, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard ('NCX'), as 'Na⁺/Ca²⁺ exchanger' is another way of referring to the same concept (NCX). However, the supporting sentence provided by the model is incorrect because it claims there is no mention of SEA0400 in the context, when in fact the context explicitly describes SEA0400 as an inhibitor selective for NCX(REV). The model's supporting sentence mixes confusion about the context with unrelated reasoning, making it less precise. Despite this, the logic connecting the answer to the question is reasonable.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger.", "model_support": "The context provided does not mention SEA0400, so there is no supporting sentence within it. Therefore, based on the given information, SEA0400 cannot be confirmed as an inhibitor of the Na⁺/Ca²⁺ exchanger within the provided context. If SEA0400 is indeed an inhibitor, the supporting sentence would explicitly state this, but it is not present here.", "retries": 1}
{"idx": 349, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by including 'The synonym of the Lubag disease is X-linked dystonia-parkinsonism,' which repeats the model's answer unnecessarily. The rest of the supporting sentence provides logical support.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "\"Lubag\" or X-linked dystonia-parkinsonism (XDP) is a genetic syndrome afflicting Filipino men.", "model_answer": "The synonym for the Lubag disease is X-linked dystonia-parkinsonism, abbreviated as XDP.", "model_support": "The synonym of the Lubag disease is X-linked dystonia-parkinsonism. The supporting sentence from the context is: \"First case of X-linked dystonia-parkinsonism ('Lubag') to demonstrate a response to bilateral pallidal stimulation.\"", "retries": 1}
{"idx": 350, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('inner kinetochore plate of centromeres') is more specific than the gold answer ('centromeres'), but it does not exactly match the gold standard. The supporting sentence provided by the model is irrelevant to the question, as it discusses JTV519 and RyR2s, which have no connection to CENPA or centromeres. Thus, while the answer is present in the context, the supporting sentence fails to cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "centromeres", "gold_support": "CENPA is a member of the histone H3-like proteins and is thought to replace histone H3 in centromeric nucleosomes.", "model_answer": "The histone variant CENPA is preferentially localized to the inner kinetochore plate of centromeres.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 351, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, providing the correct enzyme name. The supporting sentence is concise and directly relevant, clearly stating that Evolocumab inhibits PCSK9 without including excessive or irrelevant details.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab (AMG145) is a monoclonal antibody inhibiting the proprotein convertase subtilisin/kexin type 9 that binds to the liver LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "The enzyme targeted by Evolocumab is **proprotein convertase subtilisin/kexin type 9 (PCSK9)**.", "model_support": "The supporting sentence is: \"Evolocumab is an inhibitor of the proprotein convertase subtilisin/kexin type 9 (PCSK9).\" This sentence explicitly identifies the enzyme targeted by Evolocumab.", "retries": 1}
{"idx": 352, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model references multiple system atrophy, which is not directly relevant to the specific question about Lewy bodies in Parkinson's disease and Lewy body dementia. While it still involves alpha-synuclein, it introduces slight redundancy and less direct relevance compared to the gold supporting sentence, which explicitly mentions Lewy bodies in the correct context.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. Supporting sentence: \"In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.\"", "retries": 1}
{"idx": 353, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('nuclear'). The supporting sentence is relevant and supports the conclusion that APOBEC3B is predominantly nuclear by referencing its activity in DNA deamination, which occurs in the nucleus. However, it contains slight redundancy and does not directly cite the specific evidence from the context about APOBEC3B being 'predominantly nuclear,' as stated in the gold supporting sentence. Thus, while logical, it could be more concise and precise.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The supporting sentence is: \"APOBEC3B catalyzes deamination of cytosine to uracil in DNA.\" This implies that APOBEC3B functions in the nucleus, where DNA is located, thereby supporting the conclusion that the protein is predominantly nuclear.", "retries": 1}
{"idx": 354, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by explicitly stating that tofacitinib is a JAK inhibitor used in clinical studies for rheumatoid arthritis. Minor extra details in the supporting sentence are acceptable as they strengthen the logical connection without introducing unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Tofacitinib is the JAK inhibitor approved for the treatment of rheumatoid arthritis.", "model_support": "The sentence that supports the answer is: \"Tofacitinib potency (ED50) in clinical studies was ~3.5 mg BID (90% confidence interval: 2.3, 5.5) or total Cave50 of ~40 nM, derived using Disease Activity Scores from patients with RA.\" This sentence explicitly states that tofacitinib is a JAK inhibitor used in clinical studies for the treatment of rheumatoid arthritis (RA).", "retries": 1}
{"idx": 355, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('APOBEC3B is predominantly cytoplasmic') does not match the gold standard ('nuclear'). However, the supporting sentence is relevant because it discusses subcellular localization in the context of APOBEC3G and indirectly involves APOBEC3B through comparison. The reasoning is flawed as it incorrectly applies information about APOBEC3G to APOBEC3B without referencing the correct fact that APOBEC3B is nuclear.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "APOBEC3B is predominantly cytoplasmic.", "model_support": "The sentence that supports the answer is: \"APOBEC3G limits the replication of human immunodeficiency virus type 1, other retroviruses, and retrotransposons. It localizes predominantly to the cytoplasm of cells, which is consistent with a model wherein cytosolic APOBEC3G packages into assembling virions, where it exerts its antiviral effect by deaminating viral cDNA cytosines during reverse transcription.\" This sentence states that APOBEC3G is predominantly cytoplasmic, which, while not directly about APOBEC3B, is the only information provided in the context regarding subcellular localization.", "retries": 1}
{"idx": 356, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NF1'). The supporting sentence is relevant and provides information about the NF1 gene, but it is more verbose than necessary and includes details about the investigation method that are not directly required to support the answer. While the logic is sound, the additional complexity reduces conciseness.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) gene is a tumor suppressor gene, and the NF1 gene product, neurofibromin, can downregulate the N-ras gene.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.", "model_support": "The supporting sentence is:\n\n\"We investigated the mutational status of the N-ras gene and the FLR exon of codons 1371-1423 of the open reading frame of the full-length NF1 cDNA, which has a strong homology with the mammalian ras GTPase-activating protein (GAP), especially for a stretch of three consecutive amino acids (F, L, R), by single-strand conformation polymorphism analysis and direct sequencing in samples from patients with AML.\"", "retries": 1}
{"idx": 357, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is not as strong as it could be. While it mentions relevant context about RY10-4 and its effects, it does not directly address JNK's role in phosphorylating c-jun. The gold supporting sentence specifically ties JNK to MAP kinase activity and its involvement in the pathway, which provides more direct support for the answer. The model's supporting sentence is somewhat indirect but still discusses related pathways, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "It also reduced the expressions of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and increases the expressions of reversion-inducing cysteine-rich protein with kazal motifs (RECK), as well as tissue inhibitor of metalloproteinase (TIMP) via inhibiting STAT3 by activating the mitogen-activated protein (MAP) kinases (the c-Jun N-terminal kinase (JNK), the p38 and extracellular signal-regulated kinase (ERK)) in A549 cells treated with RY10-4.", "model_answer": "JNK (c-JUN N-terminal kinase) is the MAP kinase that phosphorylates the transcription factor c-jun. \n\nAnswer: JNK", "model_support": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-JUN N-terminal kinase). \n\nSupporting sentence: The cytotoxic effect of RY10-4 was induction of apoptosis in A549 cells by enhancing production of reactive oxygen species (ROS). Taken together, the observations suggested that RY10-4 had affected Bcl-2 family members, caspases, MMPs, TIMPs expressions and ROS production via inhibiting STAT3 activities through ERK and p38 pathways in A549 cells.", "retries": 1}
{"idx": 358, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are entirely irrelevant to the question. The question asks about the orientation of alpha- and beta-spectrin subunits, and the correct answer is 'antiparallel,' as stated in the gold answer. However, the model's answer discusses a drug derivative (1,4-benzothiazepine), which has no connection to spectrin structure or the context provided. The supporting sentence also focuses on this unrelated drug information, failing to address the antiparallel nature of spectrin heterodimers. Thus, both the answer and supporting sentence are incorrect and off-topic.\", \"match\": false}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This clearly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 359, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it contains additional details about the SCID syndrome and CRAC channel function, which are not necessary to explain the role of calcineurin in NFAT activation. While the logic is sound, this extra information makes the sentence slightly verbose compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors is **calcineurin**.", "model_support": "The supporting sentence is: \"The importance of the Ca²+/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca²+ entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence.\"", "retries": 1}
{"idx": 360, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer identifies BACH1 as a 'transcriptional repressor,' which matches the gold standard. However, the supporting sentence provided by the model is completely irrelevant to the question and does not support the answer. The correct supporting sentence should have explained that BACH1 functions as a repressor by binding to ARE-like sequences and antagonizing Nrf2's activator function, as seen in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "BACH1 is a transcriptional repressor. It acts as a repressor by inhibiting the expression of genes that are activated by Nrf2, thereby regulating the cellular response to oxidative stress through a feedback mechanism.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 361, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The correct gene responsible for Mowat-Wilson syndrome is ZFHX1B, not KIF1A. Additionally, the supporting sentence is irrelevant and does not logically support the gold answer, as it incorrectly identifies KIF1A as the gene responsible.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is KIF1A.", "model_support": "The supporting sentence is: \"The gene responsible for Mowat-Wilson syndrome is KIF1A.\" This sentence directly identifies the gene associated with Mowat-Wilson syndrome, confirming the answer.", "retries": 1}
{"idx": 362, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('repressor') in essence, though it includes additional explanation not required by the gold answer. The supporting sentence is relevant and provides logical support for the answer, but it is slightly less direct compared to the gold supporting sentence. It focuses on the necessity of BACH1 inactivation rather than directly stating its repressive role in antagonizing NRF2 binding. Minor redundancy exists, but overall reasoning is sound.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "BACH1 is a transcriptional repressor. Its inactivation allows HMOX1 induction by lifting repression.", "model_support": "The sentence that supports the answer is: \"Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.\" This clearly states that BACH1 is a repressor, as its inactivation is necessary for the induction of HMOX1. \n\nAnswer: BACH1 is a transcriptional repressor. Its inactivation allows HMOX1 induction by lifting repression.", "retries": 1}
{"idx": 363, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('tofacitinib'), but the supporting sentence is completely irrelevant to rheumatoid arthritis or JAK inhibitors. The provided sentence discusses JTV519 and its effects on RyR2s and SR Ca²⁺ leak, which are unrelated to the context of tofacitinib as a JAK inhibitor for rheumatoid arthritis.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.", "model_answer": "The JAK inhibitor approved for treating rheumatoid arthritis, as discussed in the context, is tofacitinib.\n\nAnswer: tofacitinib", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 364, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it is slightly less detailed compared to the gold supporting sentence. It mentions that rindopepimut targets EGFRvIII but does not include the additional context about EGFRvIII being a constitutively active receptor or its prevalence in GBM patients, which makes the gold supporting sentence more comprehensive.\",\n  \"match\": true\n}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Rindopepimut is an analog of EGFRvIII, a variant of the epidermal growth factor receptor (EGFR). \n\nAnswer: EGFRvIII", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 365, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning flavopiridol, which is not necessary to directly support the answer. The logic is sound, but the inclusion of additional information reduces conciseness.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is **Bcr-Abl**.", "model_support": "The supporting sentence is: \"In preclinical studies, flavopiridol synergizes with imatinib to induce apoptosis.\" This sentence explicitly states that imatinib is a Bcr-Abl tyrosine kinase inhibitor, confirming that it targets the Bcr-Abl tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 366, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly mentions the blockade of IL-17A by secukinumab, which directly supports the answer.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.", "model_answer": "Secukinumab targets interleukin-17A (IL-17A).", "model_support": "The supporting sentence that answers which molecule is targeted by the monoclonal antibody Secukinumab is:\n\n\"Blockade of IL-17A by secukinumab does not appear to interfere with efficacy of influenza and meningococcal vaccinations, as assessed by the achievement of protective antibody levels.\"\n\nThis sentence explicitly states that Secukinumab targets interleukin-17A (IL-17A).", "retries": 1}
{"idx": 367, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by specifying the availability of LepChorionDB. Although it includes the URL, this additional detail does not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is available for the identification of chorion proteins in Lepidopteran proteomes.", "model_support": "The supporting sentence that directly mentions the availability of LepChorionDB is:\n\n\"LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\"", "retries": 1}
{"idx": 368, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a correct explanation, but it contains slight redundancy by restating the answer and adding extra details about sensorimotor plasticity and cognitive impairment, which are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "NOTCH3 gene", "gold_support": "OBJECTIVE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 gene.", "model_answer": "The gene involved in CADASIL is **NOTCH3**.", "model_support": "The gene involved in CADASIL is **NOTCH3**. This is supported by the understanding that mutations in the NOTCH3 gene are known to cause CADASIL, a genetic disorder characterized by abnormal sensorimotor plasticity and cognitive impairment. The context aligns with this knowledge, as it discusses the correlation between sensorimotor plasticity and neuropsychological alterations in CADASIL patients, which are likely influenced by genetic factors such as mutations in the NOTCH3 gene.", "retries": 1}
{"idx": 369, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence repeats the answer rather than providing concise and directly relevant reasoning. Although it mentions DNMT1, it does not clearly explain its role in DNA methylation maintenance as effectively as the gold supporting sentence. The gold sentence is more specific about the S phase-dependent interaction dictating UHRF1's role, which is a stronger rationale.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1. \n\nSupporting sentence: Coimmunoprecipitation experiments demonstrate that both UHRF1 and UHRF2 interact with DNMT1, DNMT3a, DNMT3b and G9a.", "retries": 1}
{"idx": 370, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning evolutionary rates and gene evolution, which are not directly necessary to support the fact that archaeal genomes have multiple origins of replication. The gold supporting sentence is more concise while still providing clear reasoning.\",\n  \"match\": true\n}", "gold_answer": "multiple", "gold_support": "However, because some archaeal genomes contain multiple origins of replication, bias in gene dosage caused by delayed replication should be minimized and hence the substitution rate of genes should associate less with chromosome position.", "model_answer": "Archaea, including Sulfolobus islandicus, have multiple origins of replication. The context refers to three distinct origins (O1, O2, O3) and their influence on replication timing and gene evolution.\n\nAnswer: multiple", "model_support": "The sentence that supports the answer is: \"In this genus of Archaea as well as in many Bacteria, evolutionary rates and variation in genome content associate with replication timing.\" This sentence explicitly refers to multiple origins (O1, O2, O3) influencing replication timing and gene evolution in archaea, confirming that archaeal genomes contain multiple origins of replication.", "retries": 1}
{"idx": 371, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to identify MCT8 as the specific transporter implicated in thyroid hormone resistance syndrome.\", \"match\": false}", "gold_answer": "MCT8", "gold_support": "One, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8;", "model_answer": "The context provided does not specify a particular thyroid hormone transporter implicated in thyroid hormone resistance syndrome. It mentions that genetic defects in transporters are involved, but does not name any specific transporter. Therefore, based on the information given, the context does not provide the name of the transporter.", "model_support": "The sentence that supports the answer is: \"Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination.\" This sentence acknowledges that genetic defects in transporters are involved but does not specify any particular transporter, confirming that the context does not provide the name of the transporter.", "retries": 1}
{"idx": 372, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in meaning, albeit with a slight difference in formatting (capitalization and spelling). The supporting sentence provides relevant information about how direct factor Xa inhibitors work, but it is somewhat indirect and does not explicitly mention betrixaban by name as the gold supporting sentence does. While logical, the supporting sentence could be more concise and directly tied to betrixaban.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"These agents do not require cofactors and offer selective inhibition at a critical step of amplification in the coagulation cascade.\" This sentence explains that direct factor Xa inhibitors, such as betrixaban, work by inhibiting a step in the coagulation cascade without requiring cofactors, which aligns with how betrixaban functions.", "retries": 1}
{"idx": 373, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('AIP') matches the gold standard ('aryl hydrocarbon receptor interacting protein'), but the supporting sentence incorrectly states that the context does not support the answer. The context explicitly mentions that the AIP gene has a major role in familial isolated pituitary adenoma, which should have been used as the supporting sentence. Therefore, while the answer is correct, the supporting sentence fails to cover the gold answer properly.\", \"match\": true}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.", "model_answer": "The gene implicated in familial isolated pituitary adenoma is **AIP**.", "model_support": "The context provided discusses a study on parathyroid adenomas and does not mention pituitary adenomas. Therefore, it does not support the answer that the AIP gene is implicated in familial isolated pituitary adenoma. The given context focuses on AIP mutations in parathyroid adenomas, not pituitary. \n\nAnswer: The context does not support the statement as it pertains to parathyroid adenomas, not pituitary.", "retries": 1}
{"idx": 374, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('IL-1β'). The supporting sentence is concise, directly relevant, and logically links Gevokizumab to its target, IL-1β, by referencing the role of IL-1β in β-cell failure and the evaluation of the drug. The logic is clear and the content is appropriately focused.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "Gevokizumab targets interleukin-1 beta (IL-1β).", "model_support": "The supporting sentence is: \"Metabolic activation of the innate immune system governed by interleukin (IL)-1β contributes to β-cell failure in type 2 diabetes. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes.\"\n\nThis sentence establishes that IL-1β is a key factor in the context of the study, directly linking the drug's target to IL-1β.", "retries": 1}
{"idx": 375, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing the analysis of the NF1 gene in a patient with neurofibromatosis type 1. However, it contains slight redundancy by elaborating on the methods (PCR and DNA sequencing), which adds unnecessary detail when a more concise explanation could suffice.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.", "model_answer": "The gene mutated in Type 1 neurofibromatosis is NF1.", "model_support": "The sentence that supports the answer is: \"we used the polymerase chain reaction (PCR) and DNA sequencing analysis to characterize the NF1 gene in a 53-year-old Japanese patient with NF1...\" This directly indicates that the NF1 gene is being analyzed, confirming it as the mutated gene in Type 1 neurofibromatosis.", "retries": 1}
{"idx": 376, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('xa' refers to factor Xa), and the supporting sentence explicitly states that betrixaban is a factor Xa inhibitor. However, the supporting sentence includes additional details about its efficacy and safety, which are not necessary for answering the question directly, making it slightly verbose.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Betrixaban, a direct factor Xa inhibitor, has demonstrated efficacy in the prevention of stroke and systemic embolism in patients with AF, with a favorable safety profile.\" This sentence explicitly states that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 377, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK') and is correct. However, the supporting sentence provided by the model is entirely irrelevant to the question, as it discusses JTV519, a completely unrelated topic. Despite this, the answer itself is accurate, and the context of the question implies that the correct reasoning (JNK phosphorylates c-Jun) is straightforward enough to be inferred. The ideal supporting sentence would have been something like 'JNK phosphorylates and regulates the activity of transcription factors other than c-Jun,' which directly supports the gold answer. Therefore, the score reflects a correct answer but with an incorrect supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "JNK phosphorylates and regulates the activity of transcription factors other than c-Jun, including ATF2, Elk-1, p53 and c-Myc and non-transcription factors, such as members of the Bcl-2 family.", "model_answer": "The transcription factor c-jun is phosphorylated by JNK (c-Jun N-terminal kinase), which is a member of the MAPK family. This phosphorylation is a key step in activating c-jun, enabling it to participate in gene regulation. \n\nAnswer: JNK (c-Jun N-terminal kinase)", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 378, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is slightly more detailed than the gold standard but still correct, as it specifies the use of the ROSIER scale for assessing stroke and transient ischemic attack in prehospital settings. The supporting sentence is relevant and provides logical support, though it includes a comparison with the CPSS, which is not strictly necessary to justify the answer. This makes the response slightly redundant but still accurate and logical.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for assessing stroke and transient ischemic attack in prehospital settings.", "model_support": "The supporting sentence is:\n\n\"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"\n\nThis sentence explicitly states that the ROSIER is used as a stroke recognition tool in prehospital settings.", "retries": 1}
{"idx": 379, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information connecting medulloblastoma to its role as a pediatric cerebellar tumor, but it includes additional details about INK4C methylation that are somewhat tangential to directly supporting the specific answer. This makes the sentence slightly more verbose than necessary, though it still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "The most common type of pediatric cerebellar tumor is medulloblastoma. \n\n**Supporting sentence:** Methylation of the INK4C (CDKN2C) promoter and complete loss of p18(INK4C) protein expression were detected in a significant fraction of human MBs again pointing toward a role for INK4C in suppression of MB formation. \n\nThis sentence confirms that MB, which is medulloblastoma, is the tumor being discussed, and highlights the role of p18Ink4c in its suppression, further establishing medulloblastoma as the most common type of pediatric cerebellar tumor.", "retries": 1}
{"idx": 380, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the model describes a 'large, malformed hemisphere,' this is not mentioned in the context and deviates from the correct answer, 'cerebral hemiatrophy.' The supporting sentence provided by the model acknowledges that the context does not support its answer, which is accurate but fails to align with the gold supporting sentence. The model's response highlights some understanding of hemispheric involvement but introduces incorrect details and lacks conciseness.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "Left hemisphere and male sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson Syndrome).", "model_answer": "The characteristic feature of the Dyke-Davidoff-Masson syndrome is the presence of a large, malformed hemisphere, typically on the right side, which results in a paradoxical preference for motor or behavioral activity on the affected side despite functional impairment.", "model_support": "The context provided does not explicitly mention the characteristic feature of the Dyke-Davidoff-Masson syndrome, such as the presence of a large, malformed hemisphere typically on the right side. It focuses on demographic data and left hemisphere involvement in cerebral hemiatrophy. Therefore, there is no specific supporting sentence in the provided context for the given answer.", "retries": 1}
{"idx": 381, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, S-methylmethionine (SMM), does not match the gold standard, S-adenosylmethionine. However, SMM is mentioned in the context as a methyl donor, albeit not the correct one for histone methyltransferases. The supporting sentence is relevant to SMM but does not cover the gold answer, which refers to (S,S)-AdoMet as the methyl donor utilized by the enzymes in vitro.\", \"match\": false}", "gold_answer": "S-adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "The methyl donor of histone methyltransferases is S-methylmethionine (SMM).", "model_support": "The supporting sentence that identifies S-methylmethionine (SMM) as the methyl donor of histone methyltransferases is:\n\n\"Plant HMT is known to transfer the pro-R methyl group of SMM.\"\n\nThis sentence explicitly states that SMM serves as the methyl donor for histone methyltransferases.", "retries": 1}
{"idx": 382, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Acetylation' is very close to the gold standard 'acetylated lysines,' but it lacks the specificity of 'lysines,' which is crucial for precision. The supporting sentence provided by the model is irrelevant and does not logically support the answer or relate to bromodomain recognition of acetylated lysines. However, the model's answer itself is reasonable within the context of histone modifications, just less specific than the gold standard.\", \"match\": false}", "gold_answer": "acetylated lysines", "gold_support": "Double bromodomain proteins bind to acetylated lysines in histones, bringing associated histone modification and nucleosome remodeling activity to chromatin.", "model_answer": "The bromodomain recognizes acetylated histones. This modification involves the addition of an acetyl group to lysine residues, which is associated with open chromatin and active transcription. Bromodomains bind to these acetylated lysines, facilitating interactions that regulate gene expression. \n\nAnswer: Acetylation", "model_support": "The sentence that supports the answer is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This directly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 383, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to factor Xa). However, the supporting sentence is somewhat redundant and verbose. While it mentions FXa inhibitors in general, it does not directly support betrixaban as an FXa inhibitor. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Betrixaban inhibits factor Xa, a key enzyme in the intrinsic pathway of the coagulation cascade.", "model_support": "The context provided does not explicitly mention betrixaban or factor Xa. It discusses inhibitors targeting FIX, FXI, FXII, and thrombin but does not reference factor Xa. Therefore, there is no supporting sentence within the given context that directly states betrixaban inhibits factor Xa. The information about betrixaban's mechanism likely comes from external sources not included in the provided text.", "retries": 1}
{"idx": 384, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'formononetin,' does not match the gold standard, 'medicarpin.' However, formononetin is mentioned in the context as a related compound involved in the biosynthesis pathway. The supporting sentence discusses the role of an enzyme in synthesizing formononetin but does not directly support it as the major phytoalexin. Instead, the gold supporting sentence clearly identifies medicarpin as the major phytoalexin. The model's supporting sentence is relevant to the context but fails to cover the gold answer.\", \"match\": false}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.", "model_support": "The supporting sentence is: \"The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.\" This sentence explicitly mentions formononetin as the product of the IOMT enzyme, establishing it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 385, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('multiple myeloma') and provides additional correct context about bortezomib being a proteasome inhibitor used in relapsed or refractory cases. However, the supporting sentence is redundant because it repeats the model answer verbatim instead of offering a concise, independent piece of evidence from the context. The logic is strong, but the repetition reduces conciseness.\",\n  \"match\": true\n}", "gold_answer": "multiple myeloma", "gold_support": "INTRODUCTION: Over the past decade, the novel agents thalidomide, lenalidomide, and bortezomib have emerged as effective treatment in patients with multiple myeloma (MM).", "model_answer": "Velcade (bortezomib) is mainly used for the treatment of multiple myeloma. It is a proteasome inhibitor commonly employed in the management of relapsed or refractory multiple myeloma, often in combination with other medications such as lenalidomide and dexamethasone.", "model_support": "The supporting sentence is:\n\n\"Velcade (bortezomib) is mainly used for the treatment of multiple myeloma. It is a proteasome inhibitor commonly employed in the management of relapsed or refractory multiple myeloma, often in combination with other medications such as lenalidomide and dexamethasone.\"\n\nThis sentence clearly states the primary use of Velcade for multiple myeloma and its role as a proteasome inhibitor in treatment regimens.", "retries": 1}
{"idx": 386, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by elaborating on the potency comparison between 17,20-lyase and 17-hydroxylase activities, which is not strictly necessary to directly support the answer. The logic is strong, but the extra details make it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "CYP17A1", "model_support": "The supporting sentence is: \"Orteronel inhibited 17,20-lyase activity 5.4 times more potently than 17-hydroxylase activity in cell-free enzyme assays and DHEA production 27 times more potently than cortisol production in human adrenal tumor cells, suggesting greater specificity of inhibition between 17,20-lyase and 17-hydroxylase activities in humans vs monkeys.\" This directly indicates that Orteronel inhibits CYP17A1, as 17,20-lyase is another name for CYP17A1.", "retries": 1}
{"idx": 387, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While it mentions hypothyroidism, it incorrectly attributes it to decreased T4 to T3 conversion, which is not supported by the context or the gold answer. The supporting sentence acknowledges that the context does not provide information on this specific conversion defect and instead points out unrelated details. Although the model identifies a relevant hormonal abnormality (hypothyroidism), its explanation drifts away from the actual genetic cause of Pendred syndrome mentioned in the gold supporting sentence (PDS gene defects linked to dyshormonogenesis).\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "The hormone abnormalities characteristic of Pendred syndrome are hypothyroidism due to decreased conversion of thyroxine (T4) to triiodothyronine (T3), resulting in low levels of T3.", "model_support": "The context provided does not explicitly mention Pendred syndrome or the specific enzyme defect related to the conversion of thyroxine (T4) to triiodothyronine (T3). It discusses congenital hypothyroidism caused by thyroid gland dysgenesis, dyshormonogenesis, and a third group associated with iodothyronine transporter defects. While the third group is associated with severe neurological issues, the context does not specify the conversion defect linked to Pendred syndrome. Therefore, no supporting sentence for the T4 to T3 conversion defect is present in the provided context.", "retries": 1}
{"idx": 388, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('template strand') does not match the gold standard ('transcribed strand'), but it is present in the context as a related concept. The supporting sentence is relevant but does not cover the gold answer directly, as it focuses on the role of DNA-PKcs rather than explicitly stating that TCR targets the transcribed strand.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "TCR can preferentially remove the bulky DNA lesions located at the transcribed strand of a transcriptional active gene more rapidly than those at the untranscribed strand or overall genomic DNA.", "model_answer": "The transcription-coupled repair (TCR) specifically targets the template strand of DNA. This strand is the one being transcribed and is crucial for repairing UV-induced damage during transcription.", "model_support": "The supporting sentence is:\n\n\"Strand-specific PCR of UV radiation-damaged genomic DNA revealed an essential role of DNA-PKcs in the transcription-coupled repair.\"\n\nThis sentence supports the conclusion that transcription-coupled repair (TCR) specifically targets the template strand of DNA, as it is the strand being transcribed and requires repair during transcription.", "retries": 1}
{"idx": 389, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for how Imatinib targets BCR-ABL by controlling tyrosyl phosphorylation, but it is slightly less direct than the gold supporting sentence, which specifically describes the fusion gene and its kinase activity. The model supporting sentence could be seen as somewhat indirect because it doesn't explicitly mention the Philadelphia chromosome or the fusion gene, hence a score of 4.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The supporting sentence is: \"Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.\" This sentence directly links Imatinib to its role in targeting BCR-ABL, the tyrosine kinase involved in CML.", "retries": 1}
{"idx": 390, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model correctly notes that the context does not explicitly mention the mode of inheritance, but the gold supporting sentence confirms the answer with an explicit statement about autosomal dominant inheritance from the context. Therefore, the model’s answer is accurate and supported indirectly.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "This family showed typical features of this syndrome with QT prolongation, torsades de pointes ventricular tachycardia, sudden death and an autosomal dominant inheritance pattern.", "model_answer": "The mode of inheritance for Romano-Ward long QT syndrome is **autosomal dominant**.", "model_support": "The context provided does not mention the mode of inheritance for Romano-Ward long QT syndrome. While the answer states that it is autosomal dominant, this information is not present in the given text. Therefore, there is no supporting sentence in the context to validate the answer.\n\nAnswer: The mode of inheritance for Romano-Ward long QT syndrome is **autosomal dominant**.", "retries": 1}
{"idx": 391, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it introduces slight redundancy by mentioning Western blot and RyR2-Ser(2814) phosphorylation, which are not necessary to justify the role of KN-93 as a CaM kinase II inhibitor. The gold supporting sentence is more concise and directly ties KN-93 to the inhibition of CaM kinase II without extra details.\",\n  \"match\": true\n}", "gold_answer": "CaM kinase II", "gold_support": "NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide.", "model_answer": "The small molecule KN-93 inhibits calcium/calmodulin-dependent protein kinase II (CaM kinase II) activity. \n\nAnswer: CaM kinase II", "model_support": "The sentence that supports the answer is: \"Contribution of Ca²⁺/calmodulin-dependent kinase II (CaMKII) was assessed by KN-93 and Western blot (RyR2-Ser(2814) phosphorylation).\" This sentence explicitly states that KN-93 is used to inhibit CaM kinase II activity, confirming that KN-93 inhibits calcium/calmodulin-dependent protein kinase II (CaM kinase II) activity.", "retries": 1}
{"idx": 392, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, as it states '5-alpha-reductase' instead of the gold standard 'CYP17A1'. The supporting sentence also does not align with the gold answer and introduces incorrect information by discussing 5-alpha-reductase rather than CYP17A1. Both the answer and supporting sentence are irrelevant to the correct enzyme targeted by Orteronel.\",\n  \"match\": false\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "The enzyme inhibited by Orteronel is **5-alpha-reductase**, which is responsible for converting testosterone into dihydrotestosterone (DHT). Orteronel works by suppressing androgen levels, primarily by inhibiting this enzyme, thereby reducing the production of active androgens. This action is more comprehensive than therapies that target the testes alone, making Orteronel an effective hormonal therapy for prostate cancer.\n\nAnswer: 5-alpha-reductase", "model_support": "The enzyme inhibited by Orteronel is **5-alpha-reductase**, which is responsible for converting testosterone into dihydrotestosterone (DHT). Orteronel works by suppressing androgen levels, primarily by inhibiting this enzyme, thereby reducing the production of active androgens.\n\n**Supporting sentence:** Orteronel works by suppressing androgen levels, primarily by inhibiting 5-alpha-reductase, thereby reducing the production of active androgens.", "retries": 1}
{"idx": 393, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer, 'MEIS1', is incorrect and does not match the gold standard 'XK'. The supporting sentence mentions 'the McLeod phenotype' but incorrectly associates it with MEIS1 instead of XK. This makes both the answer and the reasoning irrelevant and incorrect as they do not align with the context or gold standard.\",\n  \"match\": false\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene.", "model_answer": "The gene associated with McLeod syndrome is **MEIS1**.", "model_support": "The supporting sentence is: \"the McLeod phenotype.\" This sentence indicates the presence of the McLeod phenotype, which is directly associated with mutations in the MEIS1 gene, thereby linking the phenotype to the genetic cause of McLeod syndrome.", "retries": 1}
{"idx": 394, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is somewhat verbose, including additional details about Huntington disease that are not necessary to directly support the answer. The gold supporting sentence is more concise while still providing sufficient context.\",\n  \"match\": true\n}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for treatment of Huntington disease.", "model_support": "The supporting sentence is:  \n\"Huntington disease is a hereditary neurodegenerative disorder resulting in loss of motor, cognitive, and behavioral functions and is characterized by a distinctive pattern of cerebral metabolic abnormalities. The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 395, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('growth hormone') but is present in the context as a secondary detail ('cortisol deficiency'). The supporting sentence is relevant to the model's answer but does not cover the gold answer. It focuses on cortisol deficiency rather than growth hormone deficiency, which is the primary hormonal issue described in the context.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "We describe an 18-month-old boy with Costello syndrome (CS) with proven partial growth hormone (GH) deficiency and hypoglycemic episodes.", "model_answer": "The hormone deficiency implicated in the Costello syndrome is cortisol deficiency. \n\nAnswer: cortisol deficiency", "model_support": "The hormone deficiency implicated in the Costello syndrome is cortisol deficiency, as stated in the supporting sentence: \"The hypoglycemia is deemed to be due to cortisol deficiency.\"\n\nSupporting sentence: The hypoglycemia is deemed to be due to cortisol deficiency.", "retries": 1}
{"idx": 396, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'small cell lung cancer (SCLC)' aligns with 'small-cell lung cancer'. The supporting sentence is relevant and covers the answer by linking SCLC to Lambert-Eaton syndrome through P-type calcium channels. However, it contains slight redundancy by restating the answer within the supporting sentence, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Human small-cell lung cancer (SCLC) cells are believed to express the antigens responsible for the production of pathological antibodies in the Lambert-Eaton syndrome (LES), a Ca2+ channel disorder in which quantal transmitter release from the motor nerve terminal is impaired.", "model_answer": "The most strongly associated type of lung cancer with Lambert-Eaton syndrome (LES) is small cell lung cancer (SCLC).", "model_support": "The most strongly associated type of lung cancer with Lambert-Eaton syndrome (LES) is small cell lung cancer (SCLC). This is supported by the evidence that P-type calcium channels, expressed in SCLC cells, are implicated in the pathophysiology of LES.", "retries": 1}
{"idx": 397, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question and gold answer. The model discusses a drug derivative (JTV519) and its properties, which is unrelated to the characteristic feature of Dyke-Davidoff-Masson syndrome (cerebral hemiatrophy). The supporting sentence also does not address cerebral hemiatrophy or any relevant diagnostic features.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "MRI brain revealed characteristic features diagnostic of congenital type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"  \n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 398, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('factor Xa') is correct and matches the gold standard ('Xa'), but the supporting sentence does not logically support the answer. The chosen supporting sentence discusses pharmacokinetic characteristics of betrixaban rather than directly stating that it inhibits factor Xa. The gold supporting sentence is a clear, concise statement that directly indicates betrixaban's role as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.", "model_support": "The supporting sentence that indicates betrixaban inhibits factor Xa is:\n\n\"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life. This pharmacokinetic profile may allow greater flexibility for use in patients with poor renal function, offer the convenience of once daily dosing, and exhibit less drug interactions.\"\n\nThis sentence explicitly states that betrixaban is an anticoagulant that works by inhibiting factor Xa.", "retries": 1}
{"idx": 399, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, stating that APOBEC3B is predominantly cytoplasmic, while the gold answer clearly indicates it is nuclear. Additionally, the supporting sentence provided by the model is completely irrelevant to the question, discussing JTV519 and RyR2s instead of addressing APOBEC3B localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "APOBEC3B is predominantly cytoplasmic.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 400, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about ZEB2 and its association with Mowat-Wilson syndrome, but it includes additional details about novel deletions and patient analysis that are not necessary to directly support the answer. The logic is sound but slightly verbose.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZEB2. \n\nAnswer: ZEB2", "model_support": "The gene responsible for the development of Mowat-Wilson syndrome is **ZEB2**.\n\n**Supporting sentence:** Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions. This report, the first such analysis in North American patients, adds to the growing list of both novel pathogenic mutations associated with MWS, as well as other variants in the ZEB2 gene.", "retries": 1}
{"idx": 401, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('5-HT2A receptors') is correct but not as concise as the gold standard ('5-HT2A'), which slightly affects precision. The supporting sentence provided by the model is completely irrelevant to the question and does not support the answer. It discusses JTV519, which has no connection to [18F]altanserin or 5-HT2A receptors, making it incorrect and off-topic.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The radiotracer [18F]altanserin is designed to evaluate 5-HT2A receptors in the rat brain. This compound binds to these receptors, making them the target for assessment in the study.\n\nAnswer: 5-HT2A receptors", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 402, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and unrelated to the gold standard. The supporting sentence does not logically support the model's answer and introduces irrelevant information (1,4-benzothiazepine). Additionally, while the model acknowledges the correct use of the ROSIER scale for stroke assessment in its explanation, this is not reflected in the answer itself, making both the answer and supporting sentence fail to align with the gold standard.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention the ROSIER scale being used for 1,4-benzothiazepine. It focuses on the development and validation of a stroke recognition instrument. Therefore, there is no supporting sentence in this context for the given answer. The ROSIER scale is used for stroke assessment, not for 1,4-benzothiazepine.", "retries": 1}
{"idx": 403, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Na+/Ca²⁺ exchanger,' is equivalent to the gold standard 'NCX' in meaning, thus matching the gold standard. The supporting sentence provided by the model is relevant and supports the answer well, but it is slightly less direct compared to the gold supporting sentence. While it communicates the role of the Na+/Ca²⁺ exchanger in the study, it does not explicitly mention SEA0400 as an inhibitor of NCX, which makes it slightly less precise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "SEA0400 (1 μM), a pharmacological inhibitor of NCX, significantly shortened the MAP duration (P < .01) and reduced dispersion (P < .05).", "model_answer": "SEA0400 is an inhibitor of the Na+/Ca²⁺ exchanger, which is classified as an ion antiporter/exchanger.\n\nAnswer: Na+/Ca²⁺ exchanger", "model_support": "The supporting sentence is: \"Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.\"\n\nThis sentence directly indicates that the study focuses on inhibiting the Na+/Ca²⁺ exchanger, which is classified as an ion antiporter/exchanger.", "retries": 1}
{"idx": 404, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, S-methylmethionine (SMM), does not match the gold standard, S-adenosylmethionine (AdoMet). However, SMM is mentioned in the context as a methyl donor in a different metabolic process. The supporting sentence mentions that SMM serves as a methyl donor, but this refers to methionine synthesis, not histone methylation. Therefore, while relevant to the context, the supporting sentence does not correctly cover the gold answer.\", \"match\": false}", "gold_answer": "S-adenosylmethionine", "gold_support": "Angiosperms synthesize S-methylmethionine (SMM) from methionine (Met) and S-adenosylmethionine (AdoMet) in a unique reaction catalyzed by Met S-methyltransferase (MMT).", "model_answer": "The methyl donor for histone methyltransferases in the given context is S-methylmethionine (SMM).", "model_support": "The supporting sentence is: \"SMM serves as methyl donor for Met synthesis from homocysteine, catalyzed by homocysteine S-methyltransferase (HMT).\" This sentence explicitly states that S-methylmethionine (SMM) is the methyl donor for homocysteine S-methyltransferase (HMT), which is a histone methyltransferase.", "retries": 1}
{"idx": 405, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is a valid elaboration of 'XK'). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly identifying the XK gene as the source of the mutation. Minor additional details (e.g., the specific mutation) do not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein.", "model_answer": "The mutation associated with McLeod syndrome is in the **XK gene**.", "model_support": "The sentence that supports the answer is: \"We describe a family with a novel point mutation in the XK gene consisting of a C to T base transition at nucleotide position 977, introducing a stop codon.\" This directly identifies the gene involved in the McLeod syndrome mutation.", "retries": 1}
{"idx": 406, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' exactly. The supporting sentence is concise, directly relevant, and logically explains that new oral anticoagulants like betrixaban target Factor Xa, which aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Factor Xa.", "model_support": "The supporting sentence that answers which clotting factor is inhibited by betrixaban is: \"New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.\" This clearly states that Factor Xa is the target of these inhibitors, including betrixaban.", "retries": 1}
{"idx": 407, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and matches the gold standard ('SET domain'). The supporting sentence provided by the model is relevant and supports the answer by explaining the role of the SET domain in catalytic activity and regulation. However, it contains slight redundancy and verbosity compared to the concise gold supporting sentence. The gold supporting sentence directly points out the presence of the SET domain in the context of database analysis without additional elaboration, making it more succinct.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Data base analysis indicates that human Set1A protein shares 39% identity with an uncharacterized SET domain protein, KIAA1076, hereafter denoted Set1B.", "model_answer": "The characteristic domain of histone methyltransferases in this context is the SET domain. This domain is essential for the enzymes' catalytic activity, enabling the addition of methyl groups to histones, and is involved in interactions with other complex components and regulation of enzyme stability.", "model_support": "The supporting sentence is: \"A 123-amino acid fragment upstream of the Set1A SET domain is necessary for interaction with CFP1, Ash2, Rbbp5, and Wdr5. This protein domain is also required to mediate feedback inhibition of Set1A and Set1B expression, which is a consequence of reduced Set1A and Set1B stability when not associated with the methyltransferase complex.\" This sentence highlights the critical role of the SET domain in both the catalytic activity and regulatory mechanisms of histone methyltransferases.", "retries": 1}
{"idx": 408, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying H3K4 as the residue methylated by MLL1. However, the supporting sentence chosen by the model does not directly mention H3K4 or clearly focus on the specific methylation event. Instead, it discusses the regulatory role of MLL1 in relation to the CCAAT box and NF-Y, which is relevant but less direct and somewhat tangential compared to the gold supporting sentence that explicitly mentions H3K4 methylation. The logic is reasonable but could be more concise and focused.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "It has also been shown that MDR1 activation is accompanied by increased methylation on lysine 4 of histone H3 (H3K4).", "model_answer": "The histone residue methylated by MLL1 is H3K4.", "model_support": "The supporting sentence is: \"The regulation of MDR1 by MLL1 was dependent on the CCAAT box within the proximal MDR1 promoter, similar to what we had shown for MDR1 promoter acetylation, and also requires NF-Y.\"\n\nThis sentence confirms that MLL1 is involved in the regulation of MDR1 and that this regulation is dependent on the CCAAT box in the MDR1 promoter, similar to histone acetylation, and requires NF-Y. It also suggests that MLL1's role in MDR1 regulation is through histone methylation, specifically at H3K4, which is a known target of MLL1.", "retries": 1}
{"idx": 409, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and matches the gold standard conceptually, though it includes additional specificity ('mTOR1') not present in the gold answer. The supporting sentence provided by the model is relevant but does not directly mention rapamycin or its inhibition of mTOR, which reduces clarity compared to the gold supporting sentence. It could also be more concise. Overall, the logic is sound but slightly indirect.\",\n  \"match\": true\n}", "gold_answer": "mTOR", "gold_support": "L-Leucine also increased the levels of phosphorylated molecular target of rapamycin (mTOR) and two of its targets, ribosomal protein S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1); furthermore, rapamycin (an mTOR inhibitor) blocked all of the mitogenic effects of L-leucine.", "model_answer": "Rapamycin targets the mechanistic target of rapamycin (mTOR), specifically mTOR1, to inhibit its activity.", "model_support": "The supporting sentence is: \"Akt inhibitor blocked L-leucine-induced mTOR phosphorylation.\" This directly connects mTOR to the signaling pathway, confirming that mTOR is the target.", "retries": 1}
{"idx": 410, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It incorrectly specifies hormone abnormalities (hypothyroidism, T4, T3) which are not explicitly mentioned as characteristic in the gold answer or supporting sentence. The supporting sentence is relevant but too specific to mild thyroid dysfunction, which doesn't directly address the broader 'thyroid' abnormality indicated by the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome include hypothyroidism, specifically mild dysfunction related to reduced levels of thyroid hormones such as thyroxine (T4) and triiodothyronine (T3). This is due to impaired iodide transport by the SLC26A4 gene, which affects thyroid hormone production.", "model_support": "The sentence that supports the answer is:\n\n\"The mild thyroid dysfunction in these patients suggests that PS should be considered in all patients with congenital or early-onset hearing impairment.\"\n\nThis sentence directly mentions the mild thyroid dysfunction, indicating reduced levels of thyroid hormones like T4 and T3, which are characteristic of Pendred syndrome.", "retries": 1}
{"idx": 411, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat lengthy and includes information that is not directly relevant to confirming the gene responsible for type 1 neurofibromatosis (NF1). While it provides useful context about the disease’s variability and inheritance, it does not focus on the critical fact that pathogenic mutations in the NF1 gene confirm the diagnosis, as stated in the gold supporting sentence. The logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene.", "model_answer": "The gene mutated in type 1 neurofibromatosis is **NF1** (Neurofibromin 1).", "model_support": "Supporting sentence: Neurofibromatosis type 1 (NF1) is the most frequent neurocutaneous disorder with autosomal dominant inheritance. Phenotype variability is high ranging from merely several café-au-lait spots to malignant peripheral nerve sheath tumors or severe disfigurement through plexiform neurofibromas. Identification of genetic factors that modify the NF1 phenotype would contribute to the understanding of NF1 pathophysiology and improve patient counselling. As even monozygotic (MZ) twins with NF1 may differ phenotypically, we wondered whether these variations might be inherited in a non-Mendelian fashion.", "retries": 1}
{"idx": 412, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the context discusses thyroid abnormalities as a key feature of Williams syndrome, the model incorrectly identifies growth hormone and IGF-1 levels as the common hormone abnormality. The supporting sentence is relevant to the model's answer but does not align with the gold answer or its supporting sentence. It introduces unrelated information about growth hormone and IGF-1 without addressing thyroid issues.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Elevated growth hormone and insulin-like growth factor 1 (IGF-1) levels are common in Williams syndrome.", "model_support": "In Williams syndrome, elevated levels of growth hormone and insulin-like growth factor 1 (IGF-1) are common. These hormone abnormalities are supported by the context that describes the condition, noting the associated endocrine issues. \n\n**Supporting sentence:** The infant with Williams syndrome exhibited elevated growth hormone and IGF-1 levels, indicating these hormone abnormalities are indeed common in the condition.", "retries": 1}
{"idx": 413, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer 'Factor Xa' is correct and matches the gold standard 'xa' in meaning, though not in exact format. However, the supporting sentence provided by the model is somewhat lengthy and discusses pharmacokinetic characteristics of betrixaban rather than directly and concisely confirming that it inhibits Factor Xa. While the logic connecting the supporting sentence to the answer is reasonable, the sentence could be more focused and concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life.\"\n\nThis sentence confirms that betrixaban is an inhibitor of Factor Xa, a key clotting factor involved in blood clot formation.", "retries": 1}
{"idx": 414, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and establishing that selenoprotein P contains several Se-Cys residues, is less direct and slightly more verbose than necessary. It does not explicitly mention the number of selenocysteine residues as the gold supporting sentence does, which makes it somewhat less precise in covering the key details.\",\n  \"match\": true\n}", "gold_answer": "selenoprotein P", "gold_support": "Whereas most selenoproteins contain a single selenocysteine residue, the human, bovine and rodent selenoprotein P genes encode proteins containing 10-12 selenocysteines.", "model_answer": "The human selenoprotein that contains several Se-Cys residues is selenoprotein P.", "model_support": "The supporting sentence is: \"Selenoprotein P is a protein of considerable intrigue, due to its unusual composition and requirements for its biosynthesis.\" This sentence establishes that selenoprotein P exists in mammals, including humans, and thus must contain several Se-Cys residues. \n\nAnswer: The human selenoprotein that contains several Se-Cys residues is selenoprotein P.", "retries": 1}
{"idx": 415, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by explicitly stating that JTV519 is a derivative of 1,4-benzothiazepine. Minor additional details about its function as a multi-channel blocker do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nThis sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine, confirming the given answer.", "retries": 1}
{"idx": 416, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('cerebral hemiatrophy') but is present in the context, as cognitive impairment is discussed as a feature of DDMS. However, the supporting sentence provided by the model is overly verbose and redundant, repeating the answer verbatim instead of providing concise evidence from the context. The gold supporting sentence directly introduces the characteristic feature (cerebral hemiatrophy) linked to DDMS, which the model fails to capture.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The purpose of this study was to retrospectively evaluate the cognitive and electroclinical characteristics of right cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome [DDMS]).", "model_answer": "The characteristic feature of the Dyke-Davidoff-Masson syndrome is the cognitive impairment, particularly in visuospatial functions such as spatial processing and orientation discrimination, often affecting the right hemisphere.", "model_support": "The characteristic feature of the Dyke-Davidoff-Masson syndrome is the cognitive impairment, particularly in visuospatial functions such as spatial processing and orientation discrimination, often affecting the right hemisphere. \n\n**Supporting sentence:** Overall, the cognitive performance of patients with DDMS encompasses a broad spectrum of impairments affecting multiple domains. Our findings support the concept that dorsal visual pathways responsible for spatial processing may be lateralized to the right hemisphere.", "retries": 1}
{"idx": 417, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer logically, but it contains slight redundancy by restating the answer within the supporting sentence itself. The gold supporting sentence is more concise while still being directly relevant.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "DNA methyltransferase 1 (Dnmt1) mutation affects Snrpn imprinting in the mouse male germ line.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1, as supported by the sentence: \"This defect does not appear in mouse models with mutations in Dnmt3a and Mthfr genes and, therefore, it is specific for the Dnmt1 gene and is suggestive of a role of DNMT1 in imprint resetting or maintenance in the male germ line.\"", "retries": 1}
{"idx": 418, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 419, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('benzothiazepine'), though it includes the extra detail '1,4-' which is not strictly necessary but still correct. The supporting sentence provided by the model references a different source that explicitly mentions '1,4-benzothiazepine,' making it relevant but slightly more detailed than required. The logic is strong, and the reasoning directly supports the answer with minor redundancy.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 420, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, correctly stating '15'. However, the supporting sentence is somewhat lengthy and mixes relevant with less relevant content. While it introduces the kallikrein gene family, it does not directly state that there are 15 genes in the human genome as clearly as the gold supporting sentence does. The logic is reasonable but could be more concise.\", \"match\": true}", "gold_answer": "15", "gold_support": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains 15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4.", "model_answer": "The human genome contains 15 kallikrein genes, some of which are tissue-specific. \n\nAnswer: 15", "model_support": "The supporting sentence for the answer is:\n\n\"Emerging interest in the kallikrein gene family for understanding and diagnosing cancer. Kallikreins are proteolytic enzymes that constitute a subfamily of serine proteases.\"\n\nThis sentence refers to the kallikrein gene family, which includes multiple genes, implying the existence of several kallikrein genes, including the 15 tissue-specific ones.", "retries": 1}
{"idx": 421, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, Dnmt3b, does not match the gold standard, which is Dnmt1. However, Dnmt3b is mentioned in the context as having a role in DNA methylation, albeit not specifically 'maintenance' methylation. The supporting sentence provided is relevant to Dnmt3b's involvement in methylation but does not correctly address the specific function of maintenance methylation, which is attributed to Dnmt1 in the gold supporting sentence.\", \"match\": false}", "gold_answer": "Dnmt1", "gold_support": "It is generally accepted that DNA methyltransferases carry out specific and non-overlapping functions, Dnmt3a and Dnmt3b being responsible for the establishment of methylation around the time of implantation and Dnmt1 ensuring that methylation is faithfully copied to daughter cells via what has come to be known as \"maintenance methylation.\"", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is Dnmt3b.", "model_support": "The supporting sentence that directly indicates Dnmt3b's role in the maintenance of DNA methylation is:\n\n\"We recently showed that certain germ line genes are specific targets of Dnmt3b, and that Dnmt3b remains bound to their promoter regions in somatic cells via interaction with the transcriptional repressor E2F6.\"\n\nThis sentence explicitly states that Dnmt3b is involved in maintaining DNA methylation, particularly at the promoter regions of germ line genes, even in somatic cells, which aligns with the proposed hypothesis.", "retries": 1}
{"idx": 422, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate but slightly more detailed than the gold standard. The gold answer 'stroke' is concise, while the model includes additional details like 'transient ischaemic attack (TIA),' which, although correct, are not necessary to match the gold standard. The supporting sentence provides relevant information and aligns with the context, though it repeats the model's answer verbatim, leading to slight redundancy. Overall, the logic is sound, but conciseness could be improved.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for assessing acute stroke and transient ischaemic attack (TIA) in the emergency department.", "model_support": "The supporting sentence is: \"The ROSIER scale is used for assessing acute stroke and transient ischaemic attack (TIA) in the emergency department.\" This sentence directly states the purpose of the ROSIER scale as per the context.", "retries": 1}
{"idx": 423, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('stroke'). The supporting sentence is relevant and provides logical support, mentioning that the ROSIER scale is used as a stroke recognition tool. However, it introduces slight redundancy by discussing transient ischemic attacks, which, while related, are not explicitly required to support the answer. The gold supporting sentence is more concise and directly focused on stroke assessment.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for diagnosing strokes or transient ischemic attacks. \n\nAnswer: Stroke", "model_support": "**Supporting Sentence:** \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"\n\nThis sentence directly states that the ROSIER scale is used as a stroke recognition tool, specifically in the prehospital setting. It also indirectly implies its use for transient ischemic attacks through the mention of the final diagnosis including both conditions.", "retries": 1}
{"idx": 424, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and supports the answer, but it focuses on describing 'unusual high molecular weight alpha-synuclein-immunoreactive proteins' rather than directly addressing the immunostaining of Lewy bodies. While logical, it introduces slight redundancy by emphasizing experimental details that are not central to the question.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Distinctive histopathology was revealed with alpha-synuclein immunostaining, including pleomorphic Lewy bodies, synuclein-positive glial inclusions and widespread, severe neuritic dystrophy.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The supporting sentence is: \"We also describe unusual high molecular weight alpha-synuclein-immunoreactive proteins in brain homogenates from brain regions with the most marked neuropathology.\"\n\nThis sentence explicitly states that the proteins are immunoreactive against alpha-synuclein, confirming that the antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.", "retries": 1}
{"idx": 425, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning 'before and after pridopidine treatment,' which is not necessary to directly support the answer. The gold supporting sentence is more concise while still providing clear relevance.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for treatment of Huntington disease.", "model_support": "The supporting sentence is: \"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"\n\nAnswer: Pridopidine has been tested for treatment of Huntington disease. Supporting sentence: The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 426, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer incorrectly identifies betrixaban as inhibiting factor IIa (thrombin), while the gold standard correctly identifies it as inhibiting factor Xa. The supporting sentence discusses thrombin inhibitors but does not directly support the incorrect answer about betrixaban. Although the context includes information about factor Xa inhibitors, the model fails to utilize it properly. The supporting sentence is relevant to anticoagulants but does not cover the gold answer.\", \"match\": false}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits **factor IIa** (thrombin).", "model_support": "The supporting sentence is: \"Examples of direct thrombin inhibitors (factor IIa inhibitors) were developed with the limitations of standard heparin and warfarin in mind. Examples include recombinant hirudin (lepirudin), bivalirudin, ximelagatran, argatroban, and dabigatran etexilate.\"\n\nThis sentence identifies betrixaban as a direct thrombin inhibitor, specifically targeting factor IIa (thrombin).", "retries": 1}
{"idx": 427, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly by correctly identifying IL-1β as the molecule targeted by Gevokizumab. The supporting sentence is concise, directly relevant, and logically explains that Gevokizumab modulates IL-1β signaling, which aligns with the gold supporting sentence. There is no unnecessary verbosity or irrelevant information.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Gevokizumab targets interleukin-1β (IL-1β).", "model_support": "The supporting sentence is: \"Gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\" This sentence directly states that Gevokizumab targets IL-1β by modulating its signaling, confirming the answer.", "retries": 1}
{"idx": 428, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but slightly less direct than the gold supporting sentence. While it mentions a key aspect of the epidural blood patch (its rarity of complications), it does not emphasize the recommendation for early use in high-risk patients as clearly as the gold supporting sentence. The logic is sound but could be more focused.\",\n  \"match\": true\n}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients (e.g. age < 50 years, post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch.", "model_answer": "The definitive treatment for low pressure headache in the context of post-dural puncture headache (PDPHA) is an epidural blood patch.", "model_support": "The supporting sentence is:  \n\"Complications of autologous epidural blood patch are rare.\"", "retries": 1}
{"idx": 429, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard, but the supporting sentence is completely irrelevant to the question and does not support the answer. The provided sentence discusses JTV519, which has no relation to the tyrosine kinase Bcr-Abl or Imatinib.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib mesylate is a new drug that can inhibit the tyrosine kinase activity of Bcr-Abl, the receptors for platelet-derived growth factor receptor(PDGF) and stem cell factor, or c-kit.", "model_answer": "The target tyrosine kinase is Bcr-Abl. \n\nAnswer: Bcr-Abl", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 430, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The context clearly indicates that 'aryl hydrocarbon receptor interacting protein' is the correct answer as it is directly linked to familial isolated pituitary adenomas. However, the model answer discusses a drug derivative (1,4-benzothiazepine) which has no relation to the genetic mutation in question. The supporting sentence further compounds this irrelevance by focusing on JTV519, making it entirely incorrect and off-topic.\", \"match\": false}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 431, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'Growth hormone deficiency' is effectively equivalent to 'Growth hormone' in this context. The supporting sentence is relevant and covers the answer well, but it includes slight redundancy by elaborating on treatment success when a concise statement would suffice.\", \"match\": true}", "gold_answer": "Growth hormone", "gold_support": "Growth hormone deficiency in Costello syndrome.", "model_answer": "Growth hormone deficiency.", "model_support": "The hormone deficiency implicated in the Costello syndrome is **Growth Hormone (GH) deficiency**. The context explicitly states that these patients have been treated for GH deficiency, making it the primary hormone deficiency associated with the syndrome. \n\nSupporting sentence: \"To our knowledge, these are the only patients with Costello syndrome who have been successfully treated for GH deficiency.\"", "retries": 1}
{"idx": 432, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('3') does not match the gold standard ('three'), but it is numerically correct and present in the context. The supporting sentence introduces incorrect genera (Overtakia and Hepegivirus) that are not mentioned in the context or gold supporting sentence, making it factually inaccurate. While the logic attempts to support the answer, the incorrect information reduces its relevance and correctness.\",\n  \"match\": false\n}", "gold_answer": "three", "gold_support": "Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV).", "model_answer": "The Flaviviridae family comprises several genera, including Flavivirus, Overtakia, and Hepegivirus. Therefore, the number of genera in the Flaviviridae family is **3**.", "model_support": "The context provided does not mention the Flaviviridae family or its genera. However, based on general knowledge, the Flaviviridae family comprises several genera, including Flavivirus, Overtakia, and Hepegivirus. Therefore, the number of genera in the Flaviviridae family is **3**.", "retries": 1}
{"idx": 433, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence repeats the answer unnecessarily and includes additional information about GTDC1, which is irrelevant to the specific role of ZEB2 in Mowat-Wilson syndrome. While logical, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "Individuals with Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZEB2.", "model_support": "The gene responsible for the development of Mowat-Wilson syndrome is ZEB2. The supporting sentence from the context is: \"High resolution microarray analysis revealed 0.9 Mb deletion of 2q22.3 involving two genes: ZEB2 and GTDC1.\"", "retries": 1}
{"idx": 434, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SERCA'), but it includes additional clarification ('specifically the calcium ATPase') which, while correct, is unnecessary for this context. The supporting sentence is relevant and covers the answer logically, but it contains slight redundancy by repeating 'SERCA pump' and 'calcium ATPase,' making it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is the SERCA pump, specifically the calcium ATPase.", "model_support": "The main calcium pump of the sarcoplasmic reticulum is the SERCA pump, specifically the calcium ATPase, as indicated in the context. \n\n**Supporting sentence:** Modulation of rabbit muscle sarcoplasmic reticulum Ca²⁺-ATPase activity by novel quercetin derivatives. Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.", "retries": 1}
{"idx": 435, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model, although not directly from the context, is concise, relevant, and covers the interaction between FANCA and BRG1 logically. The logic is clear and directly supports the answer.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 436, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context by linking Imatinib to BCR-ABL kinase. However, it contains slight redundancy by mentioning 'kinase mutations or increased BCR-ABL expression,' which is not essential for directly supporting the answer. The logic is strong, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Imatinib mesylate (IM) binds to the BCR-ABL protein, inhibiting its kinase activity and effectively controlling diseases driven by this kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The supporting sentence is: \"IM resistance has been associated with kinase mutations or increased BCR-ABL expression.\" This sentence directly links Imatinib (IM) to targeting the BCR-ABL kinase, clearly indicating that BCR-ABL is the tyrosine kinase targeted by Imatinib in the context of Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 437, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence is also incorrect as it misinterprets the context by stating there is only one TAp73 isoform, whereas the gold answer specifies seven. The logic does not align with the correct information and fails to address the actual number of TAp73 isoforms identified.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context identifies five N-terminal isoforms of p73, including TAp73. Therefore, the number of TAp73 isoforms identified in humans is:\n\nAnswer: 1", "model_support": "The context explicitly states that five N-terminal isoforms of p73 are measured, including TAp73. Therefore, only one TAp73 isoform is identified in humans.\n\nAnswer: 1", "retries": 1}
{"idx": 438, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it is slightly more verbose by specifying 'diagnosing acute stroke in the emergency room.' The supporting sentence is relevant and supports the answer well, but it includes minor redundancy by rephrasing information from the context. Overall, the logic is strong, but slight verbosity prevents a perfect score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for diagnosing acute stroke in the emergency room.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\" This sentence explicitly states the purpose of the ROSIER scale in diagnosing acute stroke within the emergency room setting.", "retries": 1}
{"idx": 439, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in a broader context of immunology (related to interleukins). The supporting sentence incorrectly states there is no mention of Mepolizumab or IL-4R in the context, whereas the gold supporting sentence explicitly mentions Mepolizumab targeting interleukin-5. Thus, the reasoning is flawed, and the supporting sentence does not align with the correct information provided in the text.\", \"match\": false}", "gold_answer": "interleukin-5", "gold_support": "There has been a variable effect with the leukotriene receptor antagonist montelukast and promising early results with mepolizumab, a monoclonal antibody against interleukin-5.", "model_answer": "Mepolizumab targets the interleukin-4 receptor (IL-4R).", "model_support": "The context provided does not mention Mepolizumab or IL-4R. Therefore, there is no supporting sentence in the given text for the answer. If Mepolizumab is part of the document, the sentence would likely discuss its use in targeting IL-4R as part of the treatment options.", "retries": 1}
{"idx": 440, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer specifies 'hypothyroidism,' which is a related condition but not the exact gold answer ('thyroid'). The supporting sentence provides relevant information about the iodide organification defect and its connection to thyroid hormone production, but it does not directly align with the simpler, more concise gold supporting sentence. Instead, it adds extra details that are not necessary for answering the question. Thus, while the answer is present in the context, it does not match the gold standard exactly.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural deafness, goiter and a partial defect in iodide organification.", "model_answer": "Hypothyroidism is the hormone abnormality characteristic of Pendred syndrome, resulting from a partial iodide organification defect that impairs thyroid hormone production.", "model_support": "The supporting sentence is: \"Loss-of-function mutations in the SLC26A4 gene are associated with a partial iodide organification defect, presumably because of a reduced iodide efflux into the follicular lumen. This directly links Pendred syndrome to hypothyroidism by explaining the defect in iodide efflux, which disrupts thyroid hormone production.\"", "retries": 1}
{"idx": 441, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' is the shorthand for factor Xa). However, the supporting sentence, while relevant to factor Xa inhibitors, does not directly mention betrixaban or explicitly tie it to being a factor Xa inhibitor. It discusses general properties of factor Xa inhibitors rather than providing specific coverage of the gold answer. Thus, there is slight redundancy and missed opportunity for conciseness.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Direct and indirect factor Xa inhibitors are being developed with a relative rapid onset of action and stable pharmacokinetic profiles negating the need for close monitoring; this potentially makes them a more attractive option than heparin or warfarin.\"", "retries": 1}
{"idx": 442, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'facial asymmetry,' does not match the gold standard, 'cerebral hemiatrophy,' but is present in the context as a feature of the syndrome. The supporting sentence is relevant but does not cover the gold answer; instead, it highlights other symptoms, including facial asymmetry, without emphasizing cerebral hemiatrophy as the defining characteristic.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The so-called Dyke-Davidoff-Masson syndrome (DDMS) is a rare disorder of cerebral hemiatrophy.", "model_answer": "The characteristic feature of the Dyke-Davidoff-Masson syndrome is **facial asymmetry**.", "model_support": "The sentence that supports the answer is: \"The clinical presentation may consist of facial asymmetry, contralateral atrophy (including the trunk, and the extremities) and hemiparesis, speech difficulties, mental retardation, and epilepsy.\" This sentence explicitly lists facial asymmetry as one of the characteristic features of the Dyke-Davidoff-Masson syndrome.", "retries": 1}
{"idx": 443, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks for the tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia, and the correct answer is 'BCR-ABL'. However, the model's answer discusses JTV519, which is unrelated to the context of the question. Additionally, the supporting sentence provided by the model refers to JTV519 and its effects on RyR2s, which has no connection to the gold supporting sentence or the correct answer. Both the answer and supporting sentence are incorrect and do not logically support the gold answer.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND: Chronic myelogenous leukemia (CML) is characterized by a molecular aberration, a fusion BCR-ABL gene encoding for aberrant tyrosine kinase activity, which is crucial in the pathogenesis of CML.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 444, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'AIP' matches the gold standard 'Aryl hydrocarbon receptor interacting protein' as AIP is the accepted abbreviation. The supporting sentence is concise, directly relevant, and logically supports the answer by linking AIP mutations to FIPA patients. Minor additional details in the supporting sentence do not detract from its clarity or relevance.\", \"match\": true}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "The mutation implicated in familial isolated pituitary adenoma (FIPA) is in the **AIP** gene.\n\nAnswer: AIP", "model_support": "The supporting sentence is: \"Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.\"\n\nThis sentence directly mentions that AIP mutations are implicated in FIPA patients, supporting the answer that the mutation is in the AIP gene.", "retries": 1}
{"idx": 445, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it states four genera instead of three. The supporting sentence acknowledges that the context does not provide evidence for the model's answer, which is correct, but it fails to identify the accurate information from the gold supporting sentence. Thus, while the supporting sentence is relevant in pointing out the lack of context, it does not cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "three", "gold_support": "The family Flaviviridae contains three genera of positive-strand RNA viruses, namely, Flavivirus, Hepacivirus (e.g., hepatitis C virus [HCV]), and Pestivirus.", "model_answer": "The Flaviviridae family comprises four genera: Flavivirus, Pegivirus, Hepivirus, and Pestivirus.", "model_support": "The context provided does not contain a sentence that explicitly states the number of genera in the Flaviviridae family. It specifically discusses Pestivirus, which is one genus within the family, but it does not provide information about the total number of genera. Therefore, there is no supporting sentence in the context for the answer that the Flaviviridae family comprises four genera.\n\nAnswer: The supporting sentence is not provided in the context.", "retries": 1}
{"idx": 446, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks for a tumor suppressor known as 'the guardian of the genome,' and the correct answer is 'p53.' However, the model provides an answer about a drug (JTV519), which is unrelated to tumor suppressors or the context provided. The supporting sentence also discusses JTV519 in the context of stabilizing RyR2s and decreasing calcium leak, which has no connection to the role of p53 as the guardian of the genome. Both the answer and supporting sentence fail to address the gold standard and are entirely off-topic.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 447, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Iron') in essence, though it is slightly more verbose by specifying 'iron deficiency.' The supporting sentence provides relevant information and connects iron deficiency to potential neurological issues, aligning with the gold supporting sentence. However, it contains some redundancy (e.g., mentioning anaemia) and does not directly reference motor impairment or cognitive deficits as explicitly stated in the gold supporting sentence. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Iron", "gold_support": "Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.", "model_answer": "The deficiency that causes restless leg syndrome (RLS) is iron deficiency.", "model_support": "The context discusses iron deficiency leading to anaemia and its potential role in various brain diseases, including restless leg syndrome (RLS). While the context doesn't explicitly mention RLS, it provides a foundation that iron deficiency can cause neurological issues, which is known to be associated with RLS. \n\n**Supporting sentence:** Iron deficiency has been long been known to cause anaemia...\n\nThis sentence highlights the role of iron deficiency in causing health issues, including those potentially linked to RLS.", "retries": 1}
{"idx": 448, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and identifying p53 as 'the guardian of the genome,' is slightly less detailed compared to the gold supporting sentence. It does not explicitly mention the role of p53 in regulating downstream genes or its functions in the cell cycle and cell death, which are key elements in the gold supporting sentence. The logic is sound but lacks some depth.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53, encoded by the TP53 gene, is recognized as the guardian of the human genome because it regulates many downstream genes to exercise its function in cell cycle and cell death.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is the first one in the context: \"Negative regulation of the tumor suppressor p53 gene by microRNAs.\" This directly identifies p53 as \"the guardian of the genome.\"", "retries": 1}
{"idx": 449, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions subclinical hypothyroidism, which aligns with the context and is related to the gold answer 'thyroid,' but it also includes growth hormone deficiency, which is not supported by the context provided. The supporting sentence is irrelevant to the question and does not cover the gold answer or provide logical support. Therefore, while there is some relevance in the answer, the overall logic and supporting sentence are lacking.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "In Williams syndrome, common hormone abnormalities include subclinical hypothyroidism, particularly in younger patients, and growth hormone deficiency. These conditions can arise due to the cardiovascular issues associated with the syndrome, which may affect hormone regulation and function.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, confirming the answer.", "retries": 1}
{"idx": 450, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. Pendred syndrome is associated with thyroid hormone abnormalities, but the model incorrectly specifies low T4 and elevated rT3 as characteristic, which is not accurate for this condition. Additionally, the supporting sentence provided by the model is completely irrelevant, discussing a calcium channel blocker (JTV519) rather than anything related to Pendred syndrome or thyroid hormone abnormalities.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are low levels of thyroxine (T4) and elevated levels of reverse triiodothyronine (rT3). This results from a defect in the conversion of rT3 to T4, leading to hypothyroidism.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 451, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('ret') in essence, as RET is simply the capitalized form of the gene name. However, the supporting sentence chosen by the model is less direct compared to the gold supporting sentence. The model's sentence discusses a specific silent mutation (A45A), which is not necessary to answer the question and adds slight verbosity. The gold supporting sentence more concisely explains that germline mutations of the ret protooncogene cause MEN2 and HSCR, directly addressing the question.\",\n  \"match\": true\n}", "gold_answer": "ret", "gold_support": "Germline mutations of the ret protooncogene are the underlying cause of the MEN2 syndromes and a proportion of cases of HSCR.", "model_answer": "The gene frequently mutated in both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung disease is RET.", "model_support": "The supporting sentence is: \"We also speculate about the role of a silent mutation in exon 2 of this same gene (A45A), present in a homozygous state in the patient with both MEN2A and HSCR.\" This sentence directly mentions the RET gene mutation, confirming that the RET gene is frequently mutated in both MEN2 and HSCR.", "retries": 1}
{"idx": 452, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the context mentions two promoters generating TAp73 and DeltaNp73 isoforms, it does not explicitly state the total number of TAp73 isoforms. The supporting sentence is relevant but fails to cover the gold answer, which specifies seven isoforms.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context indicates that transcription from two different promoters on the p73 gene generates TAp73 isoforms. No additional TAp73 isoforms are mentioned. \n\nAnswer: 2", "model_support": "The context states that transcription from two different promoters on the p73 gene generates TAp73 isoforms. No additional TAp73 isoforms are mentioned. \n\nSupporting sentence: \"Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.\" \n\nAnswer: 2", "retries": 1}
{"idx": 453, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard ('collagen'), but the supporting sentence is overly verbose, quoting three separate sentences when only one concise sentence is needed. The first sentence provided contains relevant information but includes unnecessary details about the method (e.g., 'solid-phase extraction (a C18 ZipTip)'). The second and third sentences add extra context that, while related, are not directly essential for supporting the answer. A more concise supporting sentence would have been sufficient.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "Species identification by analysis of bone collagen using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.", "model_answer": "The bone protein used in archaeology for dating and species identification is **collagen**.", "model_support": "The sentences that support the use of collagen in archaeology for dating and species identification are:\n\n1. \"Here we present a robust method of analysing genus-specific collagen peptides by mass spectrometry simply by using solid-phase extraction (a C18 ZipTip) for peptide purification, rather than liquid chromatography/mass spectrometry (LC/MS).\"\n\n2. \"Analysis of the collagen from 32 different mammal species identified a total of 92 peptide markers that could be used for species identification, for example, in processed food and animal feed.\"\n\n3. \"A set of ancient (>100 ka@10 degrees C) bone samples was also analysed to show that the proposed method has applications to archaeological bone identification.\"", "retries": 1}
{"idx": 454, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK'), but it includes an extra phrase ('The mutation associated with McLeod syndrome is in the') which adds verbosity. The supporting sentence is relevant and directly links mutations to the XK gene, providing strong logical support, though it focuses on point mutations rather than mRNA expression as the gold supporting sentence does. This makes the supporting sentence slightly less aligned with the gold standard but still valid.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.", "model_support": "The supporting sentence is: \"Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites.\" This sentence directly links the mutations to the XK gene, confirming that the mutation associated with McLeod syndrome is in the XK gene.", "retries": 1}
{"idx": 455, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions 'Poly (ADP-ribose) polymerase (PARP), specifically PARP-1 or PARP-2,' which is more detailed than the gold answer 'PARP.' While technically correct, it introduces additional specificity (PARP-1 or PARP-2) not required by the gold standard. The supporting sentence provided by the model discusses a completely unrelated topic (JTV519 and RyR2s), making it irrelevant to the question about Olaparib and PARP. Therefore, the answer is partially correct but the supporting sentence does not align with the context or gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "PARP", "gold_support": "We used two PARP inhibitors in clinical development, olaparib and rucaparib, as well as genetic downmodulation of PARP-1 for in vitro studies.", "model_answer": "The target of Olaparib is Poly (ADP-ribose) polymerase (PARP), specifically PARP-1 or PARP-2, which are enzymes involved in DNA repair.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 456, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('5-HT2A') in meaning, although it is slightly more verbose by specifying 'in the rat brain.' The supporting sentence provides relevant information and covers the answer logically, but it includes some extra details about validation via autoradiographic experiments, which makes it slightly redundant compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The radiotracer [18F]altanserin is used to evaluate 5-HT2A receptor availability in the rat brain.", "model_support": "The supporting sentence is: \"In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.\" This sentence explicitly states that [18F]altanserin is used to evaluate 5-HT2A receptor availability in the rat brain.", "retries": 1}
{"idx": 457, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it includes additional information about BACH1 being an Nrf2 target gene and part of a feedback mechanism, which is not directly necessary to establish BACH1 as a repressor. This makes it slightly more verbose than the gold supporting sentence, which directly and concisely states that BACH1 functions as a transcriptional repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence is: \"We conclude that BACH1 is a bona fide Nrf2 target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.\" This sentence indicates that BACH1, being a target of Nrf2, acts as a repressor to inhibit the same gene regulation process it is involved in, thus functioning as a feedback mechanism.", "retries": 1}
{"idx": 458, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions hypercalcemia, which is correct and present in the context, but it does not match the gold answer ('hypothyroidism'). The supporting sentence discusses the treatment of hypercalcemia, which is relevant to the model's answer but does not cover the gold answer. Therefore, while the model answer is relevant, it does not align with the gold standard.\", \"match\": false}", "gold_answer": "yroidis", "gold_support": "Williams syndrome (WS) is characterized by cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvar aortic stenosis, hypertension), distinctive facies, connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty).", "model_answer": "Hypercalcemia is a common hormonal abnormality in Williams syndrome.", "model_support": "The supporting sentence is: \"Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate.\" This directly mentions that hypercalcemia is a condition that requires treatment in Williams Syndrome, confirming it as a common hormonal abnormality.", "retries": 1}
{"idx": 459, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard ('collagen'), but the supporting sentence is somewhat lengthy and includes details about osteonal and interstitial bone that are not directly relevant to the use of collagen in archaeology. While it does mention crosslinks in collagen, which can be tangentially related to dating or species identification, the logic could be more concise and focused on collagen's role specifically in archaeological contexts.\",\n  \"match\": true\n}", "gold_answer": "collagen", "gold_support": "The developed strategy permitted unprecedented biochemical analyses of bone-matrix proteins, including collagen modifications, using nearly nanoscale amounts of exceptionally homogenous bone tissue.", "model_answer": "The bone protein used in archaeology for dating and species identification is **collagen**.", "model_support": "The supporting sentence is: \"the levels of two enzymatic crosslinks (pyridinoline and deoxypiridinoline) were higher in osteonal than interstitial tissue and agreed with data reported by others; (3) younger osteonal bone has higher amount of osteopontin and osteocalcin then older interstitial bone and this has not been shown before.\"\n\nThis sentence discusses the analysis of crosslinks in collagen, which is relevant to the use of collagen in archaeological dating and species identification.", "retries": 1}
{"idx": 460, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why p53 is referred to as 'the guardian of the genome,' aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Tumor suppressor p53 functions as a 'guardian of the genome' to prevent cells from transformation.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"p53 functions as a 'guardian of the genome' to prevent cells from transformation.\" This sentence directly identifies p53 as the \"guardian of the genome,\" fulfilling the requirement of the question.", "retries": 1}
{"idx": 461, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'cathepsin B (CTSB)', is incorrect and does not match the gold standard 'LEKTI'. The supporting sentence is overly verbose and does not logically support the incorrect answer. Instead of identifying LEKTI as the defective protein in Netherton syndrome, it discusses diagnostic tools without directly linking them to the correct protein. Therefore, both the answer and supporting sentence are irrelevant to the gold standard.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome and its multifaceted defective protein LEKTI.", "model_answer": "The protein causing Netherton syndrome is cathepsin B (CTSB).", "model_support": "The supporting sentence is: \"Following the identification of the NS causative gene and protein, specific diagnostic tools have been developed, thus breaking up the challenge of distinguishing NS from other congenital ichthyoses with overlapping features, and from severe, early-onset forms of atopic dermatitis or psoriasis.\" This sentence indicates that the causative protein was identified, which is cathepsin B (CTSB), enabling the development of diagnostic tools.", "retries": 1}
{"idx": 462, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question and context. The mention of 'JTV519' and '1,4-benzothiazepine' has no connection to Rindopepimut or EGFRvIII. Furthermore, the supporting sentence does not address the gold answer (EGFRvIII) or provide any relevant information regarding Rindopepimut being an analog of a growth factor. Both the answer and supporting sentence fail to logically support the correct response.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "In the provided context, there is no mention of Rindopepimut being an analog of any growth factor. The context strictly discusses Rindopepimut as a peptide vaccine against EGFRvIII, without any reference to growth factors or JTV519.\n\nAnswer: There is no supporting sentence in the context provided for Rindopepimut being an analog of a growth factor.", "retries": 1}
{"idx": 463, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'factor Xa' matches the gold standard 'xa'. However, the supporting sentence is somewhat misleading as it refers to indirect factor Xa inhibitors (e.g., fondaparinux), while betrixaban is a direct factor Xa inhibitor. The logic connecting betrixaban to the correct category of direct factor Xa inhibitors could be clearer and more precise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux.\" This indicates that betrixaban, as a member of the factor Xa inhibitor class, falls into this category. \n\nAnswer: factor Xa", "retries": 1}
{"idx": 464, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides logical support, but it is slightly verbose and does not directly mention betrixaban as one of the inhibitors. It explains why factor Xa is targeted but does not explicitly link it to the specific drug in question, unlike the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\" This sentence clearly states that factor Xa is the target of the inhibitors, including betrixaban.", "retries": 1}
{"idx": 465, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The model provides information about JTV519 and 1,4-benzothiazepine, which has no connection to rindopepimut or EGFRvIII. The gold answer (EGFRvIII) is not mentioned, and the supporting sentence does not address the correct context.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 466, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Thrombin') does not match the gold standard ('xa'), but it is present in the context as a valid clotting factor targeted by some anticoagulants. The supporting sentence mentions direct thrombin inhibitors but does not logically connect betrixaban to thrombin or explicitly support the gold answer (Factor Xa). Instead, it introduces ambiguity by implying betrixaban could be a thrombin inhibitor, which is incorrect.\", \"match\": false}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Thrombin", "model_support": "The supporting sentence that identifies betrixaban as a direct thrombin inhibitor is:\n\n\"Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.\"\n\nThis sentence categorizes betrixaban under direct thrombin inhibitors, indicating that it inhibits thrombin, a key clotting factor.", "retries": 1}
{"idx": 467, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by specifying that the study provides evidence for the use of pridopidine in Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "One-year safety and tolerability profile of pridopidine in patients with Huntington disease.", "model_answer": "Pridopidine has been tested for treatment of Huntington disease.", "model_support": "The supporting sentence is:\n\n\"This study provides Class IV evidence that pridopidine ( < 90 mg/day) is generally safe and well-tolerated in patients with Huntington disease for up to 1 year.\"", "retries": 1}
{"idx": 468, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence includes information about Tsix repressing Xist, which, while correct, is not directly necessary to support the answer. The gold supporting sentence is more concise and directly ties Xist to X-chromosome inactivation without introducing additional elements like Tsix. The model's supporting sentence is relevant but contains slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "During XCI, one X is randomly silenced by Xist.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The sentence that supports the answer is: \"X chromosome choice is determined by asymmetric expression of Tsix whose antisense action represses Xist.\" This directly links Tsix to repressing Xist, the transcript responsible for X-chromosome inactivation. \n\nAnswer: Xist.", "retries": 1}
{"idx": 469, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model is irrelevant as it discusses Rubinstein-Taybi syndrome without mentioning Mowat-Wilson syndrome or the gene ZEB2. The logic does not support the gold answer, making both the answer and supporting sentence incorrect.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "A similar issue of differential diagnosis was raised by a large 4.3 Mb 2q22.3q23.1 deletion encompassing ZEB2, the gene responsible for the Mowat-Wilson syndrome, whose signs may overlap with RSTS.", "model_answer": "The gene responsible for the development of the Mowat-Wilson syndrome is ZFHX1B, also known as NEK1.", "model_support": "None of the sentences in the provided context discuss the Mowat-Wilson syndrome or the gene ZFHX1B (also known as NEK1). The context focuses on Rubinstein-Taybi syndrome (RSTS) and related chromosomal rearrangements, including deletions and duplications involving genes like TWIST1, CREBBP, EP300, and NF1-REP sub-duplicons. There is no mention of Mowat-Wilson syndrome or ZFHX1B in this text.", "retries": 1}
{"idx": 470, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard (NF1), but the supporting sentence is completely irrelevant to the question and does not support the answer. The provided sentence discusses JTV519, which has no connection to neurofibromatosis or the NF1 gene. While the answer itself is correct, the supporting sentence fails to provide any logical or relevant backing for it.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene.", "model_answer": "The gene mutated in type 1 neurofibromatosis is **NF1**.", "model_support": "The sentence that directly supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"\n\nThis sentence identifies JTV519 as a derivative of 1,4-benzothiazepine, confirming the answer.", "retries": 1}
{"idx": 471, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence clearly identifies JTV519 as a derivative of 1,4-benzothiazepine, aligning perfectly with the gold standard.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This directly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 472, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it includes 'Factor' which is technically correct but slightly more verbose than necessary. The supporting sentence provides relevant context by mentioning 'direct Xa inhibitors,' which correctly implies betrixaban's mechanism, but it does not directly quote the most concise and specific information from the context about betrixaban being a direct Xa inhibitor. It is logical but less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Direct factor Xa inhibitors include rivaroxiban, which has shown promising results for VTE prophylaxis and is being studied for VTE treatment, as well as apixaban and betrixaban, which are at earlier stages of clinical validation.", "model_answer": "Betrixaban inhibits Factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.\" This sentence lists the types of newer agents, including direct Xa inhibitors, which implies that betrixaban, as a newer agent, falls into this category, thereby inhibiting Factor Xa.", "retries": 1}
{"idx": 473, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence provides relevant information about TSH abnormalities, but it does not directly cover the gold answer, which focuses on thyroid-related issues more broadly. The logic is reasonable but too narrowly focused on TSH rather than the overall thyroid dysfunction.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "In Williams syndrome, a common hormone abnormality involves TSH, where its bioactivity is slightly below normal and its response to TRH is exaggerated, suggesting subclinical hypothyroidism-like features.", "model_support": "The supporting sentence is: \"The TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].\" This sentence details the TSH abnormalities in Williams syndrome, including exaggerated TRH response and reduced bioactivity, which align with the answer provided.", "retries": 1}
{"idx": 474, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states there are 2 TAp73 isoforms, whereas the gold answer indicates there are 7. The supporting sentence does not logically support the gold answer and instead reinforces the incorrect count by focusing only on TA and ΔN without mentioning the existence of multiple TAp73 isoforms. The reasoning is flawed and does not align with the correct information.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context specifies that p73 is expressed as TA (TAp73) and ΔN isoforms. Therefore, there are two TAp73 isoforms identified in humans.\n\nAnswer: 2", "model_support": "The context specifies that p73 is expressed as TA (TAp73) and ΔN isoforms. Therefore, there are two TAp73 isoforms identified in humans.\n\nAnswer: 2", "retries": 1}
{"idx": 475, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('BCR-Abl' is equivalent to 'BCR-ABL'). The supporting sentence is concise, directly relevant, and clearly explains that Imatinib targets BCR-Abl in Philadelphia chromosome positive chronic myelogenous leukemia. Although it repeats the answer itself, this does not detract from the strong logical support.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "In chronic myeloid leukemia (CML), BCR-ABL-mediated oncogenic signaling can be successfully targeted with the BCRABL- inhibitors imatinib, nilotinib, and dasatinib leading to complete cytogenetic (Philadelphia chromosome not detectable upon cytogenetic testing of bone marrow) and even complete molecular (BCR-ABL not detectable by PCR in peripheral blood) responses.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia chromosome positive chronic myelogenous leukemia is BCR-Abl. \n\nAnswer: BCR-Abl", "model_support": "The supporting sentence is: \"The tyrosine kinase targeted by Imatinib in Philadelphia chromosome positive chronic myelogenous leukemia is BCR-Abl.\" This clearly identifies Imatinib's target as BCR-Abl. \n\nAnswer: The supporting sentence is: \"The tyrosine kinase targeted by Imatinib in Philadelphia chromosome positive chronic myelogenous leukemia is BCR-Abl.\"", "retries": 1}
{"idx": 476, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('I-1' is equivalent to 'Inhibitor 1'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying the phosphorylation condition that activates I-1 as a PP1 inhibitor.\", \"match\": true}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.", "model_answer": "The main inhibitor of protein phosphatase 1 (PP1) in this context is **I-1**. When phosphorylated at Thr35, I-1 inhibits PP1's enzymatic activity.", "model_support": "The supporting sentence is: \"Non-phosphorylated I-1 is inactive, whereas I-1 phosphorylated by protein kinase A (PKA) at Thr35 is a potent PP1 inhibitor.\"\n\nThis sentence directly identifies I-1 as the main inhibitor of PP1 when it is phosphorylated by PKA at Thr35.", "retries": 1}
{"idx": 477, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('JNK'). The supporting sentence is relevant and directly mentions JNK phosphorylation as responsible for c-Jun phosphorylation, which aligns with the gold supporting sentence. However, the model's supporting sentence is slightly more verbose than necessary and includes additional details (e.g., about DHA’s effects on Nrf2 and HO-1), which are not essential to support the specific answer regarding JNK.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "In parallel with these immunosuppressive phenomena, DHA attenuated post-stroke oxidative stress, c-Jun N-terminal kinase (JNK) phosphorylation, c-Jun phosphorylation and activating protein-1 (AP-1) activation but further elevated ischemia-induced NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression.", "model_answer": "The MAP kinase that phosphorylates c-jun is JNK (Jun N-terminal kinase).", "model_support": "The supporting sentence is:  \n\"DHA treatment also had an immunosuppressive effect in lipopolysaccharide/interferon-γ-stimulated glial cultures by attenuating JNK phosphorylation, c-Jun phosphorylation and AP-1 activation and augmenting Nrf2 and HO-1 expression.\"  \n\nThis sentence directly mentions that JNK phosphorylation is reduced by DHA treatment, confirming that JNK is the MAP kinase responsible for phosphorylating c-jun.", "retries": 1}
{"idx": 478, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks about the ion antiporter/exchanger that SEA0400 inhibits, and the correct answer is 'NCX' as per the gold standard. However, the model's answer refers to '1,4-benzothiazepine,' which is unrelated to the context of the question. Additionally, the supporting sentence discusses JTV519, which is not relevant to SEA0400 or NCX. Both the answer and supporting sentence fail to address the gold answer or provide logical support.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 479, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by indicating that alpha-synuclein is a component of Lewy bodies. However, it introduces slight redundancy by mentioning synphilin-1's interaction with alpha-synuclein, which is not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\" This directly states that alpha-synuclein is a component of Lewy bodies, as synphilin-1 interacts with it and is found within these structures.", "retries": 1}
{"idx": 480, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "The database is called **mpMoRFsDB**.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This directly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 481, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer is correct and matches the gold standard ('PLN' is the accepted abbreviation for Phospholamban). However, the supporting sentence provided by the model is irrelevant to the question and does not logically support the answer. The gold supporting sentence directly explains the regulatory role of PLN in SERCA2a function, whereas the model's supporting sentence discusses JTV519 and RyR2s, which are unrelated to the regulation of SERCA2a by PLN.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is Phospholamban.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 482, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant but contains additional context about dementia with Lewy bodies that is not directly necessary to support the answer. It could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"Dementia with Lewy bodies (DLB)... is characterized by the widespread distribution of Lewy bodies in virtually every brain area.\"", "retries": 1}
{"idx": 483, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer 'factor Xa' matches the gold standard 'xa'. However, the supporting sentence does not directly cover the gold answer. The chosen supporting sentence discusses the pharmacological profile of the drugs and their lack of need for monitoring but does not explicitly state that betrixaban is a direct inhibitor of factor Xa. This makes the support weaker and less relevant to the specific question.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"These drugs have a pharmacological profile that does not require monitoring in order to adjust therapy, which is the mainstay of warfarin management.\"\n\nThis sentence indicates that the new oral anticoagulants, including betrixaban, have a mechanism that doesn't rely on monitoring, suggesting they target specific clotting factors without the need for regular checks, thus implying they inhibit factors like factor Xa.", "retries": 1}
{"idx": 484, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "The database for molecular recognition features (MoRFs) in membrane proteins is **mpMoRFsDB**.", "model_support": "The supporting sentence is: \"mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins.\" This sentence explicitly mentions the database's name, mpMoRFsDB, which is the answer to the question.", "retries": 1}
{"idx": 485, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer of '3 nm' does not match the gold standard of '10 nm', but it is mentioned in the context as a relevant detail about protofilaments. The supporting sentence refers to the 3 nm protofilaments, which is accurate for that specific part but does not support the gold answer (10 nm). The supporting sentence is relevant but fails to cover the correct diameter of fully assembled intermediate filaments.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Scanning tunneling microscope (STM) and transmission electron microscope (TEM) micrographs showed that acidic keratins and basic keratins can assemble into dimers and further into 10 nm filamentsin vitro.", "model_answer": "The average diameter of intermediate filaments is **3 nm**.", "model_support": "The supporting sentence is: \"fully assembled plant keratin intermediate filaments consist of several thinner filaments of 3 nm in diameter.\"", "retries": 1}
{"idx": 486, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and covering the role of zfhx1b in biliary development, does not explicitly mention that zfhx1b is the causative gene for Mowat-Wilson syndrome as a whole, which is the key point of the gold supporting sentence. The logic is sound, but the supporting sentence could be more precise.\",\n  \"match\": true\n}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "The gene responsible for the development of the Mowat-Wilson syndrome-related biliary issues is **zfhx1b**.", "model_support": "The supporting sentence is: \"Using the zebrafish model system to determine whether zfhx1b has a role in vertebrate biliary development.\" This sentence directly connects zfhx1b to its role in biliary development, confirming its responsibility in the context of Mowat-Wilson syndrome-related issues.", "retries": 1}
{"idx": 487, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('chromatin structure or histone modifications') does not match the gold standard ('development'), but it is present in the context. The supporting sentence is relevant to the model's answer, discussing the epigenetic landscape and pluripotency, but it does not align with the gold answer regarding development. Thus, while there is some relevance, the core focus is missed.\",\n  \"match\": false\n}", "gold_answer": "development", "gold_support": "The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs).", "model_answer": "The process that Conserved noncoding elements (CNEs) mostly regulate is **chromatin structure or histone modifications**. These elements influence the epigenetic landscape, maintaining bivalent domains in embryonic stem cells that keep genes poised for activation while silencing them.", "model_support": "The supporting sentence is:  \n\"These results highlight the importance of DNA sequence in defining the initial epigenetic landscape and suggest a novel chromatin-based mechanism for maintaining pluripotency.\"", "retries": 1}
{"idx": 488, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX') in meaning, though it is slightly more descriptive by specifying 'Na⁺/Ca²⁺ exchanger (NCX)'. The supporting sentence is relevant and supports the answer logically, but it is less direct than the gold supporting sentence. It refers to the prevention of SNP effects by SEA0400, which indirectly points to NCX inhibition, whereas the gold sentence explicitly mentions the Na⁺/Ca²⁺ exchange inhibitor.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger (NCX).", "model_support": "The supporting sentence is: \"These effects of SNP were prevented by SEA0400.\" This indicates that SEA0400 inhibits the mechanism by which SNP causes cytotoxicity, which is mediated through the Na⁺/Ca²⁺ exchanger (NCX).", "retries": 1}
{"idx": 489, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the supporting sentence provided by the model is not identical to the gold supporting sentence, it still accurately reflects the context and provides sufficient support for the answer.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "BACKGROUND: A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 490, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('5-HT2A') in meaning, though it is slightly more verbose by including 'receptors' in the phrasing. The supporting sentence provided by the model is relevant and captures the purpose of the study, but it is less precise than the gold supporting sentence, which explicitly mentions both the radiotracer [18F]altanserin and its suitability for quantifying 5-HT2ARs. The model's supporting sentence is slightly less detailed and could be considered somewhat redundant when mentioning 'evaluate' and 'determine,' which convey similar ideas.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.", "model_support": "The supporting sentence is: \"PURPOSE: To determine 5-HT2A receptor availability in the rat brain.\" This sentence clearly states the goal of the study, which is to evaluate the 5-HT2A receptors using [18F]altanserin.", "retries": 1}
{"idx": 491, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The question asks for the most prevalent form of arrhythmia worldwide, which is clearly stated as 'AF' in the gold answer. However, the model's answer discusses a drug derivative unrelated to the prevalence of arrhythmia. The supporting sentence also does not address the question or gold answer.\", \"match\": false}", "gold_answer": "AF", "gold_support": "Atrial fibrillation (AF) is associated with increased morbidity and is in addition the most prevalent cardiac arrhythmia.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 492, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it includes additional information about Cockayne syndrome gene products, which is not directly necessary to answer the question. This makes the sentence slightly more verbose than needed, hence a score of 4 instead of 5.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of DNA. This strand is the newly synthesized one rich in RNA, which is transcribed from the template strand. TCR specifically addresses DNA damage in this region to maintain transcription continuity and prevent blockages. \n\nAnswer: transcribed strand", "model_support": "The supporting sentence is: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"\n\nThis sentence explicitly states that transcription-coupled repair (TCR) targets the transcribed strand of DNA, which aligns with the answer provided.", "retries": 1}
{"idx": 493, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as Friedreich's ataxia is unrelated to DUX4 expression. The supporting sentence discusses FSHD but does not correct the answer or provide relevant reasoning for Friedreich's ataxia. Both the answer and supporting sentence fail to align with the gold standard.\", \"match\": false}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **Friedreich's ataxia.**", "model_support": "The supporting sentence for the association of DUX4 expression with FSHD is: \"We also propose that DUX4 expression during development is important for the pathogenesis of FSHD.\" This statement highlights the role of DUX4 in FSHD, aligning with the study's findings.", "retries": 1}
{"idx": 494, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The molecule targeted by Gevokizumab is IL-1β, not IL-1 receptor type I (IL-1RI). However, the supporting sentence is relevant as it discusses Gevokizumab's impact on IL-1β binding to IL-1RI, though it does not directly support the incorrect answer. The model confuses the target molecule with the receptor it affects.\", \"match\": false}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by Gevokizumab is **IL-1 receptor type I (IL-1RI)**.", "model_support": "The sentence that supports the answer is:\n\n\"Gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions.\"\n\nThis sentence directly states that Gevokizumab targets IL-1 receptor type I (IL-1RI).", "retries": 1}
{"idx": 495, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('template strand') does not match the gold standard ('transcribed strand'), but it is present in the context as a related concept. The supporting sentence is relevant to the mechanism of TCR and explains the stalling of RNA polymerase II, which is correct. However, it does not directly support the gold answer ('transcribed strand') and instead focuses on the template strand, leading to a mismatch.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "Among these is a process called transcription-coupled repair (TCR) that catalyzes the removal of DNA lesions from the transcribed strand of expressed genes, often resulting in a preferential bias of damage clearance from this strand relative to its non-transcribed counterpart.", "model_answer": "The transcription-coupled repair (TCR) targets the template strand of DNA. This is because TCR is triggered when RNA polymerase II stalls due to DNA damage encountered during transcription elongation on the template strand.\n\nAnswer: The template strand.", "model_support": "The supporting sentence is: \"The signal for TCR is the stalled RNA polymerase II that results when DNA damage prevents its translocation during transcription elongation.\"\n\nThis sentence explains that TCR is initiated when RNA polymerase II stalls on the template strand due to DNA damage, making TCR specifically target the template strand.", "retries": 1}
{"idx": 496, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than the gold standard, including additional details ('a key clotting factor in the intrinsic pathway of blood clotting') that are not required. The supporting sentence is relevant but does not directly confirm the model's answer as it discusses a 'factor Xa decoy' rather than explicitly stating that betrixaban inhibits factor Xa. It mixes useful information with less relevant content, making it less concise and slightly off-target.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa, a key clotting factor in the intrinsic pathway of blood clotting.", "model_support": "The supporting sentence is:\n\n\"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence confirms that betrixaban inhibits factor Xa, a key clotting factor in the intrinsic pathway of blood clotting.", "retries": 1}
{"idx": 497, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('thrombin') does not match the gold standard ('xa'), but the context includes information about factor Xa inhibition by betrixaban. The supporting sentence is relevant to the model's answer but does not cover the gold answer, as it incorrectly identifies the target of betrixaban.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Betrixaban inhibits **thrombin**.", "model_support": "Betrixaban inhibits **thrombin**. \n\nSupporting sentence: Betrixaban inhibits **thrombin**.", "retries": 1}
{"idx": 498, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard, identifying 'dermatitis herpetiformis' as the typical rash associated with gluten. However, the supporting sentence, while relevant and logical, contains slight redundancy by reiterating the model's own answer instead of being more concise. The gold supporting sentence provides a clearer and more direct explanation without unnecessary repetition.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "The typical rash associated with gluten is the skin lesion seen in dermatitis herpetiformis. These lesions are grouped and often present as itchy or painful blisters, commonly associated with gluten sensitivity or celiac disease.", "model_support": "The supporting sentence is: \"The typical rash associated with gluten is the skin lesion seen in dermatitis herpetiformis. These lesions are grouped and often present as itchy or painful blisters, commonly associated with gluten sensitivity or celiac disease.\"", "retries": 1}
{"idx": 499, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (FSHD), but it is slightly more verbose by including 'FacioScapulohumeral Dystrophy' instead of just 'FSHD.' The supporting sentence provides relevant context about FSHD but does not directly mention the ectopic expression of DUX4 or its association with the disease. Instead, it focuses on muscle weakness in FSHD, which is somewhat indirect but still related. Overall, the logic is sound, though the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **FacioScapulohumeral Dystrophy (FSHD)**.", "model_support": "The supporting sentence is:  \n\"These studies offer insight into the autonomous distribution of muscle weakness that is characteristic of FSHD.\"", "retries": 1}
{"idx": 500, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and does not match the gold standard. The question asks for the main regulatory molecule of SERCA2A function in cardiac muscle, which is 'phospholamban' according to the gold answer. Instead, the model provides '1,4-benzothiazepine,' which is unrelated to the question. Additionally, the supporting sentence discusses JTV519, a drug derivative, which is irrelevant to the role of phospholamban as the regulator of SERCA2A. Both the answer and supporting sentence are incorrect and do not logically support the gold answer.\", \"match\": false}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban has been suggested to be a key regulator of cardiac sarcoplasmic reticulum (SR) Ca cycling and contractility and a potential therapeutic target in restoring the depressed Ca cycling in failing hearts.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The sentence that supports the answer is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This clearly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 501, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The supporting sentence explicitly identifies TBC1D7 as part of the TSC1-TSC2 complex and explains its functional role, which aligns perfectly with the gold standard.\", \"match\": true}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "The third subunit of the TSC1-TSC2 complex upstream of mTORC1 is TBC1D7.\n\nAnswer: TBC1D7", "model_support": "The supporting sentence is: \"We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.\"\n\nThis sentence explicitly identifies TBC1D7 as the third subunit of the TSC1-TSC2 complex, functioning together with TSC1 and TSC2 to form the TSC-TBC complex.", "retries": 1}
{"idx": 502, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and mentioning alpha-synuclein, focuses more on the uncertainty regarding APP isoforms rather than directly and concisely stating that alpha-synuclein is the main component of Lewy bodies. This introduces slight redundancy and shifts focus from the key point.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence that relates to the main component of Lewy bodies is:  \n\"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"  \n\nThis sentence directly mentions alpha-synuclein, the main component of Lewy bodies.", "retries": 1}
{"idx": 503, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for medulloblastoma, but it is slightly less precise than the gold supporting sentence. While it correctly identifies the tumor type being studied, it does not explicitly state that medulloblastoma is the most common pediatric cerebellar tumor, which is a key part of the reasoning in the gold supporting sentence.\", \"match\": true}", "gold_answer": "medulloblastoma", "gold_support": "Mouse models have increased our understanding of the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor that often forms in the cerebellum.", "model_answer": "The most common type of pediatric cerebellar tumor is the medulloblastoma.", "model_support": "The supporting sentence is: **\"In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model.\"** This sentence explicitly identifies the type of tumor being studied as medulloblastoma, which is the most common type of pediatric cerebellar tumor.", "retries": 1}
{"idx": 504, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('Xa'), although it is slightly more verbose by including 'a key enzyme in the blood clotting process.' The supporting sentence, however, is lengthy and contains information not directly relevant to confirming that betrixaban inhibits factor Xa. While it does eventually mention 'anti-Xa activity,' which supports the answer, the sentence could be significantly more concise. Overall, the logic is reasonable but diluted by unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa, a key enzyme in the blood clotting process.", "model_support": "The supporting sentence is: \"Betrixaban is currently being evaluated for prophylaxis against venous thromboembolic disease (VTED) and the prevention of stroke and systemic embolism associated with nonvalvular atrial fibrillation, its role in the management of acute VTED and acute coronary syndromes is yet to be defined based on clinical data and evaluation. Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence confirms that betrixaban inhibits factor Xa, a key enzyme in blood clotting.", "retries": 1}
{"idx": 505, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke' and captures the essential meaning. The supporting sentence is relevant and covers the answer, but it includes slight redundancy by specifying 'differentiation of acute stroke from stroke mimics,' which is more detailed than necessary. Overall, the logic is strong, but a more concise version would improve the score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used to recognize and differentiate acute stroke from other disorders in the emergency room setting, aiding in timely identification of stroke patients. \n\nAnswer: Acute stroke", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room setting.\" This sentence clearly states that the ROSIER scale is used to recognize and differentiate acute stroke from other disorders, such as seizures and syncope, in the emergency room.", "retries": 1}
{"idx": 506, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct and matches the gold standard. However, the supporting sentence provided by the model is completely irrelevant to the question and does not support the use of flumazenil as an antidote for benzodiazepine overdose. The sentence discusses JTV519, which is unrelated to the context of flumazenil or benzodiazepine overdose treatment.\",\n  \"match\": true\n}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is the first benzodiazepine antagonist which can be used in humans and is a well established for treatment of benzodiazepine overdose.", "model_answer": "Flumazenil is the antidote for benzodiazepine overdose as it acts as a benzodiazepine receptor antagonist, counteracting the effects of the overdosed drugs.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 507, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct in describing the use of the ROSIER scale but is more verbose than the gold standard 'Stroke.' The supporting sentence from the model is somewhat relevant and explains the purpose of the ROSIER scale, but it focuses on its ineffectiveness in certain cases rather than directly supporting the exact use for stroke recognition. It mixes relevant information with additional context about lower specificity, making it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used to recognize stroke in emergency rooms, helping healthcare providers differentiate between acute cerebrovascular disease and other conditions presenting similarly.", "model_support": "The supporting sentence is: \"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\"\n\nThis sentence explicitly states that the ROSIER scale's purpose is to differentiate between acute stroke and stroke mimics, aligning with the given answer.", "retries": 1}
{"idx": 508, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it lists clotting factors II, VII, IX, and X, which are associated with vitamin K antagonists, not betrixaban. Betrixaban specifically inhibits factor Xa, as per the gold answer. The supporting sentence provided by the model is irrelevant and does not logically support the correct answer. It discusses ATI-5923, a different drug, and its properties rather than focusing on betrixaban or its action on factor Xa. The verbosity and lack of relevance result in a very poor score.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Most are small synthetic molecules that target factor IIa (e.g., dabigatran etexilate, AZD-0837) or factor Xa (e.g., rivaroxaban, apixaban, betrixaban, DU176b, idrabiotaparinux).", "model_answer": "Betrixaban inhibits the following clotting factors: II, VII, IX, and X.", "model_support": "The supporting sentence is: \"A new vitamin K antagonist (ATI-5923) with improved pharmacological properties compared with warfarin is also being evaluated in a phase III trial.\" This sentence identifies betrixaban as a vitamin K antagonist, which typically inhibits clotting factors II, VII, IX, and X.", "retries": 1}
{"idx": 509, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer 'GBA' is correct as it refers to the gene encoding glucocerebrosidase, which matches the context. However, it does not exactly match the gold answer 'glucocerebrosidase.' The supporting sentence provided by the model is completely irrelevant to Gaucher disease or the mutated gene and does not logically support the answer.\",\n  \"match\": false\n}", "gold_answer": "glucocerebrosidase", "gold_support": "A 26-year-old Bedouin with moderate thrombocytopenia and enlarged spleen and liver was diagnosed as having type I Gaucher disease based on the presence of Gaucher cells in the bone marrow biopsy and enzymatic determination of glucocerebrosidase activity.", "model_answer": "The gene mutated in the Gaucher disease described in the context is GBA.\n\nAnswer: GBA", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 510, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The question asks about the vertebral region associated with Bertolotti's syndrome, but the model's answer refers to a drug derivative unrelated to the context. The supporting sentence also discusses a drug rather than addressing the lumbosacral region or Bertolotti's syndrome.\", \"match\": false}", "gold_answer": "Lumbosacral", "gold_support": "Lumbosacral transitional vertebra causing Bertolotti's syndrome: a case report and review of the literature.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This directly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 511, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence is relevant and provides information about antiparallel dimers, but it is more detailed and indirect compared to the gold supporting sentence, introducing additional context about sequence analysis and evolutionary divergence. While logical, it contains slight redundancy and could be more concise.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Spectrins comprise α- and β-subunits made up predominantly of a series of homologous repeating units of about 106 amino acids; the α- and β-chains form antiparallel dimers by lateral association, and tetramers through head-to-head contacts between the dimers.", "model_answer": "Alpha-spectrin and beta-spectrin form antiparallel heterodimers.", "model_support": "The supporting sentence is:  \n\"an analysis of the sequences of the strongly interacting repeats, βIR1, βIIR1, αIR21 and αIIR20 and repeats in α-actinin, which also interact very strongly in forming an antiparallel dimer, affords a possible explanation for the different properties of the two spectrin isoforms in respect of the stability of the inter-chain interactions, and also suggests the evolutionary path by which the erythroid and non-erythroid sequences diverged.\"", "retries": 1}
{"idx": 512, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, stating 'Two TAp73 isoforms' when the gold answer specifies '7'. The supporting sentence does not logically support even the model's incorrect answer, as it merely mentions two types of p73 isoforms (TAp73 and DeltaNp73) in a general context without specifying the total number. Furthermore, the information provided in the supporting sentence is irrelevant to the gold answer, which requires identifying seven distinct isoforms.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Two TAp73 isoforms have been identified in humans.", "model_support": "The supporting sentence is:\n\n\"Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.\"\n\nThis sentence directly states that there are two isoforms of TAp73 in humans: TAp73 and DeltaNp73.", "retries": 1}
{"idx": 513, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Factor IIa', does not match the gold standard answer, 'xa'. However, the supporting sentence is relevant as it correctly identifies betrixaban as an anticoagulant and provides some context about its classification among novel anticoagulants. The key issue is that the model incorrectly specifies the target of betrixaban as Factor IIa instead of Factor Xa, which is inconsistent with both the gold answer and the provided context.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits Factor IIa. \n\nAnswer: Factor IIa", "model_support": "The context provided does not mention betrixaban, so there is no supporting sentence within it. However, based on external knowledge, betrixaban is an oral factor IIa inhibitor used in anticoagulation therapy.", "retries": 1}
{"idx": 514, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, identifying 'calsequestrin' as the main calcium-binding protein. The supporting sentence is relevant and provides correct information about calsequestrin; however, it includes specific experimental details (e.g., NH2-terminal sequence, purification methods) that are not necessary to support the answer. This makes it slightly more verbose than the gold supporting sentence, which directly states the role of calsequestrin in calcium sequestration.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum (SR) of muscle cells during relaxation.", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The supporting sentence is: \"Finally, the NH2-terminal amino acid sequence of this 60,000-Da immunoreactive protein purified by fast protein liquid chromatography was identical to that of rabbit skeletal and canine cardiac calsequestrin.\" This confirms that the protein in question is calsequestrin, the main calcium-binding protein of the sarcoplasmic reticulum.", "retries": 1}
{"idx": 515, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard ('RANKL'). The supporting sentence is relevant and explains that Denosumab binds to RANKL, which interacts with the RANK receptor. However, it introduces slight redundancy by specifying 'a ligand that interacts with the RANK receptor,' which, while accurate, is unnecessary verbosity given the context. Overall, the logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Denosumab (AMG 162), a fully human monoclonal antibody to RANKL, shares the pharmacologic attributes of OPG but has a significantly longer half-life that allows less frequent administration.", "model_answer": "Denosumab binds to RANKL, a ligand that interacts with the RANK receptor.", "model_support": "The supporting sentence is: \"Denosumab binds to RANKL, a ligand that interacts with the RANK receptor.\" This sentence directly explains that Denosumab (Prolia) binds to RANKL, which is a ligand that interacts with the RANK receptor, providing the necessary information for the answer.", "retries": 1}
{"idx": 516, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard, as 'AIP gene' is a valid shorthand for 'aryl hydrocarbon receptor interacting protein.' However, the supporting sentence, while relevant, is less precise compared to the gold supporting sentence. It mentions the unclear mechanism of AIP's role rather than directly referencing its discovery or specific mutation prevalence in FIPA families. The logic is sound but slightly less informative.\",\n  \"match\": true\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.", "model_answer": "The mutation implicated in familial isolated pituitary adenoma is associated with the **AIP gene**.", "model_support": "The supporting sentence is: \"The exact mechanism by which the lack of AIP leads to pituitary adenomas is not clear.\" This sentence directly refers to the AIP gene, indicating its implication in the condition.", "retries": 1}
{"idx": 517, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes specific details about mutations (T790M, L858R, and exon 19 deletions) that are not required by the question. The supporting sentence refers to the method's sensitivity for detecting EGFR mutations but does not directly state the association between EGFR mutations and drug response, making it somewhat indirect. While the logic is reasonable, the supporting sentence could be more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the responses to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with non-small-cell lung cancer (NSCLC).", "model_answer": "The mutations in the epidermal growth factor receptor (EGFR) gene, specifically the T790M mutation in exon 20 and the L858R mutation in exon 21, as well as deletions in exon 19, determine the response to both erlotinib and gefitinib.", "model_support": "The supporting sentence is:\n\n\"The present method is sensitive and specific for the detection of deletions and mutations in the EGFR gene and is thus suitable for use in laboratory tests.\"", "retries": 1}
{"idx": 518, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly identifies Bach1 as a transcriptional repressor with logical reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The sentence that supports the answer is: \"Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.\" This explicitly identifies Bach1 as a transcriptional repressor.", "retries": 1}
{"idx": 519, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the information is not provided, while the gold answer (10 nm) is clearly mentioned in the context. The supporting sentence is irrelevant to the question and does not logically support any part of the gold answer. Both the answer and supporting sentence fail to address the correct information.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.", "model_answer": "The context does not provide specific numerical values for the average diameter of intermediate filaments. It only states that as temperature increases, both the average diameter and length of the filaments increase. Therefore, the information required to answer the question is not available in the provided text.\n\nAnswer: The information about the average diameter of intermediate filaments is not provided in the context.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 520, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('AF' is an acceptable abbreviation for 'Atrial fibrillation'). However, the supporting sentence provided by the model incorrectly states that there is no supporting sentence in the context, while the context does include a relevant sentence indicating AF's prevalence. The gold supporting sentence directly provides this information. Despite this, the model’s answer itself is correct.\", \"match\": true}", "gold_answer": "af", "gold_support": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population.", "model_answer": "Atrial fibrillation (AF) is the most prevalent form of arrhythmia worldwide.", "model_support": "The context provided does not contain a sentence that explicitly states that Atrial Fibrillation (AF) is the most prevalent form of arrhythmia worldwide. The context focuses on AF in athletes, discussing its increased incidence and risk factors, but does not mention AF's global prevalence. Therefore, there is no supporting sentence within the provided context for this answer.\n\nAnswer: There is no supporting sentence in the provided context for this answer.", "retries": 1}
{"idx": 521, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by identifying JTV519 as a derivative of 1,4-benzothiazepine. Minor extra details in the supporting sentence do not detract from its relevance or accuracy.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This directly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 522, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that there is no supporting sentence in the provided context, this is accurate because the context indeed lacks a direct mention of tofacitinib's approval for rheumatoid arthritis. The gold supporting sentence, while correct, is not part of the given context, so the model's observation about the missing support is valid.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "After two decades of research and development activity focussed on orally active kinase inhibitors, the first such drug (the JAK inhibitor Xeljanz, tofacitinib) was approved by the FDA in November 2012 for the treatment of rheumatoid arthritis (RA).", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is **tofacitinib**. \n\nAnswer: tofacitinib", "model_support": "The context provided does not include a specific sentence that directly mentions tofacitinib or its approval for treating rheumatoid arthritis. The context discusses the development of JAK inhibitors, including fostamatinib, but does not explicitly reference tofacitinib or its regulatory approval status. Therefore, there is no supporting sentence within the given context for the approval of tofacitinib.", "retries": 1}
{"idx": 523, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"", "retries": 1}
{"idx": 524, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer incorrectly states that betrixaban inhibits factor IIa, whereas the gold answer clearly identifies it as a factor Xa inhibitor. The supporting sentence provided by the model is irrelevant, discussing clinical trials without addressing the mechanism of action or correcting the error in the answer. This leads to an incorrect and unsupported response.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Betrixaban inhibits factor IIa.", "model_support": "Betrixaban inhibits factor IIa.\n\nSupporting sentence: Betrixaban was tested in Phase II studies in orthopedic thromboprophylaxis (EXPERT) and atrial fibrillation (EXPLORE-Xa), and is being evaluated in a Phase III trial of extended thromboprophylaxis in medical patients (APEX). This article details the pharmacology, preclinical and clinical development of betrixaban.\n\n**Answer:** Betrixaban inhibits factor IIa.", "retries": 1}
{"idx": 525, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but fails to cover the gold answer, as it incorrectly concludes there is only one TAp73 isoform without evidence for the existence of multiple isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "1. **Context Analysis**: The context discusses the p73 tumor suppressor, which exists in two main isoforms: TAp73 (TA isoform) and ΔNp73 (ΔN isoform). TAp73 is described as similar to p53 in function, acting as a tumor suppressor.\n\n2. **Question Focus**: The question asks specifically about the number of TAp73 isoforms identified in humans.\n\n3. **Answer Extraction**: From the context, only one TAp73 isoform is mentioned as being the TA isoform of p73. The context does not indicate the existence of additional TAp73 isoforms.\n\n**Answer**: 1", "model_support": "The context specifies that TAp73 is the TA isoform of the p73 gene. It does not mention any other isoforms of TAp73. Therefore, there is only one TAp73 isoform identified in humans.\n\nAnswer: 1", "retries": 1}
{"idx": 526, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence in the context is:  \n\"The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.\"  \n\nThis sentence directly identifies p53 as \"the guardian of the genome.\"", "retries": 1}
{"idx": 527, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant information and confirms that alpha-synuclein immunostaining was used, but it is slightly verbose and includes details about the regions examined, which are not necessary to directly support the answer. The logic is sound, but the extra information reduces conciseness.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "The antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The supporting sentence is: \"We examined substantia nigra, paralimbic regions (entorhinal cortex, cingulate gyrus, insula and hippocampus), and neocortex (frontal and occipital association cortices) with double alpha-synuclein and ubiquitin immunostaining in 25 cases meeting neuropathological criteria for DLB.\"\n\nThis sentence directly indicates that alpha-synuclein immunostaining was conducted, confirming that the antibody is raised against alpha-synuclein.", "retries": 1}
{"idx": 528, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is incorrect in stating that the context does not explicitly mention hypertrophic cardiomyopathy; however, this does not affect the rating of the answer itself, which is correct. Since the evaluation focuses on the answer and its match to the gold standard, the score reflects the accurate answer.\", \"match\": true}", "gold_answer": "hypertrophic cardiomyopathy", "gold_support": "The most common cause of death was hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).", "model_answer": "The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy.", "model_support": "The context provided does not explicitly state that hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young athletes. It discusses the methodology of a study, including the identification and verification of cases through Internet searches and coroner reports, but does not provide specific information on the causes of sudden cardiac death. While it mentions that the findings were comparable to previous reports, it does not offer details on the specific causes, such as hypertrophic cardiomyopathy. Therefore, there is no sentence within the context that directly supports the answer.", "retries": 1}
{"idx": 529, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and logically supports the answer, but it is slightly verbose and includes additional details about SCID syndrome that are not necessary to directly support the role of calcineurin in NFAT activation.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "calcineurin", "model_support": "The supporting sentence is: \"The importance of the Ca²+/calcineurin/NFAT signaling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca²+ entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence.\"", "retries": 1}
{"idx": 530, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, specifying '5-HT2A receptor' which aligns with '5-HT2A'. The supporting sentence provided by the model is relevant but contains some redundancy and less direct focus on the specific use of [18F]altanserin for evaluating 5-HT2A receptors. It introduces details about radiometabolites (FBP and altanserinol) that are not necessary to directly support the answer. While the logic is sound and connected to the context, a more concise and targeted sentence like the gold supporting sentence would improve clarity.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "[18F]Altanserin is a ligand for the 5-HT2A receptor. It is used in positron emission tomography (PET) to study the distribution and function of this receptor in the brain. The context does not mention its use for evaluating other receptors, so the primary receptor evaluated is the 5-HT2A receptor.\n\nAnswer: 5-HT2A receptor", "model_support": "The supporting sentence for the answer is:  \n\"In analogy to its analog ketanserin, we postulated 4-(4-fluorobenzoyl)piperidine (FBP) and altanserinol for the previously observed two polar radiometabolites, corresponding to dealkylation at the piperidine nitrogen and reduction at the ketone, respectively.\"", "retries": 1}
{"idx": 531, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, identifying BACH1 as a 'repressor.' However, the supporting sentence provided by the model is somewhat redundant and lacks the detailed reasoning present in the gold supporting sentence. While it correctly states that BACH1 is a transcriptional repressor, it does not include the specific context of BACH1 forming a heterodimer with the small Maf family or its role in repressing the MARE element, which would have made the support more informative and directly relevant.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The supporting sentence is: \"Bach1 is a transcriptional repressor.\" This sentence clearly identifies Bach1's role as a repressor in gene transcription.", "retries": 1}
{"idx": 532, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model references multiple system atrophy instead of Parkinson's disease or Lewy body dementia, which are more directly relevant to the gold supporting sentence. The chosen sentence is still relevant and accurate but slightly less precise in context compared to the ideal supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of the Lewy bodies is alpha-synuclein. Supporting sentence: \"In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.\"", "retries": 1}
{"idx": 533, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('beta-Trcp'), but the supporting sentence does not effectively cover the gold answer. The chosen supporting sentence discusses Tyk2's stabilization of IFNAR1 and its independence from beta-Trcp binding, which is tangential to the main point that beta-Trcp mediates ubiquitination and degradation of IFNAR1. It fails to directly address or logically support the role of beta-Trcp in the ubiquitination process as described in the gold supporting sentence. Therefore, while the answer is correct, the supporting sentence is relevant but does not adequately cover the gold answer.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of IFNAR1 is beta-Trcp, which is part of the SCF complex. \n\nAnswer: beta-Trcp", "model_support": "The supporting sentence is: \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"\n\nThis sentence indicates that beta-Trcp's role in stabilizing IFNAR1 is not involved, suggesting that beta-Trcp is responsible for the ubiquitination and degradation of IFNAR1 under normal conditions, as the stabilization by Tyk2 is independent of beta-Trcp and ubiquitination.", "retries": 1}
{"idx": 534, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.", "model_answer": "The molecule targeted by Mepolizumab is interleukin-5. \n\nAnswer: interleukin-5", "model_support": "Supporting sentence: Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signaling.", "retries": 1}
{"idx": 535, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is not the most concise or directly relevant choice. While it discusses a detail about p53 (phosphorylation within the RD), it does not explicitly state that p53 is referred to as 'the guardian of the genome,' which is critical for fully supporting the answer. The gold supporting sentence is more direct and clearly links p53 to its nickname.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The sentence that supports the answer is:\n\n\"These effects are further modulated by phosphorylation of a conserved serine within the RD.\"\n\nThis sentence discusses the role of the regulatory domain (RD) of p53, which is part of the mechanism by which p53 functions as a tumor suppressor and guardian of the genome.", "retries": 1}
{"idx": 536, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the model correctly states that hormone analysis was normal, it overlooks the characteristic association of Pendred syndrome with thyroid abnormalities (specifically goiter), which is central to the condition. The supporting sentence is relevant but does not cover the gold answer, as it focuses solely on the normal hormone analysis and negative perchlorate test without addressing thyroid involvement.\", \"match\": false}", "gold_answer": "Thyroid", "gold_support": "Thyroid goiter was found in 46.5% of cases.", "model_answer": "There are no characteristic hormone abnormalities in Pendred syndrome. The hormone analysis conducted in the study was normal, and the perchlorate test, which is indicative of the condition, was negative. \n\nAnswer: No characteristic hormone abnormalities; hormones tested were normal.", "model_support": "The supporting sentence is: \"Hormone analysis was normal and perchlorate test negative in all cases.\" This directly states that no hormone abnormalities were found in the patients with Pendred syndrome.", "retries": 1}
{"idx": 537, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('L-dopa'). The supporting sentence is relevant and provides context about L-dopa being studied in combination with a peripheral decarboxylase inhibitor, which includes benserazide. However, it contains slight redundancy by mentioning additional biochemical details that are not strictly necessary to support the answer, making it less concise than the ideal.\",\n  \"match\": true\n}", "gold_answer": "L-dopa", "gold_support": "In a cross-sectional study blood was obtained, 2 h after dosing, from 104 patients with idiopathic parkinsonism, divided into four groups: no L-dopa treatment (group 1), L-dopa alone (group 2), L-dopa + benserazide (Madopar) (group 3) and L-dopa + carbidopa (Sinemet) (group 4).", "model_answer": "Benserazide is co-administered with L-dopa as a peripheral decarboxylase inhibitor to prevent L-dopa breakdown and enhance its effectiveness. \n\nAnswer: Benserazide", "model_support": "The supporting sentence is:  \n\"The effect of levodopa (L-dopa), alone or in combination with a peripheral decarboxylase inhibitor (PDI), on plasma levels of aromatic-L-amino acid decarboxylase (ALAAD, = dopa decarboxylase), L-dopa, 3-O-methyl-dopa (3-OMD), dopamine (DA), noradrenaline, adrenaline and dopamine beta-hydroxylase has been studied.\"", "retries": 1}
{"idx": 538, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although not ideal, is concise and directly relevant, covering the answer with clear and logical reasoning by referencing the XK gene mutation as the cause of McLeod syndrome. Minor extra details do not detract from the strong logic.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.\n\nAnswer: XK", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 539, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Ser129' is equivalent to 'serine 129'). The supporting sentence is concise, directly relevant, and logically explains the connection between Ser129 phosphorylation and Lewy bodies, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "serine 129", "gold_support": "Alpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies.", "model_answer": "The residue of alpha-synuclein phosphorylated in Lewy bodies is Ser129.", "model_support": "The sentence that supports the answer is: \"Gprk2 phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity.\" This directly connects the phosphorylation of Ser129 to the process of inclusion formation, which leads to the formation of Lewy bodies in Parkinson's disease.", "retries": 1}
{"idx": 540, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in essence, as both refer to the same clotting factor. The supporting sentence is relevant and provides logical support for the answer, mentioning the inhibition of factor Xa. However, it contains slight redundancy by discussing why factor Xa is a promising target, which is not directly necessary to support the specific answer. Thus, while accurate, it could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"Their inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\"", "retries": 1}
{"idx": 541, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively conveys the role of p53 in preserving genomic integrity, aligning well with the gold standard.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is:\n\n**p53**", "model_support": "The supporting sentence is:  \n\"A role for p53 in the frequency and mechanism of mutation. When p53 function is impaired, its ability to preserve genomic integrity is compromised.\"", "retries": 1}
{"idx": 542, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context (cytoplasmic vs. nuclear). The supporting sentence acknowledges that the context does not explicitly confirm the model's answer and notes the lack of direct evidence, but it fails to reference the specific sentence in the context that directly states APOBEC3B is predominantly nuclear. Thus, while the supporting sentence shows awareness of the issue, it does not adequately support or correct the model's incorrect answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "The context provided does not explicitly state whether the APOBEC3B protein is predominantly cytoplasmic or nuclear. While the user's answer suggests it is cytoplasmic, based on the given information, there is no direct evidence in the context to support this conclusion. Therefore, the answer cannot be definitively confirmed from the provided text.", "retries": 1}
{"idx": 543, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer with detailed reasoning, explaining the homology between the cloned protein and human selenoprotein P. However, it contains slight redundancy by elaborating on additional details like the tandem repeat and untranslated region, which are not strictly necessary to support the answer.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression.", "model_answer": "The human selenoprotein that contains several Se-Cys residues is selenoprotein P.", "model_support": "The supporting sentence is: \"The coding nucleotide sequence of its cDNA insert displayed high homology to rat and human selenoprotein P cDNA but contained 12 rather than 10 TGAs (12 rather than 10 selenocysteines in deduced amino acids), a tandem repeat of one CACTCC (His-Ser) and seven CATCCCs (His-Pro), and a 3' untranslated region approximately 890 bases shorter than that of rat liver selenoprotein P.\"\n\nThis sentence indicates that the cloned protein has 12 selenocysteines, which suggests that the human selenoprotein P, being homologous, would also contain several Se-Cys residues.", "retries": 1}
{"idx": 544, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Betrixaban inhibits factor Xa,' is correct and matches the gold standard ('Xa'). However, the supporting sentence provided is overly verbose and includes irrelevant information about pharmacokinetics, clinical evaluations, and reversal agents, none of which directly supports the specific fact that betrixaban inhibits factor Xa. The gold supporting sentence is much more concise and directly relevant. Thus, while the answer is correct, the supporting sentence does not adequately cover the gold answer due to excessive verbosity and inclusion of unrelated details.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence that confirms that betrixaban inhibits factor Xa is:\n\n**\"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life. This pharmacokinetic profile may allow greater flexibility for use in patients with poor renal function, offer the convenience of once daily dosing, and exhibit less drug interactions. Betrixaban is currently being evaluated for prophylaxis against venous thromboembolic disease (VTED) and the prevention of stroke and systemic embolism associated with nonvalvular atrial fibrillation, its role in the management of acute VTED and acute coronary syndromes is yet to be defined based on clinical data and evaluation. Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity. Currently, there are no specific reversal agents for the novel anticoagulants. The availability of an effective reversal agent would be very attractive for the management of associated bleeding, bleeding due to trauma, or the need for emergent surgery.\"**\n\nThis sentence explicitly states that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 545, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking Imatinib to BCR-ABL kinase inhibition, though it introduces additional context about leukemia stem cells, which slightly increases verbosity without being directly necessary.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "CML is induced by the BCR-ABL oncogene, whose gene product is a BCR-ABL tyrosine kinase.", "model_answer": "The tyrosine kinase involved in Philadelphia-chromosome positive chronic myelogenous leukemia that is the target of Imatinib (Gleevec) is **BCR-ABL**.", "model_support": "The supporting sentence is: \"However, the inability of BCR-ABL kinase inhibitors to completely kill leukemia stem cells (LSCs)...\" This sentence directly links Imatinib (Gleevec) to targeting BCR-ABL, a tyrosine kinase involved in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 546, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, 'thrombin', is incorrect as the gold answer specifies 'xa' (Factor Xa) as the correct target of betrixaban. The supporting sentence provided is entirely irrelevant to the question, discussing JTV519 instead of addressing the action or classification of betrixaban. This results in an output that neither matches the gold standard nor logically supports the correct answer.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "The clotting factor inhibited by betrixaban is **thrombin**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nThis sentence identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 547, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence, while relevant, is more detailed than necessary and does not directly mention the key statistic (5.2 women per man) that clearly supports the answer. It introduces additional information about risk factors and household duties, which adds some redundancy. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "Supporting sentence: Colombian women with RA are more at risk of having an early age at onset and developing polyautoimmunity and abdominal obesity, and they perform more household duties than their male counterparts.", "retries": 1}
{"idx": 548, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model discusses a completely irrelevant point about 1,4-benzothiazepine, which is not mentioned in the context at all. This makes both the answer and supporting sentence irrelevant to the question and gold answer.\", \"match\": false}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention PBT2 being a derivative of 1,4-benzothiazepine. Instead, it describes PBT2 as a second-generation 8-OH quinoline derivative of clioquinol. Therefore, there is no sentence in the context that supports the claim that PBT2 has been tested for 1,4-benzothiazepine.", "retries": 1}
{"idx": 549, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer (FXI) does not match the gold standard (xa), but FXI is mentioned in the context, making it relevant though incorrect. The supporting sentence discusses various inhibitors being assessed, including FXI, but does not directly support the inhibition of FXa by betrixaban. It mixes relevant content with some irrelevant details and fails to cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "The drug betrixaban is an oral direct thrombin inhibitor. It targets the enzyme thrombin, which is part of the coagulation cascade, rather than a specific clotting factor like FXI or FXII. However, based on the context provided, which mentions inhibitors targeting factors such as FXI, FXII, and others, the answer is:\n\nAnswer: FXI", "model_support": "The drug betrixaban is an oral direct thrombin inhibitor. It targets the enzyme thrombin, which is part of the coagulation cascade. The context provided mentions that inhibitors are being assessed against various components of the hemostatic pathway, including FVIIa-tissue factor (FVIIa/TF) complex, FIX, FXI, FXII, and others. While FXI is listed as a target, betrixaban specifically targets thrombin, which aligns with the context's mention of inhibitors affecting other factors. Therefore, the supporting sentence in the context is:\n\n\"Inhibitors to FVIIa-tissue factor (FVIIa/TF) complex, FIX, FXI, and FXII are being assessed.\"\n\nHowever, the correct answer based on the context is that betrixaban inhibits **thrombin**, which is part of the coagulation cascade.", "retries": 1}
{"idx": 550, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context explicitly mentions memory loss as one of the strongest associations with Gulf War Syndrome, yet the model denies its presence. The supporting sentence compounds this error by incorrectly stating that memory problems are not mentioned, despite clear evidence in the context. Both the answer and supporting sentence are irrelevant and fail to logically support the correct response.\", \"match\": false}", "gold_answer": "memory loss", "gold_support": "The strongest associations were for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8), night sweats (OR 9.9, 95% CI 6.5-15.2), general fatigue (OR 9.6, 95% CI 8.3-11.1) and sexual dysfunction (OR 4.6, 95%CI 3.2-6.6).", "model_answer": "The context provided does not mention memory problems as a reported issue in Gulf War Syndrome. The study focuses on physical symptoms and self-reported ill health without detailing cognitive effects like memory loss.", "model_support": "The context provided does not mention memory problems as a reported issue in Gulf War Syndrome. The study focuses on physical symptoms and self-reported ill health without detailing cognitive effects like memory loss.", "retries": 1}
{"idx": 551, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to Factor Xa). The supporting sentence is relevant and provides useful context by identifying Factor Xa as a critical enzyme in the coagulation cascade. However, it contains slight redundancy by elaborating on thrombin generation, which is not necessary to directly support the answer. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "EXPERT OPINION: A large body of Phase II and Phase III data is now available for FXa inhibitors such as rivaroxaban, apixaban, edoxaban and betrixaban.", "model_answer": "Factor Xa (FXa) is the target of betrixaban. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Factor Xa (FXa) is a critical enzyme in the coagulation cascade responsible for thrombin generation.\" This sentence directly identifies FXa as the target of betrixaban, confirming that betrixaban inhibits Factor Xa. \n\nAnswer: Factor Xa", "retries": 1}
{"idx": 552, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The KFERQ motif is incorrectly associated with the canonical autophagy pathway instead of chaperone-mediated autophagy (CMA). The supporting sentence provided by the model is irrelevant because it states there is no supporting information in the context, whereas the context clearly mentions CMA and its relation to the KFERQ motif. The correct supporting sentence should have referenced CMA as a selective form of lysosomal degradation targeting proteins with the KFERQ motif.\", \"match\": false}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.", "model_answer": "The KFERQ motif is associated with the canonical autophagy pathway. It facilitates the recognition of cytosolic proteins by LC3, leading to autophagosome formation and the degradation of these proteins.\n\nAnswer: The KFERQ motif is associated with the canonical autophagy pathway.", "model_support": "The context provided does not mention the KFERQ motif or the canonical autophagy pathway. Therefore, there is no supporting sentence in the given context for the answer regarding the KFERQ motif and autophagy.", "retries": 1}
{"idx": 553, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Betrixaban is a direct inhibitor of factor Xa') does not match the gold standard ('Xa'), although it correctly identifies the target in a more verbose manner. The supporting sentence provided by the model is completely irrelevant to the question, discussing JTV519 and calcium channels instead of betrixaban or factor Xa inhibition. Therefore, while the answer is correct in meaning, the lack of conciseness and the unrelated supporting sentence result in a low score.\", \"match\": false}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban is a direct inhibitor of factor Xa. It works by specifically targeting this clotting factor to prevent blood clot formation.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 554, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, stating that alpha-spectrin and beta-spectrin form parallel heterodimers when the gold standard clearly indicates they form antiparallel heterodimers. The supporting sentence provided by the model is irrelevant to the question, discussing JTV519 and its effects on RyR2s, which has no connection to spectrin dimerization. Both the answer and supporting sentence fail to match the gold standard or provide logical support.\",\n  \"match\": false\n}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Alpha-spectrin and beta-spectrin form **parallel** heterodimers. This orientation allows for the formation of a lattice structure crucial for the structural organization of red blood cells. The study indicates that the terminal nonhomologous domains are not essential for dimerization, supporting the idea that the primary interaction involves parallel alignment based on motifs facilitating beta-structure formation.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 555, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes additional information ('and transient ischemic attack (TIA)') which is not explicitly mentioned in the gold answer. The supporting sentence provides relevant context but is somewhat lengthy and does not directly focus on the specific use of the ROSIER scale for stroke as concisely as the gold supporting sentence. The logic is reasonable, but the answer could be more concise.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for diagnosing stroke and transient ischemic attack (TIA) in emergency settings.", "model_support": "The supporting sentence is: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 556, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer includes hypothyroidism, which matches the gold standard 'thyroid,' but it also adds growth hormone deficiency and other pituitary hormone issues, which are not supported by the context provided. The supporting sentence mentions pituitary gland issues due to a GATA1 deletion, which is not mentioned in the context or the gold supporting sentence. Thus, while relevant, the model's supporting sentence does not directly cover the gold answer and introduces unsupported details.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "In Williams syndrome, common hormone abnormalities include hypothyroidism due to thyroid gland hypoplasia or aplasia and growth hormone deficiency. Additionally, there may be issues with other pituitary hormones, as the pituitary gland development is affected by the GATA1 deletion. \n\nAnswer: Hypothyroidism, growth hormone deficiency, and potentially other pituitary hormone deficiencies.", "model_support": "The hormone abnormalities common in Williams syndrome, as supported by the context, include hypothyroidism due to thyroid gland hypoplasia or aplasia and growth hormone deficiency caused by pituitary gland developmental issues. The genetic cause, a GATA1 deletion, affects both thyroid and pituitary gland development, leading to these deficiencies. \n\n**Supporting sentence:** The pituitary gland development is affected by the GATA1 deletion, potentially leading to other pituitary hormone deficiencies.", "retries": 1}
{"idx": 557, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation of how LEKTI deficiency contributes to Netherton syndrome, aligning with the context provided. However, it is slightly less direct than the gold supporting sentence, which explicitly mentions the SPINK5 gene mutation leading to LEKTI deficiency as the cause of NS. The model’s supporting sentence focuses on the downstream effect (overprocessing of GH) rather than directly stating the genetic cause, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "LEKTI", "gold_support": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.", "model_answer": "The protein causing Netherton syndrome is **LEKTI**.", "model_support": "The supporting sentence for the answer is: **\"It is proposed that a lack of inhibition of proteases due to a deficiency of LEKTI in the pituitary gland leads to the overprocessing of human GH in NS.\"**  \n\nThis sentence directly links LEKTI deficiency to Netherton syndrome (NS) by explaining the proposed mechanism through which LEKTI deficiency contributes to the condition.", "retries": 1}
{"idx": 558, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('alpha-Synuclein') in meaning, though it includes an unnecessary article ('The main component of Lewy bodies is alpha-synuclein'). The supporting sentence provides relevant context but does not directly state that alpha-synuclein is the main component of Lewy bodies. Instead, it vaguely mentions the presence of Lewy bodies without specifying their composition, making it slightly less precise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is:\n\n\"Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.\"", "retries": 1}
{"idx": 559, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is somewhat indirect and focuses on p53's role in mitochondrial regulation rather than its broader and more direct roles (e.g., cell cycle arrest, apoptosis, DNA repair) that justify its 'guardian of the genome' title. While the logic connecting p53 to genomic integrity is reasonable, the supporting sentence could be more concise and directly relevant to the gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Often referred to as the Guardian of the Genome, the list of known functions of p53 include regulatory roles in cell cycle arrest, apoptosis, angiogenesis, DNA repair and cell senescence.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The supporting sentence for the answer is: \"p53 may regulate contractile-induced increases in mitochondrial content via modulating mitochondrial transcription factor A (Tfam) content and/or activity, given that p53 KO mice display reduced skeletal muscle mitochondrial DNA, Tfam messenger RNA and protein levels.\"\n\nThis sentence highlights p53's role in maintaining mitochondrial function and genome integrity, which aligns with its function as the \"guardian of the genome.\"", "retries": 1}
{"idx": 560, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it only mentions two isoforms (TAp73 and DeltaNp73) instead of the seven that exist. The information provided is accurate for the specific isoforms mentioned but fails to address the full scope of the question.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The TAp73 isoforms identified in humans are two: TAp73 and DeltaNp73.\n\nAnswer: 2", "model_support": "Supporting sentence: The p73 gene is able to encode transcriptionally active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms.", "retries": 1}
{"idx": 561, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('beta-TrCP'). However, the supporting sentence provided by the model is incorrect because it states that the context does not provide information about beta-TrCP, which is untrue. The gold supporting sentence demonstrates that the context does mention beta-TrCP as a main E3 ubiquitin ligase involved in IkappaB-alpha degradation. Despite this error in the supporting sentence, the answer itself is correct.\", \"match\": true}", "gold_answer": "beta-TrCP", "gold_support": "Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involved in IkappaB-alpha degradation.", "model_answer": "The E3 ubiquitin ligase responsible for ubiquitinating IkB is beta-TrCP, which is part of the IKK complex. This ligase facilitates the proteasomal degradation of IkB, a key regulatory step in the NF-kappaB pathway. \n\nAnswer: beta-TrCP", "model_support": "The context does not provide information about the E3 ubiquitin ligase beta-TrCP or its role in ubiquitinating IkB. The discussion centers on clusterin's (CLU) regulatory activity on the NF-kappaB pathway, particularly through its disulfide constraint region, and how DeltaCLU interacts with IkB after TNF-alpha stimulation. There is no mention of beta-TrCP or the ubiquitination process.\n\n**Answer:** The context does not include a sentence that supports identifying beta-TrCP as the E3 ubiquitin ligase responsible for ubiquitinating IkB.", "retries": 1}
{"idx": 562, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The characteristic domain of histone methyltransferases is the 'SET domain,' not lysine 9 on histone H3, which is the target of methylation. Additionally, the supporting sentence provided by the model is completely irrelevant, discussing a calcium channel blocker (JTV519) instead of anything related to histone methyltransferases or the SET domain.\", \"match\": false}", "gold_answer": "SET domain", "gold_support": "We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity.", "model_answer": "The characteristic domain of histone methyltransferases such as SUV39H1 and Suv39h1 is the lysine residue at position 9 (K9) on the amino terminus of histone H3. This is where they specifically add methyl groups.\n\nAnswer: lysine 9 (K9) on the amino terminus of histone H3.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 563, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('activator') does not match the gold standard ('repressor'), but it is present in the context. The supporting sentence refers to Bach1 as a potential target for treatment, which implies its role in promoting bone loss but does not directly indicate it as a repressor of HO-1. The logic is somewhat relevant but does not fully align with the gold answer.\", \"match\": false}", "gold_answer": "repressor", "gold_support": "This study was undertaken to clarify the effects of HO-1 and its repressor Bach1 in osteoclastogenesis.", "model_answer": "BACH1 is an activator.", "model_support": "The supporting sentence is: \"Bach1 may be worthy of consideration as a target for treatment of inflammatory bone loss in diseases including RA.\" This suggests that Bach1 is involved in promoting bone loss, acting as an activator.", "retries": 1}
{"idx": 564, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'factor Xa'). The supporting sentence provides relevant information and logically supports the answer by identifying that betrixaban is among the drugs targeting factor Xa. However, it includes slight redundancy by elaborating on other drugs and thrombin, which was not necessary for answering the question directly.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "The clotting factor inhibited by betrixaban is **factor Xa**.", "model_support": "The supporting sentence in the context that indicates which clotting factor is inhibited by betrixaban is:\n\n\"Multiple new oral anticoagulants have been developed as potential replacements for VKAs for stroke prevention in AF. Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. ...).\"\n\nThis sentence confirms that one of the target clotting factors is factor Xa, which is inhibited by drugs like betrixaban.", "retries": 1}
{"idx": 565, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Nestin'). The supporting sentence is relevant and provides logical support for the answer, though it includes additional details about Prominin-1 that are not necessary for directly supporting the use of Nestin as a marker. This makes it slightly more verbose than the gold supporting sentence, which is more concise and directly mentions Nestin in the context of being a nonspecific precursor cell marker.\",\n  \"match\": true\n}", "gold_answer": "Nestin", "gold_support": "A small subset of Prominin-1(+) cells coexpressed the nonspecific precursor cell marker Nestin as well as GFAP and Sox2.", "model_answer": "Nestin is an intermediate filament protein commonly used as a marker for neuronal precursor cells in the subventricular zone.", "model_support": "The supporting sentence that highlights Nestin as an intermediate filament protein used as a marker for neuronal precursor cells in the subventricular zone is:\n\n\"Upon fluorescence-activated cell sorting, only Prominin-1/Nestin double-positive cells fulfilled the defining stem cell criteria of proliferation, self-renewal, and multipotentiality as assessed by a neurosphere assay.\"\n\nThis sentence confirms that Nestin, along with Prominin-1, is used to identify neuronal precursor cells in the subventricular zone.", "retries": 1}
{"idx": 566, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('iron'), though it includes additional explanatory details. The supporting sentence provides relevant context and reasoning but is slightly verbose, repeating information about the study's objective rather than directly focusing on the key relationship between iron depletion and RLS. Overall, the logic is strong, but some redundancy lowers the score.\",\n  \"match\": true\n}", "gold_answer": "iron", "gold_support": "High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.", "model_answer": "Iron deficiency is the cause of restless leg syndrome (RLS) as indicated by the study, which shows that IV iron effectively reduces RLS severity compared to oral iron, especially in female donors below 50 years of age.", "model_support": "The supporting sentence is: \"Iron depletion is common in regular blood donors. The objective of the study was to investigate the frequency and severity of iron depletion in regular blood donors and whether IV iron is more effective than oral to avoid iron depletion and symptoms thereof, especially restless legs syndrome (RLS).\" This sentence establishes that iron deficiency is the cause of RLS by framing the study's purpose to explore this relationship.", "retries": 1}
{"idx": 567, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard, identifying the inheritance pattern as autosomal dominant. However, it adds extra details about incomplete penetrance and the zebrafish model, which are not part of the gold answer but are still factually accurate. The supporting sentence provided by the model is relevant and supports the answer, but it is somewhat verbose and includes additional information beyond what is strictly necessary to justify the answer. This makes it less concise than ideal, though the logic remains sound.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Li-Fraumeni syndrome (LFS) is a highly penetrant, autosomal dominant, human familial cancer predisposition.", "model_answer": "The inheritance pattern of Li–Fraumeni syndrome is autosomal dominant with incomplete penetrance, though in the zebrafish model used, it is fully penetrant.", "model_support": "The inheritance pattern of Li–Fraumeni syndrome is autosomal dominant with incomplete penetrance, though in the zebrafish model used, it is fully penetrant.\n\n**Supporting sentence:** As in humans with LFS, tumors arise in heterozygotes and display loss of heterozygosity (LOH). This report of LOH indicates that Knudson's two-hit hypothesis, a hallmark of human autosomal dominant cancer syndromes, can be modeled in zebrafish. Furthermore, as with some LFS mutations, the zebrafish p53(I166T) allele is a loss-of-function allele with dominant-negative activity in vivo. Additionally, we demonstrate that the p53 regulatory pathway, including Mdm2 regulation, is evolutionarily conserved in zebrafish, providing a bona fide biological context in which to systematically uncover novel modifier genes and therapeutic agents for human LFS.", "retries": 1}
{"idx": 568, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer correctly identifies Factor X as the target of betrixaban, aligning with the gold standard 'xa'. The supporting sentence mentions Factor X inhibitors and provides relevant context, but it is slightly indirect and does not explicitly link betrixaban to Factor X in the same clear way as the gold supporting sentence. It contains minor redundancy by discussing clinical advancement rather than directly quoting the list of Factor X inhibitors. Overall, the logic is strong but could be more precise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Betrixaban is an inhibitor of Factor X, a clotting factor involved in the intrinsic pathway of blood coagulation.", "model_support": "The supporting sentence is: \"Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.\" This identifies Factor X as a target for inhibitors, specifically mentioning betrixaban as a Factor X inhibitor.", "retries": 1}
{"idx": 569, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it is slightly more verbose than necessary. The supporting sentence is relevant and supports the answer by mentioning the use of the ROSIER scale as a stroke recognition tool in the prehospital setting. However, it includes additional details (comparison with CPSS) that are not essential to directly support the answer, introducing slight redundancy.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for assessing and diagnosing strokes in prehospital settings.", "model_support": "The supporting sentence is: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 570, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation linking Xist to X chromosome inactivation, but it contains slight redundancy by elaborating on 'possible role' when the gold supporting sentence is more concise. Overall, the support is strong but could be more direct.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "Expression of the X inactive-specific transcript (Xist) is thought to be essential for the initiation of X chromosome inactivation and dosage compensation during female embryo development.", "model_answer": "The transcript responsible for X-chromosome inactivation is **Xist**.", "model_support": "The sentence that supports the answer is: \"These results suggest that Xist expression precedes the onset of late replication in the bovine embryo, in a pattern compatible with a possible role of bovine Xist in the initiation of X chromosome inactivation.\" This directly links Xist expression to the process of X chromosome inactivation, confirming that Xist is the transcript responsible for this function.", "retries": 1}
{"idx": 571, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct in identifying XIST as the transcript responsible for X-chromosome inactivation, matching the gold standard. However, the supporting sentence provided by the model is completely irrelevant to the question and does not support the answer. The supporting sentence discusses JTV519 and RyR2s, which are unrelated to XIST or X-chromosome inactivation. Therefore, while the answer matches the gold standard, the lack of a relevant supporting sentence reduces the score.\",\n  \"match\": true\n}", "gold_answer": "XIST", "gold_support": "The human XIST gene, a candidate for a role in X chromosome inactivation, has recently been cloned and sequenced, yielding a 17 kb cDNA with no apparent significant, conserved open reading frame.", "model_answer": "The transcript responsible for X-chromosome inactivation is the XIST transcript. It is a non-coding RNA that plays a key role in silencing one of the X chromosomes in female mammals through epigenetic mechanisms.", "model_support": "The sentence that supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 572, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the conclusion that BACH1 is a repressor by highlighting increased HO-1 expression in Bach1-deficient mice, which logically implies repression by Bach1. However, it contains slight redundancy by mentioning 'in all brain sites studied,' which is not essential for the core argument. The gold supporting sentence is more direct and concise.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence is: \"Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied.\" This indicates that Bach1 functions as a repressor by reducing HO-1 expression.", "retries": 1}
{"idx": 573, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is completely incorrect and unrelated to the question. The supporting sentence also does not address the gold answer or provide any relevant information about SAM as the methyl donor. Both the answer and supporting sentence are irrelevant to the context of the question.\",\n  \"match\": false\n}", "gold_answer": "SAM", "gold_support": "To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor, we have carried out structure-guided design, synthesis, and characterization of orthogonal vSET methyltransferase mutant/SAM analogue pairs using a 'bump-and-hole' strategy.", "model_answer": "The drug JTV519 is derived from the group of chemical compounds known as 1,4-benzothiazepines.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The sentence that supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 574, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it contains slight redundancy and verbosity compared to the more concise gold supporting sentence. The logic is clear, but the additional details make it less direct than ideal.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.", "model_answer": "H3K4", "model_support": "Supporting sentence: MLL1 and MLL2 are associated with Hut-78 in a native chromatin-enriched extract. Thus, we identified a molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-kappaB-dependent gene induces its expression and potentially the invasive potential of lymphoma cells harbouring constitutive activity of the alternative NF-kappaB-activating pathway.\n\nThe histone residue methylated by MLL1 is H3K4.", "retries": 1}
{"idx": 575, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Factor Xa' is correct and matches the gold standard 'xa'. However, the provided supporting sentence is completely irrelevant to the question and answer, discussing a different topic (JTV519 and RyR2s). The gold supporting sentence provides the necessary context about betrixaban being an orally active direct factor Xa inhibitor, which is absent in the model's supporting sentence. While the answer is accurate, the lack of proper support reduces the score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Factor Xa", "model_support": "The supporting sentence for the answer is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence identifies JTV519 as a derivative of 1,4-benzothiazepine.\n\n**Answer:** Factor Xa", "retries": 1}
{"idx": 576, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The gold answer specifies 'the transcribed strand,' while the model incorrectly states that 'both DNA strands' are targeted by transcription-coupled repair (TCR). The supporting sentence is relevant but does not cover the gold answer, as it mentions repair of both strands without clarifying that TCR specifically targets the transcribed strand.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Both DNA strands are targeted by transcription-coupled repair (TCR) in active genes, as efficient repair occurs in both strands within transcriptionally active regions.\n\nAnswer: Both DNA strands.", "model_support": "The sentence that supports the answer is:  \n\"Within active genes, both DNA strands continue to be proficiently repaired.\"\n\nAnswer: Both DNA strands are targeted by transcription-coupled repair (TCR) in active genes, as efficient repair occurs in both strands within transcriptionally active regions.", "retries": 1}
{"idx": 577, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it explains the lack of a direct supporting sentence in the context, which adds unnecessary verbosity. The gold supporting sentence is concise and directly relevant.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Inheritance seems most likely to be autosomal recessive.", "model_answer": "The mode of inheritance of Wilson's disease is autosomal recessive.", "model_support": "The mode of inheritance for Wilson's disease is autosomal recessive, but the provided context does not include a specific sentence that directly mentions Wilson's disease. Therefore, there is no supporting sentence in the context for this answer.", "retries": 1}
{"idx": 578, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and covering the answer, contains additional details about the regulatory domain stabilizing the p53 tetramer, which is not necessary to directly support the answer. This makes the supporting sentence slightly more verbose than needed, though it still provides logical support.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The sentence supporting the answer is: \"the regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.\" This sentence explicitly identifies p53 as the tumor suppressor referred to as \"the guardian of the genome.\"\n\nAnswer: The tumor suppressor referred to as \"the guardian of the genome\" is p53. Supporting sentence: the regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.", "retries": 1}
{"idx": 579, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'EGFR' matches the gold standard 'epidermal growth factor receptor (EGFR) gene' in meaning, though it is less detailed. The supporting sentence provided by the model is relevant and covers the relationship between EGFR mutations and sensitivity to erlotinib and gefitinib, but it is slightly verbose and includes additional statistical details not necessary for supporting the answer. Overall, the logic is strong, but a more concise explanation would have warranted a full score.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor.", "model_answer": "The mutations determine the response to both erlotinib and gefitinib in EGFR. \n\nAnswer: EGFR", "model_support": "The supporting sentence is: \"we found that 7 of 10 gefitinib-sensitive tumors had similar types of alterations; no mutations were found in eight gefitinib-refractory tumors (P = 0.004). Five of seven tumors sensitive to erlotinib (Tarceva), a related kinase inhibitor for which the clinically relevant target is undocumented, had analogous somatic mutations, as opposed to none of 10 erlotinib-refractory tumors (P = 0.003).\" This sentence directly links EGFR mutations to the response to both erlotinib and gefitinib.", "retries": 1}
{"idx": 580, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains slightly redundant information about the KCNQ1 and KCNE1 proteins, which is not directly necessary to support the mode of inheritance. The logic is sound, but the additional details make it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "autosomal recessive", "gold_support": "Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait.", "model_answer": "The mode of inheritance for Long QT Jervell and Lange-Nielsen syndrome is autosomal recessive.", "model_support": "The mode of inheritance for Long QT Jervell and Lange-Nielsen syndrome is autosomal recessive. \n\n**Supporting sentence:** The KCNQ1 and KCNE1 proteins coassemble in a potassium channel, and mutations in either the KCNQ1 gene or the KCNE1 gene disrupt endolymph production in the stria vascularis in the cochlea, causing deafness. KCNQ1 seems to be the major gene in JLNS.", "retries": 1}
{"idx": 581, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it mentions general knowledge not present in the context and adds information about the context lacking the detail, which slightly detracts from conciseness. The gold supporting sentence directly points to the relevant information within the context, making it more concise and focused.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease is caused by exposure to toxins produced by Clostridium botulinum and other botulinum toxin-producing clostridia.", "model_answer": "The most known bacterium responsible for botulism, including sausage-poisoning, is **Clostridium botulinum**.", "model_support": "The context provided does not explicitly identify the bacterium responsible for botulism. While it discusses the disease and its management, it does not mention *Clostridium botulinum* by name. Therefore, the supporting sentence is not found within the given context. However, based on general knowledge, *Clostridium botulinum* is the known cause of botulism, including sausage-poisoning.", "retries": 1}
{"idx": 582, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('PP1' is equivalent to 'Protein Phosphatase-1'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It explicitly mentions the interaction between Hsp20 and PP1, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "PP1", "gold_support": "Interestingly, the activity of type 1 protein phosphatase (PP1), a known regulator of PLN signaling, was significantly reduced by Hsp20 overexpression, suggesting that the Hsp20 stimulatory effects are partially mediated through the PP1-PLN axis.", "model_answer": "The protein phosphatase that interacts with HSP20 is Protein Phosphatase-1 (PP1). \n\nAnswer: Protein Phosphatase-1", "model_support": "The supporting sentence is: \"Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling.\" This directly identifies the interaction between Hsp20 and PP1, confirming the answer.", "retries": 1}
{"idx": 583, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard, but the supporting sentence is completely irrelevant to the question and does not support the answer. The provided sentence discusses JTV519, which has no relation to Riociguat or Adempas.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is **Riociguat**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 584, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct in essence but more verbose than the gold standard. The supporting sentence provides relevant information, including sensitivity and specificity values, which indirectly supports the use of ROSIER for stroke assessment. However, it does not directly reference the purpose of the scale as clearly as the gold supporting sentence. The logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for assessing and diagnosing acute stroke in the emergency department.", "model_support": "The supporting sentence is: \"The ROSIER had a sensitivity of 83% (95% CI 78 to 87) and specificity of 44% (95% CI 34 to 53), and the FAST had a sensitivity of 81% (95% CI 76 to 86) and a specificity of 39% (95% CI 30 to 48).\"  \nThis sentence confirms that the ROSIER scale is used for assessing and diagnosing acute stroke in the emergency department, as indicated by its sensitivity and specificity values.", "retries": 1}
{"idx": 585, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('l-DOPA'), but the supporting sentence contains slight redundancy. While it correctly identifies that l-DOPA is co-administered with benserazide, the mention of buspirone introduces unnecessary information that does not directly support the answer. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "l-DOPA", "gold_support": "In experiment 1, l-DOPA-primed rats were pre-treated with Vehicle (0.9% NaCl), various doses of the partial 5-HT(1A) agonist, buspirone (0.25, 1.0 or 2.5 mg/kg, ip) or buspirone (2.5 mg/kg, ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip).", "model_answer": "Benserazide is usually co-administered with l-DOPA.", "model_support": "The supporting sentence is: \"In experiment 2, l-DOPA-naïve rats received co-administration of l-DOPA+buspirone (1.0 or 2.5 mg/kg, ip) for 2 weeks.\"\n\nThis sentence clearly indicates that l-DOPA is co-administered with buspirone, which aligns with the answer that benserazide is usually co-administered with l-DOPA, as benserazide is a common co-agonist used with l-DOPA in Parkinson's treatment.", "retries": 1}
{"idx": 586, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect because it claims there is no explicit sentence in the context that supports the answer, while the gold supporting sentence clearly provides relevant and direct support from the context. The correct supporting sentence should have referenced the role of BCR-ABL as stated in the context. Despite this, the logic connecting the answer to the question is strong.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "The target tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia that Imatinib (Gleevec) targets is **BCR-ABL**.", "model_support": "There is no sentence in the provided context that explicitly states that Imatinib targets BCR-ABL. The context discusses Imatinib's efficacy in CML treatment but does not mention the specific tyrosine kinase it targets. Therefore, the answer cannot be supported by a sentence from the given context.", "retries": 1}
{"idx": 587, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer correctly identifies multiple myeloma as the main disease treated by Velcade (bortezomib), matching the gold standard. However, the supporting sentence is somewhat verbose and indirectly ties the efficacy of bortezomib to multiple myeloma through a discussion on selectivity for solid tumors, which is not directly mentioned in the context. While relevant, it introduces additional details that aren't necessary to support the gold answer, making it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, a dipeptidyl boronic acid and potent inhibitor of the 26S proteasome, is remarkably effective against multiple myeloma (MM) but not against solid tumors.", "model_answer": "Velcade (bortezomib) is mainly used for treating multiple myeloma, a type of blood cancer. It works by inhibiting the proteasome, which is crucial for breaking down abnormal proteins in cancer cells, leading to their death.", "model_support": "The context discusses the use of dipeptidyl boronic acid proteasome inhibitors for solid tumors, highlighting the challenge of selectivity and the need for tumor-specific protease release mechanisms. While the specific use of Velcade (bortezomib) for multiple myeloma isn't directly mentioned, the broader context on proteasome inhibitors supports their role in targeting cancer cells by inhibiting protein degradation, which is central to Velcade's mechanism in treating multiple myeloma. \n\n**Supporting Sentence:** Achieving efficacy against solid tumors therefore is likely to require making the inhibitor more selective for tumor tissue over normal tissues.", "retries": 1}
{"idx": 588, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in essence, though it is slightly more verbose by saying 'factor Xa' instead of just 'xa'. The supporting sentence provides relevant information and correctly identifies betrixaban as a factor Xa inhibitor. However, it includes some extra details about categorizing factor Xa inhibitors that are not strictly necessary to support the answer, making it somewhat redundant.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context discusses various anticoagulants, including factor Xa inhibitors and thrombin inhibitors. Betrixaban is a known factor Xa inhibitor, specifically a direct one. While the context doesn't explicitly mention betrixaban, it categorizes factor Xa inhibitors, which includes both direct and indirect types. Therefore, betrixaban inhibits factor Xa.\n\nAnswer: Betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 589, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context provided does not explicitly state the number of TAp73 isoforms, but the gold answer indicates there are 7. The supporting sentence focuses on the two promoters (P1 and P2) controlling TAp73 and ΔNp73 but does not provide evidence to support the claim of only one TAp73 isoform. Therefore, both the answer and supporting sentence are inaccurate and fail to align with the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context specifies that p73 has two isoforms: TAp73 (pro-apoptotic) and ΔNp73 (anti-apoptotic). It does not mention any other isoforms beyond these two. Therefore, the total number of TAp73 isoforms identified is one.\n\nAnswer: 1", "model_support": "The supporting sentence is:  \n\"p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively.\"\n\nThis sentence specifies that there is one TAp73 isoform (pro-apoptotic) and one ΔNp73 isoform (anti-apoptotic). Therefore, the number of TAp73 isoforms identified is one.", "retries": 1}
{"idx": 590, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and mentions JNK phosphorylation, which aligns with the gold answer. However, it contains slight redundancy by including p38MAPK, which is not directly necessary for supporting the specific role of JNK in phosphorylating c-jun.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "OBJECTIVE: To investigate the effects of antidepressant citalopram on the gene expressions of tumor necrosis factor-alpha (TNF-α) and interleukin 1 beta (IL-1β), and to discuss the impacts of citalopram on p38 and c-jun N-terminal kinase (JNK) of mitogen-activated protein kinase (MAPK) family in microglial cells.", "model_answer": "JNK (Jun N-terminal kinase) is the MAP kinase responsible for phosphorylating the transcription factor c-jun.", "model_support": "The supporting sentence is:\n\n\"the phosphorylation of p38MAPK and JNK were observed after pretreatment for 30 min.\"\n\nThis sentence directly mentions the phosphorylation of JNK, which is part of the MAPK pathway, supporting the answer that JNK phosphorylates the transcription factor c-jun.", "retries": 1}
{"idx": 591, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and logically covers the answer by referencing betrixaban as a factor Xa inhibitor. Minor additional context about its role in stroke prevention is acceptable without introducing unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Another factor Xa inhibitor, edoxaban, is under evaluation in an ongoing phase III clinical trial and others such as AZD0837, betrixaban and darexaban are still in safety and tolerability phase II studies.", "model_answer": "The clotting factor inhibited by betrixaban is **factor Xa**.", "model_support": "The clotting factor inhibited by betrixaban is **factor Xa**.\n\nSupporting sentence: The context discusses the development of new oral anticoagulants, including factor Xa inhibitors, which prevent stroke in atrial fibrillation. Betrixaban is a known factor Xa inhibitor, as mentioned in the context.", "retries": 1}
{"idx": 592, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions 'methylthioadenosine (MTA)' as the methyl donor, which does not match the gold standard 'SAM'. However, MTA is discussed in the context, making the answer relevant but incorrect. The supporting sentence provided by the model is entirely irrelevant to the question, discussing a '1,4-benzothiazepine derivative' that has no connection to histone methylation or SAMe/MTA, thus failing to support the answer.\",\n  \"match\": false\n}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "The methyl donor for histone methyltransferases in this context is **methylthioadenosine (MTA)**, derived from S-adenosylmethionine (SAMe).", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a **1,4-benzothiazepine** derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.", "retries": 1}
{"idx": 593, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is more detailed than necessary. The gold answer simply states 'IL-1β,' while the model specifies the interaction between IL-1β and its receptor, which adds extra information not required by the question. The supporting sentence provides relevant information about Gevokizumab's mechanism, but it is somewhat lengthy and includes additional details about reducing association rates that are not essential to supporting the answer. Logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Gevokizumab targets the interaction between interleukin-1β (IL-1β) and its receptor IL-1RI, reducing its binding affinity.", "model_support": "The supporting sentence is: \"Gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions.\" This sentence directly states that Gevokizumab targets the interaction between IL-1β and IL-1RI, reducing the binding affinity, which aligns with the answer provided.", "retries": 1}
{"idx": 594, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'bone collagen,' is essentially correct and matches the gold standard 'collagen,' as bone collagen is the protein referred to in the context. However, it includes the extra word 'bone,' which, while accurate, is slightly redundant since 'collagen' alone suffices. The supporting sentence provided by the model is incorrect because it claims there is no relevant supporting sentence in the context, whereas the gold supporting sentence clearly exists and directly supports the answer. Despite this, the logic behind the model's answer is strong, hence a score of 4.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "In archaeological studies, the isotopic enrichment values of carbon and nitrogen in bone collagen give a degree of information on dietary composition.", "model_answer": "Bone collagen is the protein used in archaeology for dating and species identification.", "model_support": "The context provided does not include any sentence that directly supports the use of bone collagen in archaeology for dating and species identification. The focus of the context is on liquid chromatography/isotope ratio mass spectrometry measurements of amino acids in plant proteins, discussing applications in plant sciences, nutrition, environmental food-web studies, and indirectly mentioning archaeology without specifying bone collagen. Therefore, there is no supporting sentence within the provided context for the given answer.", "retries": 1}
{"idx": 595, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model answer matches the gold standard exactly by identifying 'phospholamban (PLN)' as the main regulatory molecule. The supporting sentence provided is concise, directly relevant, and explains the regulatory role of PLN over SERCA2A through its phosphorylation states, aligning logically with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is **phospholamban (PLN)**.", "model_support": "The supporting sentence is:\n\n\"Dephosphorylated PLN inhibits SERCA2a. Phosphorylation of PLN by either cAMP or cGMP-dependent protein kinase at Ser16 or the Ca2+-calmodulin-dependent protein kinase (CaMKII), at Thr17, relieves this inhibition, increasing SR Ca2+ uptake and SR Ca2+ load.\"\n\nThis sentence clearly establishes phospholamban (PLN) as the main regulatory molecule of SERCA2A function by showing that its phosphorylation directly affects the activity and function of SERCA2A.", "retries": 1}
{"idx": 596, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis.", "model_answer": "Mepolizumab targets interleukin-5 (IL-5).\n\nAnswer: interleukin-5", "model_support": "The sentence \"Mepolizumab is an anti-interleukin-5 monoclonal antibody\" directly supports the answer, as it explicitly states that Mepolizumab targets interleukin-5.", "retries": 1}
{"idx": 597, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and identifies flumazenil as the antidote for benzodiazepine overdose, but it is slightly less detailed compared to the gold supporting sentence, which provides more comprehensive reasoning about its use in various scenarios. The chosen sentence is accurate but could offer more context.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Flumazenil is the antidote used in benzodiazepine overdose.", "model_support": "The supporting sentence is: \"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.\" This sentence directly identifies flumazenil as the antidote used to manage chlordiazepoxide toxicity, a form of benzodiazepine overdose.", "retries": 1}
{"idx": 598, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and irrelevant to the question about the methyl donor of histone methyltransferases. The supporting sentence discusses a drug (JTV519) and its classification as a benzothiazepine derivative, which has no connection to the gold answer or the context provided. Both the answer and supporting sentence fail to address the correct topic.\", \"match\": false}", "gold_answer": "adenosylmethionine", "gold_support": "The purified cytochrome can act as a methyl acceptor for a methyltransferase activity in the cell extract that uses S-adenosylmethionine as methyl donor.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 599, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides additional context about the SET domain's role in histone methyltransferase activity, though it includes slightly more detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.", "model_answer": "The characteristic domain of histone methyltransferases, as seen in this context, is the SET domain. This domain is crucial for the enzymatic activity of adding methyl groups to histones, particularly in processes like gene silencing mediated by the Polycomb group proteins.\n\nAnswer: SET domain", "model_support": "The supporting sentence is: \"Based on known SET domain structures, the mutations likely affect either the lysine-substrate binding pocket, the binding site for the adenosylmethionine methyl donor, or a critical tyrosine predicted to interact with the substrate lysine epsilon-amino group.\"", "retries": 1}
{"idx": 600, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard, but the supporting sentence is completely irrelevant to the question and does not cover the gold answer. The provided sentence discusses JTV519 and its effects on RyR2s, which has no connection to Orteronel or CYP17A1.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "CYP17A1", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 601, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '(-)-medicarpin,' matches the gold standard 'medicarpin' in identifying the major phytoalexin in alfalfa, though it includes additional stereochemical detail not required by the gold answer. The supporting sentence is relevant and covers the answer logically but contains slight redundancy by elaborating on the role of isoflavone reductase (IFR) rather than directly quoting the simpler gold supporting sentence. This makes the explanation more detailed than necessary, warranting a score of 4.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa is (-)-medicarpin.", "model_support": "The supporting sentence is: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\" This sentence directly identifies (-)-medicarpin as the product of the enzyme IFR, which is crucial in phytoalexin biosynthesis in alfalfa.", "retries": 1}
{"idx": 602, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides additional useful context, but it includes some extra details about pHMMs and future studies that are not strictly necessary to directly support the answer, making it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for the identification of chorion proteins in Lepidopteran proteomes is **LepChorionDB**.", "model_support": "The supporting sentence is: \"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins.\"", "retries": 1}
{"idx": 603, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard but is slightly more verbose than necessary. The supporting sentence does not directly explain the role of BCR-ABL or its connection to Imatinib as clearly as the gold supporting sentence. Instead, it discusses alternative treatments and drug resistance, which is relevant context but less focused and precise compared to the gold standard.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive CML is **BCR-ABL**.", "model_support": "The supporting sentence is:\n\n\"Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance, a cocktail therapy of different kinase inhibitors and additional chemotherapeutics may be needed for complete remission of CML in some cases.\"", "retries": 1}
{"idx": 604, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that BACH1 acts as a repressor by mentioning its role in repressing MARE-dependent gene expression. There is no redundancy or unnecessary information.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcription factor Bach1 heterodimerizes with small Maf proteins to repress MARE-dependent gene expression.", "model_answer": "BACH1 is a repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor. \n\nSupporting sentence: The transcription factor Bach1 heterodimerizes with small Maf proteins to repress Maf recognition element (MARE)-dependent gene expression.", "retries": 1}
{"idx": 605, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard, correctly identifying alpha-synuclein as the main component of Lewy bodies. However, the supporting sentence is somewhat off-topic, as it refers to multiple system atrophy rather than Parkinson's disease or Lewy body dementia, which are more directly relevant to the question. The logic connecting the supporting sentence to the answer is reasonable but could be more precise and concise.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of the Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.\" This sentence explicitly states that alpha-synuclein is the main component of Lewy bodies, as it forms the inclusions characteristic of alpha-synucleinopathies.", "retries": 1}
{"idx": 606, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A' vs. '5-HT2A receptors'), and the supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by stating the specific purpose of using [18F]altanserin to evaluate 5-HT2A receptors. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or relevance.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.\n\nAnswer: 5-HT2A receptors", "model_support": "The sentence that supports the answer is:\n\n\" PURPOSE: To determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.\"\n\nThis sentence directly states the purpose of the study, which is to evaluate 5-HT2A receptors using [18F]altanserin.", "retries": 1}
{"idx": 607, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is more specific than the gold answer by mentioning 'transvaginal ultrasound,' but it is still correct and aligns with the context provided. The supporting sentence is relevant and captures the essence of the method used (transvaginal ultrasound), but it includes additional details about its sensitivity and use in diagnosing detrusor instability, making it slightly redundant for the given question.\", \"match\": true}", "gold_answer": "ultrasound", "gold_support": "OBJECTIVE: To determine whether transvaginal ultrasound measurement of bladder wall thickness can be used as a screening test for detrusor instability in women with urinary symptoms.", "model_answer": "Bladder wall thickness is measured using transvaginal ultrasound.", "model_support": "The supporting sentence is:  \n\"The measurement of a mean bladder wall thickness greater than 5 mm with transvaginal ultrasound is a sensitive screening method for diagnosing detrusor instability in symptomatic women without outflow obstruction.\"", "retries": 1}
{"idx": 608, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence is relevant and provides logical support by referencing antiparallel spectrin dimers. However, it contains slight redundancy by elaborating on specific repeats (HEalpha1,2 and HEalpha2,3) that are not directly mentioned in the gold supporting sentence, making it less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Two of the less stably folded fragments, human erythroid alpha-spectrin repeats 13 and 14 (HEalpha13,14) and human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel spectrin dimers.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The supporting sentence is: \"More stably folded fragments, human erythroid alpha-spectrin repeats 1 and 2 (HEalpha1,2) and human erythroid alpha-spectrin repeats 2 and 3 (HEalpha2,3), lie nearly opposite each other on antiparallel spectrin dimers of a tetramer.\"\n\nThis sentence indicates that alpha-spectrin repeats form antiparallel structures with beta-spectrin, confirming the formation of antiparallel heterodimers.", "retries": 1}
{"idx": 609, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ZEB2', does not match the gold standard 'SIP-1', but it is present in the context as an alternative name for the same gene. The supporting sentence is relevant and correctly identifies ZEB2 as associated with Mowat-Wilson syndrome, but it does not cover the specific gold answer 'SIP-1'. Therefore, while correct in a broader sense, it fails to fully align with the gold standard.\", \"match\": false}", "gold_answer": "SIP-1", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is **ZEB2**.", "model_support": "The sentence that supports the answer is: \"This report, the first such analysis in North American patients, adds to the growing list of both novel pathogenic mutations associated with MWS, as well as other variants in the ZEB2 gene.\" \n\nThis sentence explicitly mentions ZEB2 gene variants associated with Mowat-Wilson syndrome (MWS), confirming that ZEB2 is responsible for the development of MWS.", "retries": 1}
{"idx": 610, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains slight redundancy by discussing bone contaminants and chemical pretreatment, which are not directly necessary to support the role of collagen in dating and species identification. The logic is sound, but the sentence could be more concise.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "Collagen is the most suitable fraction and is the material normally used in radiocarbon dating.", "model_answer": "The bone protein used in archaeology for dating and species identification is collagen.", "model_support": "The supporting sentence is: \"Bone contaminants can strongly alter the carbon isotopic fraction values of the samples, so chemical pretreatment for (14)C dating by accelerator mass spectrometry (AMS) is essential.\"\n\nThis sentence highlights the importance of extracting and treating collagen, a bone protein, for 14C dating, confirming its role in archaeological dating and species identification.", "retries": 1}
{"idx": 611, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (specific hormones like T3, T4, and TSH) not explicitly mentioned in the gold answer, which only specifies 'thyroid.' The supporting sentence refers to measurements of thyroid hormone levels and related tests, which supports the answer but is somewhat lengthy and mixes in extra procedural information. While the logic connecting the supporting sentence to the answer is reasonable, it could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are hypothyroidism (low levels of thyroid hormones such as T3 and T4) and elevated levels of TSH.", "model_support": "The supporting sentence is: \"For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scintigraphy were conducted.\"\n\nThis sentence indicates that thyroid hormone levels, including T3, T4, and TSH, were measured, which aligns with the characteristic abnormalities of hypothyroidism and elevated TSH in Pendred syndrome.", "retries": 1}
{"idx": 612, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with a minor addition of '1,4-', which is acceptable as it provides more specific detail without altering the core meaning. The supporting sentence is relevant and covers the answer, but it introduces extra information about JTV519 being a multi-channel blocker and its effects on RyR2s and SR Ca²⁺ leak, which is not directly necessary to support the answer. This makes the supporting sentence slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The sentence that supports the answer is:  \n*In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.*", "retries": 1}
{"idx": 613, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While the model's supporting sentence includes a bit more context ('The p53 tumor suppressor protein has long been recognized as the central factor protecting humans from cancer'), this additional detail does not detract from the clarity or correctness of the response, and the key information aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The p53 tumor suppressor protein has long been recognized as the central factor protecting humans from cancer. It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.\"", "retries": 1}
{"idx": 614, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer incorrectly refers to 'Friedreich's ataxia (FSHD)', which is a confusion of two different diseases. The correct disease, as per the gold standard, is FSHD (facioscapulohumeral muscular dystrophy). The supporting sentence is relevant but does not correct the error in the answer and fails to directly clarify that FSHD is the condition associated with DUX4 ectopic expression. Thus, while the context provided is somewhat related, it doesn't fully support the gold answer due to the incorrect naming in the answer itself.\",\n  \"match\": false\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **Friedreich's ataxia (FSHD)**.", "model_support": "The supporting sentence is:\n\n\"FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.\"\n\nThis sentence directly connects Friedreich's ataxia (FSHD) with the ectopic expression of the DUX4 protein, as it highlights that FSHD results from the inefficient repression of the retrotransposed gene DUX4 within a macrosatellite repeat array.", "retries": 1}
{"idx": 615, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking alpha-synuclein to the pathogenesis of DLB, which involves Lewy bodies. However, it introduces additional information about differential expression of isoforms that is not directly necessary to support the answer, making it slightly redundant.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"These results show differential overexpression of alpha-synuclein 112 in DLB, a finding that could be of importance in DLB pathogenesis.\" This suggests that alpha-synuclein is a key component involved in the pathogenesis of DLB, which is characterized by the presence of Lewy bodies.", "retries": 1}
{"idx": 616, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Benserazide', does not match the gold standard, which is 'L-Dopa'. However, the supporting sentence is relevant as it mentions the co-administration of JL-18 with L-Dopa/benserazide, indirectly acknowledging the relationship between benserazide and L-Dopa. Despite this, the supporting sentence does not directly support the correct answer ('L-Dopa') and instead emphasizes benserazide, leading to a lower score.\", \"match\": false}", "gold_answer": "L-Dopa", "gold_support": "They were injected subcutaneously (s.c.) with L-Dopa methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-Dopa/benserazide) alone or in combination with JL-18 (at the doses of 0.1, 0.3, or 0.9 mg/kg, s.c.).", "model_answer": "Benserazide", "model_support": "The supporting sentence is: \"Co-administration of JL-18, at low doses with L-Dopa/benserazide, produced a dose-dependent reduction in L-Dopa-induced dyskinesias without a parallel return to parkinsonism.\"\n\nThis sentence explicitly states that JL-18 was co-administered with L-Dopa/benserazide, confirming that benserazide is a co-administered drug as part of the study.", "retries": 1}
{"idx": 617, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'the transcribed strand' as the target of transcription-coupled repair (TCR). The supporting sentence is concise, directly relevant, and logically explains that TCR focuses on the transcribed strand by highlighting the role of stalled RNA polymerase at sites of DNA damage. This aligns well with the gold supporting sentence in identifying the transcribed strand as the key target of TCR.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "The transcription-coupled repair (TCR) specifically targets the transcribed strand of active genes. This is because TCR relies on the RNA polymerase II complex, which stalls at DNA damage sites in the transcribed strand, facilitating the recruitment of repair proteins to address the damage there. \n\nAnswer: transcribed strand", "model_support": "The supporting sentence that directly indicates which gene strand is targeted by transcription-coupled repair (TCR) is:\n\n\"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage.\"\n\nThis sentence explicitly states that TCR targets the transcribed strand of active genes, as the RNA polymerase stalls at damage sites in this region, facilitating repair.\n\n**Answer:** The transcription-coupled repair (TCR) specifically targets the transcribed strand of active genes. This is because TCR relies on the RNA polymerase II complex, which stalls at DNA damage sites in the transcribed strand, facilitating the recruitment of repair proteins to address the damage there. \n\n**Supporting sentence:** An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage.", "retries": 1}
{"idx": 618, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the inheritance pattern of myotonic dystrophy as autosomal dominant, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Dystrophic myotonia is a sufficiently rare disease inherited mainly by the autosomal dominant type.", "model_answer": "Myotonic dystrophy is inherited in an **autosomal dominant** manner.", "model_support": "The supporting sentence is: \"Myotonic dystrophy is inherited in an autosomal dominant manner.\" This directly answers the question about the inheritance pattern of myotonic dystrophy.", "retries": 1}
{"idx": 619, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer mentions specific abnormalities (subclinical and overt hypothyroidism), which are correct but more detailed than the gold answer ('thyroid'). The supporting sentence is relevant and supports the answer by providing specific data from the study. However, it could be considered somewhat lengthy and includes details not strictly necessary to support the broader concept of 'thyroid' abnormalities as in the gold answer. Therefore, while logical and mostly concise, the answer and supporting sentence could align more closely with the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "Subclinical and overt hypothyroidism are common hormone abnormalities in Williams syndrome.", "model_support": "**Answer:**  \nSubclinical and overt hypothyroidism are common hormone abnormalities in Williams syndrome.  \n\n**Supporting sentence:** Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).", "retries": 1}
{"idx": 620, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Zfhx1b' matches the gold standard 'ZFHX1B' in terms of content, as it refers to the same gene with a minor difference in formatting (case sensitivity). The supporting sentence is relevant and connects the mutation in Zfhx1b to features resembling Mowat-Wilson syndrome. However, it does not explicitly mention the role of heterozygous mutations or provide the broader clinical context seen in the gold supporting sentence, making it slightly less comprehensive.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is Zfhx1b.", "model_support": "The supporting sentence is:\n\n\"These mutant mice display craniofacial and gastrointestinal malformations that show resemblance to those found in human patients with Mowat-Wilson syndrome.\"\n\nThis sentence directly connects the mutation in Zfhx1b to the development of Mowat-Wilson syndrome by highlighting the resemblance between the mouse model and human patients.", "retries": 1}
{"idx": 621, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'CaN' is correct and matches the gold standard 'phosphatase 2B' since CaN is another name for calcineurin, which is phosphatase 2B. The supporting sentence is relevant and provides accurate reasoning by linking CaN to the dephosphorylation and activation of NFAT. However, it introduces slight redundancy by elaborating on NFAT nuclear localization, which, while correct, makes the sentence slightly more verbose than necessary.\", \"match\": true}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "The calcium/calmodulin dependent protein phosphatase involved in the activation of NFAT transcription factors is **CaN**.", "model_support": "The sentence that supports the answer is: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\" This sentence explicitly states that CaN, a calcium/calmodulin dependent protein phosphatase, is responsible for dephosphorylating NFAT, which is essential for its activation and nuclear localization.", "retries": 1}
{"idx": 622, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information about medicarpin being a major secondary metabolite in alfalfa; however, it does not directly mention the rapid accumulation of medicarpin in response to elicitor treatment, which is central to the gold supporting sentence. While logical and related, the supporting sentence could be more precise.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "The major phytoalexin in alfalfa is **medicarpin**.", "model_support": "The supporting sentence is: \"The isoflavonoid conjugates medicarpin-3-O-glucoside-6''-O-malonate (MGM), afrormosin-7-O-glucoside (AG), and afrormosin-7-O-glucoside-6''-O-malonate (AGM) were isolated and characterized from cell suspension cultures of alfalfa (Medicago sativa L.), where they were the major constitutive secondary metabolites.\" This sentence establishes that these conjugates, including medicarpin, are the major secondary metabolites in alfalfa, supporting medicarpin as a key phytoalexin.", "retries": 1}
{"idx": 623, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. It incorrectly describes a congenital brain malformation affecting the brainstem, cerebellum, and spinal cord, which is not characteristic of Dyke-Davidoff-Masson syndrome. The correct answer is 'cerebral hemiatrophy.' The supporting sentence is relevant to the context of brain malformations but does not cover the gold answer or align with the correct characteristic feature. Therefore, while the model answer is present in the broader context of brain disorders, it fails to address the specific feature of this syndrome.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is the presence of a specific congenital brain malformation affecting the brainstem, cerebellum, and sometimes the spinal cord, which leads to the associated clinical symptoms.", "model_support": "The supporting sentence is: \"The characteristic feature of Dyke-Davidoff-Masson syndrome is the presence of a specific congenital brain malformation affecting the brainstem, cerebellum, and sometimes the spinal cord, which leads to the associated clinical symptoms.\"", "retries": 1}
{"idx": 624, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'the coding strand,' does not match the gold standard, 'the transcribed strand.' While the supporting sentence provided by the model is relevant and mentions TCR in the context of active genes, it does not directly support the specific answer given by the model. Furthermore, the supporting sentence mixes information about CS fibroblasts without clearly linking it to the correct strand targeted by TCR. Hence, the answer is incorrect, and the supporting sentence fails to cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "The coding strand is targeted by transcription-coupled repair (TCR).", "model_support": "The supporting sentence is: CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes.\n\nThe gene strand targeted by transcription-coupled repair (TCR) is the coding strand, as TCR occurs during the transcription of active genes, affecting the strand that is being transcribed into mRNA.", "retries": 1}
{"idx": 625, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('autosomal dominant'). However, the supporting sentence is incorrect because it claims there is no supporting sentence in the context, while the context explicitly states that DM2 is an 'autosomal dominant' disorder in the BACKGROUND section. Despite this, the model answer itself is correct.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "BACKGROUND: Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant pattern.", "model_support": "The context provided does not include a sentence that explicitly states the inheritance pattern of myotonic dystrophy. Therefore, there is no supporting sentence within the given text to confirm that myotonic dystrophy is inherited in an autosomal dominant pattern.\n\nAnswer: There is no supporting sentence in the context provided to indicate that myotonic dystrophy is inherited in an autosomal dominant pattern.", "retries": 1}
{"idx": 626, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Hypothyroidism' is very close to the gold standard 'thyroid,' as hypothyroidism directly relates to thyroid dysfunction. However, 'thyroid' is a more general and accurate term given the context of the question. The supporting sentence provided by the model is relevant and supports the answer logically, though it focuses on subclinical hypothyroidism rather than the broader thyroid abnormalities highlighted in the gold supporting sentence. Slight redundancy exists in the model’s supporting sentence but overall, it captures the essence of the issue.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "The hormone abnormality commonly associated with Williams syndrome, as indicated by the context, is related to the thyroid hormones. Patients may exhibit subclinical hypothyroidism, characterized by an exaggerated and prolonged TSH response to TRH and an altered TSH bioactivity to immunoreactivity ratio, suggesting issues with TSH regulation. This is similar to conditions involving hypothalamic hypothyroidism, implying a possible hypothalamic origin for these thyroid abnormalities. Therefore, the primary hormone issue in Williams syndrome relates to the thyroid axis, particularly affecting TSH function. \n\nAnswer: Hypothyroidism", "model_support": "The supporting sentence is: \"TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism.\" This sentence directly indicates that there is an abnormal TSH response, leading to the diagnosis of hypothyroidism in Williams syndrome.", "retries": 1}
{"idx": 627, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides detailed information about tofacitinib's potency in clinical studies for rheumatoid arthritis, which supports the answer well. However, it includes additional details (e.g., ED50 values and confidence intervals) that are not strictly necessary to justify the answer, making it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis mentioned in the context is tofacitinib.", "model_support": "The supporting sentence is: \"Tofacitinib potency (ED50) in clinical studies was ~3.5 mg BID (90% confidence interval: 2.3, 5.5) or total Cave50 of ~40 nM, derived using Disease Activity Scores from patients with RA.\" This explicitly mentions tofacitinib's use in clinical trials for rheumatoid arthritis, indicating its approval for this treatment.", "retries": 1}
{"idx": 628, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'). The supporting sentence is relevant and covers the answer by correctly identifying betrixaban as an inhibitor of factor Xa. However, it contains slight redundancy and verbosity, as it explains the inference process without directly quoting the concise and explicit information available in the context. A more direct reference to the sentence stating that betrixaban is a specific direct inhibitor of factor Xa would have improved conciseness.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence for the statement that betrixaban inhibits factor Xa is not explicitly present in the provided context. However, based on the information that betrixaban is a new oral anticoagulant with a unique pharmacokinetic profile, it can be inferred that it inhibits factor Xa, as this is a characteristic of such drugs. While the context does not detail the exact mechanism, the classification of betrixaban as an oral anticoagulant aligns with its function in preventing blood clots by targeting factor Xa.", "retries": 1}
{"idx": 629, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks about the tumor suppressor known as 'the guardian of the genome,' and the correct answer is 'p53,' as stated in the gold answer. However, the model's answer refers to 'JTV519,' which is unrelated to the context of tumor suppressors or p53. Additionally, the supporting sentence provided by the model discusses JTV519's role as a benzothiazepine derivative, which does not support the gold answer. Both the answer and supporting sentence are incorrect and off-topic.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 630, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SET domain'), but it includes additional information about the enzymatic catalysis, which is not strictly necessary. The supporting sentence is relevant and supports the answer by mentioning both the chromodomain and the SET domain, but it does not directly reference the key evidence from the gold supporting sentence that mutations impair activity despite an intact SET domain. This makes the reasoning slightly less precise than the gold standard.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Deletion of the chromodomain or point mutation of the conserved amino acids, W64A or W67A, of SUV39H1 impaired enzyme activity despite the presence of an intact catalytic SET domain.", "model_answer": "The characteristic domain of histone methyltransferases is the SET domain, which is responsible for the enzymatic catalysis of histone methylation.", "model_support": "The supporting sentence is: \"SUV39H1 utilizes both the chromodomain and the SET domain for catalysis.\" This sentence directly states that SUV39H1, a histone methyltransferase, uses the SET domain in its catalytic process.", "retries": 1}
{"idx": 631, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to mention 'growth hormone deficiency' explicitly, which is critical for matching the gold standard.\",\n  \"match\": false\n}", "gold_answer": "growth hormone", "gold_support": "Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients.", "model_answer": "The context does not explicitly mention a hormone deficiency associated with Costello syndrome. However, mutations in HRAS, part of the Ras signaling pathway, may indirectly affect growth hormone or insulin-like growth factor (IGF) signaling, though this is speculative and not directly supported by the provided information. \n\nAnswer: The context does not specify a hormone deficiency implicated in Costello syndrome.", "model_support": "The context does not specify a hormone deficiency implicated in Costello syndrome.\n\nSupporting sentence: The context does not explicitly mention a hormone deficiency associated with Costello syndrome. However, mutations in HRAS, part of the Ras signaling pathway, may indirectly affect growth hormone or insulin-like growth factor (IGF) signaling, though this is speculative and not directly supported by the provided information.", "retries": 1}
{"idx": 632, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard ('p53'), but the supporting sentence is completely irrelevant to the question and does not support the answer. The provided sentence discusses JTV519 and its effects on RyR2s and SR Ca²⁺ leak, which has no connection to p53 or its role as 'the guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 633, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it only mentions five N-terminal isoforms without clarifying that there are seven TAp73 isoforms specifically.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The study identifies five N-terminal isoforms of p73, including TAp73, DeltaNp73, DeltaN'p73, Ex2p73, and Ex2/3p73. Therefore, only one TAp73 isoform has been identified in humans.\n\nAnswer: 1", "model_support": "Supporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "retries": 1}
{"idx": 634, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Euclidean distance', does not match the gold standard 'delta-distance'. However, the concept of measuring differences in genomic signatures is related to the context. The supporting sentence acknowledges that the context does not support the model's answer and correctly identifies that delta-distance is discussed in the context as the commonly used measure. Despite this, the supporting sentence does not cover the gold answer directly, leading to a lower score.\", \"match\": false}", "gold_answer": "delta-distance", "gold_support": "The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.", "model_answer": "The most common measure of differences between dinucleotide relative abundance, or genomic signatures, is the **Euclidean distance**. This is because it provides a straightforward way to compare high-dimensional data, such as the frequencies of each dinucleotide in a vector space. Each dimension of the vector corresponds to a specific dinucleotide, and the distance between two vectors reflects how different their genomic signatures are.\n\nAnswer: Euclidean distance", "model_support": "The context provided does not explicitly mention or support the use of Euclidean distance as the most common measure for differences in dinucleotide relative abundance. While the context discusses Mahalanobis distance and delta-distance as methods for comparing genomic signatures, it does not reference Euclidean distance. Therefore, the answer is based on external knowledge, and the context does not provide a supporting sentence for this measure.", "retries": 1}
{"idx": 635, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The question asks about the ion antiporter/exchanger that SEA0400 inhibits, which is the Na(+)/Ca(2+) exchanger according to the gold answer. However, the model incorrectly provides '1,4-benzothiazepine' as the answer, which pertains to a different molecule (JTV519) and not SEA0400. Additionally, the supporting sentence discusses JTV519 instead of SEA0400, making it irrelevant to the gold answer and question.\", \"match\": false}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 636, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer verbatim, it still aligns well with the gold supporting sentence in terms of relevance and conciseness.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "Botulism is a disease characterized by neuromuscular paralysis and is produced from botulinum neurotoxins (BoNTs) found within the Gram positive bacterium Clostridium botulinum.", "model_answer": "The most known bacterium responsible for botulism is *Clostridium botulinum*.", "model_support": "The supporting sentence is: \"The most known bacterium responsible for botulism is *Clostridium botulinum*.\"", "retries": 1}
{"idx": 637, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it focuses on a specific detail (methylation process) rather than directly quoting the more concise and clear gold supporting sentence. This makes it slightly less ideal despite being logical and correct.\", \"match\": true}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The sentence that supports the answer is: \"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\" This directly identifies medicarpin as a key phytoalexin in alfalfa, resulting from the methylation process discussed in the context.", "retries": 1}
{"idx": 638, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'beta-Trcp', is correct but incomplete compared to the gold standard 'SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)'. The supporting sentence provided by the model is entirely irrelevant to the question and does not support the answer. It discusses a completely unrelated topic (JTV519 and RyR2s), which makes it incorrect and illogical in this context.\",\n  \"match\": false\n}", "gold_answer": "SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of IFNAR1 is beta-Trcp.\n\nAnswer: beta-Trcp", "model_support": "The supporting sentence that answers the question is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 639, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking ZFHX1B mutations to malformations, which aligns with the gold supporting sentence. However, the model's supporting sentence is slightly less direct than the gold supporting sentence, as it does not explicitly mention 'severe mental retardation' or 'multiple congenital defects,' which are key aspects of the syndrome. This makes it somewhat less comprehensive, but the logic is still strong.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "ZFHX1B mutations cause a complex developmental phenotype characterized by severe mental retardation (MR) and multiple congenital defects.", "model_answer": "The gene responsible for the Mowat-Wilson syndrome is ZFHX1B.", "model_support": "The sentence that supports the answer is:\n\n\"Thus, as well as causing neural defects, ZFHX1B mutations may also cause other malformations.\"\n\nThis sentence directly links ZFHX1B to the Mowat-Wilson syndrome by indicating that mutations in ZFHX1B can cause not only neural defects but also other malformations, thus establishing its role in the syndrome.", "retries": 1}
{"idx": 640, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly indirect and less comprehensive compared to the gold supporting sentence. It mentions BCR-ABL in the context of resistance rather than directly describing it as the target of Imatinib, which makes it less ideal despite being logically connected.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is characterised by the occurrence of the Philadelphia (Ph) chromosome (9/22 translocation) and the formation of a fusion protein--the BCR-ABL transcript with constitutive activation of the BCR-ABL tyrosine kinase and consequent changes in the intracellular signal transduction, which is responsible for the deregulated myeloid cell proliferation.", "model_answer": "The target tyrosine kinase is BCR-ABL. \n\nAnswer: BCR-ABL", "model_support": "The sentence that supports the answer is:\n\n\"the development of resistance owing to reactivation of the BCR-ABL signal transduction.\"\n\nThis sentence explicitly mentions BCR-ABL as the target tyrosine kinase involved in the leukemia, confirming that Imatinib targets this enzyme.", "retries": 1}
{"idx": 641, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, as 'stroke' is the disorder the ROSIER scale is used for. However, the model's answer is more verbose than necessary, providing additional context ('recognizing and diagnosing acute stroke in the emergency room setting') that, while correct, is not required by the gold standard. The supporting sentence is relevant and supports the answer well but contains slight redundancy by rephrasing information from the context. Overall, it provides good logical support but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing and diagnosing acute stroke in the emergency room setting.", "model_support": "The supporting sentence that aligns with the answer is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\" \n\nThis sentence explicitly states the purpose of the ROSIER scale, which is to recognize and diagnose acute stroke in the emergency room setting.", "retries": 1}
{"idx": 642, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, though it includes 'Sodium glucose co-transporter 2 (SGLT2)' which is slightly more detailed than the gold answer but still correct. The supporting sentence is relevant and supports the answer logically, though it does not directly quote the gold supporting sentence. It introduces a broader context by mentioning that SGLT2 inhibition is a treatment for T2DM, which adds slight redundancy but remains accurate and relevant.\", \"match\": true}", "gold_answer": "sodium glucose co-transporter 2", "gold_support": "The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies.", "model_answer": "The mechanism of action of Canagliflozin is inhibition of the Sodium glucose co-transporter 2 (SGLT2).", "model_support": "The sentence that supports the answer is: \"Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM).\" This directly identifies Canagliflozin's mechanism of action as inhibiting the Sodium glucose co-transporter 2 (SGLT2).", "retries": 1}
{"idx": 643, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The correct answer is 'Fungi', as microsporidia were reclassified to belong to the Fungi kingdom based on protein sequence evidence. The supporting sentence provided by the model discusses Haplosporidia and metchnikovellids being placed in the phylum Sporozoa, which is irrelevant to the classification of microsporidia within Fungi. While the context includes Protozoa, the model fails to use the relevant information about Microsporidia's inclusion in Fungi due to their relation to conventional fungi.\",\n  \"match\": false\n}", "gold_answer": "Fungi", "gold_support": "The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.", "model_answer": "Microsporidia belong to the Protozoa kingdom according to the current classification scheme.", "model_support": "The sentence that supports the answer is: \"Haplosporidia and the (formerly microsporidian) metchnikovellids are now both placed within the phylum Sporozoa.\"\n\nThis sentence specifically states that microsporidia, now referred to as Haplosporidia and metchnikovellids, are classified within the phylum Sporozoa, which is part of the Protozoa kingdom.", "retries": 1}
{"idx": 644, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that there is no specific supporting sentence in the provided context, the gold supporting sentence shows that a concise and directly relevant sentence was indeed available in the background. The model's answer is correct, and had it cited the gold supporting sentence, it would have been ideal. However, since the scoring focuses on the answer and relevance of reasoning, the output still deserves full points.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND/AIM: Imatinib mesylate, a tyrosine kinase inhibitor with specific activity against the breakpoint cluster region--Abelson murine leukemia (BCR-ABL) tyrosine kinase has been developed for treatment of chronic myelogenous leukemia (CML).", "model_answer": "The target tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL. Imatinib (Gleevec) specifically inhibits this kinase. \n\nAnswer: BCR-ABL", "model_support": "The context provided does not contain a specific sentence that directly supports the assertion that Imatinib (Gleevec) targets the BCR-ABL tyrosine kinase. The study focuses on the clinical effects and outcomes of Imatinib treatment in chronic myelogenous leukemia (CML) patients but does not explicitly mention the molecular target of Imatinib. Therefore, the supporting sentence for this answer is not present within the given context.", "retries": 1}
{"idx": 645, "gptscore_json": "{\"score\": 2, \"reason\": \"The model answer does not match the gold standard ('Jnk') but is present in the context as a general reference to MAP kinase. The supporting sentence is relevant but does not cover the gold answer specifically, as it mentions MAP kinase phosphorylating c-jun without specifying Jnk.\", \"match\": false}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "The MAP kinase, specifically part of the ERK family (such as ERK1 or ERK2), phosphorylates the transcription factor c-jun as part of the signal transduction pathway.\n\nAnswer: The MAP kinase phosphorylates c-jun.", "model_support": "The supporting sentence is: \"These substrates include transcription factors that are regulated by MAP kinase phosphorylation (e.g., Elk-1, c-Myc, c-Jun, c-Fos, and C/EBP beta).\" This sentence explicitly lists c-jun as a transcription factor phosphorylated by MAP kinase.", "retries": 1}
{"idx": 646, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'acute stroke' is very close to the gold standard 'stroke,' and the difference is minor. The supporting sentence is relevant and covers the answer well but contains slight redundancy by specifying 'acute stroke' rather than just 'stroke,' which slightly deviates from the gold standard. Overall, the logic is strong and directly supports the answer.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for acute stroke.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\" This directly indicates that the ROSIER scale is used for acute stroke.", "retries": 1}
{"idx": 647, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it introduces slight redundancy by mentioning TA-p73 and p63, which are not necessary to directly support the specific role of p53 as 'the guardian of the genome.' The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The supporting sentence is: \"The tumor suppressor p53 homologues, TA-p73, and p63 have been shown to function as tumor suppressors.\" This sentence establishes p53 as a tumor suppressor, known as \"the guardian of the genome,\" even though the context focuses on its homologues TA-p73 and p63.", "retries": 1}
{"idx": 648, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but uses a simplified term 'PCSK9' instead of the full name 'proprotein convertase subtilisin/kexin type 9.' The supporting sentence is somewhat lengthy and mixes relevant information with additional details about Evolocumab’s therapeutic effects, which are not necessary to directly support the answer. While the logic is reasonable, the supporting sentence could be more concise.\",\n  \"match\": false\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.", "model_answer": "Evolocumab targets the enzyme PCSK9, which is involved in the degradation of low-density lipoprotein (LDL) in the liver. By inhibiting PCSK9, Evolocumab helps reduce LDL levels, offering an additional treatment option for patients who need further lipid lowering, especially when statins are insufficient or not tolerated.", "model_support": "The supporting sentence for the answer that Evolocumab targets the enzyme PCSK9 is found in the expert opinion section of the context. It states that Evolocumab inhibits PCSK9, which is involved in the degradation of low-density lipoprotein (LDL) in the liver. This directly identifies the enzyme targeted by Evolocumab.\n\n**Supporting sentence:**  \n\"Evolocumab is an innovative powerful lipid-lowering drug, additive to statins and with an apparently large therapeutic range associated to a low rate of mild adverse events. If available data will be confirmed in long-term trials with strong outcomes, Evolocumab will provide an essential tool to treat high-risk patients who need to reach ambitious LDL-C target.\"", "retries": 1}
{"idx": 649, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is concise and aligns with the gold standard ('Stroke'), though it provides additional context about diagnosing acute stroke and differentiating from mimics. The supporting sentence is relevant and covers the gold answer logically but contains slight redundancy by rephrasing part of the model's answer. Overall, it effectively supports the correct interpretation of the ROSIER scale's purpose.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for diagnosing acute stroke in the emergency room setting. It helps differentiate between stroke and mimickers like seizures or syncope.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"\n\nThis sentence directly states that the ROSIER scale is used to differentiate acute stroke from mimickers like seizures or syncope in the emergency room setting.", "retries": 1}
{"idx": 650, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, ERK, does not match the gold standard, which is c-Jun NH2-terminal kinase (JNK). However, the model's answer is present in the context, as ERK is mentioned. The supporting sentence provided by the model correctly identifies that there is no direct support for ERK phosphorylating c-jun in the context, but it fails to cover the gold answer (JNK). Therefore, while the supporting sentence is relevant in pointing out the lack of evidence, it does not align with the gold answer.\", \"match\": false}", "gold_answer": "c-Jun NH2-terminal kinase", "gold_support": "E2 also attenuated the LPS activation of p38 mitogen-activated protein kinase (MAPK) but not that of extracellular-regulated protein kinase 1/2 (ERK1/2) and c-Jun NH2-terminal kinase (JNK).", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is **ERK (Extracellular signal-regulated kinase)**.", "model_support": "The context provided does not contain a sentence that directly supports the assertion that ERK phosphorylates the transcription factor c-jun. The study focuses on the role of p38 MAPK, NF-κB, and AP-1 in the inhibitory effects of estrogen on nitric oxide production, but it does not mention ERK or c-jun. Therefore, there is no supporting sentence in the given context for this answer.", "retries": 1}
{"idx": 651, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' is completely incorrect and unrelated to the question about the ROSIER scale, which is used for stroke recognition. The supporting sentence is also flawed, as it does not directly support the incorrect answer and instead vaguely references the ROSIER scale’s sensitivity without addressing its application to stroke. This makes both the answer and supporting sentence irrelevant to the gold standard.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided discusses the ROSIER scale, which is used to differentiate acute stroke from stroke mimics in the emergency room setting. The scale is not related to the chemical compound 1,4-benzothiazepine. The supporting sentence for the answer would be:\n\n**Supporting sentence:** The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.\n\nThis sentence indicates that the ROSIER scale is used for assessing and differentiating acute stroke from mimickers, not for any specific disorder related to 1,4-benzothiazepine.", "retries": 1}
{"idx": 652, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa') in essence, though it is slightly more verbose by specifying 'factor Xa' rather than just 'xa'. The supporting sentence provides relevant information about betrixaban being a direct inhibitor of factor Xa and supports the answer logically. However, it contains additional details that, while related to the context, are not strictly necessary to justify the answer, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"The objective is to substitute these indirect inhibitors of factor Xa (heparins, low molecular weight heparins and fondaparinux) in the prevention of venous and arterial thromboembolic episodes. The new direct inhibitors do not require routine laboratory monitoring of blood coagulation. They inhibit the extrinsic and the intrinsic pathways of blood coagulation.\" \n\nThis sentence establishes that betrixaban, along with the other drugs mentioned, is a direct inhibitor of factor Xa.", "retries": 1}
{"idx": 653, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in essence, though it is slightly more verbose. The supporting sentence provides relevant information by mentioning the inhibition of anti-Xa levels, which aligns with the gold supporting sentence. However, it contains slight redundancy and does not directly quote the exact description from the context ('oral direct inhibitor of factor Xa'), leading to a score of 4 instead of 5.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Factor Xa.", "model_support": "The supporting sentence is: \"A dose- and concentration-dependent effect of betrixaban on inhibition of thrombin generation and anti-Xa levels was observed.\"\n\nThis sentence directly states that betrixaban inhibits Factor Xa, as it mentions the inhibition of anti-Xa levels.", "retries": 1}
{"idx": 654, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('XK'), but the supporting sentence provided is completely irrelevant to the question and does not support the answer. The correct supporting sentence should reference the XK gene mutation as described in the gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.\n\nAnswer: XK", "model_support": "The sentence that supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 655, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is incorrect as it states that no relevant information exists in the context, while the gold supporting sentence clearly provides the necessary information from the background section. The model missed identifying the relevant sentence which directly mentions 'anti-interleukin-17A monoclonal antibody'. Despite this, the answer itself is correct.\", \"match\": true}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.", "model_answer": "The molecule targeted by the monoclonal antibody Secukinumab is **interleukin-17A (IL-17A)**.", "model_support": "The context provided does not contain a sentence that directly identifies the molecule targeted by the monoclonal antibody Secukinumab. The study focuses on the administration method and efficacy of Secukinumab for psoriasis but does not explicitly mention the target molecule. Therefore, there is no supporting sentence within the context for this answer.", "retries": 1}
{"idx": 656, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard in identifying 'Experimental Autoimmune Encephalomyelitis (EAE)' as the most widely used model for studying multiple sclerosis. However, the supporting sentence provided by the model is less direct and includes additional details about pharmacological treatments, which are not necessary to support the answer. The gold supporting sentence is more concise and directly relevant to the study of EAE models, making the model's supporting sentence slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "Experimental Autoimmune Encephalomyelitis (EAE)", "gold_support": "The aim of our study was to characterize the sensory abnormalities and in particular the clinical signs linked to persistent pain in two models of Experimental Autoimmune Encephalomyelitis (EAE) in the rat.", "model_answer": "The most widely used model for studying multiple sclerosis (MS) is the experimental autoimmune encephalomyelitis (EAE) model.", "model_support": "The supporting sentence is:  \n\"The second part of our study aimed at characterizing from a pharmacological point of view the most robust model (\"EAE+Cyclosporine\") and showed that Gabapentin, Duloxetine and Tramadol partially relieved some of the clinical signs.\"", "retries": 1}
{"idx": 657, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Mechanistic Target Of Rapamycin') does not match the gold standard ('mammalian target of rapamycin'), although it is a correct alternative name for mTOR. The supporting sentence provided by the model is irrelevant to the question, as it discusses JTV519 and RyR2s, which are unrelated to the definition or context of mTOR. Thus, while the answer is present in the broader context of mTOR knowledge, the supporting sentence fails to align with the gold supporting sentence or provide relevant support.\",\n  \"match\": false\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.", "model_answer": "mTOR stands for Mechanistic Target Of Rapamycin. It is a protein kinase involved in regulating cell growth, proliferation, and survival, functioning as part of two main complexes, mTORC1 and mTORC2, which respond to nutrient availability and control cellular processes.", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 658, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer describes the rash's characteristics but does not directly match the gold answer, 'dermatitis herpetiformis,' which is the name of the condition associated with gluten. The supporting sentence repeats the model's descriptive answer without referencing dermatitis herpetiformis or providing relevant context from the gold supporting sentence. While the description of the rash is correct and related to gluten ingestion, it fails to focus on the specific disease name as required.\", \"match\": false}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is a red, itchy, blistery eruption, often symmetric and found in areas such as the elbows, knees, and lower back.", "model_support": "The supporting sentence is: \"The typical rash associated with gluten is a red, itchy, blistery eruption, often symmetric and found in areas such as the elbows, knees, and lower back.\"", "retries": 1}
{"idx": 659, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A receptor' vs. '5-HT2A'). The supporting sentence is concise, directly relevant, and logically covers the answer by explicitly stating that [18F]altanserin is a ligand for the 5-HT2A receptor. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or accuracy.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "The [18F]altanserin is used to evaluate the 5-HT2A receptor. \n\nAnswer: 5-HT2A receptor", "model_support": "The supporting sentence is: \"Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.\" This sentence explicitly identifies [18F]altanserin as a ligand for the 5-HT2A receptor, confirming its use in evaluating this receptor.", "retries": 1}
{"idx": 660, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, with only a minor difference in capitalization which does not affect correctness. The supporting sentence is relevant and contains the correct definition of mTOR within a broader context. However, it includes slight redundancy by referencing mTORC2 specifically, which is unnecessary for defining mTOR itself.\",\n  \"match\": true\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "The role of the distinct mammalian target of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation and survival in PAH and their therapeutic relevance are unknown.", "model_answer": "mTOR stands for Mammalian Target Of Rapamycin.", "model_support": "The supporting sentence that defines what mTOR stands for is:  \n\"mTORC2 (mammalian target of rapamycin complex 2)\".", "retries": 1}
{"idx": 661, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'Pridopidine' being a dopamine agonist is mentioned in the context, this fact is unrelated to the question about which disorder it has been tested for. The supporting sentence discusses its classification as a dopamine agonist, but this does not cover the gold answer (Huntington disease). Thus, the model's answer is incorrect and the supporting sentence fails to address the correct information.\", \"match\": false}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine is a member of the ergoline class of compounds, specifically a dopamine agonist.", "model_support": "The supporting sentence is: \"ACR16 (pridopidine) is a potent and selective dopamine D3 receptor agonist.\" This sentence explicitly identifies Pridopidine as a dopamine agonist, specifically a member of the ergoline class of compounds.", "retries": 1}
{"idx": 662, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('nuclear'), but the supporting sentence, while relevant and logical, contains additional details about the nuclear import process that are not necessary to directly support the answer. The gold supporting sentence is more concise and directly states the key fact about APOBEC3B's steady-state nuclear localization.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The supporting sentence is: \"Here, we show that A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase).\" This sentence explicitly states that APOBEC3B (A3B) undergoes active nuclear import, indicating it is predominantly found in the nucleus.", "retries": 1}
{"idx": 663, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard, but the supporting sentence is completely irrelevant to the question and gold answer. It discusses a completely unrelated topic (JTV519 and RyR2s) instead of providing any information about LepChorionDB or its use in identifying chorion proteins. The supporting sentence does not cover the gold answer at all.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is the database available for the identification of chorion proteins in Lepidopteran proteomes.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 664, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('nestin'). However, the supporting sentence incorrectly states that there is no supporting information in the context, while the context explicitly mentions nestin as a marker for precursor cells. The correct supporting sentence should have referenced this detail, making the provided support incomplete and slightly misleading despite the accurate answer.\",\n  \"match\": true\n}", "gold_answer": "nestin", "gold_support": "The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats.", "model_answer": "Nestin is the intermediate filament protein used as a non-specific marker for neuronal precursor cells in the subventricular zone.", "model_support": "The provided context does not explicitly mention Nestin or any intermediate filament protein markers related to neuronal precursor cells in the subventricular zone. Therefore, there is no supporting sentence within the given context for Nestin being used as a marker.", "retries": 1}
{"idx": 665, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('xa' for factor Xa) but is present in the context as factor II (prothrombin). The supporting sentence is relevant to anticoagulants but does not specifically cover the gold answer, as it discusses the potential of new compounds without clearly identifying betrixaban as a factor Xa inhibitor. The reasoning provided by the model incorrectly associates betrixaban with factor II inhibition instead of factor Xa.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits **factor II (prothrombin)**.", "model_support": "The supporting sentence is: \"These new compounds have the potential to complement heparins and fondaparinux for short-term anticoagulation and/or to replace VKA for long-term anticoagulation in most patients.\"\n\nThis sentence suggests that betrixaban, as a new oral anticoagulant, has the potential to replace vitamin K antagonists (VKA), which inhibit factor II (prothrombin). Therefore, it implies that betrixaban inhibits factor II, similar to VKAs.", "retries": 1}
{"idx": 666, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK'). The supporting sentence is relevant and covers the answer, but it is slightly more verbose than necessary. It provides additional context about the weak background signal without a specific staining pattern, which, while related, is not as direct as the gold supporting sentence that explicitly states the syndrome is caused by mutations of the XK gene. Overall, the logic is sound, but some redundancy exists.\", \"match\": true}", "gold_answer": "XK", "gold_support": "It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function.", "model_answer": "The mutation associated with McLeod syndrome in the given context is of the **XK gene**.", "model_support": "The supporting sentence is:  \n\"In contrast, there was only a weak background signal without a specific staining pattern for XK and Kell in the McLeod muscle.\"  \n\nThis sentence suggests that the lack of physiological XK expression correlates to the type 2 fiber atrophy in McLeod myopathy, and it directly relates to the association of the XK gene mutation with McLeod syndrome.", "retries": 1}
{"idx": 667, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively highlights that NER activity (and thus TCR) occurs in the transcribed strand, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of genes.\n\nAnswer: transcribed strand", "model_support": "The supporting sentence is: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"\n\nThis sentence indicates that transcription-coupled repair (TCR) targets the transcribed strand of genes, as evidenced by the absence of NER in the non-transcribed strand when Elc1 is deleted.", "retries": 1}
{"idx": 668, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about the database's availability, but it does not fully cover the functionality or description of LepChorionDB as a tool for identifying chorion proteins, which is present in the gold supporting sentence. Thus, while correct, the supporting sentence could be more comprehensive.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is the database available for the identification of chorion proteins in Lepidopteran proteomes.", "model_support": "The supporting sentence is: \"LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\" This sentence directly identifies the database LepChorionDB and mentions its availability, fulfilling the question's requirement.", "retries": 1}
{"idx": 669, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains some redundancy by describing symptoms rather than directly focusing on the synonym. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym for Lubag disease is **X-linked dystonia-parkinsonism**.", "model_support": "Supporting sentence: This disease is characterized by dystonia dominating the first 10-15 years of the disorder, which is associated with or replaced by parkinsonian features in later years of life.", "retries": 1}
{"idx": 670, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('IL-1β'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the mechanism of gevokizumab targeting IL-1β. Minor extra details in the supporting sentence are acceptable as they enhance clarity without introducing unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Gevokizumab targets interleukin-1 beta (IL-1β).", "model_support": "The supporting sentence is: \"gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\" This sentence directly states that Gevokizumab targets interleukin-1 beta (IL-1β).", "retries": 1}
{"idx": 671, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains additional details about pHMMs and future studies, which are not necessary for directly supporting the answer. This makes it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is available for the identification of chorion proteins in Lepidopteran proteomes.", "model_support": "The supporting sentence is:  \n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins. LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\"", "retries": 1}
{"idx": 672, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Serotonin 5-HT2A receptor' matches the gold standard '5-HT2A' exactly in meaning, despite a slight difference in wording. The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin is used for PET studies of the serotonin 5-HT2A receptor, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The receptors that can be evaluated using [18F]altanserin are the serotonin 5-HT2A receptors. \n\nAnswer: Serotonin 5-HT2A receptor", "model_support": "The supporting sentence is: \"the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"\n\nThis sentence explicitly states that [18F]altanserin is used for evaluating the serotonin 5-HT2A receptors in PET studies.", "retries": 1}
{"idx": 673, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer is correct and matches the gold standard 'autosomal dominant,' though it includes additional details about mutation expansion and lack of sex dependence that were not required. The supporting sentence is relevant and covers the answer but contains redundancy by quoting two sentences when one concise sentence could suffice. Despite this, the logic connecting the supporting sentence to the answer is strong.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Myotonic dystrophy type 1 is a neuromuscular, degenerative and progressive disease, with an autosomal dominant pattern of inheritance, variable expressivity and incomplete penetrance.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant pattern, where the mutation can expand in size across generations, often leading to more severe symptoms in successive generations. The inheritance does not depend on the sex of the transmitting parent.", "model_support": "The sentence \"Transmission of the DM1 mutation is sex and size dependent among the Costa Rican patients. There is an important increment in the size of the mutation between generations and there are no differences in mutation size respect to the transmitting sex.\" supports the answer by highlighting the autosomal dominant inheritance pattern, the increase in mutation size across generations, and the lack of sex dependence in mutation transmission.", "retries": 1}
{"idx": 674, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly indirect and does not explicitly mention that HEXA is the gene most commonly mutated in Tay-Sachs disease. Instead, it refers to an investigation of specific mutations without clearly linking them to the HEXA gene as the primary cause, making it less concise and direct compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "HEXA", "gold_support": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.", "model_answer": "The gene most commonly mutated in Tay-Sachs disease is **HEXA**.", "model_support": "The supporting sentence that indicates the gene most commonly mutated in Tay-Sachs disease is: \"To investigate the genetic history of the IJ-specific mutations (C1351G and G749T)...\" This sentence refers to the specific mutations linked to Tay-Sachs disease, which are known to be associated with the HEXA gene.", "retries": 1}
{"idx": 675, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states BACH1 is an activator when the gold standard clearly identifies it as a repressor. The supporting sentence provided by the model is irrelevant and does not logically support the claim that BACH1 is an activator. Instead, it discusses heme-regulated NES and protein sorting, which do not address BACH1's role as a transcriptional repressor. This results in a score of 1 due to the incorrect answer and lack of logical relevance in the supporting sentence.\", \"match\": false}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1 and beta-globin genes, both of which are known to be transcriptionally induced by heme.", "model_answer": "BACH1 is an activator.", "model_support": "The context supports that BACH1 is an activator. When heme synthesis is inhibited, Bach1 accumulates in the nucleus, where it can activate gene expression. This indicates that Bach1 functions as a transcriptional activator. \n\nSupporting sentence: This region functioned as a heme-regulated NES dependent on the exporter Crm1. These results extend the regulatory roles for heme in protein sorting, and suggest that Bach1 transduces metabolic activity into gene expression.", "retries": 1}
{"idx": 676, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin evaluates 5-HT2A receptors. Although it paraphrases rather than directly quoting the context, it still aligns well with the gold supporting sentence in meaning and precision.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "The receptors that can be evaluated using [18F]altanserin are the 5-HT2A receptors. \n\nAnswer: 5-HT2A receptors", "model_support": "The receptors that can be evaluated using [18F]altanserin are the 5-HT2A receptors, as indicated by the context.\n\nSupporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 677, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('fungi'), and the supporting sentence provides relevant information that leads to the correct conclusion. However, the supporting sentence is slightly verbose and includes unnecessary details (e.g., mentioning Eukaryota and discussing what the context does not state), which detracts from conciseness. The logic is sound but could be more direct.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine compounds.", "model_support": "The context provided does not explicitly state the kingdom to which Microsporidia belong. However, it mentions that Microsporidia are part of the fungal tree of life, which suggests they belong to the kingdom **Fungi**. The context does not include a specific sentence confirming their classification within the kingdom of Eukaryota or another taxonomic group. Therefore, based on the information given, Microsporidia are classified within the **Fungal kingdom**.\n\nAnswer: Microsporidia belong to the kingdom **Fungi**.", "retries": 1}
{"idx": 678, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes additional details like specific hormones (T4 and T3) and 'impaired iodine metabolism,' which are not explicitly required by the gold answer ('thyroid'). The supporting sentence is somewhat lengthy, discussing methods of assessment rather than directly pointing out the thyroid abnormalities. It mixes relevant content with procedural details, making it less concise than ideal, though the logic connecting thyroid function and iodine metabolism to Pendred syndrome is reasonable.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome include hypothyroidism, characterized by low levels of thyroid hormones such as thyroxine (T4) and triiodothyronine (T3), and impaired iodine metabolism.", "model_support": "The sentence that supports the answer is: \n\n\"For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted.\"\n\nThis sentence directly indicates that thyroid hormones and iodine metabolism were specifically assessed in the study, confirming the presence of hypothyroidism and impaired iodine metabolism in Pendred syndrome patients.", "retries": 1}
{"idx": 679, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard conceptually by specifying 'Factor Xa,' although it includes additional descriptive information ('a key clotting factor in the intrinsic pathway of blood coagulation') which is not strictly necessary. The supporting sentence is relevant and supports the answer but contains slight redundancy by mentioning the evaluation context rather than directly focusing on betrixaban’s role as an FXa inhibitor. Overall, the logic is sound, and the match to the gold answer is present.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Betrixaban inhibits Factor Xa, a key clotting factor in the intrinsic pathway of blood coagulation.", "model_support": "The supporting sentence is:  \n\"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).\"", "retries": 1}
{"idx": 680, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' can be interpreted as shorthand for 'Factor Xa'). The supporting sentence is relevant and aligns with the context, but it contains slight redundancy by discussing the broader class of anticoagulants rather than directly stating that betrixaban is a factor Xa inhibitor. This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The drug betrixaban is an inhibitor of factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"\n\nThis sentence indicates that betrixaban belongs to the factor Xa inhibitor class, thereby inhibiting factor Xa.", "retries": 1}
{"idx": 681, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin evaluates 5-HT2A receptors by correlating uptake with receptor binding, which aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "[18F]altanserin is used to evaluate 5-HT2A receptors.", "model_support": "The supporting sentence is: \"The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.\" This sentence explicitly states that [18F]altanserin is used to evaluate 5-HT2A receptors by showing a correlation between uptake and receptor binding.", "retries": 1}
{"idx": 682, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by explaining how LepChorionDB was constructed, but it contains slight redundancy by mentioning the use of pHMMs, which is not directly necessary to establish its utility for identifying chorion proteins. Overall, it provides logical support with minor verbosity.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is the database available for the identification of chorion proteins in Lepidopteran proteomes.", "model_support": "The supporting sentence is:  \n\"A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.\"", "retries": 1}
{"idx": 683, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('XK'), but it is slightly more verbose than necessary. The supporting sentence, while relevant, is somewhat lengthy and focuses on the grandson's condition rather than directly stating that mutations in the XK gene cause McLeod syndrome. It mixes relevant information with additional details about the patient's family, which could be more concise.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.", "model_support": "The supporting sentence is: \"This confirms that the patient's 7-year-old grandson, who is currently asymptomatic, also has the XK0 allele and is therefore likely to develop MLS.\"\n\n**Answer:** This confirms that the patient's 7-year-old grandson, who is currently asymptomatic, also has the XK0 allele and is therefore likely to develop MLS.", "retries": 1}
{"idx": 684, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'KX' is very close to the gold standard 'XK', as both refer to the same gene associated with McLeod syndrome. The supporting sentence provides relevant information about the absence of the Kx antigen, which is characteristic of McLeod syndrome, and indirectly points to the KX gene. However, it does not explicitly mention the mapping of the McLeod locus (XK) to the specific region in Xp21, which is more directly stated in the gold supporting sentence. The supporting sentence contains slight redundancy but still supports the answer logically.\", \"match\": true}", "gold_answer": "XK", "gold_support": "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.", "model_answer": "The mutation associated with McLeod syndrome is in the KX gene. \n\nAnswer: KX", "model_support": "The supporting sentence that directly links the KX gene to McLeod syndrome is:\n\n\"McLeod syndrome, characterized by acanthocytosis and the absence of a red-blood-cell Kell antigen (Kx), is a multisystem disorder involving a late-onset myopathy, splenomegaly, and neurological defects.\"\n\nThis sentence explicitly mentions the absence of the Kx antigen, which is a defining characteristic of McLeod syndrome, thereby associating it with the KX gene.", "retries": 1}
{"idx": 685, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that the supporting sentence is based on general knowledge, the gold supporting sentence from the context directly confirms this general knowledge by stating that immunohistochemistry for alpha-synuclein was used to detect Lewy bodies. Thus, the reasoning aligns perfectly with the gold standard, and the support provided in the context is concise and relevant.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).", "model_answer": "The antibody used for immunostaining Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The context provided does not include a specific sentence that directly mentions the antibody used for immunostaining Lewy bodies. However, based on general knowledge, Lewy bodies are typically identified using antibodies raised against alpha-synuclein. Therefore, the answer is:\n\n**Answer:** alpha-synuclein\n\nThere is no supporting sentence in the provided context for this answer, as it is based on general knowledge about the immunostaining of Lewy bodies.", "retries": 1}
{"idx": 686, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it includes the full name for clarity. The supporting sentence is relevant and covers the answer by linking DUX4 expression to FSHD, but it introduces additional details (e.g., 'non-spliced DUX4-fl isoform') that are not necessary to directly support the answer, making it slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is facio-scapulo-humeral dystrophy (FSHD).", "model_support": "The supporting sentence is: \"The DUX4-fl pathogenic transcript was detected in FSHD biopsies but also in controls. Importantly, in FSHD fetuses, we mainly detected the non-spliced DUX4-fl isoform.\" This sentence indicates that DUX4 is ectopically expressed in FSHD, linking it to the disease.", "retries": 1}
{"idx": 687, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as it correctly identifies thyroid hormones (T3 and T4) as being altered in AHDS. However, the mention of 'thiouracil' appears to be an error, as thiouracil is not a hormone but a drug that affects thyroid function. The supporting sentence provides relevant context about MCT8 mutations and their association with AHDS but includes unnecessary details about specific family cases and neurological symptoms, which do not directly support the answer about altered thyroid hormone levels. The logic is reasonable but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels.", "model_answer": "The altered hormone concentrations in patients with the Allan–Herndon–Dudley syndrome (AHDS) are primarily the thyroid hormones, including T3 (triiodothyronine) and T4 (thiouracil). Despite some patients presenting with normal serum T3 levels, the mutation in the MCT8 gene affects the transport of these hormones, particularly T3, across the blood-brain barrier, leading to functional issues even if circulating levels appear normal.", "model_support": "The supporting sentence is:  \n\"Mutations in the MCT8 gene coding for the monocarboxylate thyroid hormone transporter 8 have been associated with AHDS. Here we describe a family with the presence of a MCT8 gene mutation, p.A224T, in three consecutive generations. In two generations its presence was detected in the hemizygous state in two males with neurological abnormalities including mental retardation, axial hypotonia, hypertonia of arms and legs and athetoid movements. One of them presented normal thyroid hormone levels.\"", "retries": 1}
{"idx": 688, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard by correctly identifying 'experimental autoimmune encephalomyelitis (EAE)' as the most widely used model for studying multiple sclerosis. However, the supporting sentence mentions 'Lewis rats' instead of broadly stating mice or directly referencing the EAE model's role in MS research, which introduces slight redundancy and specificity not present in the gold supporting sentence. The logic is sound, but the provided sentence could be more concise and directly aligned with the gold standard.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE) is an animal model for studying multiple sclerosis (MS).", "model_answer": "The most widely used model for studying multiple sclerosis (MS) is the experimental autoimmune encephalomyelitis (EAE) model in mice.", "model_support": "The supporting sentence is:  \n\"To test this hypothesis, acute EAE Lewis rats were treated dose dependently with the calpain inhibitor calpeptin.\"  \nThis sentence explicitly states that the EAE model in mice (Lewis rats are a type of mouse) is used for studying MS.", "retries": 1}
{"idx": 689, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct in identifying that the ROSIER scale is used for stroke recognition, but it is more verbose than necessary and includes extra details not required by the gold standard. The supporting sentence refers to the sensitivity of the ROSIER scale compared to other tools, which is relevant but does not directly align with the gold supporting sentence, which focuses on the development and validation of the ROSIER scale as a stroke recognition instrument. While the logic is reasonable, the supporting sentence could be more concise and directly tied to the purpose of the scale.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for identifying acute stroke in the emergency room setting. It helps differentiate stroke from stroke mimics and is a rapid assessment tool for early recognition.", "model_support": "The supporting sentence is: \"The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.\" This sentence explicitly states that the ROSIER scale is used for identifying acute stroke in the emergency room, demonstrating its effectiveness compared to other tools.", "retries": 1}
{"idx": 690, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains p53's role as the 'guardian of the genome,' aligning well with the gold supporting sentence. Minor additional context in the model's supporting sentence does not detract from its clarity or relevance.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nAnswer: p53", "model_support": "The supporting sentence is: \"A role for p53 in the frequency and mechanism of mutation.\" This sentence establishes p53's role in genomic stability, supporting its function as a guardian of the genome.", "retries": 1}
{"idx": 691, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence acknowledges that the context does not provide the information but incorrectly relies on general knowledge to justify an answer of '1', which is factually wrong. The correct number of TAp73 isoforms, according to the gold answer, is 7. Additionally, the supporting sentence fails to logically support the gold answer or demonstrate relevance to the correct information.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "1 TAp73 isoform has been identified in humans.", "model_support": "The context does not specifically mention the number of TAp73 isoforms identified in humans. However, based on general knowledge, TAp73 is considered a single isoform of the p73 protein. Therefore, the answer is:\n\nAnswer: 1 TAp73 isoform has been identified in humans.", "retries": 1}
{"idx": 692, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for the role of calsequestrin in the sarcoplasmic reticulum, but it contains some redundancy and extends beyond what is necessary to directly support the answer. The chosen supporting sentence could be more concise, as the gold supporting sentence demonstrates by focusing directly on calsequestrin's role as a high-capacity calcium-binding protein.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The supporting sentence is: \"Our data suggest that the arrhythmogenic CASQ2(D307H) mutation impairs SR Ca²⁺ storing and release functions and destabilizes the Ca²⁺-induced Ca²⁺ release mechanism by reducing the effective Ca²⁺ buffering inside the SR and/or by altering the responsiveness of the Ca²⁺ release channel complex to luminal Ca²⁺.\" This sentence is part of the context provided and supports the conclusion that calsequestrin is the main calcium-binding protein of the sarcoplasmic reticulum.", "retries": 1}
{"idx": 693, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct in identifying the 5-HT2A receptors, which matches the gold standard. However, the provided supporting sentence is entirely irrelevant to the question and does not support the answer. It discusses JTV519, which is unrelated to [18F]altanserin or 5-HT2A receptors. The supporting sentence fails to cover the gold answer or provide logical reasoning.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 694, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and supports the answer by indicating that betrixaban inhibits Factor Xa as part of its mechanism. However, it contains slight redundancy by mentioning both extrinsic and intrinsic pathways, which is not directly necessary to justify the specific inhibition of Factor Xa. A more concise explanation could have been provided.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits Factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"They inhibit the extrinsic and the intrinsic pathways of blood coagulation.\" This sentence indicates that betrixaban, along with other drugs mentioned, inhibits Factor Xa.", "retries": 1}
{"idx": 695, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'), but the supporting sentence, while relevant and logical, contains slight redundancy. It discusses R16's structure in detail without directly referencing the heterodimer formation as clearly as the gold supporting sentence. The provided sentence is still accurate but could be more concise.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The supporting sentence is: \"R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.\" This sentence directly describes the antiparallel arrangement of the spectrin repeat, confirming that alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "retries": 1}
{"idx": 696, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe),' is very close to the gold standard 'SAM,' which is an acceptable abbreviation. However, the supporting sentence provided by the model is somewhat off-topic, discussing the conversion of SAMe to MTA and SAH rather than directly stating its role as a methyl donor for histone methyltransferases. While the logic is reasonable, the supporting sentence could be more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "The methyl donor of histone methyltransferases in this context is **S-adenosylmethionine (SAMe)**.", "model_support": "The supporting sentence is: \"SAMe doubles intracellular MTA and S-adenosylhomocysteine (SAH) levels.\" This indicates that SAMe, through its conversion to SAH, serves as the methyl donor for histone methyltransferases.", "retries": 1}
{"idx": 697, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning TCR's role in repairing the transcribed strand, but it contains slight redundancy by introducing details about Cockayne syndrome gene products, which are not necessary to directly support the answer.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of DNA. This strand is the coding (sense) strand from which RNA is transcribed, as TCR addresses damage that arises during transcription to allow the process to resume. \n\nAnswer: transcribed strand", "model_support": "The supporting sentence is: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"\n\nThis sentence clearly indicates that transcription-coupled repair (TCR) specifically targets the transcribed strand of DNA, which is the coding (sense) strand from which RNA is transcribed.", "retries": 1}
{"idx": 698, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'). The supporting sentence is relevant and supports the answer by highlighting DUSP8's interaction with specific JNK isoforms, which aligns with the gold standard. However, it contains slight redundancy by specifying certain JNK isoforms (JNK1β, JNK2α), which adds more detail than necessary compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.", "model_answer": "The protein affected by DUSP8 activation is JNK. DUSP8 (M3/6) dephosphorylates JNK, regulating its activity.", "model_support": "The supporting sentence is: \"M3/6 exhibited stronger binding towards JNK1β and JNK2α isoforms and this was reflected in higher enzymatic activity towards JNK2α2 when compared to JNK1α1 in vitro.\" This sentence demonstrates that DUSP8 (M3/6) binds to and affects the activity of specific JNK isoforms, directly supporting the answer that JNK is the protein affected by DUSP8 activation.", "retries": 1}
{"idx": 699, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model does not directly mention BCR-ABL as the target of Imatinib, which is central to the gold supporting sentence. The chosen supporting sentence discusses newer TKIs rather than explicitly stating the role of BCR-ABL in Imatinib's mechanism. Despite this, the logic connecting Imatinib to its target is still valid, though slightly indirect.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "The discovery of targeted tyrosine kinase inhibition of BCR-ABL kinase dramatically changed the treatment of CML.", "model_answer": "The target tyrosine kinase for Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The supporting sentence in the context is:\n\n\"The newer, more potent TKIs, nilotinib and dasatinib, have demonstrated improved efficacy over imatinib as first-line therapy...\"\n\nThis sentence mentions Imatinib as a tyrosine kinase inhibitor, which is implied to target BCR-ABL in the context of chronic myeloid leukemia. However, the exact mention of BCR-ABL as the target is not explicitly provided in the context.", "retries": 1}
{"idx": 700, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('flumazenil'), but the supporting sentence is irrelevant and does not support the use of flumazenil in benzodiazepine overdose. Instead, it discusses an unrelated compound (JTV519) and its effects on RyR2s and SR Ca²⁺ leak, which has no logical connection to the question or gold answer.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "A 54-y-old man ingested 2 g of bulk laboratory diazepam and was treated with activated charcoal, enhanced diuresis and flumazenil infusion.", "model_answer": "Flumazenil is used as an antidote in benzodiazepine overdose.", "model_support": "The sentence that supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"\n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 701, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence chosen by the model is less direct and relevant compared to the gold supporting sentence. While the model's supporting sentence mentions CASQ2 mutations and their pathological link to arrhythmias, it does not explicitly state that calsequestrin is a high-capacity calcium-binding protein in the sarcoplasmic reticulum, which is critical for directly supporting the answer. The gold supporting sentence provides this information more clearly and concisely.\",\n  \"match\": true\n}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "The main calcium binding protein of the sarcoplasmic reticulum is **calsequestrin**.", "model_support": "The supporting sentence is: \"These results establish at the cellular level the pathological link between CASQ2 mutations and the predisposition to adrenergically mediated arrhythmias observed in patients carrying CASQ2 defects.\"\n\nThis sentence explicitly links CASQ2 mutations (which encode calsequestrin) to arrhythmias, confirming calsequestrin as the main calcium binding protein of the sarcoplasmic reticulum involved in these conditions.", "retries": 1}
{"idx": 702, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard ('EWS/FLI1'), but the supporting sentence is completely irrelevant to the question and does not support the answer. The provided sentence discusses JTV519 and RyR2s, which are unrelated to Ewing sarcoma or the role of EWS/FLI1. Therefore, while the answer is correct, the lack of relevance in the supporting sentence reduces the score significantly.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "The fusion protein involved in the development of Ewing sarcoma is **EWS/FLI1**.", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 703, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard with a slightly different but acceptable phrasing ('Spleen tyrosine kinase (Syk kinase)'). The supporting sentence is relevant and directly ties fostamatinib to being a Syk kinase inhibitor, although it is somewhat less specific than the gold supporting sentence, which explicitly mentions the objective of the study. The minor verbosity in the supporting sentence is acceptable but prevents a perfect score.\",\n  \"match\": true\n}", "gold_answer": "spleen tyrosine kinase", "gold_support": "OBJECTIVE: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies.", "model_answer": "The enzyme inhibited by fostamatinib is **Spleen tyrosine kinase (Syk kinase)**.", "model_support": "The supporting sentence is: \"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.\" This sentence directly identifies fostamatinib as a Syk kinase inhibitor.", "retries": 1}
{"idx": 704, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('lung tissue') does not match the gold standard ('squamous cell carcinoma'). However, the answer is indirectly related to the context as NCI-H520 cells are indeed derived from lung tissue, though more specifically from squamous cell carcinoma. The supporting sentence discusses the lack of explicit information in the context regarding the derivation of the NCI-H520 cell-line, which is accurate but does not directly support the gold answer. The supporting sentence should have highlighted that the NCI-H520 cells were described as squamous cell carcinoma cells in the context.\", \"match\": false}", "gold_answer": "squamous cell carcinoma", "gold_support": "Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population.", "model_answer": "The NCI-H520 cell-line was derived from the lung tissue.", "model_support": "The context does not explicitly mention the derivation of the NCI-H520 cell-line, but it focuses on lung cancer tissues and the expression of Musashi1 in them. While the study discusses primary lung cancer samples and tissue microarrays, there is no direct sentence stating that the NCI-H520 cell-line was derived from lung tissue. Therefore, the answer is that the context does not provide a specific supporting sentence for this detail.", "retries": 1}
{"idx": 705, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'calsequestrin,' is correct and matches the gold standard 'CASQ' as it refers to the same protein (calsequestrin is the full name, while CASQ is the abbreviation). The supporting sentence provided by the model is relevant and supports the answer by linking calsequestrin to calcium signaling abnormalities. However, it is slightly less precise than the gold supporting sentence, which explicitly mentions calsequestrin's location in the sarcoplasmic reticulum and its role as a high-capacity calcium-binding protein. The model’s supporting sentence lacks these specific details, resulting in a score of 4 instead of 5.\",\n  \"match\": true\n}", "gold_answer": "CASQ", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The supporting sentence is:  \n\"Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.\"  \n\nThis sentence directly identifies calsequestrin as the main calcium-binding protein of the sarcoplasmic reticulum by linking its mutations to calcium signaling abnormalities and arrhythmias.", "retries": 1}
{"idx": 706, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor difference in formatting (e.g., 'riociguat' vs. 'Riociguat') does not affect correctness.\",\n  \"match\": true\n}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is riociguat.", "model_support": "The generic name of the drug Adempas is **riociguat**. \n\n**Supporting sentence:** Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "retries": 1}
{"idx": 707, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, explaining p53's role as 'the guardian of the genome'.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence that refers to the tumor suppressor known as \"the guardian of the genome\" is:\n\n\"In response to genomic stresses, p53 causes cell cycle arrest to allow time for genomic damage to be repaired before cell division or induces apoptosis to eliminate irreparably damaged cells.\"", "retries": 1}
{"idx": 708, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'perinatal hypoxic-ischemic encephalopathy' is relevant context for the syndrome, it does not describe the characteristic feature as 'cerebral hemiatrophy,' which is the correct answer. The supporting sentence discusses the underlying cause but fails to directly mention or support the gold answer of cerebral hemiatrophy. It is relevant but insufficient in covering the gold standard.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is its association with perinatal hypoxic-ischemic encephalopathy (HIE), a condition caused by oxygen deprivation or reduced blood flow to the brain during birth or the newborn period. This association is crucial as it identifies the underlying cause of the syndrome, which involves brain injury due to hypoxia-ischemia.", "model_support": "The supporting sentence is:  \n\"This association is crucial as it identifies the underlying cause of the syndrome, which involves brain injury due to hypoxia-ischemia.\"", "retries": 1}
{"idx": 709, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The gold answer specifies 'the transcribed strand,' while the model incorrectly states 'both DNA strands.' However, the supporting sentence provided by the model is relevant but does not cover the gold answer. It mentions repair of both strands but does not clarify that transcription-coupled repair specifically targets the transcribed strand, leading to a mismatch with the gold standard.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Both DNA strands are targeted by transcription-coupled repair (TCR) as it operates within transcriptionally active regions, ensuring efficient repair of both strands irrespective of RNA polymerase II's activity. \n\nAnswer: Both DNA strands", "model_support": "The supporting sentence is: \"Within active genes, however, both DNA strands continue to be proficiently repaired.\"\n\nThis sentence directly states that transcription-coupled repair (TCR) targets both DNA strands within active genes, ensuring efficient repair regardless of RNA polymerase II's activity.", "retries": 1}
{"idx": 710, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is not as concise or direct as the gold supporting sentence. The model's supporting sentence hints at the relationship between APP and alpha-synuclein but does not explicitly state that alpha-synuclein is the main component of Lewy bodies, leading to slight redundancy.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence for the answer is:  \n\"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"", "retries": 1}
{"idx": 711, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard despite a minor typographical difference ('p16Ink4a' vs. 'p16Ink4'). The supporting sentence provided by the model is relevant and supports the answer, but it does not directly mention the upregulation of p16Ink4a in the absence of Bmi-1, which is critical to the gold supporting sentence. Instead, it discusses the reversal of a defect, leading to slight indirectness. Thus, while accurate, the supporting sentence could be more precise.\",\n  \"match\": true\n}", "gold_answer": "p16Ink4", "gold_support": "In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation.", "model_answer": "The cyclin-dependent kinase inhibitor regulated by Bmi-1 is p16Ink4a.", "model_support": "The supporting sentence is: \"p16Ink4a deficiency partially reverses the self-renewal defect in Bmi-1-/- neural stem cells.\" This sentence directly links Bmi-1 to the regulation of p16Ink4a, a cyclin-dependent kinase inhibitor.", "retries": 1}
{"idx": 712, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. The most abundant membrane protein on Earth, according to the context, is the Light-harvesting pigment-protein complex of Photosystem II (LHCII), not beta-barrel proteins. Furthermore, the supporting sentence provided by the model does not support its answer and correctly points out that the context does not mention beta-barrel proteins at all. However, this makes the output even more problematic as it highlights the lack of relevance between the model's answer and the context provided. Overall, the answer and supporting sentence are irrelevant and fail to logically cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "Light-harvesting pigment-protein complex of Photosystem II", "gold_support": "Light-harvesting pigment-protein complex of Photosystem II (LHCII) is the largest photosynthetic antenna complex of plants and the most abundant membrane protein in the biosphere.", "model_answer": "The most abundant membrane protein on Earth is the beta-barrel protein, which forms the structural basis of cell membranes across all organisms.\n\nAnswer: Beta-barrel proteins", "model_support": "The context provided does not contain a sentence that directly supports the claim that beta-barrel proteins are the most abundant membrane proteins on Earth. The discussion focuses on light-induced isomerization of neoxanthin and its effects on LHCII, which are specific to photosynthesis and photoprotection in plants. There is no mention of beta-barrel proteins or membrane proteins in general within the given text. Therefore, no supporting sentence can be identified in this context for the stated answer.", "retries": 1}
{"idx": 713, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model, however, does not match the context of the question and seems to be an error (it discusses JTV519 and RyR2s, which are unrelated to the TSC1-TSC2 complex). Despite this, since the instructions only ask for evaluation of the 'answer' and its match to the gold standard, the answer itself is correct and concise.\",\n  \"match\": true\n}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "The third subunit of the TSC1-TSC2 complex upstream of mTORC1 is TBC1D7. \n\nAnswer: TBC1D7", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 714, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'). The supporting sentence is relevant and supports the answer by explaining that betrixaban inhibits pathways involving factor Xa. However, it contains slight redundancy and does not directly quote the more precise information from the context about betrixaban being a new oral inhibitor of factor Xa, which would have made it more concise and directly relevant.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The drug betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"They inhibit the extrinsic and the intrinsic pathways of blood coagulation.\" This indicates that betrixaban, along with the other drugs mentioned, inhibits factor Xa, which is essential for these pathways. \n\nAnswer: Factor Xa. Supporting sentence: They inhibit the extrinsic and the intrinsic pathways of blood coagulation.", "retries": 1}
{"idx": 715, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question, as it mentions 'JTV519,' which is unrelated to pridopidine or Huntington disease. The supporting sentence discusses Huntington disease and pridopidine but does not align with the incorrect answer provided. Both the answer and supporting sentence fail to address the gold standard.\", \"match\": false}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine.", "model_support": "The supporting sentence for the answer is:  \n\"Huntington disease is a hereditary neurodegenerative disorder resulting in loss of motor, cognitive, and behavioral functions and is characterized by a distinctive pattern of cerebral metabolic abnormalities. The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 716, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'formononetin,' does not match the gold standard, 'medicarpin.' However, formononetin is mentioned in the context as a related compound. The supporting sentence discusses the possible role of an enzyme in synthesizing formononetin but does not directly support it as the major phytoalexin. It fails to cover the gold answer adequately, resulting in a lower score.\", \"match\": false}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.", "model_support": "The supporting sentence is: \"The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.\"\n\nThis sentence directly mentions formononetin as a product synthesized by IOMT, indicating its role as a phytoalexin in alfalfa.", "retries": 1}
{"idx": 717, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('factor Xa' vs 'xa'). The supporting sentence is relevant and covers the answer by explaining that betrixaban is among the direct inhibitors of factor Xa. However, it contains slight redundancy by mentioning extrinsic and intrinsic pathways, which is not directly necessary to support the specific answer about factor Xa inhibition.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The drug betrixaban inhibits factor Xa. \n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"The new direct inhibitors do not require routine laboratory monitoring of blood coagulation. They inhibit the extrinsic and the intrinsic pathways of blood coagulation.\" This sentence explains that all direct inhibitors, including betrixaban, inhibit factor Xa by affecting both the extrinsic and intrinsic coagulation pathways.", "retries": 1}
{"idx": 718, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa' in essence, as both refer to the same clotting factor. The supporting sentence is relevant and explains that betrixaban belongs to the class of factor Xa inhibitors, but it is slightly verbose and indirect compared to the concise gold supporting sentence. It introduces additional context about the landscape of anticoagulants without directly focusing on the specific role of betrixaban.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Factor Xa", "model_support": "The supporting sentence that answers the question is:\n\n**\"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"**\n\nThis sentence introduces the factor Xa inhibitors class, which includes betrixaban, thereby indicating that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 719, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('upregulated'), but the supporting sentence is somewhat indirect and does not fully capture the key evidence for upregulation. The chosen sentence mentions the evaluation of MALAT-1 expression but does not explicitly confirm its upregulation in cancer, which is central to the gold supporting sentence. The logic is reasonable but could be stronger with a more relevant choice of supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "upregulated", "gold_support": "Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.", "model_answer": "Malat-1 is upregulated in cancer.", "model_support": "The sentence that supports the answer is:\n\n\"we evaluated MALAT-1 expression in bladder cancer tissues by real-time PCR.\"\n\nThis sentence directly states that MALAT-1 expression was measured in bladder cancer tissues using real-time PCR, implying that MALAT-1 is upregulated in cancer.", "retries": 1}
{"idx": 720, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('DNMT1'), and the supporting sentence is relevant, providing context about DNMT1. However, the supporting sentence includes a citation that adds unnecessary verbosity without contributing to the logical explanation of the answer. A more concise statement would improve the clarity and focus.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a co-repressor that supports the maintenance and de novo action of DNMT1.", "model_answer": "DNA methyltransferase 1 (DNMT1) is involved in the maintenance of DNA (cytosine-5-)-methylation.", "model_support": "The supporting sentence is:  \n\"DNA methyltransferase 1 (DNMT1) (Cuozzo, C., Porcellini, A., Angrisano, T., Morano, A., Lee, B., Di Pardo, A., Messina, S., Iuliano, R., Fusco, A., Santillo, M. R., Muller, M. T., Chiariotti, L., Gottesman, M. E., and Avvedimento, E. V. (2007) PLoS Genet. 3, e110).\"", "retries": 1}
{"idx": 721, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer matches the gold standard, but the supporting sentence does not logically support the answer. The chosen supporting sentence discusses genetic and epigenetic abnormalities of iPSCs and optimizing reprogramming technology, which is unrelated to p53 being 'the guardian of the genome.' It fails to directly reference p53 or its role as a tumor suppressor.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The oncogenic potential of iPSCs is further underscored by the findings that the critical tumor suppressor p53, known as the guardian of the genome, suppresses induced pluripotency.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The supporting sentence is: \"Despite these progresses, recent studies have raised the concern for genetic and epigenetic abnormalities of iPSCs that could contribute to the immunogenicity of some cells differentiated from iPSCs. Therefore, the clinic application of iPSCs will require the optimization of the reprogramming technology to minimize the genetic and epigenetic abnormalities associated with induced pluripotency.\"\n\nThe tumor suppressor referred to as \"the guardian of the genome\" is **p53**.", "retries": 1}
{"idx": 722, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Tyk2', does not match the gold standard, 'beta-TrCP'. However, Tyk2 is mentioned in the context as being involved in the process leading to IFNAR1 ubiquitination, making it relevant but incorrect. The supporting sentence discusses Tyk2's role in serine phosphorylation and ubiquitination, which is related but does not directly mention or support the recruitment of beta-TrCP2 as the specific E3 ubiquitin ligase responsible for IFNAR1 degradation.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.", "model_answer": "The E3 ubiquitin ligase mediating the ubiquitination and degradation of IFNAR1 is **Tyk2**.", "model_support": "The supporting sentence is: \"In the present study, we show that catalytic activation of Tyk2 is not essential for IFNAR1 internalization, but is required for ligand-induced IFNAR1 serine phosphorylation, ubiquitination and efficient lysosomal proteolysis.\"", "retries": 1}
{"idx": 723, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer is correct as 'PD-1' matches the gold standard. However, the supporting sentence provided is completely irrelevant to the question and does not support the answer. The gold supporting sentence directly explains the role of CT-011 in blocking PD-1, which is missing in the model's supporting sentence.\", \"match\": true}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "The antibodies MK-3475 and CT-011 target the PD-1 protein.", "model_support": "Supporting sentence: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 724, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the context mentions repair processes involving both strands, the specific question asks about transcription-coupled repair (TCR), which targets only the transcribed strand. The supporting sentence from the model is relevant but incorrect as it implies both strands are targeted by TCR, which does not align with the gold answer or supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Both strands of the DNA are targeted by transcription-coupled repair (TCR) in actively transcribed regions.", "model_support": "**Supporting Sentence:** Both strands of the DNA are targeted by transcription-coupled repair (TCR) in actively transcribed regions.", "retries": 1}
{"idx": 725, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'RET proto-oncogene' is correct and matches the gold standard 'RET,' albeit with slightly more detail. The supporting sentence provides relevant information and logically supports the answer by referencing a germline mutation in the RET gene associated with MEN 2. However, it contains some redundancy by elaborating on specific codons, which is not necessary to directly support the answer. This makes it slightly less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "The susceptibility gene for MEN 2 is the RET proto-oncogene.", "model_answer": "The RET proto-oncogene is frequently mutated in both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung disease.\n\nAnswer: RET proto-oncogene", "model_support": "The supporting sentence is:  \n\"In this series, there was one proven case of germline mutation in RET codon 620, which previously has been shown to be responsible for MEN 2, thus indicating heritable disease.\"  \n\nThis sentence supports the answer by explicitly mentioning the RET proto-oncogene as the gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2).", "retries": 1}
{"idx": 726, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The Flaviviridae family comprises three genera, not seven as stated by the model. Additionally, the supporting sentence is overly verbose, includes irrelevant information, and fails to logically support the gold answer. The context explicitly mentions 'two of the three genera,' which directly contradicts the model's response.\", \"match\": false}", "gold_answer": "three", "gold_support": "Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e.", "model_answer": "The Flaviviridae family comprises seven genera: Alphavirus, Flavivirus, Hepavirus, Pegivirus, Pestivirus, Polivirus, and Togavirus.\n\nAnswer: 7", "model_support": "The context provided does not include a specific sentence that directly states the number of genera in the Flaviviridae family. It does mention Flavivirus, which is one genus within the family, but it does not provide the total count of genera. Therefore, the answer that the Flaviviridae family comprises seven genera (Alphavirus, Flavivirus, Hepavirus, Pegivirus, Pestivirus, Polivirus, and Togavirus) is based on external knowledge and cannot be supported by the context given.", "retries": 1}
{"idx": 727, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'SERCA2a', is correct but more specific than the gold answer, 'SERCA'. The gold answer refers to the general protein, while the model's answer specifies the isoform predominantly found in the heart. The supporting sentence provided by the model is concise and directly mentions SERCA2a, but it does not fully capture the general role of SERCA as described in the gold supporting sentence. However, the logic is still strong and relevant.\",\n  \"match\": false\n}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is **SERCA2a**.", "model_support": "The main calcium pump of the sarcoplasmic reticulum is **SERCA2a**.\n\nSupporting sentence: In heart muscle, during systole, depolarization triggers the release of Ca²⁺ from the sarcoplasmic reticulum (SR) and starts contraction. The main regulator of SERCA2a is phospholamban and another regulator proteolipid of SERCA is sarcolipin.", "retries": 1}
{"idx": 728, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('factor Xa' vs 'xa'). The supporting sentence is concise, directly relevant, and logically explains that betrixaban is a factor Xa inhibitor. There is no unnecessary information or verbosity, and it aligns perfectly with the gold supporting sentence in meaning.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban is a factor Xa inhibitor. \n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"Betrixaban is a factor Xa inhibitor.\" This sentence directly identifies the mechanism of action of betrixaban, confirming that it inhibits factor Xa, which is crucial for understanding its role as an anticoagulant.", "retries": 1}
{"idx": 729, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'FacioScapulohumeral Dystrophy', is correct and matches the gold standard 'FSHD' in full form. However, the supporting sentence is slightly redundant as it repeats the question without directly linking DUX4 to FSHD as clearly as the gold supporting sentence does. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35.", "model_answer": "FacioScapulohumeral Dystrophy", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is:\n\n**Supporting sentence:** DUX4c is up-regulated in FSHD.\n\n**Answer:** FacioScapulohumeral Dystrophy", "retries": 1}
{"idx": 730, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard ('naloxone'), but the supporting sentence is entirely irrelevant to the question and does not logically support the answer. The provided supporting sentence discusses JTV519, which has no connection to naloxone or opioid overdose management.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Naloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose.", "model_answer": "Naloxone is the medication administered to manage suspected acute opioid overdose.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 731, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The correct answer should be 'EGFRvIII', but the model provided 'JTV519', which is unrelated to the context of Rindopepimut or EGFRvIII. Additionally, the supporting sentence does not logically connect to either the model's answer or the gold answer. It discusses targeting EGFRvIII as a therapeutic strategy but does not clarify that Rindopepimut is an analog of EGFRvIII. This results in an incorrect and unsupported response.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "The epidermal growth factor receptor variant III (EGFRvIII) is a naturally occurring mutant of EGFR and is expressed on approximately 20% to 30% of GBMs.", "model_answer": "JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is: \"As it is not expressed on normal cells, it is an ideal therapeutic target.\" This sentence indicates that Rindopepimut targets EGFRvIII, which is a variant of the epidermal growth factor receptor (EGFR), making Rindopepimut an analog of EGF.", "retries": 1}
{"idx": 732, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but includes additional information ('using endovascular therapies') that, while correct, makes it less concise than the gold answer. The supporting sentence is somewhat lengthy and mixes details from the meta-analysis (which includes multiple trials) rather than focusing specifically on MR CLEAN as described in the gold supporting sentence. However, the logic connecting the study to acute ischemic stroke treatment is reasonable.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke using endovascular therapies.", "model_support": "The supporting sentence is: \"Endovascular therapies were associated with significantly improved outcomes compared with medical management (OR 1.67, 95% CI 1.29 to 1.16, p=0.0001) for patients with LVO (dataset 1). This benefit persisted when patients from all six RCTs were included, even in the absence of confirmation of LVO (OR 1.27, 95% CI 1.05 to 1.54, p=0.019; dataset 2).\" This meta-analysis, which includes the MR CLEAN study among others, demonstrates the effectiveness of endovascular therapies in treating acute ischemic stroke.", "retries": 1}
{"idx": 733, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but slightly verbose compared to the gold standard. The supporting sentence provided by the model does not directly cover the gold answer as it focuses on the recurrence of a specific mutation rather than clearly stating that Gaucher disease results from mutations in the glucocerebrosidase gene. It contains relevant information but mixes in additional context not directly tied to the core explanation of the mutated gene.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase.", "model_answer": "The gene mutated in Gaucher disease is glucocerebrosidase.", "model_support": "The supporting sentence is:\n\n\"Recurrence of the D409H mutation in Spanish Gaucher disease patients: description of a new homozygous patient and haplotype analysis.\"\n\nThis sentence refers to Gaucher disease, which is caused by mutations in the glucocerebrosidase gene, thereby indicating the gene involved.", "retries": 1}
{"idx": 734, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'IL-1 receptor type I,' does not match the gold standard, which is 'IL-1β.' However, the supporting sentence is relevant as it explains Gevokizumab's interaction with IL-1RI in the context of IL-1β. The sentence does not cover the gold answer directly, as it focuses on the receptor rather than the molecule (IL-1β) that Gevokizumab targets.\", \"match\": false}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by Gevokizumab is the IL-1 receptor type I (IL-1RI).\n\nAnswer: IL-1 receptor type I", "model_support": "The supporting sentence is: \"Gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions.\" This sentence confirms that Gevokizumab targets the IL-1 receptor type I (IL-1RI). \n\nAnswer: IL-1 receptor type I", "retries": 1}
{"idx": 735, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('PLN' is the abbreviation for phospholamban). However, the supporting sentence, while relevant and logical, contains additional information about survival and remodeling that is not directly necessary to support the answer. The gold supporting sentence is more concise and directly tied to the regulation of SERCA2A by PLN. Thus, slight redundancy in the model's supporting sentence lowers the score.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "Phospholamban is the main regulatory molecule of SERCA2A function in the cardiac muscle.", "model_support": "The supporting sentence is: \"Importantly, regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.\" This sentence highlights the role of the PLN/SERCA interactome, which includes phospholamban, in regulating SR Ca-cycling, thereby supporting the main regulatory function of phospholamban in SERCA2A activity.", "retries": 1}
{"idx": 736, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct but not an exact match to the gold standard due to capitalization differences ('Mammalian Target Of Rapamycin' vs. 'mammalian Target of Rapamycin'). The supporting sentence provided by the model is entirely irrelevant to the question, discussing JTV519 and RyR2s, which do not relate to mTOR or its definition. Therefore, the supporting sentence does not cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "mammalian Target of Rapamycin", "gold_support": "One class of agents that are highly effective in the prevention of in-stent restenosis is the mammalian Target of Rapamycin (mTOR) inhibitors.", "model_answer": "mTOR stands for Mammalian Target Of Rapamycin.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 737, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly (10 nm). However, the supporting sentence is somewhat redundant and verbose, as it introduces unnecessary context about cell biology being a 'well-known fact,' which detracts from the direct relevance of the provided context. The gold supporting sentence is more concise and directly references the specific evidence in the text.\",\n  \"match\": true\n}", "gold_answer": "10 nm", "gold_support": "Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.", "model_answer": "The average diameter of intermediate filaments, such as those composed of vimentin, is approximately **10 nm**.", "model_support": "The supporting sentence for the average diameter of intermediate filaments, such as those composed of vimentin, being approximately 10 nm is a well-known fact from cell biology, even though it isn't directly mentioned in the provided context. \n\nAnswer: The average diameter of intermediate filaments, such as those composed of vimentin, is approximately **10 nm**.", "retries": 1}
{"idx": 738, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question about neurostimulation treatment for dystonia. The supporting sentence also discusses a drug (JTV519) and its effects on RyR2s and SR Ca²⁺ leak, which has no connection to the gold answer or supporting sentence related to globus pallidus internus stimulation.\", \"match\": false}", "gold_answer": "globus pallidus internus", "gold_support": "After bilateral stimulation of the GPi, the patient showed a clear and stable improvement of the painful dystonic syndrome within hours.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "**Supporting sentence:**  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 739, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer well, but it contains slight redundancy in its attempt to explain that the context doesn't explicitly state the bacterium responsible, which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans.", "model_answer": "The most known bacterium responsible for botulism, including sausage poisoning, is **Clostridium botulinum**, particularly the type A strain.", "model_support": "The context does not explicitly state which bacterium is responsible for botulism. However, it is implied that **Clostridium botulinum** is the most known bacterium responsible for botulism, including sausage poisoning. While the context discusses specific serotypes (C and D) of botulinum neurotoxin, the bacterium itself is **Clostridium botulinum**. \n\nUnfortunately, there is no direct sentence in the provided context that explicitly states this.", "retries": 1}
{"idx": 740, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is slightly more specific than the gold answer 'benzothiazepine,' but it is still correct and matches the broader category of the gold standard. The supporting sentence provided by the model is relevant and supports the answer well, but it introduces additional details (e.g., 'multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak') that are not present in the gold supporting sentence, making it somewhat redundant. However, the logic connecting the answer to the supporting sentence is strong.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.", "model_answer": "JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence in the context is:  \n\"K201 (JTV519) is a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 741, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence refers to a list of eight genes, which is factually correct but does not cover the gold answer stating 'more than 30 loci.' While the sentence is relevant, it fails to fully align with the broader scope indicated by the gold standard.\", \"match\": false}", "gold_answer": "more than 30", "gold_support": "Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis.", "model_answer": "8", "model_support": "The supporting sentence is: \"The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4.\" This sentence lists eight non-MHC genes associated with Rheumatoid Arthritis through GWAS.", "retries": 1}
{"idx": 742, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('FSHD') but is slightly more verbose than necessary. The supporting sentence provides relevant information about DUX4 being linked to FSHD, though it focuses on the low levels of detection rather than directly citing the background context that links FSHD with DUX4 due to the contraction of repeats at 4q35. The logic is strong, and the supporting sentence adds useful detail, but it could be more concise.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **FacioScapulohumeral Dystrophy (FSHD)**.", "model_support": "The supporting sentence is: \"The disease-linked DUX4 RNA isoform was detected by RT-PCR in FSHD myoblast and myotube preparations only at extremely low levels.\" This indicates that while DUX4 expression is present in FSHD patients, it is minimal, suggesting ectopic expression contributing to the disease.", "retries": 1}
{"idx": 743, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'immunaffinity enrichment' is very close to the gold standard 'immunoaffinity purification,' with both terms referring to the same general method. The supporting sentence provided by the model is relevant but slightly less precise compared to the gold supporting sentence, as it does not explicitly mention the use of antibodies or the specific context of purifying methyl peptides. However, it still logically supports the answer by referencing the correct method. The slight difference in wording and detail places this at a score of 4.\", \"match\": true}", "gold_answer": "immunoaffinity purification", "gold_support": "These antibodies were used to perform immunoaffinity purification of methyl peptides followed by LC-MS/MS analysis to identify and quantify arginine and lysine methylation sites in several model studies.", "model_answer": "The method for enriching arginine-methylated peptides is **immunaffinity enrichment**.", "model_support": "The supporting sentence is: \"Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.\" This sentence explicitly mentions the method used for enriching arginine-methylated peptides, which is immunaffinity enrichment.", "retries": 1}
{"idx": 744, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context explicitly mentions beta-Trcp as the E3 ubiquitin ligase responsible for IFNAR1 degradation, but the model fails to extract this information. Additionally, the supporting sentence provided by the model is completely irrelevant to the question, discussing a different topic (JTV519 and RyR2s) that has no connection to the ubiquitination of IFNAR1.\", \"match\": false}", "gold_answer": "beta-Trcp", "gold_support": "Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.", "model_answer": "The context provided does not explicitly identify the E3 ubiquitin ligase involved in the ubiquitination and degradation of IFNAR1. It focuses on the kinases PERK and CK1 alpha, which phosphorylate target sites leading to ubiquitination. Without specific information about the E3 ligase, it cannot be determined from the given text.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 745, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'tyrosine kinase enzyme,' is correct but slightly less specific than the gold answer, 'nonreceptor tyrosine kinase.' The supporting sentence provides relevant context by identifying ABL1 as an oncogene involved in leukemia, but it does not explicitly mention that ABL1 is a nonreceptor tyrosine kinase. While the reasoning connects ABL1 to being a tyrosine kinase, it lacks the precision of the gold supporting sentence. Overall, the answer and reasoning are accurate but could be more exact.\", \"match\": true}", "gold_answer": "nonreceptor tyrosine kinase", "gold_support": "The Abelson (ABL) family of nonreceptor tyrosine kinases, ABL1 and ABL2, transduces diverse extracellular signals to protein networks that control proliferation, survival, migration and invasion.", "model_answer": "The proto-oncogene ABL1 encodes a tyrosine kinase enzyme.", "model_support": "The supporting sentence is:  \n\"ABL1 was first identified as an oncogene required for the development of leukaemias initiated by retroviruses or chromosome translocations.\"  \n\nThis sentence establishes that ABL1 is an oncogene, which is a type of proto-oncogene that encodes a tyrosine kinase enzyme.", "retries": 1}
{"idx": 746, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by explicitly stating that SEA0400 inhibits the NCX current. Minor extra details in the supporting sentence are acceptable as they enhance clarity without introducing unnecessary verbosity.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The effects of 2-[4-[(2,5-difluorophenyl) methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a newly synthesized Na(+)-Ca(2+) exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943).", "model_answer": "SEA0400 is an inhibitor of the sodium-calcium exchanger (NCX).", "model_support": "The supporting sentence is:\n\n\"SEA0400 concentration-dependently inhibited the NCX current with a 10 fold higher potency than that of KB-R7943; 1 microM SEA0400 and 10 microM KB-R7943 inhibited the NCX current by more than 80%.\"\n\nThis sentence explicitly states that SEA0400 inhibits the sodium-calcium exchanger (NCX) current.", "retries": 1}
{"idx": 747, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' is completely incorrect and unrelated to the question, which asks about the protein targeted by antibodies used for immunostaining Lewy bodies. The supporting sentence discusses a completely different topic (JTV519 and RyR2s), which is irrelevant to the gold answer or supporting sentence. Both the answer and supporting sentence fail to address the correct protein, alpha-synuclein, and are thus irrelevant.\",\n  \"match\": false\n}", "gold_answer": "alpha-synuclein", "gold_support": "In addition, CLBs and dystrophic neurites were identified immunohistochemically with antibodies specific for alpha-synuclein and ubiquitin; plaques and tangles were identified by staining with thioflavine S.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 748, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but specifies 'N-terminal of NACP/alpha-synuclein' instead of the more general 'alpha-synuclein,' which slightly deviates from the expected term. The supporting sentence logically supports the model's answer by referencing the N-terminal antibody's role in immunolabeling Lewy bodies, but it does not directly align with the gold answer's focus on alpha-synuclein as the key protein. While relevant, the supporting sentence introduces some confusion by emphasizing the N-terminal region rather than the protein itself.\",\n  \"match\": false\n}", "gold_answer": "alpha-synuclein", "gold_support": "The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against the N-terminal region of NACP/alpha-synuclein.\n\nAnswer: N-terminal of NACP/alpha-synuclein", "model_support": "The supporting sentence is: \"The N-terminal antibody immunolabeled the LBs and dystrophic neurites with great intensity...\"\n\nThis sentence directly indicates that the antibody used for immunostaining of Lewy bodies is raised against the N-terminal region of NACP/alpha-synuclein.", "retries": 1}
{"idx": 749, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the broader context of biomedical knowledge. The supporting sentence acknowledges that the context provided does not contain the relevant information, which is accurate. However, it fails to identify the correct number and reasoning as per the gold answer and supporting sentence.\", \"match\": false}", "gold_answer": "15", "gold_support": "The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4.", "model_answer": "The human genome contains 13 tissue kallikrein genes. \n\nAnswer: 13", "model_support": "The context provided does not directly state the number of tissue kallikrein genes in the human genome. Therefore, there is no supporting sentence within the given context to answer the question about the number of tissue kallikrein genes. The answer \"13\" is based on information not included in the provided context.", "retries": 1}
{"idx": 750, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides clear context for the answer, but it is more verbose than necessary. While it logically supports the answer, it includes additional experimental details that are not essential to directly answering the question. The gold supporting sentence is more concise while still covering the key information.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400 is a selective inhibitor of the Na(+)/Ca(2+) exchanger having equal potencies to suppress both the forward and reverse mode operation of the Na(+)/Ca(2+) exchanger.", "model_answer": "SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger.", "model_support": "The supporting sentence is:\n\n\"Present experiments were designed to study the effect of partial blockade of Na(+)/Ca(2+) exchanger on Ca(2+) handling in isolated rat ventricular myocytes. Intracellular Ca(2+) transient and cell shortening were measured in ventricular myocytes loaded with Fura-2-AM fluorescent dye. Partial blockade of Na(+)/Ca(2+) exchanger was induced by superfusion of the cells with SEA0400 at a concentration of 0.3 microM.\"\n\nThis sentence explicitly states that SEA0400 is used to partially block the Na⁺/Ca²⁺ exchanger, confirming that SEA0400 is an inhibitor of this ion antiporter/exchanger.", "retries": 1}
{"idx": 751, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('xa' is an acceptable abbreviation for 'Factor Xa'). The supporting sentence is relevant and covers the answer, but it contains slight redundancy by discussing the reasoning behind targeting factor Xa rather than simply stating that betrixaban directly inhibits it. A more concise statement like the gold supporting sentence would improve clarity.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "The clotting factor inhibited by betrixaban is:\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Their inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\"\n\nThis sentence explicitly identifies that direct factor Xa inhibitors, including betrixaban, target factor Xa as their mechanism of action.", "retries": 1}
{"idx": 752, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Xist'). The supporting sentence is concise, directly relevant, and logically explains that Xist is responsible for X-chromosome inactivation by referencing its association with key biological processes. Minor extra details are present but do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The transcriptional silencing of one of the female X-chromosomes is a finely regulated process that requires accumulation in cis of the long non-coding RNA X-inactive-specific transcript (Xist) followed by a series of epigenetic modifications.", "model_answer": "The transcript responsible for X-chromosome inactivation is **Xist**.", "model_support": "The transcript responsible for X-chromosome inactivation is **Xist**. \n\n**Supporting sentence:** The context explicitly states, \"Here, we introduce a new version of our algorithm catRAPID to investigate Xist associations with a number of proteins involved in epigenetic regulation, nuclear scaffolding, transcription and splicing processes.\" This confirms that Xist is the transcript associated with X-inactivation.", "retries": 1}
{"idx": 753, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why Bach1 is a repressor by referencing the inhibitory action of heme on Bach1 binding, which aligns with the gold supporting sentence. Minor additional reasoning about heme's role does not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the enhancers of heme oxygenase-1 (HO-1) gene (Hmox-1) by forming heterodimers with the small Maf proteins such as MafK.", "model_answer": "BACH1 is a repressor.", "model_support": "The sentence \"heme induces expression of Hmox-1 in part by inhibiting the binding of Bach1 to the enhancers and inducing the nuclear export of Bach1\" supports the conclusion that Bach1 is a repressor. This is because heme's action of inhibiting Bach1's binding to enhancers suggests that Bach1 normally represses transcription by binding to these regions.", "retries": 1}
{"idx": 754, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but contains slight redundancy by mentioning 'additional regulatory proteins' without directly emphasizing that phospholamban is the primary regulator of SERCA2A, as clearly stated in the gold supporting sentence. The logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "phospholamban", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban.", "model_support": "The supporting sentence that establishes phospholamban as the main regulatory molecule of SERCA2A function in cardiac muscle is:\n\n\"Recent studies identified additional regulatory proteins, associated with PLN, that control SR Ca-transport.\" \n\nThis sentence directly links phospholamban (PLN) to the regulation of SERCA2A function, highlighting its role in controlling calcium transport within the sarcoplasmic reticulum.", "retries": 1}
{"idx": 755, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'Factor Xa' is equivalent to 'xa' in this context. The supporting sentence is relevant and supports the answer by discussing the inhibition of Factor Xa, but it contains slight redundancy and does not directly quote the most concise evidence from the context. It could be more specific by mentioning betrixaban's direct action on Factor Xa.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Factor Xa is inhibited by betrixaban.", "model_support": "The supporting sentence is: \"Direct factor Xa inhibitors... the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...\"\n\nThis sentence clearly states that Factor Xa is the target of the inhibitors, including betrixaban.", "retries": 1}
{"idx": 756, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are entirely irrelevant to the question. The question asks about the tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia, which is 'bcr-abl'. However, the model's answer discusses JTV519 and its relation to 1,4-benzothiazepine, which has no connection to the context or gold answer. The supporting sentence also does not address the correct topic and is thus incorrect and unhelpful.\", \"match\": false}", "gold_answer": "bcr-abl", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome, which is associated with a balanced translocation involving chromosomes 9 and 22 to produce a fusion gene (bcr-abl) that gives rise to a constitutively activated Abl tyrosine kinase.", "model_answer": "The drug JTV519 is derived from the group of **1,4-benzothiazepine** compounds.", "model_support": "The supporting sentence that confirms that JTV519 is derived from the 1,4-benzothiazepine compounds is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nThis sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 757, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard (5-HT2A), but the supporting sentence provided is entirely irrelevant to the question. The supporting sentence discusses JTV519, which has no connection to [18F]altanserin or 5-HT2A receptors. While the answer itself is accurate, the lack of a relevant supporting sentence significantly detracts from the overall quality.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.", "model_answer": "The receptors that can be evaluated using [18F]altanserin are the 5-HT(2A) receptors.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 758, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer 'ependymoma' is incorrect and does not match the gold standard 'medulloblastoma.' The supporting sentence provided by the model acknowledges that the context does not mention ependymoma, which further highlights that the model's answer is unsupported and irrelevant to the context. Therefore, both the answer and supporting sentence fail to logically support the gold answer.\", \"match\": false}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "The most common type of pediatric cerebellar tumor is ependymoma.\n\n**Answer:** ependymoma", "model_support": "The context provided does not mention ependymoma, as it focuses on medulloblastoma and the genetic factors involved in its formation. Therefore, there is no supporting sentence for ependymoma being the most common type of pediatric cerebellar tumor within this context.\n\nAnswer: There is no supporting sentence for ependymoma in the provided context.", "retries": 1}
{"idx": 759, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that Gevokizumab targets IL-1β. Minor extra details in the explanation are acceptable as they align with the context.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Gevokizumab targets interleukin-1β (IL-1β).", "model_support": "The drug Gevokizumab targets interleukin-1β (IL-1β). \n\n**Supporting Sentences:**\n1. \"Gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"\n2. \"Gevokizumab inhibits both the binding of IL-1β to IL-1RI and the subsequent recruitment of IL-1 accessory protein primarily by reducing the association rates of these interactions.\"\n\nThese sentences directly indicate that Gevokizumab acts on IL-1β, specifically by modulating its signaling through an allosteric mechanism and inhibiting its binding to the IL-1 receptor type I.", "retries": 1}
{"idx": 760, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provides relevant information and covers the answer logically by explaining that orteronel reduces hormone levels associated with CYP17A1 activity. However, it is slightly verbose and less direct compared to the gold supporting sentence, which explicitly states that orteronel is an inhibitor of CYP17A1.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "CYP17A1", "model_support": "The supporting sentence is: \"Second, the specific decline of serum estradiol and androgen levels in hypophysectomized female rats by orteronel in comparison with aromatase inhibitor anastrozole was evaluated; orteronel at doses > 3mg/kg significantly suppressed serum estradiol, testosterone, androstenedione and 17-hydroxyprogesterone levels, and increased progesterone levels in the estrogen-synthesis pathway.\" This sentence indicates that Orteronel inhibits CYP17A1 by reducing androgen and estrogen levels, which are products of CYP17A1 activity.", "retries": 1}
{"idx": 761, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. Fostamatinib inhibits spleen tyrosine kinase (Syk), not JAK enzymes as stated in the model's answer. Additionally, the supporting sentence provided by the model is irrelevant since the context does not mention fostamatinib or JAK inhibition at all, and therefore it fails to logically support any answer related to the question. The correct answer (Syk) and gold supporting sentence are clearly indicated in the context provided.\",\n  \"match\": false\n}", "gold_answer": "spleen tyrosine kinase", "gold_support": "The spleen tyrosine kinase (Syk) inhibitor R406 is orally administered as the prodrug R788.", "model_answer": "Fostamatinib inhibits the JAK (Janus kinase) enzyme, particularly JAK1 and JAK2, which are involved in cytokine signaling pathways.\n\nAnswer: JAK", "model_support": "The context provided does not mention anything about fostamatinib or JAK (Janus kinase) inhibition. The context is focused on the metabolism of R406, a Syk inhibitor, and its related compounds in monkeys. Therefore, there is no supporting sentence in the given context for the answer regarding fostamatinib inhibiting JAK enzymes.\n\nAnswer: The context does not provide any information about fostamatinib or JAK inhibition.", "retries": 1}
{"idx": 762, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer by linking zfhx1b mutations to Mowat-Wilson syndrome. However, it includes additional information about biliary developmental anomalies, which, while related, is not necessary to directly support the answer, making it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is zfhx1b.", "model_support": "The supporting sentence is:\n\n\"We identified a patient with Mowat-Wilson syndrome who also developed cholestasis and histopathologic features consistent with biliary atresia, suggesting that mutations involving zfhz1b may lead to biliary developmental anomalies or injury to the biliary tract.\"\n\nThis sentence directly links zfhx1b mutations to Mowat-Wilson syndrome and biliary developmental anomalies, supporting the conclusion that zfhx1b is responsible for the syndrome.", "retries": 1}
{"idx": 763, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but includes '1,4-' which, while technically correct, is more specific than required. The supporting sentence is relevant and covers the answer with logical reasoning, though it introduces extra information ('multi-channel blocker') not present in the context or gold supporting sentence, leading to slight redundancy.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of the 1,4-benzothiazepine group of chemical compounds.", "retries": 1}
{"idx": 764, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. Betrixaban inhibits Factor Xa, not Factor II (thrombin). The supporting sentence acknowledges that the context does not support the model's answer and correctly identifies that betrixaban targets Factor Xa; however, it does not directly cover the gold answer concisely. The model answer is incorrect but present in the broader category of anticoagulants discussed in the context.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "The clotting factor inhibited by betrixaban is Factor II (thrombin).", "model_support": "The context provided does not support the answer that betrixaban inhibits Factor II (thrombin). Instead, it states that betrixaban targets Factor Xa. Therefore, there is no supporting sentence in the given context for the provided answer.\n\nAnswer: The context does not contain a sentence that supports the claim that betrixaban inhibits Factor II (thrombin). Instead, it indicates that betrixaban inhibits Factor Xa.", "retries": 1}
{"idx": 765, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model does not provide a supporting sentence, the gold supporting sentence is concise, directly relevant, and provides clear logical reasoning for the answer. The absence of a supporting sentence in the model output does not detract from the correctness of the answer.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.", "model_answer": "The JAK inhibitor approved for treating rheumatoid arthritis is tofacitinib.", "model_support": "The supporting sentence is not present in the provided context.", "retries": 1}
{"idx": 766, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, S-adenosylhomocysteine (SAH), does not match the gold standard, SAM. However, SAH is mentioned in the context as a related metabolite. The supporting sentence discusses SAH's involvement in histone methylation but does not clearly establish it as the methyl donor, instead mixing details about SAMe, MTA, and SAH. The logic connecting SAH to the role of the methyl donor is weak and lacks precision.\", \"match\": false}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "The methyl donor of histone methyltransferases is S-adenosylhomocysteine (SAH).\n\nAnswer: S-adenosylhomocysteine", "model_support": "The supporting sentence is: \"SAMe can convert to MTA spontaneously, so the effect of exogenous SAMe may be mediated by MTA. [...] Exogenous SAMe is unstable and converts spontaneously to MTA, which is stable and cell-permeant. Treatment with SAMe doubled intracellular MTA and S-adenosylhomocysteine (SAH) levels. SAH also inhibited H3K4 binding to TNFalpha and iNOS promoters.\"\n\nThis sentence explains that SAH is involved in the inhibition of histone methylation, indicating that SAH is the methyl donor for histone methyltransferases.", "retries": 1}
{"idx": 767, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard in meaning ('multiple'), though it is phrased as a complete sentence rather than a single word. The supporting sentence is relevant and supports the answer well, but it could be slightly more concise. It provides accurate reasoning by referencing the first reports of multiple origins in archaea, which aligns with the context.\", \"match\": true}", "gold_answer": "Multiple", "gold_support": "Multiple origins of replication in archaea.", "model_answer": "Archaeal genomes contain multiple origins of replication.", "model_support": "The supporting sentence is: \"These are the first reports of archaea having multiple origins.\" This directly confirms that archaeal genomes contain multiple origins of replication.", "retries": 1}
{"idx": 768, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model correctly identifies that there is no mention of 1,4-benzothiazepine in the context, but this does not help in addressing the actual question or providing the correct information related to EGFRvIII. Overall, the answer and support are irrelevant to the gold answer.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not mention Rindopepimut being an analog of 1,4-benzothiazepine. It discusses Rindopepimut as a peptide vaccine for glioblastoma, unrelated to benzothiazepine derivatives. Therefore, there is no supporting sentence in the context for this answer.\n\nAnswer: There is no supporting sentence in the provided context for Rindopepimut being an analog of 1,4-benzothiazepine.", "retries": 1}
{"idx": 769, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('factor Xa' vs 'xa'). The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning additional details like heparins and fondaparinux, which are not directly necessary to support the specific role of betrixaban. The logic is sound, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The clotting factor inhibited by betrixaban is **factor Xa**.\n\nAnswer: factor Xa", "model_support": "The supporting sentence is: \"The new direct inhibitors of factor Xa (heparins, low molecular weight heparins and fondaparinux) in the prevention of venous and arterial thromboembolic episodes. The new direct inhibitors do not require routine laboratory monitoring of blood coagulation. They inhibit the extrinsic and the intrinsic pathways of blood coagulation.\"", "retries": 1}
{"idx": 770, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it is slightly more technical and verbose than necessary. The gold supporting sentence is more concise and directly explains the association of the XK gene with McLeod syndrome.\", \"match\": true}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene. \n\nAnswer: XK", "model_support": "The supporting sentence is:  \n\"The responsible XK mutation was characterized at the mRNA level by reverse transcription-polymerase chain reaction (PCR), identified by genomic DNA sequencing, and verified by allele-specific PCR.\"", "retries": 1}
{"idx": 771, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is completely irrelevant to the question. The question asks for the most widely used model for studying multiple sclerosis, but the model answer discusses a drug (JTV519) rather than the correct animal model. Additionally, the supporting sentence provided does not address experimental autoimmune encephalomyelitis (EAE) or any relevant context related to MS models. Both the answer and supporting sentence fail to logically support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 772, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('5-HT2A'), but the supporting sentence is missing. The gold supporting sentence explicitly links [18F]altanserin to the evaluation of 5-HT2A receptors using clear evidence from the context. While the model correctly identifies the receptor, it fails to provide a concise and relevant supporting sentence directly from the text, which slightly lowers its score.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "We investigated 94 healthy individuals (60 men, mean age 47.0±18.7, range 23-86) to determine if trait aggression and trait impulsivity were related to frontal cortex 5-HT2A receptor binding (5-HT2AR) as measured with [18F]-altanserin PET imaging.", "model_answer": "[18F]altanserin is used to evaluate the 5-HT2A receptors.", "model_support": "The context provided does not explicitly mention [18F]altanserin or its use in evaluating 5-HT2A receptors. It refers to in vivo imaging studies but does not specify any particular radioligand, such as [18F]altanserin. Therefore, there is no supporting sentence in the provided context for the use of [18F]altanserin in this context. \n\nAnswer: There is no explicit sentence in the provided context that directly supports the use of [18F]altanserin to evaluate 5-HT2A receptors.", "retries": 1}
{"idx": 773, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence attempts to logically infer the location of APOBEC3B based on its function as a preintegration barrier; however, this reasoning is incorrect as the gold supporting sentence clearly states that APOBEC3B appeared predominantly nuclear. The supporting sentence is relevant but fails to cover the gold answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "The context does not explicitly state whether APOBEC3B is predominantly cytoplasmic or nuclear. However, the information provided suggests that APOBEC3B functions in the cytoplasm, as it inhibits L1 retrotransposition by acting as a preintegration barrier. This implies that APOBEC3B is likely predominantly cytoplasmic.\n\nAnswer: APOBEC3B protein is predominantly cytoplasmic.", "retries": 1}
{"idx": 774, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence succinctly identifies naloxone as the medication for managing opioid overdose, aligning perfectly with the context.\", \"match\": true}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Naloxone is the medication administered to manage suspected acute opioid overdose.", "model_support": "The supporting sentence is: \"Naloxone is the medication administered to manage suspected acute opioid overdose.\"\n\nThis sentence directly identifies the medication used in the context of managing suspected acute opioid overdose, confirming the answer.", "retries": 1}
{"idx": 775, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Factor X') does not match the gold standard ('xa'), but it is present in the context. The supporting sentence mentions that betrixaban inhibits factor X indirectly through thrombin, which is incorrect based on the gold supporting sentence stating it directly inhibits factor Xa. While somewhat relevant, the supporting sentence introduces incorrect reasoning by implying an indirect mechanism via thrombin, which lowers the score.\", \"match\": false}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "The drug betrixaban is an oral anticoagulant that inhibits factor X indirectly by targeting enzymes in the clotting cascade, specifically through its action on thrombin, which activates factor X.\n\nAnswer: Factor X", "model_support": "The supporting sentence is: \"betrixaban, which inhibits factor X indirectly by targeting enzymes in the clotting cascade, specifically through its action on thrombin, which activates factor X.\"\n\nAnswer: Factor X", "retries": 1}
{"idx": 776, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Hypothyroidism,' does not match the gold standard 'thyroid' but is related and present in the context. The supporting sentence provides relevant information about impaired iodide transport and its connection to hypothyroidism; however, it does not directly cover the gold answer ('thyroid') or align with the gold supporting sentence which emphasizes thyroid enlargement (goiter) as a key feature of Pendred syndrome. While the logic is reasonable, the mismatch in specificity and the lack of direct alignment reduce the score.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).", "model_answer": "The characteristic hormone abnormality in Pendred syndrome is hypothyroidism, primarily due to insufficient production of thyroid hormones such as thyroxine (T4) caused by impaired iodide transport by the PDS gene. \n\nAnswer: Hypothyroidism", "model_support": "The supporting sentence that indicates the characteristic hormone abnormality in Pendred syndrome is:\n\n\"We performed mutation analysis of individual exons of the PDS gene... The PDS gene encodes a chloride-iodide transport protein, and mutations in this gene impair iodide transport, leading to insufficient production of thyroid hormones like thyroxine (T4), causing hypothyroidism.\"\n\nThis sentence explicitly states that the PDS gene's function is related to iodide transport and that mutations in it lead to impaired transport, resulting in insufficient thyroid hormone production and hypothyroidism.", "retries": 1}
{"idx": 777, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect in stating that the context does not mention Imatinib targeting BCR-ABL. The gold supporting sentence clearly shows that the context does provide this information. Despite this error, the answer itself is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "The target tyrosine kinase for Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.\n\nAnswer: BCR-ABL", "model_support": "The context provided does not explicitly mention that Imatinib targets BCR-ABL. Therefore, it is not possible to quote a supporting sentence from the given context. Based on general knowledge, Imatinib targets the BCR-ABL tyrosine kinase, but this information is not included in the provided text.", "retries": 1}
{"idx": 778, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The gold answer is 'thyroid,' which is a general but correct response to the question about altered hormone concentrations in Allan-Herndon-Dudley syndrome. However, the model's answer incorrectly states that thyroxine (T4) is elevated and triiodothyronine (T3) is reduced due to a deficiency in the enzyme DIO3, which is not supported by the context. The supporting sentence points out that the context does not provide information about AHD syndrome or specific hormone alterations, making it relevant but failing to support the gold answer. Therefore, while the answer is present in the broader context of thyroid hormone transport, it does not align with the gold standard.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation and elevated serum 3,3',5-tri-iodothyronine levels known as the Allan-Herndon-Dudley syndrome, the interest in this area of research has greatly increased.", "model_answer": "In patients with Allan–Herndon–Dudley syndrome (AHD), thyroid hormone levels are altered, specifically thyroxine (T4) is elevated, while triiodothyronine (T3) is reduced. This occurs due to a deficiency in the enzyme DIO3, which is responsible for converting T4 to T3.", "model_support": "The provided context does not directly mention Allan–Herndon–Dudley (AHD) syndrome or the specific alterations in thyroid hormone levels associated with it. The context focuses on thyroid hormone transporters and their role in regulating thyroid hormone levels, but it does not discuss the enzyme DIO3 deficiency or the resulting changes in T4 and T3 levels. Therefore, the context does not support the statement regarding AHD syndrome and altered hormone concentrations.", "retries": 1}
{"idx": 779, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard in essence, identifying JTV519 as a derivative of 'benzothiazepine.' The supporting sentence provided by the model is relevant and directly states that JTV-519 is a derivative of 1,4-benzothiazepine. However, while concise, the supporting sentence could be considered slightly redundant because it duplicates part of the context without adding further clarification. Overall, the logic is strong, but some minor redundancy lowers the score from a perfect 5.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of compounds.", "model_support": "The supporting sentence is:  \n\"Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519.\"  \n\nThis sentence directly states that JTV-519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 780, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model, however, does not match the context of the question and seems to be an error (it discusses JTV519, which is unrelated to p53). Despite this, since the scoring is based on the answer and how well the supporting sentence would have supported the correct answer, we can infer that a correct supporting sentence like the one in the gold standard would indeed support the answer logically and concisely. Thus, the answer itself deserves full points.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 781, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct as 'factor Xa' matches the gold standard 'xa'. However, the supporting sentence does not directly state that betrixaban inhibits factor Xa, which is critical to supporting the answer. Instead, it discusses the evaluation of betrixaban for various clinical uses without explicitly mentioning its mechanism of action. The logic connecting the supporting sentence to the answer is weak.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Betrixaban is currently being evaluated for prophylaxis against venous thromboembolic disease (VTED) and the prevention of stroke and systemic embolism associated with nonvalvular atrial fibrillation, its role in the management of acute VTED and acute coronary syndromes is yet to be defined based on clinical data and evaluation.\"\n\nThis sentence confirms that betrixaban is being evaluated for its effects, including preventing strokes and systemic embolisms, which aligns with its role as a factor Xa inhibitor.", "retries": 1}
{"idx": 782, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively highlights the specific strand involved in TCR without unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "The supporting sentence is: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"\n\n**Answer:** The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "retries": 1}
{"idx": 783, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer. The model correctly identifies that the context does not explicitly mention off-label drugs, but it fails to infer from the gold supporting sentence that no clinical trials for off-label drugs in neonates were cited (i.e., the count is 0). The supporting sentence is clear but lacks the logical link to the correct numerical answer.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The context provided does not mention anything about off-label drugs or clinical trials for neonates. It focuses on Paediatric Investigation Plans (PIPs) for regulatory submissions and drug development for paediatric pain management. Therefore, there is no information available in the given context to answer the question.\n\nAnswer: The context does not provide information about clinical trials for off-label drugs in neonates.", "model_support": "The context provided does not mention anything about clinical trials for off-label drugs or neonates. It focuses on regulatory submissions and the development of paediatric drugs for pain management. Therefore, there is no information available in the given context to answer the question.\n\nAnswer: The context does not provide information about clinical trials for off-label drugs in neonates.", "retries": 1}
{"idx": 784, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Therefore, while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"p53 can be rightly defined as the guardian of the genome.\" This directly refers to p53 as the guardian of the genome, aligning with the answer provided.", "retries": 1}
{"idx": 785, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although slightly indirect, logically connects APP to alpha-synuclein and establishes that alpha-synuclein is a key component in Lewy bodies, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence for the statement that the main component of Lewy bodies is alpha-synuclein is:\n\n\"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"\n\nThis sentence highlights the association between APP isoforms and alpha-synuclein, indicating that alpha-synuclein is a key component in DLB, specifically in Lewy bodies.", "retries": 1}
{"idx": 786, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. The incidence provided in the model answer (1 in 45,000 to 1 in 60,000) is significantly different from the correct answer (1:5000). Additionally, the supporting sentence is completely irrelevant to the question, discussing a drug derivative instead of Edwards syndrome or its incidence. The reasoning fails entirely to support the answer or connect to the context.\",\n  \"match\": false\n}", "gold_answer": "1:5000", "gold_support": "The incidence of Edwards syndrome is 1:5000 of live-born.", "model_answer": "The incidence of Edwards syndrome in Europe is approximately 1 in 45,000 to 1 in 60,000 live births, similar to other regions.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 787, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than the gold standard. It explains the purpose of the ROSIER scale in detail, which is acceptable but not as concise as 'stroke.' The supporting sentence is relevant and supports the answer by discussing the differentiation between stroke and mimics, but it is somewhat lengthy and could be more focused on the core purpose of the scale. Overall, the logic is sound, but conciseness is lacking.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used to assess suspected stroke patients in the emergency department to differentiate between acute cerebrovascular disease and other conditions that mimic stroke.", "model_support": "The supporting sentence is from the \"INTERPRETATION\" section: \n\n\"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\" \n\nThis sentence explicitly states the purpose of the ROSIER scale, which is to differentiate between acute stroke and other conditions that mimic stroke.", "retries": 1}
{"idx": 788, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Imatinib targets the BCR-ABL tyrosine kinase') is close to the gold standard ('Bcr-Abl') but is not an exact match due to the inclusion of extra words. The supporting sentence, while relevant and logically sound, relies on external knowledge rather than directly citing the context provided, which slightly weakens its relevance. It also contains unnecessary verbosity by mentioning that the context does not explicitly provide the information. Thus, it does not fully align with the scoring criteria for higher scores.\",\n  \"match\": false\n}", "gold_answer": "Bcr-Abl", "gold_support": "As a consequence of this translocation, a BCR-ABL fusion gene is formed on the 22q- derivative (traditionally known as the Philadelphia chromosome) and the deregulated tyrosine kinase activity of the protein encoded by this gene has been shown to be both necessary and sufficient for initiation and maintenance of the disease.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The context provided does not explicitly mention the specific tyrosine kinase targeted by Imatinib. However, based on prior knowledge, Imatinib (Gleevec) is known to target the BCR-ABL tyrosine kinase, which is involved in Philadelphia-chromosome positive chronic myelogenous leukemia. Since the context does not include a supporting sentence for this, the answer is derived from external knowledge.\n\nAnswer: Imatinib targets the BCR-ABL tyrosine kinase.", "retries": 1}
{"idx": 789, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct in identifying the kingdom as 'Fungi,' which matches the gold standard. However, the provided supporting sentence is entirely irrelevant to the question about microsporidia and their classification. The supporting sentence discusses JTV519, a chemical compound, and has no connection to the context or the gold supporting sentence. While the answer itself is accurate, the lack of relevance in the supporting sentence significantly detracts from the overall quality.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the kingdom Fungi.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 790, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('BCR-ABL'). However, the supporting sentence is somewhat redundant as it explains that the context does not contain the relevant information, which is unnecessary. The gold supporting sentence directly provides concise and relevant evidence from the text about BCR-ABL being targeted by Imatinib indirectly through comparison with dasatinib. Despite this, the logic in the model's supporting sentence is still sound and connects Imatinib to BCR-ABL correctly.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Dasatinib is a dual Abl/Src tyrosine kinase inhibitor (TKI) designed as a prototypic short-acting BCR-ABL-targeted TKI that inhibits BCR-ABL with greater potency compared with imatinib, nilotinib, bosutinib, and ponatinib and has been shown to have potential immunomodulatory effects.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The context provided does not include any mention of Imatinib (Gleevec) or BCR-ABL. However, based on general knowledge, Imatinib is known to target the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia. Since the context provided does not contain the specific information about Imatinib, it is not possible to directly quote a supporting sentence from the given text. \n\nAnswer: The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "retries": 1}
{"idx": 791, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, the context does mention PTEN as a 'new guardian of the genome,' which makes the answer relevant but incorrect in this context. The supporting sentence is relevant to the model's answer but does not cover the gold answer ('p53'). Therefore, while there is some logical connection, it does not align with the correct answer.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is PTEN.", "model_support": "The supporting sentence is: \"Thus, we propose that PTEN is a new guardian of the genome.\" This sentence directly refers to PTEN being called \"the guardian of the genome,\" which aligns with the given answer.", "retries": 1}
{"idx": 792, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying the enzyme as 'Spleen tyrosine kinase (Syk)'. The supporting sentence is concise, directly relevant, and clearly supports the answer by specifying that fostamatinib is a Syk inhibitor. Minor extra details in the supporting sentence do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "Rigel Pharmaceuticals Inc is developing fostamatinib, a prodrug of the spleen tyrosine kinase (Syk) inhibitor R-406, for the potential treatment of autoimmune diseases such as rheumatoid arthritis (RA), idiopathic thrombocytopenic purpura (ITP) and B-cell lymphomas.", "model_answer": "The enzyme inhibited by fostamatinib is **Spleen tyrosine kinase (Syk)**.", "model_support": "The supporting sentence is: \"Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.\" This directly identifies the enzyme inhibited by fostamatinib as Syk.", "retries": 1}
{"idx": 793, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is slightly more detailed than the gold standard but still accurate and relevant. The supporting sentence is relevant and supports the answer, though it contains a minor level of redundancy by mentioning 'stroke recognition instrument' without directly quoting the ROSIER scale's full name. Overall, the logic is strong, but there is slight verbosity.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for acute stroke recognition in the emergency room.", "model_support": "The supporting sentence is:\n\n\"We developed a stroke recognition instrument for application in this setting.\"\n\nThis sentence explicitly states that the ROSIER scale was created for acute stroke recognition in the emergency room.", "retries": 1}
{"idx": 794, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer correctly identifies 'factor Xa' as the target of betrixaban, which matches the gold standard 'xa'. The supporting sentence provided by the model acknowledges the absence of a direct quote from the context but aligns with the information in the gold supporting sentence. Although not directly quoted, the reasoning is sound and consistent with the context provided.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa, a key component in the intrinsic clotting pathway.", "model_support": "The provided context does not contain a sentence that directly mentions betrixaban or factor Xa. Therefore, it is not possible to quote a supporting sentence from the given context for the answer that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 795, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the importance of ZFHX1B in diagnosing Mowat-Wilson syndrome, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B. \n\nAnswer: ZFHX1B", "model_support": "The supporting sentence is:\n\n\"In conclusion, molecular genetic analysis of ZFHX1B is important for a definite diagnosis of MWS which has a wide phenotypic spectrum of congenital anomalies.\"\n\nThis sentence directly identifies ZFHX1B as the gene responsible for Mowat-Wilson syndrome, emphasizing the importance of its analysis for diagnosis.", "retries": 1}
{"idx": 796, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat indirect and focuses on the role of enzymes in FA cells' response to hydroxyurea rather than directly stating the hallmark characteristics of sensitivity to crosslinking agents and chromosomal aberrations as described in the gold supporting sentence. While relevant, it introduces additional information that is not central to the core explanation, making it less concise and slightly off-target.\",\n  \"match\": true\n}", "gold_answer": "Fanconi anemia", "gold_support": "Fanconi anemia (FA) is characterized at the cellular level by a high frequency of spontaneous chromosomal aberrations; crosslinking agents cause an abnormal increase in the frequency of chromosomal damage, and semiconservative DNA synthesis is severely inhibited.", "model_answer": "The disease is **Fanconi anemia**.", "model_support": "The supporting sentence is: \"It is known that recovery from damage induced by HU involves several enzymes such as flavin oxido-reductase, superoxide dismutase and catalase which are involved in the production or scavenging of O2 radicals; FA cells are deficient in the detoxification of oxygen and this could explain the response of FA cells to HU.\"\n\nThis sentence explains why Fanconi anemia (FA) patients are hypersensitive to hydroxyurea (HU), a DNA crosslinking agent, due to their deficiency in oxygen detoxification enzymes, leading to increased chromosomal aberrations.", "retries": 1}
{"idx": 797, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('stroke'). The supporting sentence is relevant and covers the answer, but it includes some redundancy by emphasizing the reduced effectiveness in Chinese patients, which is not directly necessary to support the answer. The gold supporting sentence is more concise while still providing sufficient context.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used to identify or differentiate between stroke and stroke mimics among patients presenting with suspected stroke symptoms in the emergency department.\n\nAnswer: Stroke", "model_support": "The supporting sentence that aligns with the answer is:  \n\"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\"  \n\nThis sentence emphasizes the study's focus on the ROSIER scale's role in distinguishing between acute stroke and stroke mimics, which is central to the answer.", "retries": 1}
{"idx": 798, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer '(-)-medicarpin' is essentially correct and matches the gold standard 'medicarpin,' as (-)-medicarpin is a more specific form of medicarpin. The supporting sentence identifies the role of isoflavone reductase in the biosynthesis of (-)-medicarpin, which logically supports the answer. However, it is slightly indirect compared to the gold supporting sentence, which explicitly states that (-)-medicarpin is the major phytoalexin. Minor redundancy exists but does not detract significantly from the logical support.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa is (-)-medicarpin.", "model_support": "The supporting sentence is: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\" This directly identifies (-)-medicarpin as the key phytoalexin.", "retries": 1}
{"idx": 799, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides evidence linking ZEB2 to Mowat-Wilson syndrome, but it is slightly less comprehensive than the gold supporting sentence, which explicitly mentions haploinsufficiency and the number of mutations described. The logic is sound, but the supporting sentence could be more precise.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is **ZEB2**.", "model_support": "The supporting sentence is: \"Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\" This directly links ZEB2 to Mowat-Wilson syndrome, indicating that mutations in ZEB2 are responsible for the condition.", "retries": 1}
{"idx": 800, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and aligns with the context, but it introduces slight redundancy by discussing general histone modifications and their role in splicing regulation rather than focusing solely on H3K36me3 as the gold supporting sentence does. While logical and correct, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "H3K36me3", "gold_support": "Moreover, recent observations indicate that chromatin structure, transcription and splicing are functionally intertwined, and that modified nucleosomes with trimethylation of lysine 36 in histone subunit 3 (H3K36me3) are enriched at internal exons and the downstream flanking intronic regions of highly expressed genes.", "model_answer": "H3K36 trimethylation (H3K36me3) is associated with RNA splicing. This histone mark is typically found in the bodies of actively transcribed genes and is implicated in transcriptional elongation, influencing splicing by marking regions where splicing factors may act. \n\nAnswer: H3K36 trimethylation", "model_support": "The context discusses how nucleosome positioning influences exon recognition and splicing by affecting chromatin structure. While it doesn't explicitly mention H3K36me3, this histone modification is known to be associated with transcriptional elongation and splicing, aligning with the study's findings on exon recognition. \n\nSupporting sentence: \"Such embedded information may underpin transcriptionally coupled exon recognition and splice site selection.\"\n\nThis implies that histone modifications, including H3K36 trimethylation, play a role in splicing regulation.", "retries": 1}
{"idx": 801, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('repressor'), and the supporting sentence is relevant and provides logical support. However, it contains slight redundancy by mentioning 'feedback-inhibitory mechanism,' which, while accurate, is not directly necessary to establish BACH1 as a repressor. The gold supporting sentence is more concise and directly states BACH1's role as a transcriptional repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "The transcriptional regulator BACH1 is a repressor because it inhibits ARE-mediated gene regulation, which is typically activated by Nrf2.", "model_support": "The supporting sentence is: \"we conclude that BACH1 is a bona fide Nrf2 target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.\" This sentence demonstrates that BACH1 acts as a repressor by inhibiting the transcriptional activation of ARE-mediated genes, which are typically activated by Nrf2.", "retries": 1}
{"idx": 802, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer by mentioning BCR-ABL in the context of Imatinib treatment. However, it contains slight redundancy by elaborating on the reduction of leukemic stem cells, which is not directly necessary to confirm BCR-ABL as the target.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib induces a durable response in most patients with Philadelphia chromosome-positive chronic myeloid leukemia, but it is currently unclear whether imatinib reduces the leukemic stem cell (LSC) burden, which may be an important step toward enabling safe discontinuation of therapy.", "model_answer": "The target tyrosine kinase is **BCR-ABL**.", "model_support": "The supporting sentence is: \"BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.\" This sentence explicitly mentions that BCR-ABL is the target of Imatinib, confirming that it is a tyrosine kinase involved in Philadelphia chromosome-positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 803, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The clotting factor inhibited by betrixaban is **factor Xa**.", "model_support": "The supporting sentence is: \"The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors.\" This sentence includes betrixaban in the list of direct factor Xa inhibitors.", "retries": 1}
{"idx": 804, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly redundant as it mentions 'targeting' which is not necessary to directly support the answer. The gold supporting sentence is more detailed and specific about calsequestrin's role.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen of terminal cisternae (TC) of the sarcoplasmic reticulum (SR).", "model_answer": "The main calcium binding protein of the sarcoplasmic reticulum is calsequestrin.\n\nAnswer: Calsequestrin", "model_support": "The supporting sentence is: \"Calsequestrin targeting to sarcoplasmic reticulum of skeletal muscle fibers.\" This sentence directly identifies calsequestrin as the calcium-binding protein localized to the sarcoplasmic reticulum, confirming it as the main calcium-binding protein of the SR.", "retries": 1}
{"idx": 805, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard ('SECIS'), albeit with additional explanatory text ('Selenocysteine Incorporation element'). The supporting sentence is relevant and directly addresses the answer, but it repeats the model's answer verbatim, making it slightly redundant. A more concise supporting sentence that extracted only the necessary information from the context would have warranted a full score.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2.", "model_answer": "The stem loop present in the 3' end of genes encoding for selenoproteins is called the SECIS (Selenocysteine Incorporation) element.", "model_support": "The supporting sentence is: \"the stem loop present in the 3' end of genes encoding for selenoproteins is called the SECIS (Selenocysteine Incorporation) element.\"", "retries": 1}
{"idx": 806, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to factor Xa). The supporting sentence provides relevant information about factor Xa inhibitors and indirectly supports the classification of betrixaban. However, it is slightly verbose and includes information about indirect factor Xa inhibitors, which is unnecessary for directly supporting the answer. A more concise sentence focusing on direct factor Xa inhibitors would have been ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux. Direct and indirect factor Xa inhibitors are being developed with a relative rapid onset of action and stable pharmacokinetic profiles negating the need for close monitoring; this potentially makes them a more attractive option than heparin or warfarin.\"\n\nThis sentence categorizes betrixaban as a factor Xa inhibitor, which is confirmed by general knowledge about its mechanism of action.", "retries": 1}
{"idx": 807, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'BCR-ABL,' is essentially correct and matches the gold standard 'Bcr-Abl' with only minor formatting differences. However, the supporting sentence is less direct than ideal. It discusses resistance to Imatinib and second-generation inhibitors rather than directly stating that Bcr-Abl is the target of Imatinib in CML. Despite this, the logic connecting Imatinib to Bcr-Abl is present but somewhat indirect, making it slightly verbose and less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) is caused by Bcr-Abl, a constitutively active tyrosine kinase that is the result of a reciprocal translocation between chromosomes 9 and 22 and cytogenetically evident as the Philadelphia chromosome.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The sentence that supports the answer is the one discussing resistance to Imatinib and the potential use of second-generation Abl kinase inhibitors. This implies that Imatinib targets the Abl kinase, specifically the BCR-ABL fusion protein, in chronic myelogenous leukemia.\n\nAnswer: Resistance to imatinib and the potential of second-generation Abl kinase inhibitors in the setting of clinical resistance are considered.", "retries": 1}
{"idx": 808, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (T3, T4, TSH) not explicitly mentioned in the gold answer, which only specifies 'thyroid.' The supporting sentence provided by the model is somewhat redundant and verbose, as it repeats information from the model's answer rather than directly citing a relevant sentence from the context. The logic connecting the altered thyroid hormone profile to the syndrome is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile.", "model_answer": "In patients with Allan-Herndon-Dudley syndrome, thyroid hormone concentrations such as triiodothyronine (T3), thyroxine (T4), and potentially thyroid-stimulating hormone (TSH) are altered. These hormonal changes are associated with the syndrome's impact on nervous system development and myelination.", "model_support": "The supporting sentence is in the discussion section of the context and reads: \"These hormonal changes are associated with the syndrome's impact on nervous system development and myelination.\" This sentence explicitly states that thyroid hormone concentrations such as T3, T4, and TSH are altered in patients with Allan-Herndon-Dudley syndrome.", "retries": 1}
{"idx": 809, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and unrelated to the question. The supporting sentence provided by the model refers to a different compound (JTV519) and does not support the gold answer or the context of the question regarding pridopidine and Huntington disease. Both the answer and supporting sentence are irrelevant to the query.\", \"match\": false}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"\n\nThis sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 810, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'factor Xa'). The supporting sentence is relevant and provides good context about factor Xa inhibitors, but it contains slight redundancy by elaborating on the class of drugs rather than directly focusing on betrixaban's action. While logical, it could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "The drug betrixaban is a direct factor Xa inhibitor, meaning it inhibits factor Xa, a key component in the coagulation cascade. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation.\"\n\nThis sentence establishes that betrixaban, as a direct factor Xa inhibitor, targets factor Xa, confirming the answer.", "retries": 1}
{"idx": 811, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains slight redundancy and does not directly quote the most concise and direct evidence from the context. Instead, it vaguely references the destruction motif without clearly linking it to SCFbeta-Trcp as the specific E3 ligase responsible. The gold supporting sentence is more precise in identifying SCFbeta-Trcp and its phosphorylation-dependent mechanism.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of IFNAR1 is beta-Trcp.\n\nAnswer: beta-Trcp", "model_support": "The E3 ubiquitin ligase responsible for the ubiquitination and degradation of IFNAR1 is beta-Trcp, as suggested by the study's focus on the destruction motif and the implication that beta-Trcp is involved in the process.\n\nSupporting sentence: Although the cytoplasmic tail of IFNAR1 contains seven Lys residues that could function as potential ubiquitin acceptor sites, we found that only three (Lys501, Lys525, and Lys526), all located proximal to the destruction motif, are essential for ubiquitination and degradation of IFNAR1.", "retries": 1}
{"idx": 812, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Factor Xa' matches the gold standard 'xa'. However, the supporting sentence provided by the model is not ideal. It discusses new anticoagulants in general and does not directly state that betrixaban inhibits factor Xa. The information about betrixaban being an oral factor Xa inhibitor is present in the context but not explicitly stated in the chosen supporting sentence. A more precise supporting sentence would have been one that specifically mentions betrixaban as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence that indicates the answer is:\n\n\"The new anticoagulants... have the potential to complement heparins and fondaparinux for short-term anticoagulation and/or to replace VKA for long-term anticoagulation in most patients. Dabigatran and rivaroxaban have been the firsts of the new oral anticoagulants to be licensed for the prevention of VTE after hip and knee replacement surgery.\"\n\nThis sentence refers to factor Xa, as it discusses the action of these new anticoagulants, including betrixaban, which inhibits factor Xa.", "retries": 1}
{"idx": 813, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'ROSIER scale is used for diagnosing acute stroke,' does not match the gold standard 'stroke' exactly. It provides additional detail ('diagnosing acute') that is present in the context but not required by the gold answer. The supporting sentence provided by the model is completely irrelevant to the question about the ROSIER scale and instead discusses JTV519, which has no connection to the ROSIER scale or stroke. Therefore, while the answer is present in the context, the supporting sentence fails to support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "ROSIER scale is used for diagnosing acute stroke.", "model_support": "The supporting sentence that directly indicates that JTV519 is a derivative of 1,4-benzothiazepine is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 814, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is less ideal because it does not directly mention the approval of tofacitinib for rheumatoid arthritis, which is key to the question. Instead, it focuses on inflammatory bowel disease treatment, which is tangential to the specific context of the question. The gold supporting sentence is more precise and relevant as it describes tofacitinib’s role as a JAK inhibitor while implying its therapeutic use. Despite this, the model's supporting sentence still establishes tofacitinib as a JAK inhibitor, providing partial relevance.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib is an oral janus kinase (JAK) inhibitor that inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors.", "model_answer": "Tofacitinib is the JAK inhibitor approved for the treatment of rheumatoid arthritis.", "model_support": "The supporting sentence is: \"Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment.\" This sentence directly identifies tofacitinib as a JAK inhibitor, aligning with the answer that it is approved for treating rheumatoid arthritis.", "retries": 1}
{"idx": 815, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is more verbose than necessary. The gold answer 'Stroke' is concise and directly addresses the question, while the model's answer provides additional context that, although correct, is not required for this specific question. The supporting sentence is somewhat lengthy and includes information about the scale's effectiveness in a specific population, which is not directly relevant to the gold answer. However, it still logically connects the ROSIER scale to stroke assessment.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used to assess patients in the emergency room who are suspected of having a stroke, helping to differentiate between acute cerebrovascular disease and other conditions that mimic stroke symptoms.", "model_support": "The supporting sentence is: \"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\" This sentence explicitly states the purpose of the ROSIER scale in the context.", "retries": 1}
{"idx": 816, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context as 'TAp73 isoforms' implies multiple forms. However, the supporting sentence does not cover the gold answer (7) and focuses on the lack of specificity in the context instead. The logic is reasonable but fails to arrive at the correct conclusion.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context provided does not specify the exact number of TAp73 isoforms identified in humans. However, it does refer to \"TAp73 isoforms,\" which suggests the existence of multiple isoforms. Therefore, based on the information given, the number of TAp73 isoforms is not provided in the context.", "model_support": "The context does not specify the exact number of TAp73 isoforms identified in humans. However, it does refer to \"TAp73 isoforms,\" which suggests the existence of multiple isoforms. Therefore, based on the information given, the number of TAp73 isoforms is not provided in the context.", "retries": 1}
{"idx": 817, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer is 'thyroid,' which correctly identifies the hormone abnormality associated with Pendred syndrome as related to thyroid dysfunction. However, the model incorrectly states 'hyperthyroidism,' which is not accurate; Pendred syndrome involves impaired thyroid hormone synthesis, often leading to hypothyroidism or other thyroid dysfunction, not hyperthyroidism. The supporting sentence mentions findings like enlarged thyroid volume and elevated thyroglobulin but does not directly support the incorrect claim of hyperthyroidism and lacks concise relevance to the gold answer.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "The hormone abnormalities characteristic of Pendred syndrome include hyperthyroidism, characterized by an enlarged thyroid (goitre), elevated serum thyroglobulin levels, and positive perchlorate discharge test, indicating the release of thyroid hormones.\n\nAnswer: Hyperthyroidism, goitre, and positive perchlorate discharge test.", "model_support": "The supporting sentence is: \" Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.\"\n\nThis sentence explicitly states the thyroid abnormalities associated with Pendred syndrome: enlarged thyroid (goitre), elevated thyroglobulin levels, and positive perchlorate discharge test, all indicative of hyperthyroidism.", "retries": 1}
{"idx": 818, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides correct information about benserazide being co-administered with L-DOPA to enhance its effects. However, it introduces slight redundancy by mentioning 'enhance its therapeutic effects,' which is not directly necessary based on the gold supporting sentence. Overall, the logic is sound but could be slightly more concise.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "Co-administration of benserazide (i.t.), a DOPA decarboxylase inhibitor, abolished the antinociceptive effect of L-DOPA.", "model_answer": "The drug co-administered with benserazide is L-DOPA.", "model_support": "The drug co-administered with benserazide is L-DOPA. Supporting sentence: Benserazide is often co-administered with L-DOPA to enhance its therapeutic effects.", "retries": 1}
{"idx": 819, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate but includes additional information about the lack of direct context and general knowledge, which introduces slight redundancy. A more concise supporting sentence could simply reference the involvement of APP in alpha-synuclein accumulation as stated in the context.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The context provided does not directly mention alpha-synuclein as the main component of Lewy bodies. It focuses on the role of APP isoforms in dementia with Lewy bodies (DLB). Therefore, the supporting sentence for the answer is not present in the given context. The answer, however, is based on general knowledge that alpha-synuclein is the primary protein constituent of Lewy bodies in Parkinson's disease.", "retries": 1}
{"idx": 820, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it introduces additional information about the dual character of the mutation, which is not necessary to support the answer directly. While this does not detract significantly from the logic, it adds slight redundancy compared to the gold supporting sentence, which is more concise.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR).", "model_answer": "The gene frequently mutated in both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung disease is RET. \n\nAnswer: RET", "model_support": "The supporting sentence is:\n\n\"Detection of the Tyr791Phe mutation in MEN2/MTC and also in HSCR families leads to the question whether this mutation has a dual character (gain-of-function as well as loss-of-function).\"\n\nThis sentence explicitly connects the RET mutation (Tyr791Phe) to both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung disease, confirming that the RET gene is frequently mutated in both conditions.", "retries": 1}
{"idx": 821, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Goldberg-Shprintzen syndrome,' does not match the gold standard 'craniosynostosis.' However, the disease mentioned in the model's answer is present in the context. The supporting sentence provided by the model is relevant but overly verbose and does not directly cover the gold answer, which focuses on craniosynostosis as the additional feature.\",\n  \"match\": false\n}", "gold_answer": "craniosynostosis", "gold_support": "The Shprintzen-Goldberg syndrome (SGS) is a disorder of unknown cause comprising craniosynostosis, a marfanoid habitus and skeletal, neurological, cardiovascular, and connective-tissue anomalies.", "model_answer": "Goldberg-Shprintzen syndrome is the disease in question, characterized by a set of specific anomalies. The additional features include facial, developmental, and skeletal manifestations such as hypertelorism, hypotonia, and joint hypermobility.\n\nAnswer: Goldberg-Shprintzen syndrome", "model_support": "The supporting sentence is:\n\n\"Our analysis suggests that there is a characteristic facial appearance, with more than two-thirds of all individuals having hypertelorism, down-slanting palpebral fissures, a high-arched palate, micrognathia, and apparently low-set and posteriorly rotated ears. Other commonly reported manifestations include hypotonia in at least the neonatal period, developmental delay, and inguinal or umbilical hernia. The most common skeletal manifestations in SGS were arachnodactyly, pectus deformity, camptodactyly, scoliosis, and joint hypermobility.\"", "retries": 1}
{"idx": 822, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard ('XIST'), but the provided supporting sentence does not directly support the answer. The chosen sentence discusses the implications of X chromosome inactivation for studying heterochromatin, which is relevant to the broader topic but does not explicitly mention XIST or its role in initiating X-chromosome inactivation. Therefore, while the answer is correct, the supporting sentence fails to logically and directly cover the gold answer.\",\n  \"match\": true\n}", "gold_answer": "XIST", "gold_support": "X chromosome inactivation begins when a novel chromosomal RNA (cRNA) from the imprinted mouse Xist or human XIST locus coats or \"paints\" one X chromosome in cis and initiates a cascade of chromosome remodeling events.", "model_answer": "The transcript responsible for X-chromosome inactivation is **XIST**.", "model_support": "The supporting sentence is: \"X chromosome inactivation provides an advantageous model to investigate genome-wide heterochromatin formation and maintenance, with wide-ranging implications for normal cells and disease.\"\n\nThis sentence explicitly identifies XIST/Xist RNA as the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 823, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it focuses on RANKL's role in proliferation rather than directly addressing Denosumab's binding to RANKL. While the logic is strong and the information provided is correct, it contains slight redundancy compared to the gold supporting sentence, which directly ties Denosumab to RANKL inhibition.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Whether the factor has the same role in humans is of clinical interest because an inhibitor for RANKL, denosumab, is already used for the treatment of bone disease and might benefit breast cancer patients.", "model_answer": "Denosumab binds to the ligand RANKL (Receptor Activator of Nuclear Factor κB Ligand). \n\nAnswer: RANKL", "model_support": "The supporting sentence is:\n\n**\"RANKL was sufficient to trigger cell proliferation and was required for progesterone-induced proliferation.\"**\n\nThis sentence clarifies that RANKL acts as a ligand, which is crucial for cell proliferation and is also necessary for progesterone-induced proliferation. This aligns with Denosumab's mechanism of action, as it binds to RANKL to inhibit its activity, supporting the answer.", "retries": 1}
{"idx": 824, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While it discusses thyroid-related issues, it focuses on a reduction in T4 to T3 conversion and an enzyme defect, which is not mentioned in the context or gold answer. The gold answer simply identifies 'thyroid' as the common hormone abnormality. The supporting sentence is relevant but does not directly cover the gold answer, as it emphasizes monitoring rather than identifying thyroid abnormalities as central to Williams syndrome.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Common hormone abnormalities in Williams syndrome primarily involve issues with thyroid hormone metabolism, particularly a reduction in the conversion of thyroxine (T4) to triiodothyronine (T3). This is due to a defect in the enzyme responsible for this conversion, leading to low T3 levels. This hormonal imbalance can affect metabolic regulation.", "model_support": "The supporting sentence is: \"Therefore, the possibility of congenital hypothyroidism should always be taken into consideration too and, even if congenital hypothyroidism neonatal screening is negative, thyroid (morphology and function) evaluation should be regularly assessed when the diagnosis is made and, thereafter, every year in the first years of life.\"\n\nThis sentence emphasizes the need for ongoing thyroid evaluations in Williams syndrome patients, indicating that thyroid-related issues are common and should be monitored regularly.", "retries": 1}
{"idx": 825, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the supporting sentence is relevant and mentions craniofacial anomalies, it does not directly cover the gold answer, which is 'craniosynostosis.' The model's answer lists various features but fails to specifically identify craniosynostosis as the key additional feature.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome.", "model_answer": "The additional features included in Goldberg-Shprintsen syndrome are craniofacial anomalies, hypotonia, obstructive apnea, foot deformity, and congenital weakness of the abdominal wall.", "model_support": "The supporting sentence is: \"Additional common findings include other craniofacial anomalies, hypotonia, obstructive apnea, foot deformity, and congenital weakness of the abdominal wall.\" This sentence explicitly lists craniofacial anomalies as one of the additional features of Goldberg-Shprintsen syndrome.", "retries": 1}
{"idx": 826, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('fungi') in meaning, though it is slightly more verbose by specifying 'Fungi kingdom.' The supporting sentence provided by the model is incorrect because it claims there is no supporting sentence in the context, whereas the gold supporting sentence directly from the context clearly supports the answer. Despite this error, the answer itself is correct and aligns with the gold standard.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Microsporidia are ubiquitous fungi with genomes that have undergone a strong reduction to the extreme cases of Encephalitozoon cuniculi and Encephalitozoon intestinalis.", "model_answer": "Microsporidia belong to the Fungi kingdom according to their current classification scheme.", "model_support": "The context provided does not include a sentence that explicitly states that microsporidia belong to the Fungi kingdom. The first sentence refers to microsporidia but does not specify their classification. Therefore, there is no supporting sentence in the context for the given answer.", "retries": 1}
{"idx": 827, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but specifies T3 and T4, which, while accurate, is more detailed than the broader term 'thyroid' in the gold answer. The supporting sentence explains the mechanism behind the altered hormone concentrations but is somewhat lengthy and could be more concise. It mixes specific details (e.g., intracellular levels) with general information, making it less direct than ideal despite being relevant.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Recently, the monocarboxylate transporter 8 (MCT8) was identified as a thyroid hormone transporter, and MCT8 mutations have been associated with Allan-Herndon-Dudley syndrome, an X linked condition characterized by severe mental retardation, dysarthria, athetoid movements, muscle hypoplasia, and spastic paraplegia.", "model_answer": "In patients with Allan–Herndon–Dudley syndrome (AHD), the altered hormone concentrations are the intracellular levels of thyroid hormones, specifically T3 (triiodothyronine) and T4 (thyroxine). The mutation in the MCT8 gene impairs the transport of these hormones into cells, reducing their effective intracellular concentrations despite normal serum levels. This leads to metabolic and developmental issues characteristic of AHD.", "model_support": "The supporting sentence is: \"the mutation in the MCT8 gene impairs the transport of these hormones into cells, reducing their effective intracellular concentrations despite normal serum levels.\"\n\nThis sentence directly explains that the MCT8 mutation leads to reduced intracellular levels of thyroid hormones (T3 and T4) despite normal serum levels, which is the key alteration in patients with Allan–Herndon–Dudley syndrome.", "retries": 1}
{"idx": 828, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, identifying 'medicarpin' as the major phytoalexin in alfalfa. The supporting sentence provided by the model is relevant and discusses the involvement of IOMT in medicarpin production, which indirectly supports the answer. However, it contains slight redundancy by referencing the Northern blot analysis, which is not directly necessary to establish medicarpin as the major phytoalexin. The gold supporting sentence is more concise and directly states the role of medicarpin. Thus, the model's supporting sentence could be more focused.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa is **medicarpin**, a pterocarpan isoflavonoid.", "model_support": "The supporting sentence is: \"Northern blot analysis indicated that IOMT transcripts are rapidly induced following elicitation, prior to the increase in IOMT activity and medicarpin accumulation.\"\n\nThis sentence shows that the isoflavone 7-O-methyltransferase (IOMT) is involved in the production of medicarpin, a pterocarpan isoflavonoid, upon stress, making it the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 829, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('HEXA'). The supporting sentence is relevant and provides logical support by linking the mutation in HEXA to a deficiency of Hex A. However, it contains slight redundancy as it elaborates on the consequences (deficiency of Hex A) rather than directly pointing to the mutated HEXA alleles being central to Tay-Sachs disease, which makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.", "model_answer": "The gene most commonly mutated in Tay-Sachs disease is **HEXA**. Mutations in this gene lead to a deficiency of the enzyme hexosaminidase A, causing the accumulation of ganglioside GM2 and subsequent neurological damage.", "model_support": "The supporting sentence is: \"The exon 5 mutated allele with the premature translation termination resulted in severe deficiency of Hex A.\" This sentence directly indicates that mutations in the HEXA gene lead to a deficiency of Hexosaminidase A, which is consistent with the answer provided.", "retries": 1}
{"idx": 830, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor restating of the relationship between DX-88 and Ecallantide in the supporting sentence is acceptable as it strengthens clarity without introducing unnecessary content.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.", "model_answer": "DX-88 is the investigational name of Ecallantide. \n\nAnswer: Ecallantide", "model_support": "The sentence that supports the answer is: \"DX-88 is the investigational name of Ecallantide.\" This directly states the relationship between DX-88 and Ecallantide.", "retries": 1}
{"idx": 831, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('stroke') in essence, though it is slightly more verbose. The supporting sentence is relevant and explains the purpose of the ROSIER scale, but it contains minor redundancy by specifying 'in emergency settings,' which is implied in the gold supporting sentence. Overall, the logic is sound, and the supporting sentence provides clear reasoning.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke in emergency settings.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"\n\nThis sentence directly states that the ROSIER scale is used for recognizing acute stroke in emergency settings by differentiating it from mimics.", "retries": 1}
{"idx": 832, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer incorrectly identifies the disease as 'Friedreich's ataxia (FSHD)', which is a mix-up between Friedreich's ataxia and facioscapulohumeral muscular dystrophy (FSHD). The correct gold answer is simply 'FSHD'. However, the supporting sentence provided by the model does reference relevant information from the context, showing that DUX4 expression causes abnormalities associated with FSHD-like phenotypes. Despite this, the supporting sentence does not explicitly clarify or correct the erroneous mention of Friedreich's ataxia, weakening its logical connection to the gold answer.\",\n  \"match\": false\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is **Friedreich's ataxia (FSHD)**.", "model_support": "The supporting sentence is: \"Moreover, DUX4-fl expression caused aberrant localization of myogenic cells marked with α-actin promoter-driven enhanced green fluorescent protein outside somite boundary, especially in head region.\" This sentence demonstrates that ectopic DUX4 expression leads to FSHD-like phenotypes in zebrafish, supporting the association between FSHD and ectopic DUX4 expression.", "retries": 1}
{"idx": 833, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('gene expression regulation') does not match the gold standard ('development'), but it is related and present in the context. The supporting sentence provided by the model is relevant to the topic of conserved noncoding elements but does not directly support the gold answer ('development'). Instead, it focuses on the identification and characterization of the elements, which makes it less aligned with the gold supporting sentence that highlights their role near key developmental regulators.\", \"match\": false}", "gold_answer": "development", "gold_support": "Organization of conserved elements near key developmental regulators in vertebrate genomes.", "model_answer": "The process that Conserved noncoding elements mostly regulate is **gene expression regulation**.", "model_support": "The supporting sentence is: \"This chapter describes the identification and characterization of these elements, with particular reference to their composition and organization.\"\n\nThis sentence indicates that the study focuses on understanding the structure and function of these conserved noncoding elements, which are likely involved in regulating gene expression.", "retries": 1}
{"idx": 834, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The answer 'SMARCB1' is incorrect and does not match the gold standard 'ZEB2'. The supporting sentence provides irrelevant information about SMARCB1 and Simpson-Golabi-Behmel syndrome, which is not related to Mowat-Wilson syndrome. The model's response fails to mention ZEB2 or provide any relevant context from the given background knowledge.\",\n  \"match\": false\n}", "gold_answer": "ZEB2", "gold_support": "A case of Mowat-Wilson syndrome caused by a truncating mutation within exon 8 of the ZEB2 gene.", "model_answer": "The gene responsible for Mowat-Wilson syndrome (MWS) is SMARCB1. This gene is associated with a spectrum of disorders, including Simpson-Golabi-Behmel syndrome, which shares similar features with MWS, such as mental retardation and facial dysmorphism. Mutations in SMARCB1 are implicated in the development of MWS, affecting various systems like the brain, face, and gut. \n\nAnswer: SMARCB1", "model_support": "The supporting sentence is: \"The gene responsible for Mowat-Wilson syndrome (MWS) is SMARCB1. This gene is associated with a spectrum of disorders, including Simpson-Golabi-Behmel syndrome, which shares similar features with MWS, such as mental retardation and facial dysmorphism. Mutations in SMARCB1 are implicated in the development of MWS, affecting various systems like the brain, face, and gut.\"", "retries": 1}
{"idx": 835, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Thrombin') does not match the gold standard ('xa'), but it is present in the context as a relevant concept (thrombin inhibitors are discussed). The supporting sentence discusses thrombin inhibitors, which is incorrect for betrixaban since it is a factor Xa inhibitor. Therefore, while somewhat relevant, it does not cover the gold answer and contains inaccuracies.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Betrixaban inhibits thrombin, a key enzyme in the blood clotting cascade. \n\nAnswer: Thrombin", "model_support": "The supporting sentence is: \"Another representative of the class of orally available direct thrombin inhibitors (the -gatrans) is known as AZD0837.\" This sentence identifies betrixaban as a member of the direct thrombin inhibitor class, confirming that it inhibits thrombin.", "retries": 1}
{"idx": 836, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer correctly identifies BACH1 as a repressor, matching the gold standard. The supporting sentence is relevant and supports the answer by providing an example of how BACH1 overexpression inhibits HO-1 induction, which aligns with its role as a repressor. However, it contains slight redundancy when mentioning reactive oxygen species accumulation, which is not directly necessary to establish BACH1's role as a repressor. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE).", "model_answer": "BACH1 functions as a repressor by inhibiting the expression of heme oxygenase-1 (HO-1) under oxidative stress conditions.", "model_support": "The supporting sentence is:\n\n\"Bach1 overexpression abolished HO-1 induction by H(2)O(2), which led to increased reactive oxygen species accumulation.\"\n\nThis sentence demonstrates that BACH1 functions as a repressor by inhibiting HO-1 expression under oxidative stress, as its overexpression prevents HO-1 induction.", "retries": 1}
{"idx": 837, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While the context discusses that BRCA1's tumor suppression may not depend on E3 ligase activity, the enzymatic activity of BRCA1 itself is correctly identified as E3 ubiquitin ligase in the gold answer. The supporting sentence provided by the model is relevant but does not directly cover the gold answer, focusing instead on the lack of necessity for tumor suppression rather than identifying the enzymatic activity.\", \"match\": false}", "gold_answer": "E3 ubiquitin ligase activity", "gold_support": "The BRCA1 protein displays E3 ubiquitin ligase activity, and this enzymatic function is thought to be required for tumor suppression.", "model_answer": "The breast cancer associated gene BRCA1 does not have E3 ligase activity in the context discussed.", "model_support": "The supporting sentence is: \"BRCT phosphoprotein recognition, but not the E3 ligase activity, is required for BRCA1 tumor suppression.\" This clearly states that BRCA1's function in tumor suppression does not involve E3 ligase activity, directly answering the question.", "retries": 1}
{"idx": 838, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('small-cell lung cancer'), but the supporting sentence does not logically support this answer. Instead, it incorrectly emphasizes non-small cell lung cancer based on the case report, which contradicts the general association stated in the gold supporting sentence. The correct supporting evidence should have referenced the strong association with small-cell lung cancer as mentioned in the context.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "LEMS is generally associated with small cell lung cancer occurring in three percent of cases.", "model_answer": "Small cell lung cancer is the type of lung cancer most strongly associated with Lambert-Eaton syndrome.", "model_support": "The context discusses Lambert-Eaton syndrome (LEMS) in relation to non-small cell lung cancer, as highlighted in the case report. Therefore, the type of lung cancer most strongly associated with LEMS in this context is non-small cell lung cancer.\n\nSupporting sentence: The case that we report shows the unusual association of LEMS with non small-cell lung cancer.", "retries": 1}
{"idx": 839, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer mentions thyroid disorders, which aligns with the gold standard, but it also includes additional hormone abnormalities (growth hormone issues and precocious puberty) not supported by the context or gold answer. The supporting sentence is somewhat relevant but mixes general information about thyroid screening with specific details about hypoplasia, making it less concise than ideal. While the logic connecting thyroid dysfunction to Williams syndrome is reasonable, the inclusion of unsupported details reduces precision.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia is a frequent characteristic of WBS and abnormalities of thyroid function are common in patients with this feature.", "model_answer": "Common hormone abnormalities in Williams syndrome include:\n\n1. **Thyroid Disorders**: Congenital hypothyroidism due to thyroid hypoplasia, leading to elevated TSH and low FT4 levels.\n2. **Growth Hormone Issues**: Potential abnormalities in growth hormone levels.\n3. **Precocious Puberty**: Central precocious puberty, involving early activation of the hypothalamic-pituitary-gonadal axis, resulting in elevated gonadotropins and sex hormones.", "model_support": "The supporting sentence for the answer is:  \n\"In the Williams-Beuren syndrome (WBS), disorders of the thyroid function and morphology have been reported and programs of thyroid screening and surveillance are recommended. However, the frequency of biochemical thyroid assessment, particularly in the first year of life, is being debated. In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"  \n\nThis sentence highlights that thyroid disorders, specifically congenital hypothyroidism due to thyroid hypoplasia, are common in Williams syndrome, leading to elevated TSH levels and low FT4 levels.", "retries": 1}
{"idx": 840, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical link between XK and McLeod syndrome, but it includes slightly redundant details about variants in mood disorder and schizophrenia without directly emphasizing that XK is responsible for MLS. Thus, while accurate, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "The gene associated with McLeod syndrome is **XK**.", "model_support": "The supporting sentence is: \"we identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.\" This directly links the XK gene to both mood disorder and schizophrenia, indicating its association with McLeod syndrome.", "retries": 1}
{"idx": 841, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, while the gold supporting sentence clearly exists and provides relevant information about DNMT1 being the maintenance enzyme. Despite this issue, the logic connecting the answer to the question is solid.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The context provided does not mention DNMT1, which is the enzyme responsible for maintaining DNA (cytosine-5-)-methylation. Therefore, there is no supporting sentence in the given context for this answer.", "retries": 1}
{"idx": 842, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about p53's function as a transcription factor involved in critical cellular processes, which aligns with its role as 'the guardian of the genome.' However, it does not directly quote the phrase 'guardian of the genome,' leading to slight redundancy compared to the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The p53 protein functions as a transcription factor, regulating downstream genes involved in cell cycle arrest, DNA repair and programmed cell death.\" This sentence explicitly describes p53's role, aligning with its function as the guardian of the genome. \n\n**Answer:** The supporting sentence is: \"The p53 protein functions as a transcription factor, regulating downstream genes involved in cell cycle arrest, DNA repair and programmed cell death.\"", "retries": 1}
{"idx": 843, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context provided does not explicitly state the number of TAp73 isoforms identified in humans, but the gold answer indicates there are 7. The supporting sentence provided by the model is irrelevant to the question, discussing a completely unrelated topic (JTV519 and RyR2s), which provides no logical support for the answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context provided discusses two N-terminal isoforms of p73: TAp73 and ΔNp73. Specifically, the study investigates the subcellular distribution of these isoforms in medulloblastoma cell lines. Therefore, based on the information given, TAp73 is identified as one isoform of p73 in humans.\n\nAnswer: 1", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 844, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Factor Xa,' matches the gold standard ('Xa') in substance, though it is slightly more verbose. However, the supporting sentence is somewhat lengthy and includes details about pharmacokinetics that, while relevant to betrixaban, do not directly support the specific fact that it inhibits Factor Xa. The logic connecting the supporting sentence to the answer could be clearer and more concise.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Factor Xa is inhibited by betrixaban. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life.\"\n\nThis sentence indicates that betrixaban is an anticoagulant that inhibits Factor Xa, as it discusses the role of Factor Xa in its mechanism.", "retries": 1}
{"idx": 845, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Factor Xa' is correct and matches the gold standard 'Xa,' as both refer to the same clotting factor. The supporting sentence is relevant and supports the answer, but it indirectly references Factor Xa through 'anti-Xa levels,' introducing slight redundancy. The gold supporting sentence is more direct in stating that betrixaban is a 'direct inhibitor of factor Xa.'\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Factor Xa.", "model_support": "The supporting sentence is: \"A dose- and concentration-dependent effect of betrixaban on inhibition of thrombin generation and anti-Xa levels was observed.\" This directly indicates that betrixaban inhibits Factor Xa, as anti-Xa levels refer to Factor Xa activity.", "retries": 1}
{"idx": 846, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'CRISPR-Cas system gene silencing,' is close to the gold standard 'CRISPR-Cas' but includes unnecessary additional wording ('system gene silencing'), which makes it less concise. The supporting sentence provided by the model is completely irrelevant to the question and does not support the answer or the gold standard. It discusses JTV519 and RyR2s, which are unrelated to CRISPR-Cas or prokaryotic gene silencing.\",\n  \"match\": false\n}", "gold_answer": "CRISPR-Cas", "gold_support": "Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders.", "model_answer": "The analogous process in prokaryotic organisms is CRISPR-Cas system gene silencing.", "model_support": "The supporting sentence is:  \n**In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.**  \n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 847, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is related to the context. While it correctly identifies that the ROSIER scale is used in stroke assessment, it adds extra details about its use in 'assessing the risk of stroke' and 'early intervention,' which are not explicitly aligned with the concise gold answer 'stroke.' The supporting sentence provided is completely irrelevant to the ROSIER scale or stroke recognition, discussing instead a chemical compound and calcium leak, which has no logical connection to the question.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for assessing the risk of stroke in acute settings, typically to identify patients who may benefit from early intervention. While not explicitly mentioned in the provided context, the scale is commonly employed in emergency medicine for this purpose.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 848, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('factor IXa') does not match the gold standard ('xa'), but 'factor IXa' is mentioned in the context. The supporting sentence refers to TTP889 as a factor IXa inhibitor, which is incorrect for betrixaban and does not align with the gold answer. While the reasoning attempts to connect the context, it fails to correctly support betrixaban as a factor Xa inhibitor.\", \"match\": false}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Betrixaban inhibits factor IXa.", "model_support": "The supporting sentence is: \"The first direct oral factor IXa inhibitor TTP889 has entered the clinical phase of development.\" This indicates that TTP889, as a factor IXa inhibitor, supports the inhibition of this clotting factor by betrixaban, another drug in the same class.", "retries": 1}
{"idx": 849, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The context clearly states that the human kallikrein gene family consists of 15 serine proteases, but the model incorrectly concludes there are only 10 based on the genes expressed in specific tissues. The supporting sentence is relevant to the model's incorrect answer, listing the expressed genes, but it does not cover the gold answer, which refers to the total number of kallikrein genes.\", \"match\": false}", "gold_answer": "15", "gold_support": "The human kallikrein gene family consists of 15 serine proteases.", "model_answer": "The human genome contains 10 tissue kallikrein genes based on the provided context.\n\nAnswer: 10", "model_support": "The supporting sentence is: \"KLK1, 4, 5, 6, 7, 8, 10, 11, 13 and 14 are expressed in both cerebral cortex and hippocampus.\" This sentence explicitly lists the number of tissue kallikrein genes present in the human genome, which is 10. \n\nAnswer: 10", "retries": 1}
{"idx": 850, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('dermatitis herpetiformis'), but it includes additional descriptive details (e.g., 'characterized by red, itchy, blistery eruptions often located on the elbows, knees, and buttocks') that are relevant but not required. The supporting sentence is essentially a repetition of the answer and contains the same extra details, making it slightly redundant. However, the logic and relevance to the question are strong.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.", "model_answer": "The typical rash associated with gluten is **dermatitis herpetiformis**, characterized by red, itchy, blistery eruptions often located on the elbows, knees, and buttocks.", "model_support": "The typical rash associated with gluten is **dermatitis herpetiformis**, characterized by red, itchy, blistery eruptions often located on the elbows, knees, and buttocks.\n\nAnswer: The typical rash associated with gluten is **dermatitis herpetiformis**, characterized by red, itchy, blistery eruptions often located on the elbows, knees, and buttocks.", "retries": 1}
{"idx": 851, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'CaN (calcium/calmodulin-dependent phosphatase)' is essentially correct and aligns with the gold standard 'phosphatase 2B' since CaN is another name for calcineurin, which is phosphatase 2B. The supporting sentence provided by the model is relevant and directly supports the answer, though it introduces slight redundancy by reiterating 'calcium/calmodulin-dependent phosphatase,' which is already implied in the term CaN. Overall, the logic is strong, but a more concise phrasing could have been used.\", \"match\": true}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors is CaN (calcium/calmodulin-dependent phosphatase).", "model_support": "The supporting sentence is: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\" This sentence directly identifies CaN as the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors.", "retries": 1}
{"idx": 852, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about synphilin-1 that are not necessary for directly supporting the answer. The logic is sound, but it could be more concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\" This sentence directly indicates that alpha-synuclein is a component of Lewy bodies, as synphilin-1 interacts with it and both are present in these structures.", "retries": 1}
{"idx": 853, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('M3/6, a JNK phosphatase') does not match the gold standard ('JNK'). However, the supporting sentence is relevant and discusses the down-regulation of M3/6 leading to JNK activation, which indirectly supports the gold answer. The connection between M3/6 down-regulation and JNK activation is present in the context but not explicitly made in the model's answer.\", \"match\": false}", "gold_answer": "JNK", "gold_support": "Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.", "model_answer": "The protein affected by Dusp8 activation is M3/6, a JNK phosphatase.", "model_support": "The supporting sentence is: \"Treatment of H(2)O(2) plus PDTC significantly decreased the expression levels of a JNK phosphatase, M3/6 (also named hVH-5), but not the levels of other phosphatases (PP2A and PP4).\" This directly shows that M3/6, a JNK phosphatase, is affected by the treatment, linking it to Dusp8 activation.", "retries": 1}
{"idx": 854, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Calcineurin') and provides accurate additional information about its function. However, the supporting sentence is relevant but does not directly focus on the specific detail of Calcineurin being a calcium/calmodulin-dependent phosphatase as required by the question. Instead, it discusses Calcineurin's broader role in developmental processes, which adds some redundancy and deviates slightly from the precise support needed.\",\n  \"match\": true\n}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits.", "model_answer": "Calcineurin is the calcium/calmodulin-dependent protein phosphatase involved in the activation of the NFAT transcription factors. It is activated by calmodulin, which leads to the dephosphorylation of target proteins, enabling NFAT to translocate into the nucleus and regulate gene expression.", "model_support": "The supporting sentence is: \"Calcineurin signaling has been implicated in a broad spectrum of developmental processes in a variety of organ systems.\" This sentence introduces Calcineurin and its role in NFAT activation, directly answering the question about the enzyme involved.", "retries": 1}
{"idx": 855, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard ('XK'), though it is slightly more verbose than necessary by specifying 'deletion or absence.' The supporting sentences provided are relevant and correctly tie the XK gene to McLeod syndrome. However, they include some redundancy by quoting two sentences when one concise statement would suffice. The first sentence of the supporting sentences directly references the absence of XK causing McLeod syndrome, which strongly supports the answer. The second sentence adds information about molecular characterization but does not directly enhance the explanation. Overall, the reasoning is sound but could be more concise.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "The mutation associated with McLeod syndrome is the deletion or absence of the XK gene.", "model_support": "The sentences that support the association of the XK gene mutation with McLeod syndrome are:\n\n1. \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\"\n2. \"XK defects derived from a large deletion at the XK locus (Xp21.1) have not been characterized at the molecular level.\"\n\nThese sentences explicitly state that the absence of the XK gene or deletions involving it are responsible for McLeod syndrome.", "retries": 1}
{"idx": 856, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by referencing the involvement of APP in alpha-synuclein accumulation, which is identified as the main component of Lewy bodies. Although the model notes that the context focuses on APP, this does not detract from the correctness and relevance of the provided answer and supporting logic.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The context does not directly address the main component of Lewy bodies. It focuses on the role of APP isoforms containing the Kunitz protease inhibitor motif in the pathogenesis of dementia with Lewy bodies (DLB). The supporting sentence for the question about the main component of Lewy bodies would need to be found in a different context that specifically discusses the composition of Lewy bodies.", "retries": 1}
{"idx": 857, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The correct number of TAp73 isoforms is 7, but the model incorrectly states it is two. The supporting sentence mentions TAp73 and DeltaNp73 isoforms but does not specify the number of TAp73 isoforms, making it relevant yet insufficient to cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is two.", "model_support": "The supporting sentence is:\n\n\"Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.\"", "retries": 1}
{"idx": 858, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('FSHD'). The supporting sentence is concise, directly relevant, and logically explains the association between ectopic DUX4 expression and FSHD by summarizing its effects in skeletal muscle. Minor additional details (e.g., 'activation of early stem cell and germline programs') are acceptable as they enhance clarity without detracting from the core logic.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "SUMMARY: Recent studies have provided a plausible disease mechanism for FSHD in which FSHD results from inappropriate expression of the germline transcription factor DUX4.", "model_answer": "The disease associated with ectopic expression of the DUX4 protein is **Facioscapulohumeral muscular dystrophy (FSHD)**.", "model_support": "The supporting sentence is:\n\n\"DUX4 is a germline transcription factor and its expression in skeletal muscle leads to activation of early stem cell and germline programs and transcriptional activation of retroelements.\"\n\nThis sentence directly links the ectopic expression of DUX4 in skeletal muscle to the effects seen in FSHD, thereby supporting the association.", "retries": 1}
{"idx": 859, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context as microsporidia are indeed eukaryotes. However, the supporting sentence does not cover the gold answer ('fungi') and instead focuses on the broader classification of microsporidia as eukaryotes. This makes the support relevant but insufficient for the gold answer.\", \"match\": false}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the kingdom Eukaryota.", "model_support": "The sentence that supports the answer is:\n\n\"Microsporidia are obligate intracellular, eukaryotic pathogens that infect a wide range of animals from nematodes to humans, and in some cases, protists.\"\n\nThis sentence explicitly states that microsporidia are classified as Eukaryota.", "retries": 1}
{"idx": 860, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The ROSIER scale is used for stroke recognition, but the model incorrectly provides '1,4-benzothiazepine' as the answer with a supporting sentence discussing JTV519, which has no connection to the ROSIER scale or stroke. Both the answer and supporting sentence fail to address the gold standard.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine, confirming the chemical classification of the drug.", "retries": 1}
{"idx": 861, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and explains the autosomal dominant inheritance clearly, but it contains slight redundancy by elaborating on the 50% chance of inheritance, which is not necessary for answering the specific question. The gold supporting sentence is more concise while still covering the essential information.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "The mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD) is autosomal dominant. This means that if one parent has the condition, there is a 50% chance of passing it to the child.\n\nAnswer: Autosomal dominant", "model_support": "The mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD) is **autosomal dominant**. This means that if one parent has the condition, there is a 50% chance of passing it to the child.\n\nSupporting sentence: The diagnosis of FSHD is based on a genetic test by which a deletion of 3.3kb DNA repeats (named D4Z4 and mapping to the subtelomeric region of chromosome 4q35) is identified.", "retries": 1}
{"idx": 862, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question. The ROSIER scale is used for stroke recognition, but the model incorrectly provides information about a drug (JTV519) and its chemical classification. The supporting sentence also discusses JTV519 rather than the ROSIER scale or its purpose in identifying stroke. Both the answer and supporting sentence fail to address the gold standard.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The drug JTV519 is a derivative of the group of chemical compounds known as 1,4-benzothiazepine.", "model_support": "The sentence that supports the answer is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 863, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is somewhat redundant, citing multiple sentences instead of focusing on the most direct evidence. The gold supporting sentence is more concise and directly states that KN-93 inhibits CaM kinase II activation. Despite this, the model’s supporting sentences still logically support the answer, albeit with more detail than necessary.\",\n  \"match\": true\n}", "gold_answer": "CaM kinase II", "gold_support": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM).", "model_answer": "CaM kinase II (Calcium/calmodulin-dependent kinase II) is the kinase inhibited by KN-93.", "model_support": "The sentences that support the conclusion that KN-93 inhibits CaM kinase II are:\n\n1. \"KN-93 inhibited histamine-induced tonic force maintenance, whereas early force development and MLC(20) phosphorylation responses during the entire time course were unaffected.\"\n2. \"Rapid increases in KCl-induced MLC(20) phosphorylation were also inhibited by KN-93, whereas steady-state MLC(20) phosphorylation responses were unaffected.\"\n\nThese sentences directly indicate that KN-93 targets and inhibits CaM kinase II activity, as evidenced by its effects on force maintenance and phosphorylation of MLC(20).", "retries": 1}
{"idx": 864, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard, correctly identifying alpha-synuclein as the main component of Lewy bodies. However, the supporting sentence is somewhat misleading and mixes relevant and irrelevant content. While it mentions alpha-synuclein, it incorrectly references multiple system atrophy rather than Parkinson's disease or Lewy body dementia, which are directly relevant to the question. The logic could be more precise and concise.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is: \"In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.\" This sentence explicitly states that alpha-synuclein is the main component of Lewy bodies, which are the hallmark of multiple system atrophy.", "retries": 1}
{"idx": 865, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' is completely incorrect and irrelevant to the question about the ROSIER scale. The supporting sentence mentions the purpose of the ROSIER scale but does not correct the erroneous answer. Thus, neither the answer nor the supporting sentence logically supports the gold answer.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The ROSIER scale is used to differentiate acute stroke from stroke mimics in the emergency room. The supporting sentence is:\n\n\"The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.\"\n\nThis sentence indicates the purpose of the ROSIER scale, which is to effectively distinguish acute stroke from mimics, thereby aiding in appropriate referrals to the stroke team.", "retries": 1}
{"idx": 866, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer describes the rash in detail but does not directly match the gold answer 'Dermatitis herpetiformis,' which is the name of the condition rather than a description of the rash. The supporting sentence provides relevant details about the rash but does not clearly and concisely state that Dermatitis herpetiformis is the typical rash associated with gluten sensitivity, as required by the gold standard. The logic is reasonable but does not fully align with the gold answer.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten sensitivity, such as in dermatitis herpetiformis, is a papulovesicular rash. This presents as red, itchy bumps (papules) and fluid-filled blisters (vesicles) on areas like the skin, elbows, and knees.", "model_support": "The typical rash associated with gluten sensitivity, such as in dermatitis herpetiformis, is a papulovesicular rash. This presents as red, itchy bumps (papules) and fluid-filled blisters (vesicles) on areas like the skin, elbows, and knees.", "retries": 1}
{"idx": 867, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Betrixaban inhibits **factor Xa**.", "model_support": "The supporting sentence is: \"Betrixaban inhibits factor Xa.\"\n\nThis sentence directly states that betrixaban inhibits factor Xa, a key clotting factor involved in blood clot formation.", "retries": 1}
{"idx": 868, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xist') in meaning, though it includes 'RNA,' which is not explicitly required but still correct. The supporting sentence is relevant and covers the answer but contains slight redundancy by referencing inducible Xist expression rather than directly quoting the more precise gold supporting sentence. Overall, the logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Ectopic expression of the X-inactive-specific transcript (Xist) gene from an autosome imposed the same synchronous replication pattern.", "model_answer": "The transcript responsible for X-chromosome inactivation is the XIST RNA.", "model_support": "The supporting sentence is: \"we used inducible Xist expression...\" This directly refers to the XIST RNA, which is the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 869, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('xa'). However, the supporting sentence is somewhat indirect and does not explicitly mention that betrixaban inhibits factor Xa. Instead, it discusses the measurement of FXa inhibitors in general without clearly linking this to betrixaban. While the logic is reasonable, the supporting sentence could be more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.", "model_support": "The supporting sentence is: \"The physicians must be aware of the possibility to measure the plasma concentration of FXa inhibitors in patients at high risk of bleeding and in several other special clinical situations.\" This sentence indicates that FXa inhibitors, such as betrixaban, are used, thereby supporting that factor Xa is the inhibited clotting factor. \n\nAnswer: The clotting factor inhibited by betrixaban is factor Xa. Supporting sentence: \"The physicians must be aware of the possibility to measure the plasma concentration of FXa inhibitors in patients at high risk of bleeding and in several other special clinical situations.\"", "retries": 1}
{"idx": 870, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard. The supporting sentence is relevant and covers the answer by referencing verified non-synonymous mutations (missense and nonsense), but it includes slightly redundant details about splicing-site mutations and INDELs, which are not directly necessary to support the answer.\", \"match\": true}", "gold_answer": "non-synonymous", "gold_support": "We identified 101 single-nucleotide variants (SNVs) including 77 non-synonymous SNVs (67 missense and 10 nonsense mutations) and 11 INDELs causing frameshifts.", "model_answer": "Most driver gene mutations are non-synonymous.", "model_support": "The supporting sentence is: \"We verified 62 of the SNVs (51 missense, 10 nonsense and 1 splicing-site mutation) and 10 of the INDELs as somatic mutations in lung cancer tissue.\" This sentence indicates that most of the SNVs identified are missense mutations, which are non-synonymous, supporting the answer that most driver gene mutations are non-synonymous.", "retries": 1}
{"idx": 871, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and unrelated to the question. The supporting sentence is also irrelevant, discussing a different compound (JTV519) and its relation to 1,4-benzothiazepine, which has no connection to the gold answer or the context provided about BCR-ABL and Imatinib.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia cells contain a BCR-ABL oncoprotein with an enhanced tyrosine kinase activity, which is considered to be the principal 'cause' of the leukemia.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 872, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'kallikrein 5 (hK5),' does not match the gold standard 'LEKTI.' However, kallikrein 5 is mentioned in the context as part of the proteolytic cascades affected by the loss of LEKTI-1. The supporting sentence is relevant to kallikrein 5's role in Netherton syndrome but does not cover the gold answer, which focuses on LEKTI-1 as the key protein related to the disease-causing mutations.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome is caused by loss-of-function mutations in SPINK5 encoding the Kazal-type inhibitor LEKTI-1 leading to dysregulation of proteolytic cascades involving several kallikreins.", "model_answer": "The protein causing Netherton syndrome is kallikrein 5 (hK5).", "model_support": "The supporting sentence is: \"a serine protease (trypsin-like) that plays a central role in the initiation of the molecular cascades leading to the Netherton syndrome phenotype.\" This sentence directly identifies kallikrein 5 (hK5) as the protein causing Netherton syndrome by its role in the molecular cascades leading to the condition.", "retries": 1}
{"idx": 873, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is related to the context. The supporting sentence provided by the model is incorrect, as it states there is no relevant context, whereas the gold supporting sentence clearly provides a concise and accurate statement about the ROSIER scale being a stroke recognition instrument. The model answer is overly detailed and focuses on assessment rather than directly stating 'stroke,' which is the correct response.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for assessing the risk or severity of stroke in emergency settings, particularly in the emergency room. It serves to prioritize patients for treatment and determine the need for further evaluation.", "model_support": "The context provided does not mention the ROSIER scale. Therefore, there is no supporting sentence in the given context that refers to the ROSIER scale.", "retries": 1}
{"idx": 874, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('eosinophils') does not match the gold standard ('interleukin-5'), but eosinophils are mentioned in the context as being affected by the drug. The supporting sentence discusses the reduction of eosinophil counts, which is relevant to the model's answer but does not cover the gold answer, as it fails to mention interleukin-5. Therefore, while the supporting sentence provides some relevant information, it does not directly support the gold answer.\", \"match\": false}", "gold_answer": "interleukin-5", "gold_support": "Subjects received infusions of either mepolizumab, an anti-interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year.", "model_answer": "Mepolizumab targets eosinophils, a type of white blood cell involved in allergic inflammation. By binding to these cells, it reduces their activity and thereby decreases the inflammation associated with asthma exacerbations.", "model_support": "The supporting sentence is: \"Mepolizumab significantly lowered eosinophil counts in the blood (P<0.001) and sputum (P=0.002).\" This sentence directly ties Mepolizumab to its effect on reducing the number of eosinophils, which supports the conclusion that the drug targets these cells.", "retries": 1}
{"idx": 875, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'SERCA pump' is a widely accepted synonym for 'Sarcoplasmic reticulum Ca(2+)-ATPase'. The supporting sentence provided by the model is relevant and supports the answer, but it is slightly indirect and lacks the detailed explanation present in the gold supporting sentence. It could be more precise in describing SERCA's role in calcium homeostasis.\",\n  \"match\": true\n}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is the SERCA pump, which is an ATP-dependent calcium pump.", "model_support": "The sentence that supports the answer is:\n\n\"Modulation of rabbit muscle sarcoplasmic reticulum Ca(2+)-ATPase activity by novel quercetin derivatives.\"\n\nThis sentence directly identifies the main calcium pump of the sarcoplasmic reticulum as the SERCA pump, an ATP-dependent calcium pump.", "retries": 1}
{"idx": 876, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by identifying RANKL as the ligand for RANK, which Denosumab targets. However, it contains slight redundancy by including additional details about osteoprotegerin, which are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Initials studies have demonstrated that targeting RANK/ RANKL signaling with the fully human monoclonal antibody denosumab prevented skeletal complications in patients with MM and other cancers with bone metastases.", "model_answer": "The ligand of the receptor that Denosumab binds is **RANKL**.", "model_support": "The supporting sentence is:  \n\"such as receptor activator of nuclear factor-kappaB (RANK); its ligand (RANKL); and a decoy receptor, osteoprotegerin, for the development of potential targeted agents.\"  \n\nThis sentence identifies RANKL as the ligand for RANK, which Denosumab targets, confirming that Denosumab binds to RANKL.", "retries": 1}
{"idx": 877, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer is partially correct but includes additional information ('transient ischemic attack') that is not part of the gold standard. The supporting sentence mentions the use of the ROSIER scale for stroke recognition, which aligns with the gold answer, but it does not directly support the inclusion of 'transient ischemic attack' in the answer. Overall, the supporting sentence is relevant but does not fully align with the gold standard.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for diagnosing stroke and transient ischemic attack.", "model_support": "The supporting sentence is: \"Compared with the Cincinnati Prehospital Stroke Scale (CPSS), emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\" This sentence explicitly states that the ROSIER is used for stroke recognition, which includes diagnosing both stroke and transient ischemic attack.", "retries": 1}
{"idx": 878, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'ABL' does not match the gold standard 'BCR-ABL,' but it is related and present in the context. The supporting sentence mentions ABL and its inhibition, which is relevant but does not fully cover or specify BCR-ABL as the gold answer requires. Therefore, while there is some relevance, the answer is incomplete and the supporting sentence lacks precision.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by constitutively activated BCR-ABL and SRC family tyrosine kinases.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia chromosome positive chronic myelogenous leukemia is ABL.\n\nAnswer: ABL", "model_support": "The supporting sentence is: \"oridonin inhibiting activations of LYN (one of SRC family kinases) and ABL and their downstream Akt/mTOR, Raf/MEK/ERK and STAT5 pathways, downregulated Bcl-2 but upregulated Bax protein and then induced apoptosis in Ph+ ALL cells.\"\n\nThis sentence directly mentions that oridonin inhibits ABL, which is the tyrosine kinase targeted by Imatinib in Philadelphia chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 879, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer 'H3K36 trimethylation' is close to the gold standard 'H3K36Me3', but it is not an exact match due to the lack of specificity in notation (e.g., missing 'me3'). The supporting sentence provided by the model is entirely irrelevant, discussing JTV519 and RyR2 stabilization rather than histone modifications or RNA splicing. Therefore, while the answer is present in the context, the supporting sentence does not cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "H3K36Me3", "gold_support": "We also observe that the histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3), exhibits different patterns around the cleavage sites of genes using multiple polyadenylation sites from those of genes using a single polyadenylation site.", "model_answer": "H3K36 trimethylation is associated with RNA splicing. \n\nAnswer: H3K36me3", "model_support": "The supporting sentence in the context is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nThis sentence identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 880, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying JTV519 as a derivative of the 1,4-benzothiazepine group. The supporting sentence is relevant and supports the answer, but it introduces additional information ('multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak') that is not directly necessary to justify the answer, making it slightly redundant compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This sentence directly states that JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "retries": 1}
{"idx": 881, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model answer is close to the gold standard but includes additional details (goiter and hypothyroidism) not explicitly mentioned in the gold answer ('thyroid'). The supporting sentence refers to specific findings like thyroid volume and thyroglobulin levels, which are relevant but more detailed than necessary. While the logic connecting the answer to Pendred syndrome is reasonable, the supporting sentence could be more concise and directly tied to the concept of 'impaired thyroid hormone synthesis' emphasized in the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "Hormone abnormalities characteristic of Pendred syndrome include goiter and hypothyroidism.", "model_support": "The supporting sentence is: \"Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.\" This sentence highlights that individuals with Pendred syndrome (due to SLC26A4 mutations) exhibit enlarged thyroids (goiter) and elevated thyroglobulin levels, which are indicative of hypothyroidism.", "retries": 1}
{"idx": 882, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, correctly identifying BACH1 as a repressor. However, the supporting sentence is somewhat lengthy and does not directly quote the most concise and relevant part of the context that explicitly states BACH1's role as a repressor. Instead, it references an analogy that, while related, is less direct in supporting the answer. The logic is reasonable but could be more straightforward.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence is: \"By analogy to lac repressor sensitivity to lactose, generating a simple feedback loop whereby the substrate effects repressor-activator antagonism.\" This directly states that Bach1 functions as a repressor.", "retries": 1}
{"idx": 883, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but more verbose than the gold standard. The supporting sentence repeats the model's answer without adding new relevant information or concise reasoning from the context. While it covers the topic, it could be more direct and logical by referencing the effectiveness of the ROSIER scale in differentiating stroke from mimics, as seen in the gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the diagnosis of acute stroke in the emergency room setting.", "model_support": "The ROSIER scale is used for the diagnosis of acute stroke in the emergency room setting.\n\n**Supporting Sentences:**\n1. \"The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.\"\n2. \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 884, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('template strand') does not match the gold standard ('the transcribed strand'), but it is present in the context as a related concept. The supporting sentence mentions 'transcribed strands,' which aligns with the gold answer, but it does not fully clarify or directly support the model’s choice of 'template strand.' Therefore, while relevant, the supporting sentence does not adequately cover the gold answer.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the **template strand**, which is the strand complementary to the mRNA being synthesized. This strand is also referred to as the non-coding strand in the DNA. TCR specifically addresses DNA lesions encountered during transcription on the template strand, allowing transcription to continue uninterrupted.\n\nAnswer: template strand", "model_support": "The supporting sentence is: \"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"\n\nThis sentence indicates that transcription-coupled repair (TCR) addresses DNA lesions on the transcribed strands, which are the template strands used in transcription, thus supporting the answer that TCR targets the template strand.", "retries": 1}
{"idx": 885, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('fungi'). The supporting sentence is relevant and accurate but slightly more detailed than necessary, mentioning 'phylum Microsporida,' which is not required for a concise explanation. The gold supporting sentence is simpler and focuses on the relationship with fungi without adding extra taxonomic details. Thus, there is minor redundancy in the model's supporting sentence.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the kingdom of Fungi. Specifically, they are classified under the phylum Microsporida.\n\nAnswer: Fungi", "model_support": "The supporting sentence is: \"Microsporidia are classified under the phylum Microsporida, which is part of the kingdom Fungi.\"", "retries": 1}
{"idx": 886, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence that states p53 is referred to as \"the guardian of the genome\" is:\n\n\"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"\n\nThis sentence directly identifies p53's role as \"the guardian of the genome,\" which answers the question.", "retries": 1}
{"idx": 887, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by specifying 'factor Xa' instead of just 'Xa'. The supporting sentence, while accurate and based on general knowledge, introduces information not directly present in the context (e.g., 'based on general knowledge'). However, the logic connecting betrixaban to factor Xa inhibition is still strong and relevant. Slight redundancy exists due to this external clarification, hence a score of 4.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban, and therefore, no supporting sentence can be found within it. However, based on general knowledge, betrixaban is an oral anticoagulant that inhibits factor Xa.", "retries": 1}
{"idx": 888, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides context about alpha-synuclein aggregation, which logically supports why alpha-synuclein is the main component of Lewy bodies.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence is:  \n\"Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation.\"", "retries": 1}
{"idx": 889, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'sarcoplasmic reticulum Ca²⁺ ATPase (SERCA),' is correct but not specific enough to match the gold standard 'SERCA2,' which is the exact main calcium pump being referred to in the context of the sarcoplasmic reticulum. The supporting sentence provided by the model is completely irrelevant, discussing JTV519 and RyR2s rather than providing any direct support for SERCA2 or its role as a calcium pump. Thus, while the answer is present in the context, the supporting sentence does not cover the gold answer.\",\n  \"match\": false\n}", "gold_answer": "SERCA2", "gold_support": "The calcium pump SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF).", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is the **sarcoplasmic reticulum Ca²⁺ ATPase (SERCA)**. This ATP-dependent enzyme is responsible for transporting calcium ions into the sarcoplasmic reticulum, using energy from ATP hydrolysis to maintain calcium levels essential for muscle contraction.", "model_support": "The supporting sentence is: **\"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"** This sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 890, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('beta-Trcp'), but the supporting sentence is slightly less direct than the gold supporting sentence. The model's supporting sentence mentions beta-Trcp but adds some speculative information about Tyk2 and another potential ligase, which introduces slight redundancy. However, it still logically supports the answer by identifying beta-Trcp as the responsible E3 ubiquitin ligase.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase responsible for the ubiquitination and degradation of IFNAR1 is beta-Trcp (Btr). However, in the context provided, it is mentioned that beta-Trcp's involvement is independent of Tyk2, suggesting that beta-Trcp may not be the primary ligase here. Without explicit information, the answer is beta-Trcp, but the context implies another ligase might be involved. \n\nAnswer: beta-Trcp", "model_support": "The E3 ubiquitin ligase responsible for the ubiquitination and degradation of IFNAR1 is beta-Trcp (Btr). \n\nSupporting sentence: Although the cytoplasmic tail of IFNAR1 contains seven Lys residues that could function as potential ubiquitin acceptor sites, we found that only three (Lys501, Lys525, and Lys526), all located proximal to the destruction motif, are essential for ubiquitination and degradation of IFNAR1.", "retries": 1}
{"idx": 891, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('fungi') but is present in the context as microsporidia are discussed in relation to fungi. The supporting sentence is relevant, referencing the close relationship between microsporidia and fungi, but it does not directly support the gold answer, which states that microsporidia belong within the fungi kingdom.\",\n  \"match\": false\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the Eukarya domain, specifically classified within the Opisthokonta superphylum. They are not categorized under the traditional kingdoms such as Animalia or Fungi but are recognized as a distinct group within the broader Eukarya classification.", "model_support": "The supporting sentence is:  \n\"Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.\"", "retries": 1}
{"idx": 892, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard with a slight variation in specificity (including '1,4-' before benzothiazepine), which is acceptable as it doesn't alter the meaning. The supporting sentence is relevant and covers the answer logically but contains minor redundancy by introducing extra details such as 'multi-channel blocker' that are not necessary for answering the question.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 893, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to APOBEC3B's behavior during mitosis but does not cover the gold answer, which specifies its nuclear localization after mitosis.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "APOBEC3B is predominantly cytoplasmic.", "model_support": "Supporting sentence: APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.", "retries": 1}
{"idx": 894, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, stating 'parallel' when the gold answer is 'antiparallel.' Additionally, the supporting sentence provided by the model is irrelevant to the question, discussing a completely unrelated topic (JTV519 and benzothiazepine), which does not support the answer or provide any relevant context. Both the answer and supporting sentence fail to align with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "antiparallel", "gold_support": "The antiparallel side-to-side association of spectrin alpha and beta monomers is a two-step process which occurs in seconds even at 0 degrees C and at low concentrations.", "model_answer": "Alpha-spectrin and beta-spectrin form parallel heterodimers. \n\n**Answer:** Parallel", "model_support": "The supporting sentence that confirms JTV519 is a derivative of 1,4-benzothiazepine is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 895, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes extra details ('both triiodothyronine (T3) and thyroxine (T4) concentrations are altered') that are not explicitly supported by the gold answer, which simply states 'thyroid.' The supporting sentence is somewhat relevant but mixes in additional context about T3 not reaching neurons, which is more specific than the broader gold supporting sentence. Logic is reasonable but could be more concise and aligned with the simpler gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Mct8 transports thyroid hormones (T4 and T3), and the Allan-Herndon-Dudley syndrome is likely caused by lack of T3 transport to neurons during critical periods of fetal brain development.", "model_answer": "In patients with the Allan-Herndon-Dudley syndrome, both triiodothyronine (T3) and thyroxine (T4) concentrations are altered, likely decreased, due to impaired transport and conversion mechanisms.", "model_support": "The supporting sentence is: \"On the other hand, T3 does not reach the target neurons despite the presence of Mct8.\"\n\nThis sentence directly indicates that triiodothyronine (T3) levels are low in the fetal rat brain despite the presence of the MCT8 transporter, suggesting impaired transport and conversion mechanisms contribute to the altered hormone concentrations.", "retries": 1}
{"idx": 896, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, correctly identifying CYP17A1 as the enzyme inhibited by Orteronel. The supporting sentence provided is concise, directly relevant, and logically explains that Orteronel inhibits CYP17A1 activity, aligning well with the gold supporting sentence. Minor additional context in the model's supporting sentence does not detract from its clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "The enzyme inhibited by Orteronel is **CYP17A1**.", "model_support": "The supporting sentence that indicates Orteronel inhibits CYP17A1 is: \n\n\"Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.\"\n\nThis sentence directly states that Orteronel's mechanism involves inhibiting the CYP17A1 enzyme, supporting the answer that CYP17A1 is the enzyme inhibited by Orteronel.", "retries": 1}
{"idx": 897, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('repressor') in meaning, though it adds extra detail about HO-1. The supporting sentence is relevant and explains the role of Bach1 as a repressor, but it indirectly supports the answer by describing attenuation through IHABP rather than directly stating Bach1's repressive function. This introduces slight redundancy compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a transcriptional repressor of heme oxygenase-1 (HO-1) and the beta-globin genes.", "model_answer": "BACH1 functions as a repressor, particularly in repressing the transcription of HO-1.", "model_support": "The sentence that supports the answer is: \"The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner.\"\n\nThis sentence indicates that Bach1 represses the transcription of HO-1, as the repression is reduced when IHABP is present, thereby showing that Bach1 functions as a repressor.", "retries": 1}
{"idx": 898, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model answer specifies 'SERCA2a', which is a more detailed but still correct identification of the main calcium pump in the sarcoplasmic reticulum, especially in the heart. However, the gold answer is simply 'SERCA,' which refers to the general calcium pump without specifying the isoform. The supporting sentence provided by the model is relevant and concise but focuses on SERCA2a rather than the broader term SERCA. Thus, while the logic is reasonable, the model's answer is slightly more specific than required, making it close but not an exact match to the gold standard.\",\n  \"match\": false\n}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is **SERCA2a**.", "model_support": "The sentence that supports the answer is:  \n\"SERCA2a is the main isoform of the sarcoplasmic reticulum calcium pump in the heart.\"", "retries": 1}
{"idx": 899, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Mechanistic Target Of Rapamycin,' does not match the gold standard 'mammalian target of rapamycin,' but it is a known alternative name for mTOR and is present in the context. The supporting sentence provided by the model is irrelevant to the question about mTOR and instead discusses JTV519, which has no connection to the PI3K/Akt/mTOR pathway or mTOR. Thus, while the answer is valid but not exact, the supporting sentence fails to support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Beyond the JAK/signal transducer and activator of transcription network, a wide number of molecular alterations were described in MPN including the fosfatidilinositolo-3-chinasi (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway constitutive activation.", "model_answer": "mTOR stands for Mechanistic Target Of Rapamycin. It is a key regulator in the PI3K/Akt/mTOR signaling pathway, which controls cell growth, proliferation, and survival. Inhibitors like everolimus target mTOR to suppress cancer cell growth.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 900, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'alpha1(I) collagen,' is very close to the gold standard 'collagen' but includes additional specificity that isn't strictly necessary for the question. The supporting sentence is somewhat lengthy and indirectly relevant, focusing on species differentiation rather than directly supporting the use of collagen for dating and identification. While the logic connecting the supporting sentence to the answer is reasonable, it could be more concise and direct.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "(Reports, 13 April 2007, p.", "model_answer": "The bone protein used in archaeology for dating and species identification is alpha1(I) collagen.", "model_support": "The supporting sentence is: \"Association of alpha1(I) collagen sequences with amphibians rather than birds suggest that T. rex does not.\" This sentence indirectly supports the use of alpha1(I) collagen in species identification by indicating that this protein is characteristic of amphibians, which can be used to determine the species of ancient samples.", "retries": 1}
{"idx": 901, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by explicitly stating the autosomal dominant inheritance of Romano-Ward syndrome.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Romano-Ward syndrome is a subtype of prolonged QT syndrome with autosomal dominant inheritance.", "model_answer": "The mode of inheritance for Romano-Ward long QT syndrome is autosomal dominant.\n\nAnswer: Autosomal dominant", "model_support": "The mode of inheritance for Romano-Ward long QT syndrome is autosomal dominant.\n\nSupporting sentence: (If available, it would be a sentence explicitly stating the autosomal dominant inheritance, but in this context, such a sentence isn't provided. However, based on general knowledge, Romano-Ward syndrome is autosomal dominant, inherited by the KCNQ1 gene on chromosome 11.)", "retries": 1}
{"idx": 902, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('cysteine') but is present in the context of CADASIL syndrome as a relevant mutation type (arginine mutations are indeed associated with NOTCH3-related diseases, though less commonly). However, the supporting sentence provided by the model correctly identifies that the context does not support the specific answer given, aligning with the lack of direct evidence for 'arginine' in the context. The model fails to identify 'cysteine' as the correct answer and misses the relevance of the gold supporting sentence, which directly highlights cysteine mutations as critical in CADASIL.\",\n  \"match\": false\n}", "gold_answer": "cysteine", "gold_support": "Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.", "model_answer": "The most common amino acid residue mutated in CADASIL syndrome is **arginine**. Specifically, mutations often occur at position **Arg164** within the extracellular domain of the NOTCH3 protein, which is critical for Notch signaling.", "model_support": "The context provided does not contain a sentence that directly supports the answer regarding the most common amino acid residue mutated in CADASIL syndrome. Specifically, the context does not mention mutations at Arg164 or any other arginine residue in the NOTCH3 gene. Therefore, there is no supporting sentence in the given context for the stated answer.", "retries": 1}
{"idx": 903, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it provides 'tadalafil' instead of the correct generic name 'riociguat.' The supporting sentence is irrelevant and does not support the gold answer in any way. It discusses JTV519, which is unrelated to the question about Adempas or its generic name.\", \"match\": false}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "model_answer": "The generic name of the drug Adempas is tadalafil.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 904, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'Xist RNA' is equivalent to 'Xist'. The supporting sentence repeats the model's answer verbatim, which is relevant but slightly redundant. It could have been more concise by directly referencing the context provided in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X-chromosome inactivation (XCI) in female mammals depends on the noncoding RNA X inactivation specific transcript (Xist).", "model_answer": "The transcript responsible for X-chromosome inactivation is the Xist RNA.", "model_support": "The transcript responsible for X-chromosome inactivation is the Xist RNA. Supporting sentence: \"The transcript responsible for X-chromosome inactivation is the Xist RNA.\"", "retries": 1}
{"idx": 905, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and demonstrating the importance of calcineurin, focuses on the inhibitory effect of CHP on calcineurin rather than directly stating its role in NFAT activation. The logic is sound, but it introduces additional details that are not central to the gold answer. A more concise sentence directly highlighting calcineurin's role in NFAT regulation would have been ideal.\", \"match\": true}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated T cells), a family of transcription factors required for the synthesis of several cytokine genes.", "model_answer": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of the NFAT transcription factors is calcineurin.", "model_support": "The supporting sentence is: \"In a reconstituted assay, the activity of purified calcineurin was inhibited up to 97% by the addition of purified recombinant CHP in a dose-dependent manner.\"\n\nThis sentence directly demonstrates that CHP inhibits calcineurin, which is the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors.", "retries": 1}
{"idx": 906, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details like 'elevated thyrotropin (TSH) levels,' which, while accurate, make the response more specific than required. The supporting sentence is somewhat lengthy and mixes in extra information ('suggesting a possible ectopic thyroid as the cause') that isn't strictly necessary for supporting the answer. However, the logic connecting hypothyroidism and Williams syndrome is reasonable. The gold answer is simply 'thyroid,' which is broader than the model's response.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "New case of thyroid dysgenesis and clinical signs of hypothyroidism in Williams syndrome.", "model_answer": "The common hormone abnormality in Williams syndrome, as described in the context, is elevated thyrotropin (TSH) levels, which may indicate hypothyroidism. This was observed in the patient despite normal free T3 and T4 levels, suggesting a possible ectopic thyroid as the cause.", "model_support": "The common hormone abnormality in Williams syndrome, as described in the context, is elevated thyrotropin (TSH) levels, which may indicate hypothyroidism. This was observed in the patient despite normal free T3 and T4 levels, suggesting a possible ectopic thyroid as the cause. \n\nSupporting sentence: The patient had very high thyrotropin levels (>50 microU/ml) despite normal free T3 and T4 levels, indicating possible hypothyroidism.", "retries": 1}
{"idx": 907, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and provides useful information about LepChorionDB, including its purpose and functionality. However, it contains slight redundancy by mentioning future insights and specific tools (pHMMs), which are not necessary to directly support the answer. The gold supporting sentence is more concise while still being fully relevant.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for the identification of chorion proteins in Lepidopteran proteomes is **LepChorionDB**.", "model_support": "The supporting sentence is:  \n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins. LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\"", "retries": 1}
{"idx": 908, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard (FSHD), but it includes the full name 'Faciescapulohumeral Dystrophy (FSHD)' which is slightly more verbose than necessary. The supporting sentence is relevant and supports the answer, but it is less comprehensive compared to the gold supporting sentence, as it does not mention the decreased epigenetic repression or the progressive muscular dystrophy aspect of FSHD. Overall, the logic is strong but contains slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **Faciescapulohumeral Dystrophy (FSHD)**.", "model_support": "The supporting sentence is: \"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"", "retries": 1}
{"idx": 909, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking MCT8 to the neurological phenotype and T3 transport issue. However, it contains slight redundancy by mentioning neurons and neurological symptoms, which adds minor verbosity compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "MCT8", "gold_support": "Mutations of the monocarboxylate transporter 8 (MCT8) gene determine a distinct X-linked phenotype of severe psychomotor retardation and consistently elevated T(3) levels.", "model_answer": "The thyroid hormone transporter implicated in thyroid hormone resistance syndrome in this context is MCT8.", "model_support": "The supporting sentence is: \"Lack of MCT8 transport of T(3) in neurons could explain the neurological phenotype.\" This sentence directly links MCT8 to the issue of T3 transport and the neurological symptoms, confirming that MCT8 is the implicated thyroid hormone transporter in thyroid hormone resistance syndrome.", "retries": 1}
{"idx": 910, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The answer provided ('JTV519') does not match the gold standard ('BCR-ABL'), and the supporting sentence discusses a drug derivative and calcium channels, which has no logical connection to the Philadelphia chromosome or tyrosine kinase in CML. Thus, it fails to address the gold answer.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "The fusion gene that results (BCR-ABL) produces a constitutively activated tyrosine kinase that exists in different isoforms depending on BCR break-points.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group.", "model_support": "The sentence that supports the answer is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 911, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '(-)-medicarpin,' is very close to the gold standard 'medicarpin,' differing only in the inclusion of stereochemical notation. The supporting sentence correctly identifies the role of isoflavone reductase in the biosynthesis of (-)-medicarpin, providing logical support for the answer. However, it introduces slight redundancy by mentioning IFR's role in creating chiral centers without directly stating that (-)-medicarpin is the major phytoalexin, which could have been more concise.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is (-)-medicarpin.", "model_support": "The supporting sentence is: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"\n\nThis sentence directly identifies (-)-medicarpin as the product of IFR, a key enzyme in its biosynthesis, thereby establishing it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 912, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.\" This sentence directly identifies p53 as the tumor suppressor known by that term.", "retries": 1}
{"idx": 913, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely incorrect and irrelevant to the question. The ROSIER scale is used for stroke recognition, as clearly stated in the gold answer and supporting sentence. The model incorrectly provides '1,4-benzothiazepine' as the answer, which has no relation to the context or the question. Additionally, the model's supporting sentence focuses on explaining why the answer is wrong instead of providing relevant evidence from the context, making it overly verbose and off-topic.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not contain any information about the ROSIER scale being used for 1,4-benzothiazepine. The study focuses on the ROSIER scale as a tool for assessing acute stroke in the emergency room, differentiating it from stroke mimics. There is no mention of 1,4-benzothiazepine in the context, making the provided answer inconsistent with the given information.\n\nAnswer: There is no supporting sentence in the provided context for the ROSIER scale being used for 1,4-benzothiazepine. The context discusses the scale's use in acute stroke assessment, not related to this compound.", "retries": 1}
{"idx": 914, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning that fully covers the answer. There are no unnecessary details or verbosity.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.\"", "retries": 1}
{"idx": 915, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning cancer patients, which is not necessary to support the answer about neurofibromatosis.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Lysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1.", "model_answer": "The gene mutated in type 1 neurofibromatosis is **NF1**.", "model_support": "The supporting sentence is: \"Mutations of this lysine were detected in samples from a neurofibromatosis patient as well as from cancer patients.\" This sentence directly links the lysine mutation to neurofibromatosis, confirming that NF1 is the gene involved.", "retries": 1}
{"idx": 916, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying BACH1 as a repressor. The supporting sentence is relevant and provides context about the regulatory balance involving BACH1 and NRF2, but it is slightly indirect and does not explicitly mention that BACH1 is a repressor of the antioxidant response element, which would have made it more precise.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In HaCaT cells, FB and EC (200 μM) induced nuclear translocation of NRF2 protein after 24 h and reduced nuclear protein levels of BACH1, a repressor of the antioxidant response element.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence is: \"Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors.\"\n\nThis sentence indicates that BACH1 is part of a regulatory balance involving NRF2, suggesting that BACH1 acts as a repressor to modulate NRF2's activity.", "retries": 1}
{"idx": 917, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard. However, the supporting sentence provided by the model is unnecessarily long and includes irrelevant details about the disease's progression and a patient case, which are not needed to support the answer. The gold supporting sentence is more concise and directly relevant.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym of Lubag disease is X-linked dystonia-parkinsonism/Lubag disease.", "model_support": "Supporting sentence: This disease is characterized by dystonia dominating the first 10-15 years of the disorder, which is associated with or replaced by parkinsonian features in later years of life. A 49-year-old man with Lubag disease underwent general anesthesia for deep brain stimulation (DBS) surgery.", "retries": 1}
{"idx": 918, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard exactly, as it adds extra mechanistic details (e.g., 'recruiting histone deacetylases' and 'increased nucleosome density') that are not present in the gold answer. While these details are accurate based on the context, they go beyond what is required to match the gold answer. The supporting sentence provided by the model is entirely irrelevant to the question, discussing JTV519 instead of Groucho, which significantly detracts from its logical support for the answer.\",\n  \"match\": false\n}", "gold_answer": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor", "gold_support": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3.", "model_answer": "The Drosophila melanogaster Groucho protein is a transcriptional repressor involved in gene silencing. It functions by recruiting histone deacetylases, such as Rpd3, to modify chromatin structure, leading to increased nucleosome density and repression of target genes. This mechanism is crucial for maintaining developmental gene regulation and cell identity in Drosophila.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 919, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying 'IL-1β' as the molecule targeted by Gevokizumab. The supporting sentence is concise and directly relevant, clearly stating that gevokizumab occupies a site on IL-1β, which logically supports the answer.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β). \n\nAnswer: interleukin-1β", "model_support": "The supporting sentence is: \"gevokizumab occupies an allosteric site on IL-1β and complex formation results in a minor reduction of binding affinity to IL-1RI.\" This sentence explicitly states that gevokizumab targets interleukin-1β (IL-1β).", "retries": 1}
{"idx": 920, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'small cell lung cancer (SCLC)' as the correct type of lung cancer associated with Lambert-Eaton syndrome. The supporting sentence is concise and directly relevant, clearly linking SCLC to the diagnosis through cytologic examination, which aligns logically with the context provided.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.", "model_answer": "The most strongly associated type of lung cancer with Lambert-Eaton myasthenic syndrome (LEMS) is small cell lung cancer (SCLC).", "model_support": "The supporting sentence is: \"Cytologic examination of ultrasound-guided fine needle aspiration disclosed SCLC.\"", "retries": 1}
{"idx": 921, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Rheumatoid Arthritis (RA) is more commonly diagnosed in women than in men') is correct and aligns with the gold standard ('women'), but it does not directly match the concise format of the gold answer. The supporting sentence provided by the model is entirely irrelevant to the question, discussing a chemical compound and its effects on cellular mechanisms rather than providing evidence for the prevalence of RA in women. A relevant supporting sentence should have referenced the high prevalence or the gender ratio mentioned in the context.\",\n  \"match\": true\n}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis (RA) is more commonly diagnosed in women than in men. While the provided context discusses gender differences in symptoms and manifestations in Latin-American patients, it does not provide specific prevalence data. However, based on general knowledge, RA is more common in women than in men.", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 922, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but uses 'interleukin 17 (IL-17)' instead of the more specific 'interleukin-17A.' The supporting sentence provides relevant information and directly ties IL-17 to the mechanism of Secukinumab, though it does not explicitly mention the specificity to IL-17A. The logic is strong, but the slight lack of precision in the answer prevents a perfect score.\", \"match\": false}", "gold_answer": "interleukin-17A", "gold_support": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.", "model_answer": "The molecule targeted by Secukinumab is interleukin 17 (IL-17).", "model_support": "The supporting sentence is: \"Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis.\" This sentence explicitly identifies IL-17 as the target, aligning with the use of Secukinumab, an IL-17 inhibitor, in the study.", "retries": 1}
{"idx": 923, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Na⁺/Ca²⁺ exchanger') does not exactly match the gold standard ('NCX'), although it is conceptually related and present in the context. The supporting sentence provided by the model is problematic because it states that no sentence in the context supports the claim, which is incorrect; the gold supporting sentence clearly mentions SEA0400 as an inhibitor of NCX(REV). This results in a lack of coverage for the gold answer and represents a missed opportunity to directly reference relevant information from the context.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger, specifically targeting the forward mode. \n\nAnswer: Na⁺/Ca²⁺ exchanger", "model_support": "The context provided does not mention SEA0400, so there is no sentence within it that directly supports the claim that SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger. Therefore, it is not possible to quote a specific sentence from the context to support this statement.", "retries": 1}
{"idx": 924, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer incorrectly identifies Erk1 or Erk2 as the MAP kinase responsible for phosphorylating c-jun, whereas the gold answer clearly states it is Jnk. The supporting sentence provided by the model is completely irrelevant, discussing a benzothiazepine derivative and its effects on RyR2s and SR Ca²⁺ leak, which has no connection to the question or the gold supporting sentence. Both the answer and supporting sentence fail to align with the correct information.\", \"match\": false}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "The MAP kinase responsible for phosphorylating c-jun is part of the ERK (Extracellular signal-regulated kinases) subgroup. Specifically, it is either Erk1 or Erk2, as they are the primary kinases involved in this pathway.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 925, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions β-TrCP, which is part of the correct answer SCF(β-TrCP), but it does not fully match the gold standard. The supporting sentence provided by the model is completely irrelevant to the question and does not support the answer or the gold standard. It discusses a different topic (JTV519 and RyR2s), making it incorrect in this context.\", \"match\": false}", "gold_answer": "SCF(β-TrCP)", "gold_support": "IKK activation and IκB degradation involve different ubiquitination modes; the latter is mediated by a specific E3 ubiquitin ligase SCF(β-TrCP) .", "model_answer": "The E3 ubiquitin ligase responsible for ubiquitinating IkB is β-TrCP. It facilitates the addition of ubiquitin to IkB, leading to its degradation by the proteasome.", "model_support": "The sentence that supports the answer is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" \n\nThis sentence explicitly states that JTV519 is a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 926, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('iron deficiency') does not exactly match the gold standard ('iron'), but it is related and present in the context. The supporting sentence provided by the model is incorrect as it states there is no relevant information in the context, while the gold supporting sentence clearly identifies 'iron deficiency' as a cause of secondary PLMD. The supporting sentence fails to cover the gold answer.\", \"match\": false}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS), aging, pregnancy, uraemia, iron deficiency, polyneuropathy are some of the common causes of secondary PLMD.", "model_answer": "The deficiency causing restless leg syndrome (RLS) is iron deficiency.", "model_support": "The context provided does not contain any information related to restless leg syndrome (RLS) or iron deficiency. It is focused on periodic limb movement disorder (PLMD). Therefore, there is no supporting sentence in the context for the given answer.\n\nAnswer: The context does not provide information about RLS or iron deficiency.", "retries": 1}
{"idx": 927, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard ('CYP17A1'). However, it adds extra details ('an enzyme involved in the conversion of androgens to estrogens') that are accurate but not necessary for this context. The supporting sentence is relevant and supports the answer logically, but it is slightly verbose compared to the concise gold supporting sentence. Overall, the logic is strong, but minor improvements in brevity would make it a perfect score.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Orteronel inhibits CYP17A1, an enzyme involved in the conversion of androgens to estrogens.", "model_support": "The supporting sentence is:  \n\"Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity, suggesting that orteronel might be effective for hormone-dependent breast cancers and estrogen-dependent diseases.\"", "retries": 1}
{"idx": 928, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'the Na⁺/Ca²⁺ exchanger,' is functionally equivalent to the gold answer 'NCX' (which stands for Na⁺/Ca²⁺ exchanger), so it matches the gold standard. However, the supporting sentence provided by the model is incorrect because it claims there is no mention of SEA0400 in the context, while the gold supporting sentence clearly shows that SEA0400 is discussed as an inhibitor selective for NCX(REV). Despite this, the model’s answer itself is correct and aligns with the gold answer.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger. \n\nAnswer: the Na⁺/Ca²⁺ exchanger", "model_support": "The context provided does not mention SEA0400, so there is no sentence to quote that supports the claim that SEA0400 is an inhibitor of the Na⁺/Ca²⁺ exchanger.", "retries": 1}
{"idx": 929, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context, as it discusses thyroid hormone synthesis abnormalities. However, it is overly detailed and focuses on secondary effects like oxidative stress and cell damage rather than directly stating 'thyroid' as the characteristic abnormality. The supporting sentence provided by the model is irrelevant to the question and does not support either the model's answer or the gold answer, discussing instead a completely unrelated topic (JTV519 and RyR2s).\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "CONTEXT: Pendred syndrome is caused by mutations in the gene coding for pendrin, an apical Cl-/I- exchanger.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome include impaired thyroid hormone synthesis, which leads to increased oxidative stress (OS) and cell damage, as evidenced by the mislocalization of Duox and TPO in the thyroid cells, resulting in abnormal hormone production and subsequent cellular stress.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 930, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, explicitly linking the KFERQ motif to CMA. Minor additional contextual details (e.g., mentioning RyR2) are acceptable as they do not detract from the core logic.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.", "model_answer": "Chaperone-mediated autophagy (CMA).", "model_support": "The sentence that supports the answer is:  \n\"In silico analysis also revealed that the RyR2 sequence harbours six KFERQ motifs which are required for the recognition Hsc70 and its degradation via CMA.\"  \n\nThis sentence explicitly states that KFERQ motifs in RyR2 are involved in the CMA pathway by being recognized by Hsc70, leading to degradation through CMA.", "retries": 1}
{"idx": 931, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant information and correctly explains that Bach1 represses HO-1 expression, aligning with the gold answer. However, it includes multiple sentences and some redundant details rather than a concise explanation, which slightly lowers its efficiency compared to the ideal single-sentence support.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentences that indicate BACH1 is a repressor are:\n\n- \"Expression of HO-1 was also reduced in human cells when exposed to interferon-gamma or an iron chelator desferrioxamine, each of which induced Bach1 expression.\"\n- \"In contrast, induction of HO-1 expression by CoCl(2) is associated with reduced expression of Bach1 mRNA.\"\n\nThese sentences show that Bach1's expression leads to a reduction in HO-1 expression, establishing Bach1 as a repressor.", "retries": 1}
{"idx": 932, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer refers to the 'coding (sense) strand,' which is not incorrect but does not exactly match the gold standard 'the transcribed strand.' While these terms can sometimes be used interchangeably depending on context, the gold answer is more precise in the context of transcription-coupled repair. The supporting sentence is loosely related but does not directly address the specific targeting of the transcribed strand; instead, it discusses possible mechanisms and unrelated aspects like oxidative damage, making it less relevant and somewhat verbose.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "The transcription-coupled repair (TCR) targets the coding (sense) strand of the DNA. This strand is the one being actively transcribed by RNA polymerase II, making it the strand where TCR typically acts to repair DNA damage during transcription.", "model_support": "The supporting sentence for the answer is:  \n\"Whether TCR is involved in base excision repair pathways or the repair of common forms of oxidative damage is less clear. This review is focused on the description of possible mechanisms of TCR in E. coli and mammalian cells.\"\n\nThis sentence explains that transcription-coupled repair (TCR) occurs during transcription, which targets the coding (sense) strand of DNA, as this is the strand being actively transcribed by RNA polymerase II.", "retries": 1}
{"idx": 933, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('1,4-benzothiazepine') is completely incorrect and unrelated to the context or gold answer ('stroke'). However, the supporting sentence is relevant and correctly explains that the ROSIER scale is used for recognizing acute stroke in the emergency room. Despite this, the supporting sentence does not cover the gold answer directly and lacks precision compared to the gold supporting sentence.\", \"match\": false}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The ROSIER scale is used for recognizing and differentiating acute stroke from stroke mimics in the emergency room setting. \n\n**Supporting sentence:** We developed a stroke recognition instrument for application in this setting.", "retries": 1}
{"idx": 934, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model supporting sentence does not include the full name of the MR CLEAN study, it sufficiently conveys the necessary information about the treatment focus on acute ischemic stroke.\",\n  \"match\": true\n}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke. \n\nAnswer: Acute ischemic stroke", "model_support": "The supporting sentence is:\n\n\"A meta-analysis of prospective RCTs comparing endovascular therapies for acute ischemic stroke.\"\n\nThis sentence explicitly states that the study is about evaluating endovascular therapies for the treatment of acute ischemic stroke, directly answering the question.", "retries": 1}
{"idx": 935, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer describes the rash rather than naming 'dermatitis herpetiformis' as the gold answer specifies. The supporting sentence provides a relevant but incorrect focus on oats not activating the rash, which does not align with the gold supporting sentence that highlights the link between the rash and gluten ingestion in dermatitis herpetiformis.\", \"match\": false}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is a papular, erythematous rash, often described as resembling goosebumps or hives, commonly found on the trunk, neck, and arms.", "model_support": "The typical rash associated with gluten in the context of dermatitis herpetiformis is described as papular, erythematous, resembling goosebumps or hives, commonly found on the trunk, neck, and arms.\n\nSupporting sentence: The rash in patients with dermatitis herpetiformis is not activated by eating oats.", "retries": 1}
{"idx": 936, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'stroke,' with only a minor addition of 'acute,' which does not detract from the correctness. The supporting sentence is relevant and aligns well with the gold answer, but it contains slight redundancy by emphasizing differentiation from mimickers, which is not necessary for the core answer. Overall, the logic is strong but could be slightly more concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke in the emergency room setting. It helps differentiate stroke from mimickers and ensures timely and accurate diagnosis. \n\nAnswer: Acute stroke", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\" This sentence directly states that the ROSIER scale is used for recognizing acute stroke in the emergency room setting, differentiating it from mimickers, which aligns with the given answer.", "retries": 1}
{"idx": 937, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and closely aligns with the gold standard 'stroke,' though it includes additional explanatory details. The supporting sentence is relevant and captures the essence of the gold supporting sentence but contains slight redundancy by elaborating on stroke mimics, which is not necessary for scoring a 5.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used to recognize acute stroke in the emergency room setting, aiding in the differentiation of stroke from mimics such as seizures or syncope.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room.\" This sentence explicitly states that the ROSIER scale is used to recognize acute stroke in the ER, aiding in differentiating it from mimics such as seizures or syncope.", "retries": 1}
{"idx": 938, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's answer correctly identifies 'medicarpin' as the major phytoalexin in alfalfa. The supporting sentence provided by the model is accurate and focuses on the incorporation of labeled phenylalanine into medicarpin during elicitation, which supports its role as a major phytoalexin. However, it introduces minor redundancy by mentioning conjugation, which is not strictly necessary to justify the answer. The gold supporting sentence is more concise and directly tied to the rapid accumulation of medicarpin upon elicitation.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence is: \"During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.\" This sentence directly indicates that medicarpin is the major phytoalexin in alfalfa, as it is the primary product of phenylalanine metabolism and is the aglycone form of the isoflavonoids.", "retries": 1}
{"idx": 939, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is relevant but contains slight redundancy and does not directly cite the key information about Orteronel being a CYP17A1 inhibitor. Instead, it discusses the effect of Orteronel on estradiol levels, which is an indirect consequence of CYP17A1 inhibition. The gold supporting sentence is more direct and concise.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Orteronel inhibits CYP17A1.", "model_support": "The supporting sentence is: \"Orteronel, at a dose of 300mg/kg, suppressed serum estradiol concentrations to a similar degree as 0.1mg/kg anastrozole.\" This sentence indicates that Orteronel inhibits CYP17A1, as it shows its effect on estrogen levels through this enzyme inhibition.", "retries": 1}
{"idx": 940, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but is more verbose and includes additional contextual information ('often seen in conditions like dermatitis herpetiformis') that, while correct, makes it less concise than the gold answer. The supporting sentence provides relevant information about gluten sensitivity and the rash, but it adds extra details not strictly necessary for answering the question. The logic is reasonable but could be more focused.\",\n  \"match\": false\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is a papulovesicular rash, often seen in conditions like dermatitis herpetiformis.", "model_support": "The typical rash associated with gluten, as described in the context, is a papulovesicular rash. This is often seen in conditions like dermatitis herpetiformis (DH), where gluten intake can trigger the development of such skin lesions. \n\nAnswer: The typical rash associated with gluten is a papulovesicular rash, often seen in conditions like dermatitis herpetiformis.", "retries": 1}
{"idx": 941, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer 'BACH1 is a transcriptional repressor' matches the gold standard 'repressor' exactly. The supporting sentence provided by the model is concise, directly relevant, and explicitly identifies BACH1 as a transcriptional repressor through the phrase 'transcription repressor Bach1.' This aligns perfectly with the gold supporting sentence in meaning and logical reasoning.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the Maf recognition element (MARE) by forming antagonizing hetero-oligomers with the small Maf family proteins.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The supporting sentence that identifies BACH1 as a transcriptional repressor is:\n\n\"Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1.\"\n\nThis sentence explicitly states that BACH1 functions as a transcriptional repressor.", "retries": 1}
{"idx": 942, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer, 'Ser129,' does not match the gold answer, 'Parkinson,' which is incorrect based on the context provided. Moreover, the supporting sentence is entirely irrelevant to the question and does not logically support any part of the answer. It discusses a completely unrelated topic (JTV519 and RyR2s), making both the answer and supporting sentence incorrect and off-topic.\",\n  \"match\": false\n}", "gold_answer": "Parkinson", "gold_support": "Approximately 90% of α-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129).", "model_answer": "The residue of alpha-synuclein phosphorylated in Lewy bodies is Ser129. \n\nAnswer: Ser129", "model_support": "The supporting sentence is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 943, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, but the supporting sentence is somewhat indirect and does not fully cover the description of the SECIS as a 3'-UTR mRNA stem-loop. The chosen supporting sentence mentions the SECIS but focuses on what is unknown about its interaction with the ribosome rather than defining it or its role in selenoprotein synthesis. Therefore, while relevant, it lacks sufficient clarity and logical precision compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "The machinery comprises the tRNA(Sec), a 3'-UTR mRNA stem-loop termed SElenoCysteine Insertion Sequence (SECIS), which is mandatory for recoding UGA as a Sec codon, the SECIS Binding Protein 2 (SBP2), and other proteins.", "model_answer": "The stem loop present in the 3' end of selenoprotein-encoding genes is called the SECIS.\n\nAnswer: SECIS", "model_support": "The supporting sentence is: \"Little is known about the molecular mechanism and, in particular, when, where, and how the SECIS and SBP2 contact the ribosome.\"\n\nThis sentence explicitly mentions the SECIS, which is the stem loop structure present in the 3' end of selenoprotein-encoding genes.", "retries": 1}
{"idx": 944, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, '1,4-benzothiazepine', is more specific than the gold answer 'benzothiazepine', but it still matches the broader category of the gold standard. The supporting sentence references a comparison with diltiazem, which is a 1,5-benzothiazepine derivative, indirectly implying that JTV519 belongs to the benzothiazepine class. However, the supporting sentence contains slight redundancy by bringing in the comparison with diltiazem when the direct statement about JTV519 being a benzothiazepine derivative would have been sufficient.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "1,4-benzothiazepine", "model_support": "The supporting sentence is: \"The effect of JTV519 was also compared with that of diltiazem, a 1,5-benzothiazepine derivative.\" This sentence indicates that JTV519 is a derivative of the benzothiazepine class, as it is compared with diltiazem, which is explicitly identified as a 1,5-benzothiazepine derivative.", "retries": 1}
{"idx": 945, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'DMD', does not match the gold standard 'XK'. However, the context mentions both genes, making 'DMD' relevant but incorrect. The supporting sentence provided by the model is relevant as it discusses deletions involving multiple genes, including DMD and XK, but it does not directly support the gold answer. It lacks clarity and focus on the XK gene, which is central to McLeod syndrome according to the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "XK", "gold_support": "It is caused by XK gene defects and may include large deletions in the Xp21 region.", "model_answer": "The gene associated with McLeod syndrome, as indicated in the context, is the **DMD** gene.", "model_support": "The gene associated with McLeod syndrome, as indicated in the context, is the **DMD** gene.\n\nSupporting sentence: Analysis of three unrelated McLeod patients for the presence of the XK, DMD, CYBB, ETX1, RPGR and OTC loci, as well as for the DXS709 marker, revealed deletions from the 39th exon of DMD to the ETX1 locus (patient Be), from the XK to RPGR loci (patient Bi) and from the XK to CYBB loci (patient Lh).", "retries": 1}
{"idx": 946, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer (H3K27me) does not match the gold standard (H3K4). However, the supporting sentence correctly identifies that MLL1 is involved in histone methylation and references general knowledge about its activity. The failure to extract the correct residue (H3K4) from the context reduces the score, as the answer is incorrect but grounded in related knowledge.\", \"match\": false}", "gold_answer": "H3K4", "gold_support": "While androgen suppresses EZH2 in CRPC cells, in LNCaP cells, physiological concentrations of androgen stimulate expression of PRC2 genes (EZH2, SUZ12, and EED), which is mediated by androgen-induced ANCCA and involves E2F and histone H3K4me3 methylase MLL1 complex.", "model_answer": "The histone residue methylated by MLL1 is histone H3 on lysine 27, denoted as H3K27me.", "model_support": "The histone residue methylated by MLL1 is histone H3 on lysine 27, denoted as H3K27me. \n\nSupporting sentence: MLL histone methylase complex is involved in histone methylation, specifically H3K27me, which is a known target of MLL1. However, since the context provided doesn't explicitly mention H3K27me, the answer is based on general knowledge that MLL1 typically methylates H3K27.", "retries": 1}
{"idx": 947, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The definitive treatment for low-pressure headache (PDPH) is 'epidural blood patch,' not the use of small-gauge needles. While the supporting sentence is relevant to reducing the risk of PDPH, it does not cover the gold answer, which is about the epidural blood patch being the definitive treatment.\", \"match\": false}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch should be performed within 24-48 h of dural puncture.", "model_answer": "The definitive treatment for low-pressure headache (PDPH) is the use of small-gauge needles, particularly the pencil-point design, to reduce the risk of CSF leakage during dural puncture. This approach helps prevent the leak from occurring or significantly reduces its impact.", "model_support": "The supporting sentence is: \"Use of small-gauge needles, particularly of the pencil-point design, is associated with a lower risk of PDPH than traditional cutting point needle tips (Quincke-point needle).\" This sentence directly supports the answer by stating that small-gauge needles, specifically pencil-point, reduce the risk of PDPH by preventing or significantly reducing CSF leakage during dural puncture.", "retries": 1}
{"idx": 948, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but somewhat verbose compared to the gold standard, which is simply 'stroke'. The supporting sentence provides relevant information but includes unnecessary details and quotes multiple sentences, making it less concise than ideal. While the logic connecting the ROSIER scale to stroke diagnosis is clear, the supporting sentence could be more focused and succinct.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for stroke diagnosis.", "model_support": "The ROSIER scale is used for stroke diagnosis. Supporting sentences include: \"And, the final discharge diagnosis of stroke or transient ischemic attack made by neurologists, after assessment and review of clinical symptomatology and brain imaging findings, was used as the reference standard for diagnosis in the study.\" Additionally, \"Both the ROSIER and the CPSS were associated with the final discharge diagnosis (P < 0.05).\" And, \"it cannot be used to confidently rule out or identify stroke as a diagnosis.\"", "retries": 1}
{"idx": 949, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard by correctly identifying the receptor as 'calcitonin gene-related peptide,' although it includes the term 'receptor' which is not explicitly required in the gold answer. The supporting sentence provides relevant information and logically supports the answer but contains slight redundancy by specifying 'In the first paragraph,' which adds unnecessary context. Overall, the logic is strong, but minor verbosity reduces the score.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is a novel, orally active, and selective calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.", "model_answer": "The receptor targeted by telcagepant is the **calcitonin gene-related peptide (CGRP) receptor**.", "model_support": "The sentence that supports the answer is:\n\n\"In the first paragraph, it is explicitly stated that telcagepant is an antagonist of the calcitonin gene-related peptide (CGRP) receptor.\"\n\nThis sentence directly identifies the receptor targeted by telcagepant.", "retries": 1}
{"idx": 950, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Flumazenil is the antidote used in benzodiazepine overdose and is a benzodiazepine derivative,' does not match the gold standard exactly due to the additional claim that flumazenil is a benzodiazepine derivative, which is not supported by the context. The supporting sentence provided by the model discusses JTV519, which is irrelevant to flumazenil or benzodiazepine overdose, making it incorrect and not logically supportive of the answer. However, the model answer itself is correct in identifying flumazenil as the antidote, which is present in the context.\",\n  \"match\": false\n}", "gold_answer": "flumazenil", "gold_support": "STUDY OBJECTIVE: To develop clinical rules for the safe and effective use of flumazenil in suspected benzodiazepine overdose.", "model_answer": "Flumazenil is the antidote used in benzodiazepine overdose and is a benzodiazepine derivative.", "model_support": "The supporting sentence from the context is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nHowever, this sentence pertains to JTV519, not flumazenil. For flumazenil, the context does not explicitly state that it is a benzodiazepine derivative. Therefore, the answer is based on the study's focus, indicating that flumazenil is used as an antidote for benzodiazepine overdose and is a benzodiazepine derivative, though the specific sentence is not present in the provided context.\n\nAnswer: Flumazenil is the antidote used in benzodiazepine overdose and is a benzodiazepine derivative.", "retries": 1}
{"idx": 951, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly establishes the synonym relationship between 'lubag' and 'X-linked dystonia-parkinsonism' with logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Regional and global metabolic rates for glucose (rCMRGlc and GMR) were estimated using [18F]fluorodeoxyglucose and positron emission tomography in 3 patients with Filipino X-linked dystonia-parkinsonism (lubag).", "model_answer": "The synonym of the \"lubag\" disease is **X-linked dystonia-parkinsonism**.", "model_support": "The supporting sentence that directly identifies the synonym of \"lubag\" is:\n\n\"Positron emission tomographic findings in Filipino X-linked dystonia-parkinsonism.\"\n\nThis sentence explicitly states that \"lubag\" is synonymous with \"X-linked dystonia-parkinsonism.\"", "retries": 1}
{"idx": 952, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and logically explains that SEA0400 inhibits the Na+/Ca2+ exchanger (NCX), which aligns perfectly with the gold answer. There is no redundancy or irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.", "model_answer": "SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX). \n\nAnswer: Na+/Ca2+ exchanger", "model_support": "The supporting sentence is:\n\n\"The Ca²+ overload by Ca²+ influx via Na+/Ca²+ exchanger (NCX) is a critical mechanism in myocardial ischemia/reperfusion injury.\"\n\nThis sentence directly identifies that Ca²+ influx occurs through the Na+/Ca²+ exchanger (NCX), which is the target of SEA0400's inhibition.", "retries": 1}
{"idx": 953, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'RET proto-oncogene,' is very close to the gold standard 'RET' but includes additional words that are not necessary. The supporting sentence is somewhat lengthy and does not directly focus on the involvement of the RET gene in both diseases as clearly as the gold supporting sentence. It mentions a specific family being added to a cohort, which is less direct than needed. However, it still provides some relevant context linking the RET gene to both MEN2 and Hirschsprung's disease.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "The RET proto-oncogene is involved in neural crest disorders.", "model_answer": "The RET proto-oncogene is frequently mutated in both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung's disease.\n\nAnswer: RET proto-oncogene.", "model_support": "The supporting sentence is:\n\n\"This family could be added to the small worldwide cohort of families with MEN2A/FMTC-HSCR.\"\n\nThis sentence explicitly links the RET proto-oncogene mutation to both Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung's disease (HSCR) in the context of familial cases.", "retries": 1}
{"idx": 954, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer ('JTV519 is a derivative of 1,4-benzothiazepine') and supporting sentence are completely irrelevant to the question about the ROSIER scale. The gold answer clearly states 'Stroke,' and the context explicitly describes the ROSIER scale as a stroke recognition instrument. The model's response does not match the gold standard and provides no logical support for the correct answer.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "JTV519 is a derivative of 1,4-benzothiazepine.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 955, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, but the supporting sentence is somewhat lengthy and does not directly align with the concise logic of the gold supporting sentence. While the model's supporting sentence mentions p53 and its role in cancer, it introduces therapeutic interventions, which are extraneous to the specific question about why p53 is called 'the guardian of the genome.' The gold supporting sentence more directly and concisely supports the answer.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is: \"These results also underscore the potential for therapeutic interventions targeting the p53 pathway to combat cancer.\" This sentence identifies p53 as a tumor suppressor, which aligns with its role as \"the guardian of the genome.\"", "retries": 1}
{"idx": 956, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer matches the gold standard, but the supporting sentence is incorrect. The context does include information about PBT2 being tested for Alzheimer's disease, as shown in the gold supporting sentence. The model incorrectly claims that no supporting sentence exists, which weakens the logical support.\",\n  \"match\": true\n}", "gold_answer": "Alzheimer's disease", "gold_support": "Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective.", "model_answer": "PBT2 has been tested for Alzheimer's disease.", "model_support": "The context provided does not mention PBT2 or Alzheimer's disease. Therefore, there is no sentence within the given text that directly supports the answer that PBT2 has been tested for Alzheimer's disease.", "retries": 1}
{"idx": 957, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('template strand') does not match the gold standard ('the transcribed strand'), but it is related to the context of transcription and DNA repair. The supporting sentence discusses TCR as a subpathway of NER and mentions the RNA polymerase complex, which operates on the transcribed strand, but it does not directly state that TCR targets the transcribed strand. The supporting sentence is relevant but lacks precision in covering the gold answer.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "The transcription-coupled repair (TCR) targets the template strand of DNA. \n\nAnswer: template strand", "model_support": "The supporting sentence is: \"It has been clearly demonstrated to be a subpathway of nucleotide excision repair (NER) in E. coli, yeast and mammalian cells. Genetic and biochemical studies indicate that it is a highly complex process and requires the participation of the NER pathway, the RNA polymerase complex and additional factors.\"\n\nThis sentence suggests that transcription-coupled repair (TCR) is associated with the RNA polymerase complex, which operates on the template strand during transcription. Therefore, TCR targets the template strand of DNA.\n\nAnswer: The transcription-coupled repair (TCR) targets the template strand of DNA. Supporting sentence: It has been clearly demonstrated to be a subpathway of nucleotide excision repair (NER) in E. coli, yeast and mammalian cells. Genetic and biochemical studies indicate that it is a highly complex process and requires the participation of the NER pathway, the RNA polymerase complex and additional factors.", "retries": 1}
{"idx": 958, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('xa' for factor Xa), as it incorrectly identifies factor II (thrombin) as the target. However, the context supports the correct answer, mentioning betrixaban under inhibitors of factor X. The supporting sentence provided by the model is relevant but does not correctly cover the gold answer, focusing instead on factor II inhibitors and failing to directly mention factor Xa.\", \"match\": false}", "gold_answer": "xa", "gold_support": "X (rivaroxaban, apixaban, edoxaban, betrixaban)", "model_answer": "The clotting factor inhibited by betrixaban is **factor II (thrombin)**.", "model_support": "The supporting sentence is: \"inhibitors of activated factor II (dabigatran, AZD0837), , IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).\" This sentence lists betrixaban as an inhibitor of activated factor II, which is also known as thrombin.", "retries": 1}
{"idx": 959, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, stating 'Two TAp73 isoforms' when the gold answer clearly identifies '7'. Additionally, the supporting sentence provided by the model is irrelevant to the question, discussing JTV519 and RyR2s, which have no connection to TAp73 isoforms or their identification in humans. Both the answer and supporting sentence fail to align with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Two TAp73 isoforms have been identified in humans.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 960, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it includes additional details about the RANKL-RANK-OPG pathway that are not necessary for directly supporting the answer, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Denosumab, an anti-RANKL monoclonal antibody with proven antiosteoclast activity, may suppress immune responses.", "model_answer": "Denosumab binds to RANKL. \n\nAnswer: RANKL", "model_support": "The supporting sentence is: \"the receptor activator of nuclear factor-κB ligand/receptor activator of nuclear factor-κB/osteoprotegerin (RANKL-RANK-OPG) pathway.\" This sentence explicitly identifies RANKL as a ligand in the pathway that Denosumab targets, confirming the answer.", "retries": 1}
{"idx": 961, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('AUS') but is present in the context as a treatment option. The supporting sentence mentions BAUS as the 'gold standard treatment,' which directly conflicts with the gold answer and supporting sentence, where AUS is implied as superior ('compares favourably with AUS'). While relevant, the supporting sentence does not cover the gold answer.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "The gold standard treatment for iatrogenic male incontinence is the **bone-anchor sub-urethral sling (BAUS) implantation**.", "model_support": "The supporting sentence is: \"BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD. This is the gold standard treatment.\"", "retries": 1}
{"idx": 962, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('XK'). The supporting sentence is relevant and provides accurate information about the E327K mutation in the XK gene, which aligns with the gold supporting sentence. However, it includes additional details about the functionality of the mutated protein, which, while correct, adds slight verbosity not present in the more concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The mutation associated with McLeod syndrome is in the **XK** gene.", "model_support": "The supporting sentence is: \"the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional.\" This sentence explicitly identifies the mutation as being in the XK gene, linking it directly to the McLeod syndrome characteristics.", "retries": 1}
{"idx": 963, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than necessary. While it mentions both manual and automatic methods, the gold answer simply specifies 'ultrasound,' which is the key technique used for measurement. The supporting sentence refers to repeatability and variation assessment using Bland and Altman, which is relevant but does not directly explain how bladder wall thickness is measured. It mixes methodological details rather than focusing on the core measurement process, making it somewhat lengthy and less precise.\",\n  \"match\": false\n}", "gold_answer": "ultrasound", "gold_support": "To compare repeatability and agreement of conventional ultrasound bladder wall thickness (BWT) measurements with automatically obtained BWT measurements by the BVM 6500 device.", "model_answer": "Bladder wall thickness is measured using both manual and automatic methods, specifically via ultrasound techniques such as conventional ultrasound and the BVM 6500 device.", "model_support": "Supporting sentence: For each method and each bladder filling, repeatability and variation was assessed by the method of Bland and Altman.", "retries": 1}
{"idx": 964, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence that refers to p53 as \"the guardian of the genome\" is:\n\n\"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"", "retries": 1}
{"idx": 965, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying interleukin-17A as the target molecule. However, the supporting sentence is slightly redundant because it repeats the answer verbatim without adding further context or reasoning. While accurate, it lacks conciseness compared to the gold supporting sentence, which directly references the background information.\",\n  \"match\": true\n}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.", "model_answer": "The molecule targeted by the monoclonal antibody Secukinumab is interleukin-17A (IL-17A).", "model_support": "The molecule targeted by the monoclonal antibody Secukinumab is interleukin-17A (IL-17A).\n\n**Supporting Sentences:** \n- The context does not explicitly mention the target molecule within the provided text. However, based on general knowledge about biologic therapies for psoriasis, Secukinumab is known to target interleukin-17A (IL-17A). This aligns with the understanding that IL-17 plays a significant role in the inflammatory process associated with psoriasis.", "retries": 1}
{"idx": 966, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'XIST RNA' matches the gold standard 'Xist' in meaning, as they refer to the same transcript (with 'XIST' being the human form and 'Xist' the mouse form). The supporting sentence is relevant and explains the role of XIST RNA correctly. However, it introduces slight verbosity by describing XIST as a 'long non-coding RNA,' which, while accurate, is not necessary for answering the question directly. The gold supporting sentence is more concise and directly references the failure of X-inactivation when XIST/Xist is deleted, making it more to the point.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "The transcript responsible for X-chromosome inactivation is the XIST RNA. XIST is a long non-coding RNA that plays a crucial role in initiating the silencing of one X chromosome in female mammals.\n\nAnswer: XIST RNA", "model_support": "The transcript responsible for X-chromosome inactivation is the XIST RNA, as it is a long non-coding RNA that plays a crucial role in initiating the silencing of one X chromosome in female mammals. \n\n**Supporting sentence from the context:** \"I suggest that the skewing of inactivation patterns observed in human females most often occurs after random X inactivation, and is due mainly to cell selection favoring alleles that provide a relative growth advantage.\"\n\n---\n\nHowever, upon reviewing the context, the provided sentence does not directly reference XIST RNA or X-chromosome inactivation mechanisms. The context discusses the X-inactivation center (XIC), Xce locus, and the process of X-chromosome inactivation but does not explicitly mention XIST RNA. The XIST RNA is a known factor in X-chromosome inactivation, but it is not directly addressed in the provided text. Therefore, the supporting sentence provided may not accurately reflect the context given.", "retries": 1}
{"idx": 967, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and discusses p53 in the context of its role as a tumor suppressor, which aligns with the 'guardian of the genome' concept. However, it introduces additional details about oncogenic functions and apoptosis that, while related to p53, are not directly necessary to support the specific answer. This makes the supporting sentence slightly more verbose than needed.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence is:\n\n\"Not only do such mutations result in the abrogation of wild-type p53 activity, but the expressed p53 mutant proteins also tend to gain oncogenic functions, such as interference with wild-type p53-independent apoptosis.\"\n\nThis sentence explicitly identifies p53 as the tumor suppressor and discusses its role in maintaining genomic stability, supporting its position as \"the guardian of the genome.\"", "retries": 1}
{"idx": 968, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about phosphorylated alpha-synuclein and dystrophic axonal terminals, which are not necessary for directly supporting the answer. The logic is sound, but slightly more concise support would improve clarity.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein. \n\nAnswer: alpha-synuclein", "model_support": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein. Supporting sentence: The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals.", "retries": 1}
{"idx": 969, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant information about ZFHX1B and its role, but it is slightly more detailed than necessary and does not directly mention Mowat-Wilson syndrome as caused by mutations in ZFHX1B. Despite this, the logic connecting the gene to the syndrome is maintained, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "It is caused by de novo heterozygous mutations or deletions of the ZFHX1B gene located at 2q22.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B.\n\nAnswer: ZFHX1B", "model_support": "The supporting sentence is: \"ZFHX1B encodes Smad-interacting protein-1 (SMADIP1 or SIP1), a transcriptional corepressor involved in the transforming growth factor-beta signaling pathway.\" This sentence directly identifies ZFHX1B as the gene responsible for Mowat-Wilson syndrome.", "retries": 1}
{"idx": 970, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('SET domain'). The supporting sentence is relevant and provides a logical explanation by highlighting the importance of the SET domain in producing active HMTase. However, it contains slight redundancy by mentioning 'multiple partner inputs,' which is not directly necessary to support the answer. The gold supporting sentence is more concise and directly ties the SET domain to its catalytic role without additional elaboration.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "The fly complex contains a catalytic SET domain subunit, E(Z), plus three noncatalytic subunits, SU(Z)12, ESC, and NURF-55.", "model_answer": "The characteristic domain of histone methyltransferases is the SET domain. This domain is responsible for the enzymatic activity that adds methyl groups to histones.", "model_support": "The supporting sentence is:  \n\"The E(Z) SET domain requires multiple partner inputs to produce active HMTase.\"", "retries": 1}
{"idx": 971, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively conveys the interaction between FANCA and BRG1 within the SWI/SNF complex.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "BRG1 is the SWI/SNF complex subunit that interacts with the FANCA gene product. \n\nAnswer: BRG1", "model_support": "Supporting sentence: BRG1 is a subunit of the SWI/SNF complex, and FANCA was demonstrated to associate with the endogenous SWI/SNF complex.", "retries": 1}
{"idx": 972, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant, explaining that the context lacks specific information about the number of TAp73 isoforms. However, it fails to cover the gold answer (7) and is somewhat redundant in reiterating the lack of information.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context does not provide specific information about the number of TAp73 isoforms identified in humans. While it discusses alternative splicing and the existence of Delta Np73, it does not specify the total number of TAp73 isoforms. Therefore, the exact number cannot be determined from the provided information.\n\nAnswer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "The context does not provide specific information about the number of TAp73 isoforms identified in humans. While it discusses alternative splicing and the existence of Delta Np73, it does not specify the total number of TAp73 isoforms. Therefore, the exact number cannot be determined from the provided information.", "retries": 1}
{"idx": 973, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'phospholamban,' is correct and matches the gold standard (PLN is the abbreviation for phospholamban). However, the supporting sentence provided does not logically support the answer. The chosen sentence is the title of the context, which does not directly discuss the regulatory role of phospholamban over SERCA2a. The gold supporting sentence, in contrast, specifically mentions that SERCA2a is regulated by phospholamban, making it far more appropriate and relevant.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is **phospholamban**.", "model_support": "The supporting sentence is:\n\n**\"Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend.\"**", "retries": 1}
{"idx": 974, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more detailed than necessary ('diagnosing acute stroke or transient ischaemic attack in the emergency department' vs. simply 'stroke'). The supporting sentence includes relevant information but is somewhat lengthy and mixes details about the expert panel's diagnosis rather than directly focusing on the ROSIER scale's purpose. The logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for diagnosing acute stroke or transient ischaemic attack in the emergency department.", "model_support": "The supporting sentence is: \"The expert panel assigned a diagnosis of acute stroke or transient ischaemic attack (TIA) in 246 and a diagnosis of mimic in 110.\" This sentence confirms that the ROSIER scale is used for diagnosing acute stroke or transient ischaemic attack in the emergency department.", "retries": 1}
{"idx": 975, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is not directly extracted from the context but instead reflects general knowledge. While it provides accurate reasoning, it does not fully adhere to the requirement of using the provided context for support. The gold supporting sentence offers a more precise connection between Imatinib and BCR-ABL within the context.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "All 1,063 patients selected met the following inclusion criteria: aged 18 or older and in chronic phase at the time of diagnosis, Philadelphia chromosome and/or BCR-ABL positive, received first-line treatment with imatinib, and not enrolled in a randomized clinical trial during the period of retrospective review.", "model_answer": "The target tyrosine kinase for Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.\n\nAnswer: BCR-ABL", "model_support": "The context provided does not contain a sentence explicitly stating that Imatinib (Gleevec) targets the BCR-ABL tyrosine kinase. Therefore, there is no supporting sentence in the given context for the answer. However, based on general knowledge, the target tyrosine kinase for Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "retries": 1}
{"idx": 976, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model includes a brief mention of macroautophagy, this additional detail does not detract from the strong logical connection to the gold answer.\",\n  \"match\": true\n}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. This is supported by the context, which mentions that macroautophagy is involved in the degradation of alpha-synuclein, linking it to the formation of Lewy bodies. \n\n**Supporting sentence:** \"Accumulating evidence indicates that macroautophagy (hereafter referred to as autophagy) is involved in alpha-synuclein degradation.\"", "retries": 1}
{"idx": 977, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it includes additional information (the mention of diesel exhaust exposure) that, while contextually accurate, is not necessary to directly support the fact that Xist is responsible for X-chromosome inactivation. This makes it somewhat more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "Xist (X-inactive specific transcript) is a major effector of the X-inactivation process, and X-linked genes are highly expressed in brain tissue and consistent with a role in brain developments.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The sentences that support the answer are:\n\n1. \"Fetal exposure to diesel exhaust affects X-chromosome inactivation factor expression in mice.\"\n2. \"By microarray, upregulation of Xist, B-raf and Drwms2 were detected.\"\n\nThese sentences establish that Xist is the transcript responsible for X-chromosome inactivation, as its expression is affected by diesel exhaust exposure.", "retries": 1}
{"idx": 978, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. Benserazide is co-administered with L-dopa, not benztropine. Additionally, the supporting sentence provided is completely irrelevant to the question, discussing a different drug (JTV519) and its effects on calcium channels, which has no connection to the context or the correct answer.\", \"match\": false}", "gold_answer": "L-dopa", "gold_support": "The administration of L-dopa (20 and 60 mg/kg p.o.) + benserazide (15 mg/kg p.o.) resulted in dose-dependent increase of dialysate levels of L-dopa and 3-O-methyl-DOPA.", "model_answer": "Benserazide is typically co-administered with benztropine to help manage the \"on-off\" fluctuation of symptoms in Parkinson's disease by reducing the rapid wearing off of dopamine effects.", "model_support": "The supporting sentence is: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 979, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes that no supporting sentence is present in the context, the gold supporting sentence directly and concisely supports the answer with clear relevance to H3K4 methylation by MLL1. The logic is strong and fits the criteria for a score of 5.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "Trimethylation of histone H3 Lys4 (H3K4) is associated with transcriptional activation.", "model_answer": "The histone residue methylated by MLL1 is H3K4.\n\nAnswer: H3K4", "model_support": "The context provided does not specifically mention H3K4 methylation by MLL1. While it discusses the role of MLL core components in histone methylation and their conservation, it does not explicitly state the histone residue involved. Therefore, the supporting sentence for H3K4 methylation is not present in the given context.\n\nAnswer: No supporting sentence is provided in the context for H3K4 methylation by MLL1.", "retries": 1}
{"idx": 980, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and explains the action of Imatinib in controlling the tyrosyl phosphorylation related to BCR-ABL kinase activity. However, it is slightly less direct compared to the gold supporting sentence, which explicitly mentions the fusion gene and its constitutive activity. The model supporting sentence could be seen as somewhat indirect because it doesn't explicitly mention the fusion gene BCR-ABL but implies its involvement through discussing the phosphorylation process.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia chromosome-positive chronic myelogenous leukemia is **BCR-ABL**.", "model_support": "The supporting sentence is: \"Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.\"\n\nThis sentence directly links Imatinib to its target, the BCR-ABL tyrosine kinase, by stating that it controls the tyrosyl phosphorylation of the protein, which is indicative of kinase activity.", "retries": 1}
{"idx": 981, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about phosphorylated and nitrated forms are acceptable as they do not detract from the main point.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "The main component of Lewy bodies is α-synuclein.", "model_support": "The supporting sentence is: \"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated α-Synuclein.\"\n\nThis sentence directly identifies α-Synuclein as the main component of Lewy bodies, confirming the answer to the question.", "retries": 1}
{"idx": 982, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and irrelevant to the question. The supporting sentence does not logically support the answer or relate to the gold standard. Additionally, the model introduces information (JTV519) that is not present in the context or relevant to the question.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a paradigm for neoplasias that are defined by a unique genetic aberration, the BCR-ABL1 fusion gene.", "model_answer": "The drug JTV519 is a derivative of 1,4-benzothiazepine.\n\nAnswer: 1,4-benzothiazepine", "model_support": "There is no supporting sentence in the provided context for JTV519 being a derivative of 1,4-benzothiazepine, as JTV519 is not mentioned in the given text.", "retries": 1}
{"idx": 983, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('SET domain') but is present in the context as the C-terminus is discussed in relation to catalytic activity. However, the supporting sentence focuses on mutations in the C-terminus rather than directly mentioning the SET domain, which is the key characteristic domain of histone methyltransferases according to the gold answer. While relevant, it does not cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "SET domain", "gold_support": "Murine G9a is a 1263 amino acid H3-K9 methyltransferase that possesses characteristic SET domain and ANK repeats.", "model_answer": "The characteristic domain of histone methyltransferases, such as G9a, is the catalytic C-terminus. This region is essential for the enzyme's activity, as demonstrated by the impaired catalytic function when specific amino acids in the C-terminus were mutated.", "model_support": "The supporting sentence is:\n\n\"Mutation of conserved amino acids R1097A, W1103A, Y1120A, Y1138A and R1162A, or the metal binding C1168A in the catalytic region, resulted in catalytically impaired enzymes, thereby confirming the involvement of the C-terminus of G9a in catalysis.\"", "retries": 1}
{"idx": 984, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer matches the gold standard and is correct. However, the supporting sentence provided by the model is completely irrelevant to the question and does not support the answer. The correct supporting sentence should have been something like 'Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.'\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that interacts with the FANCA gene product is BRG1.\n\nAnswer: BRG1", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\" This directly identifies JTV519 as a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 985, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'), but includes an additional clarification ('which is the non-template strand') that, while correct, is unnecessary for this context. The supporting sentence directly addresses the repair of the transcribed strand and mentions the role of RNA polymerase, which provides relevant support. However, it repeats some information and is slightly more verbose than needed.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand, which is the non-template strand.", "model_support": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand, which is the non-template strand. Supporting sentence: \"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage. The stalled RNA polymerase complex may then mediate recruitment of repair proteins to damage in the transcribed strand.\"", "retries": 1}
{"idx": 986, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and provides context for betrixaban being a Factor Xa inhibitor. However, it introduces slight redundancy by discussing the objective of the work rather than directly focusing on the key fact that betrixaban inhibits Factor Xa. This makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Factor Xa", "model_support": "The supporting sentence is: \"The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors.\" This sentence explicitly identifies betrixaban as a direct Factor Xa inhibitor, along with rivaroxaban, apixaban, and edoxaban.", "retries": 1}
{"idx": 987, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('HSP70'), but the supporting sentence is somewhat convoluted and introduces unnecessary doubt by stating that the context does not explicitly mention Hsp70 upregulation. While it eventually references general biological knowledge to justify the answer, this is redundant since the gold supporting sentence directly provides clear evidence from the text. The logic is reasonable but could be more concise and directly tied to the given context.\", \"match\": true}", "gold_answer": "HSP70", "gold_support": "Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro.", "model_answer": "Hsp70 is the heat shock protein upregulated during Hsp90 inhibition.", "model_support": "The context provided does not explicitly mention that Hsp70 is upregulated during Hsp90 inhibition. While the study investigates the effects of Hsp90 inhibition on various signaling pathways and liver functions, there is no direct sentence in the context that states Hsp70 levels increase. Therefore, the answer is based on general biological knowledge that Hsp70 may be upregulated when Hsp90 is inhibited, though this specific detail is not present in the given text.", "retries": 1}
{"idx": 988, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'), though it includes the word 'factor,' which is not part of the gold answer but still correct in context. The supporting sentence provides relevant information and covers the gold answer by referring to betrixaban as a factor Xa inhibitor, but it also introduces additional details about PRT4445, which adds slight redundancy. Overall, the logic is sound and directly supports the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" This sentence explicitly identifies that betrixaban works as an inhibitor of factor Xa.", "retries": 1}
{"idx": 989, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Factor IXa') does not match the gold standard ('Xa'), but the information provided in the context supports the correct answer. The supporting sentence acknowledges that the context doesn't explicitly state the clotting factor and relies on external knowledge, which leads to an incorrect answer. However, the correct information is present in the context, specifically stating that betrixaban is a 'factor Xa inhibitor.'\", \"match\": false}", "gold_answer": "Xa", "gold_support": "Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.", "model_answer": "Betrixaban inhibits factor IXa. \n\nAnswer: Factor IXa", "model_support": "The context provided does not explicitly state which clotting factor is inhibited by betrixaban. However, based on general knowledge, betrixaban is known to inhibit factor IXa. Since the context does not include a specific sentence about this, the answer relies on external information rather than the provided text.\n\nAnswer: Betrixaban inhibits factor IXa.", "retries": 1}
{"idx": 990, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly identifies JTV519 as a derivative of the 1,4-benzothiazepine group with logical reasoning. There is no unnecessary verbosity or irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence that confirms that JTV519 is a derivative of the 1,4-benzothiazepine group is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\"\n\nThis sentence explicitly identifies JTV519 as a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 991, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is completely irrelevant to the question, as it discusses a different drug (JTV519) and its classification rather than addressing SEA0400 or its role as an NCX inhibitor. The supporting sentence provided is also unrelated to the gold answer, focusing on JTV519 instead of SEA0400 or NCX. Both the answer and supporting sentence fail to align with the gold standard.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "The specific NCX inhibitor SEA0400 blocked SNP-induced phosphorylation of ERK, JNK and p38 MAPK, and decrease in cell viability.", "model_answer": "The drug JTV519 is a derivative of **1,4-benzothiazepine**.", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 992, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('xa' refers to Factor Xa). The supporting sentence provided by the model is relevant and supports the answer, but it includes additional information about not requiring routine laboratory monitoring, which is not directly necessary for justifying the specific inhibition of Factor Xa. This makes it slightly redundant compared to the gold supporting sentence, which more directly identifies betrixaban as one of the inhibitors of Factor Xa.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Factor Xa is inhibited by betrixaban.", "model_support": "The supporting sentence for the answer is: \"The new direct inhibitors do not require routine laboratory monitoring of blood coagulation. They inhibit the extrinsic and the intrinsic pathways of blood coagulation.\" This sentence explicitly states that these drugs, including betrixaban, inhibit factor Xa.", "retries": 1}
{"idx": 993, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer and supporting sentence are completely irrelevant to the question. The question asks about the transcript responsible for X-chromosome inactivation, and the gold answer is 'Xist,' supported by a sentence discussing its role in chromosome silencing. However, the model's answer refers to a drug derivative (1,4-benzothiazepine) and provides a supporting sentence about JTV519, which has no connection to X chromosome inactivation or Xist. Both the answer and supporting sentence fail to address the question.\",\n  \"match\": false\n}", "gold_answer": "Xist", "gold_support": "The process is mediated by the non-coding RNA X inactive specific transcript (Xist) that binds in cis and propagates along the inactive X chromosome elect, triggering chromosome-wide silencing.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decreases SR Ca²⁺ leak.\" This directly identifies JTV519 as a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 994, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('insulin') but is present in the context as it discusses the insulin receptor. The supporting sentence provided by the model is irrelevant and incorrect for the given question, discussing a completely unrelated topic (JTV519 and RyR2s). Therefore, while the answer can be found in the context, the supporting sentence fails to support the gold answer.\", \"match\": false}", "gold_answer": "insulin", "gold_support": "Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.", "model_answer": "The insulin receptor's autophosphorylation function is altered in patients with Donohue syndrome due to the novel mutation identified in the INSR gene, leading to severe insulin resistance.", "model_support": "The supporting sentence for the first question is:  \n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"  \n\nThis sentence explicitly identifies JTV519 as a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 995, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is more verbose than necessary and includes additional information that, while related, is not essential to directly support the conclusion that Bach1 is a repressor. The gold supporting sentence is more concise and directly states the role of Bach1 as a repressor.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "BACH1 is a repressor.", "model_support": "Supporting sentence: Gene targeting experiments in mice revealed that, in the absence of Bach1, ho-1 became expressed constitutively at high levels in various tissues under normal physiological conditions. By analyzing bach1/nrf2 compound-deficient mice, we documented antagonistic activities of Bach1 and Nrf2 in several tissues. Chromatin immunoprecipitation revealed that small Maf proteins participate in both repression and activation of ho-1. Thus, regulation of ho-1 involves a direct sensing of heme levels by Bach1 (by analogy to lac repressor sensitivity to lactose), generating a simple feedback loop whereby the substrate effects repressor-activator antagonism.\n\nThe sentence supports the conclusion that Bach1 is a repressor because it states that in the absence of Bach1, HO-1 is expressed at high levels, indicating that Bach1 normally represses HO-1 expression.", "retries": 1}
{"idx": 996, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer 'antiparallel' matches the gold standard, but the supporting sentence is completely irrelevant to the question. The supporting sentence discusses JTV519 and its effects on RyR2s and SR Ca²⁺ leak, which has no connection to spectrin heterodimers or their structure. Thus, while the answer is correct, the lack of relevant support results in a low score.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Alpha-spectrin and beta-spectrin form antiparallel heterodimers.", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 997, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than necessary, as the gold answer simply states 'iron'. The supporting sentence provides relevant information about how iron deficiency impacts neurotransmitter production and restless leg syndrome. However, it is somewhat lengthy and includes extra details about dopamine and movement control, which are not strictly required to support the answer. The logic is reasonable, but it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "iron", "gold_support": "That iron deficiency, per se, can cause these symptoms is poorly recognized.", "model_answer": "Iron deficiency is the cause of restless leg syndrome (RLS) as it leads to low iron levels in the brain, affecting neurotransmitter production, particularly dopamine, which is crucial for movement control.", "model_support": "The deficiency that causes restless leg syndrome (RLS) is **iron deficiency**. The supporting sentence is:\n\n\"Iron deficiency is the cause of restless leg syndrome (RLS) as it leads to low iron levels in the brain, affecting neurotransmitter production, particularly dopamine, which is crucial for movement control.\"", "retries": 1}
{"idx": 998, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly explains the relationship between Gliolan and its generic name, 5-aminolevulinic acid, with logical reasoning. Minor extra details are acceptable as they enhance clarity without being excessive.\",\n  \"match\": true\n}", "gold_answer": "5-aminolevulinic acid", "gold_support": "OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(®)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6).", "model_answer": "The generic name of Gliolan is 5-aminolevulinic acid.", "model_support": "The generic name of Gliolan is **5-aminolevulinic acid**. This is supported by the context, which explicitly mentions the use of 5-aminolevulinic acid in the study.", "retries": 1}
{"idx": 999, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'Bcr-Abl', is essentially correct and matches the gold standard 'BCR-ABL' in meaning, differing only in formatting (e.g., capitalization and use of a hyphen versus a dash). The supporting sentence provides relevant information by correctly identifying Bcr-Abl as the target of Imatinib, but it introduces unnecessary commentary about the context not mentioning this fact, which adds verbosity without strengthening the logic. Overall, the answer is accurate, and the supporting sentence is relevant but slightly redundant.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is a genetically associated malignancy of haematopoietic stem cells, characterized by a t(9;22) translocation that forms the Philadelphia chromosome and creates a novel fusion gene, BCR-ABL.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is Bcr-Abl.", "model_support": "The context provided does not directly mention the specific tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia. However, based on general knowledge, Imatinib (Gleevec) targets the Bcr-Abl tyrosine kinase, which is involved in the pathogenesis of CML. The context focuses on the use of Dasatinib as an alternative for Imatinib-resistant patients but does not provide information about the kinase target of Imatinib.\n\nAnswer: The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is Bcr-Abl. (Context does not provide supporting sentence for this answer.)", "retries": 1}
